data_1ggr_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ggr _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.217 -0.633 0 CA-C-O 122.405 1.098 . . . . 0.14999999999999999 112.795 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.724 ' HB ' ' CG1' ' A' ' 166' ' ' ILE . 2.3 mp -105.93 130.77 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.023 0 CA-C-O 122.637 1.208 . . . . 0.14000000000000001 110.744 177.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -100.49 124.86 46.59 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.225 -1.352 . . . . 0.12 110.302 176.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.4 mm -94.79 123.4 46.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 105.961 -1.866 . . . . 0.089999999999999997 105.961 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.1 mm -92.11 146.77 5.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 CA-C-O 122.553 1.168 . . . . 0.10000000000000001 111.839 -178.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.68 121.14 51.52 Favored Pre-proline 0 N--CA 1.429 -1.504 0 N-CA-C 115.336 1.606 . . . . 0.059999999999999998 115.336 -178.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -76.16 -19.99 15.04 Favored 'Trans proline' 0 CA--C 1.558 1.709 0 C-N-CA 121.488 1.458 . . . . 0.040000000000000001 111.386 -177.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . 0.324 0.0 OUTLIER -147.44 161.22 41.48 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 123.82 0.848 . . . . 0.059999999999999998 110.185 175.253 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.9 m -82.6 148.13 28.18 Favored 'General case' 0 CA--C 1.498 -1.023 0 CA-C-O 121.709 0.766 . . . . 0.089999999999999997 111.11 177.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 156.84 -155.38 26.31 Favored Glycine 0 N--CA 1.431 -1.682 0 C-N-CA 119.078 -1.534 . . . . 0.089999999999999997 111.003 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.04 134.82 54.27 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 114.002 -1.099 . . . . 0.12 110.156 -177.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.0 mt -74.41 141.5 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 C-N-CA 117.621 -1.632 . . . . 0.089999999999999997 110.333 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.4 t -132.64 155.94 41.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 114.496 -1.229 . . . . 0.11 108.714 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.478 ' HB3' ' OE2' ' A' ' 34' ' ' GLU . 13.6 m120 -71.51 138.37 48.86 Favored 'General case' 0 CA--C 1.497 -1.076 0 CA-C-O 121.477 0.656 . . . . 0.11 111.064 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.422 ' CD1' ' CG1' ' A' ' 139' ' ' VAL . 8.2 tt -67.84 -23.67 29.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 C-N-CA 118.678 -1.209 . . . . 0.12 108.659 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.478 ' OE2' ' HB3' ' A' ' 32' ' ' ASN . 0.8 OUTLIER -73.91 -14.08 61.0 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 118.649 -1.22 . . . . 0.14000000000000001 110.589 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -95.0 12.48 28.29 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 113.694 0.998 . . . . 0.14000000000000001 113.694 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 t -86.5 130.99 47.16 Favored Pre-proline 0 C--N 1.289 -2.045 0 CA-C-O 120.955 0.407 . . . . 0.14999999999999999 109.921 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -70.49 48.01 0.72 Allowed 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 122.695 2.264 . . . . 0.17000000000000001 111.758 -173.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.536 ' CG ' HH21 ' B' ' 317' ' ' ARG . 62.6 t0 -150.68 115.82 5.34 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.662 -1.236 . . . . 0.22 107.662 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.9 m -60.4 -37.81 75.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 C-N-CA 119.016 -1.074 . . . . 1.05 111.601 -178.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . 0.406 16.1 m -62.46 -34.8 66.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 116.907 -1.917 . . . . 1.0700000000000001 112.174 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -84.25 -44.32 13.99 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 120.21 -1.556 . . . . 0.23000000000000001 109.822 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.51 -36.2 77.79 Favored 'General case' 0 CA--C 1.487 -1.461 0 N-CA-C 108.946 -0.761 . . . . 0.16 108.946 -177.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -91.06 7.78 38.73 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 118.219 -1.393 . . . . 0.81000000000000005 110.579 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.515 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 0.3 OUTLIER 52.37 39.82 28.19 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 113.943 1.09 . . . . 0.14999999999999999 113.943 176.665 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.0 mm -67.14 -30.44 49.38 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.963 0 CA-C-O 123.717 1.723 . . . . 1.05 110.676 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.293 2.3 t -89.48 -7.71 10.82 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.916 0 CA-C-N 112.366 -2.197 . . . . 1.25 111.81 -175.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.515 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . 133.45 -175.57 20.12 Favored Glycine 0 C--O 1.207 -1.574 0 N-CA-C 108.773 -1.731 . . . . 0.13 108.773 176.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -119.52 155.39 32.24 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 117.835 -1.546 . . . . 0.12 112.797 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 172.22 -137.68 4.39 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 117.703 -2.189 . . . . 0.089999999999999997 111.178 177.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 pp -135.05 175.21 11.53 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.695 0 O-C-N 121.579 -0.954 . . . . 0.070000000000000007 108.596 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -121.58 158.52 28.38 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 124.7 1.2 . . . . 0.080000000000000002 108.428 175.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.3 mt -133.36 128.87 55.85 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.84 0 O-C-N 121.595 -0.691 . . . . 0.070000000000000007 111.005 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -86.23 108.88 19.21 Favored Pre-proline 0 C--N 1.308 -1.224 0 N-CA-C 101.46 -3.533 . . . . 0.14000000000000001 101.46 174.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -71.26 150.1 58.5 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 123.735 2.956 . . . . 0.10000000000000001 113.064 -170.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.7 p -138.66 1.68 2.14 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 121.746 -0.596 . . . . 0.12 110.16 177.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -108.81 -144.48 10.85 Favored Glycine 0 CA--C 1.534 1.268 0 O-C-N 121.485 -0.759 . . . . 0.10000000000000001 114.573 -177.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -142.97 14.52 1.89 Allowed 'General case' 0 CA--C 1.492 -1.265 0 O-C-N 122.351 -0.499 . . . . 0.10000000000000001 112.068 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -157.3 155.12 30.16 Favored 'General case' 0 N--CA 1.415 -2.187 0 C-N-CA 115.405 -2.518 . . . . 0.089999999999999997 113.142 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -114.89 121.4 43.08 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.872 -1.058 . . . . 0.059999999999999998 109.077 178.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 m -114.13 174.58 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.8 0 CA-C-O 122.733 1.254 . . . . 0.070000000000000007 110.998 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.13 126.64 92.89 Favored Pre-proline 0 C--N 1.289 -2.058 0 CA-C-N 113.705 -1.589 . . . . 0.080000000000000002 109.729 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -85.84 -1.52 8.83 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 CA-C-N 120.027 1.045 . . . . 0.070000000000000007 110.439 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.2 m -158.49 164.95 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-O 121.493 0.663 . . . . 0.10000000000000001 111.185 -178.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 115' ' ' VAL . 48.5 m-20 -81.45 127.19 32.54 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 103.558 -2.756 . . . . 0.13 103.558 174.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 80' ' ' GLU . . . 174.0 -157.82 26.15 Favored Glycine 0 C--N 1.301 -1.395 0 N-CA-C 110.753 -0.939 . . . . 0.13 110.753 -175.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.0 m -123.71 134.85 53.64 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 119.854 -0.739 . . . . 0.14999999999999999 111.316 -177.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.7 mm -68.79 140.42 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.028 0 C-N-CA 117.626 -1.629 . . . . 0.13 107.365 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -101.7 -64.25 0.76 Allowed Glycine 0 C--N 1.282 -2.471 0 CA-C-O 122.029 0.794 . . . . 0.13 114.332 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.445 ' H ' ' HB2' ' A' ' 78' ' ' SER . 2.3 tmtp? -141.4 136.43 31.39 Favored 'General case' 0 C--N 1.279 -2.497 0 CA-C-O 123.053 1.406 . . . . 2.6600000000000001 111.954 -177.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 75.5 mt -116.19 125.45 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 105.532 -2.025 . . . . 0.12 105.532 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -62.65 145.41 54.64 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.172 -1.047 . . . . 0.28000000000000003 108.172 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -61.87 -14.91 38.15 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 123.67 0.788 . . . . 0.40000000000000002 110.454 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.514 ' OG1' ' ND1' ' A' ' 75' ' ' HIS . 41.4 p -97.7 5.03 49.83 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 123.618 1.675 . . . . 1.03 109.055 178.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.762 ' ND2' HH21 ' A' ' 105' ' ' ARG . 23.5 m120 50.41 44.39 26.82 Favored 'General case' 0 C--N 1.26 -3.292 0 CA-C-N 113.24 -1.8 . . . . 0.11 112.608 175.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.514 ' ND1' ' OG1' ' A' ' 73' ' ' THR . 23.7 p-80 -126.38 -1.55 6.91 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 113.652 0.982 . . . . 0.27000000000000002 113.652 -177.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.31 152.69 31.42 Favored 'General case' 0 N--CA 1.411 -2.388 0 O-C-N 120.79 -1.193 . . . . 0.10000000000000001 111.122 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -152.49 166.36 32.23 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 123.077 1.418 . . . . 0.089999999999999997 113.276 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.445 ' HB2' ' H ' ' A' ' 69' ' ' LYS 0.26 15.8 m -118.34 139.74 50.9 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 113.302 -1.772 . . . . 0.12 109.789 -178.877 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.6 tt -143.3 150.0 17.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 107.607 -1.257 . . . . 0.11 107.607 175.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.476 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 84.6 tt0 -118.37 129.89 55.68 Favored 'General case' 0 C--O 1.201 -1.483 0 N-CA-C 105.647 -1.983 . . . . 0.83999999999999997 105.647 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 93.9 p -80.9 167.31 20.02 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 118.441 -1.304 . . . . 0.14000000000000001 108.264 -176.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.406 ' C ' ' H ' ' A' ' 84' ' ' GLY . 83.0 m-20 -68.13 -31.06 70.39 Favored 'General case' 0 C--N 1.276 -2.6 0 C-N-CA 118.572 -1.251 . . . . 0.16 108.232 177.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.16 4.46 2.17 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 125.26 1.424 . . . . 0.16 112.053 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 78.68 14.48 82.03 Favored Glycine 0 C--N 1.28 -2.57 0 N-CA-C 117.386 1.715 . . . . 0.16 117.386 -178.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.422 HG22 ' CD1' ' A' ' 166' ' ' ILE . 48.8 t -92.35 133.0 35.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 121.202 2.501 . . . . 0.13 110.863 177.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.422 ' OE1' ' CB ' ' B' ' 348' ' ' PHE . 97.3 mt-10 -96.97 121.97 39.44 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 121.643 -0.661 . . . . 1.7 110.207 176.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -116.32 158.79 22.87 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 122.001 0.905 . . . . 0.10000000000000001 110.851 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -143.65 111.87 6.28 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 122.989 1.376 . . . . 0.22 109.77 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.1 t -101.7 115.56 43.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 114.046 -1.434 . . . . 0.070000000000000007 111.464 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.415 ' O ' ' HD2' ' A' ' 137' ' ' PRO . 18.4 t-80 -123.2 105.1 9.6 Favored 'General case' 0 C--O 1.2 -1.531 0 CA-C-N 115.549 -0.751 . . . . 0.23999999999999999 111.086 -178.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -63.63 124.14 20.64 Favored 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 116.665 2.098 . . . . 0.10000000000000001 116.665 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.35 -175.88 32.07 Favored Glycine 0 C--O 1.215 -1.093 0 CA-C-O 122.572 1.096 . . . . 0.11 114.526 175.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 49.0 mm -118.0 132.59 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-O 123.151 1.453 . . . . 0.14999999999999999 109.2 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 54.65 25.84 6.83 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 114.089 -1.414 . . . . 0.17999999999999999 111.246 -177.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.3 p -64.44 -19.9 65.83 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 115.437 1.643 . . . . 0.14000000000000001 115.437 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.3 p -57.06 -32.82 41.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 O-C-N 120.125 -1.609 . . . . 1.04 109.321 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -58.56 -20.07 43.53 Favored 'General case' 0 CA--C 1.566 1.594 0 C-N-CA 119.91 -0.716 . . . . 0.23999999999999999 112.098 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mp -78.19 -3.24 41.61 Favored 'General case' 0 CA--C 1.564 1.488 0 O-C-N 119.716 -1.865 . . . . 0.17000000000000001 113.86 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? 48.91 46.21 22.22 Favored 'General case' 0 C--N 1.278 -2.525 0 N-CA-C 116.077 1.88 . . . . 3.6099999999999999 116.077 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 90.76 -13.3 66.19 Favored Glycine 0 CA--C 1.542 1.77 0 N-CA-C 115.433 0.933 . . . . 0.13 115.433 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.04 121.21 12.45 Favored 'General case' 0 C--N 1.283 -2.284 0 O-C-N 121.296 -1.12 . . . . 0.16 112.016 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 122' ' ' PHE . . . 97.71 -7.03 63.01 Favored Glycine 0 C--O 1.201 -1.926 0 N-CA-C 114.87 0.708 . . . . 0.12 114.87 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -115.73 152.28 33.52 Favored 'General case' 0 C--N 1.283 -2.298 0 C-N-CA 124.117 0.967 . . . . 0.11 111.012 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.517 ' NZ ' ' O ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -141.92 113.47 7.77 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 124.597 1.159 . . . . 0.10000000000000001 109.235 176.83 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.762 HH21 ' ND2' ' A' ' 74' ' ' ASN . 4.9 ttm180 -67.32 123.56 20.68 Favored 'General case' 0 CA--C 1.462 -2.439 0 C-N-CA 120.403 -0.519 . . . . 0.12 109.924 178.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.0 mm -106.27 -35.02 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.256 0 C-N-CA 114.991 -2.684 . . . . 0.089999999999999997 108.1 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.16 178.23 5.61 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 118.675 -1.21 . . . . 0.10000000000000001 112.187 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -118.3 151.52 37.53 Favored 'General case' 0 C--O 1.213 -0.861 0 N-CA-C 112.582 0.586 . . . . 0.14000000000000001 112.582 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -60.92 137.2 58.23 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 118.559 -1.256 . . . . 1.6000000000000001 107.967 175.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.36 -5.27 84.16 Favored Glycine 0 N--CA 1.475 1.272 0 N-CA-C 111.622 -0.591 . . . . 0.14999999999999999 111.622 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -65.76 138.03 57.66 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-O 122.899 1.333 . . . . 0.13 112.888 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.511 ' CG ' HH11 ' A' ' 112' ' ' ARG . 0.0 OUTLIER -86.25 132.7 33.93 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-N 114.111 -1.404 . . . . 0.17999999999999999 107.297 175.64 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.7 m -139.93 160.35 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.04 0 C-N-CA 117.458 -1.697 . . . . 0.12 113.02 -176.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.469 ' HE3' ' OD2' ' A' ' 117' ' ' ASP . 0.5 OUTLIER -110.78 156.73 20.66 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 111.88 -2.418 . . . . 0.14999999999999999 108.398 174.671 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.422 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 44.2 t -45.73 135.73 2.12 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 CA-C-O 121.593 0.711 . . . . 0.11 111.655 176.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.14 -12.98 64.62 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 120.853 -0.689 . . . . 0.089999999999999997 114.423 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.469 ' OD2' ' HE3' ' A' ' 114' ' ' LYS . 91.6 m-20 -63.08 136.35 57.74 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 120.926 -1.338 . . . . 0.11 109.812 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.5 m -76.7 132.4 39.31 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-O 122.951 1.358 . . . . 0.089999999999999997 111.084 -177.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.44 ' O ' HG13 ' A' ' 120' ' ' ILE . 44.8 t -105.86 -48.4 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.695 0 CA-C-N 113.42 -1.718 . . . . 0.070000000000000007 109.304 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 119' ' ' VAL . 10.9 mt -148.36 143.51 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.722 0 N-CA-C 114.077 1.139 . . . . 0.070000000000000007 114.077 -177.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.47 ' O ' ' HD2' ' A' ' 104' ' ' LYS . 49.5 mt-10 -112.28 147.41 36.35 Favored 'General case' 0 CA--C 1.484 -1.587 0 C-N-CA 116.685 -2.006 . . . . 0.089999999999999997 107.314 175.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.521 ' HA ' ' O ' ' A' ' 102' ' ' GLY . 36.0 p90 -132.9 163.6 28.79 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 122.059 0.933 . . . . 0.089999999999999997 111.609 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.438 ' OD1' ' HD2' ' A' ' 125' ' ' PRO . 10.3 t0 -100.42 97.84 8.53 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 124.758 1.223 . . . . 0.13 109.799 176.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.553 ' HB3' ' HD3' ' A' ' 125' ' ' PRO . 3.2 tp -59.28 -54.75 53.13 Favored Pre-proline 0 C--N 1.292 -1.913 0 N-CA-C 116.068 1.877 . . . . 0.13 116.068 -176.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' A' ' 124' ' ' LEU . 20.7 Cg_exo -56.9 -44.71 42.17 Favored 'Trans proline' 1 C--N 1.247 -4.812 0 C-N-CA 121.472 1.448 . . . . 0.16 109.698 -175.685 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.731 ' CD1' ' HG3' ' A' ' 130' ' ' LYS . 0.5 OUTLIER -57.17 -50.96 71.21 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.132 -0.692 . . . . 0.16 109.132 177.757 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.4 mt -68.45 -31.37 70.63 Favored 'General case' 0 C--N 1.281 -2.4 0 O-C-N 121.178 -0.951 . . . . 0.14000000000000001 112.068 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -65.16 -37.61 87.93 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 106.699 -1.593 . . . . 0.16 106.699 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -75.32 -42.27 54.91 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.205 -0.907 . . . . 0.20000000000000001 113.335 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.731 ' HG3' ' CD1' ' A' ' 126' ' ' LEU . 0.1 OUTLIER -94.77 -29.3 14.84 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 116.361 1.985 . . . . 0.20000000000000001 116.361 -175.817 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.54 142.93 36.99 Favored 'General case' 0 C--N 1.262 -3.229 0 N-CA-C 115.382 1.623 . . . . 0.16 115.382 -176.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.506 ' HD2' ' HA ' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -55.68 -37.78 68.78 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.428 -0.953 . . . . 0.20000000000000001 108.428 179.025 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.8 t -163.84 143.92 8.35 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 124.986 1.314 . . . . 0.14999999999999999 110.654 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 76.8 p -95.95 -0.6 50.52 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 114.784 -1.098 . . . . 0.13 110.539 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 17.0 mt -56.36 130.43 44.63 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.22 -1.4 . . . . 0.13 107.22 177.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 93.5 m -118.81 96.98 50.57 Favored Pre-proline 0 N--CA 1.431 -1.397 0 N-CA-C 118.121 2.638 . . . . 0.080000000000000002 118.121 -173.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.415 ' HD2' ' O ' ' A' ' 90' ' ' HIS . 8.3 Cg_exo -66.94 142.86 63.94 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 117.192 -1.406 . . . . 0.10000000000000001 114.406 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . 0.313 1.6 m -125.79 104.68 13.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 105.186 -2.153 . . . . 0.059999999999999998 105.186 173.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.422 ' CG1' ' CD1' ' A' ' 33' ' ' ILE . 16.3 m -123.49 158.84 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 N-CA-C 116.258 1.948 . . . . 0.10000000000000001 116.258 -176.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.8 mp -97.57 125.44 50.71 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.294 0 N-CA-C 104.591 -2.374 . . . . 0.12 104.591 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 53.3 p -98.35 -4.42 34.92 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 123.15 1.452 . . . . 0.14000000000000001 112.927 -175.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.431 ' O ' ' C ' ' A' ' 143' ' ' MET 0.483 0.0 OUTLIER -97.86 15.23 24.47 Favored 'General case' 0 C--N 1.258 -3.41 0 C-N-CA 130.114 3.366 . . . . 0.14999999999999999 114.442 -179.679 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.431 ' C ' ' O ' ' A' ' 142' ' ' ASN . 62.1 mmm -33.76 -45.0 0.17 Allowed 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 115.584 1.698 . . . . 0.14999999999999999 115.584 -174.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -64.1 -11.71 32.51 Favored 'General case' 0 C--N 1.252 -3.663 0 O-C-N 119.852 -1.78 . . . . 0.23999999999999999 113.105 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -106.03 12.71 30.11 Favored 'General case' 0 CA--C 1.479 -1.777 0 CA-C-N 121.18 1.809 . . . . 0.17999999999999999 111.546 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 2.5 pt -120.34 140.86 43.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 C-N-CA 115.979 -2.288 . . . . 0.14999999999999999 113.96 -177.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.638 ' HB2' ' HB3' ' A' ' 168' ' ' LYS 0.258 12.0 tptt -74.46 -54.77 6.9 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 114.496 -1.229 . . . . 0.19 109.786 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 166' ' ' ILE . 0.0 OUTLIER -147.33 145.57 29.38 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 123.729 1.728 . . . . 0.14000000000000001 114.017 177.053 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.65 112.35 21.97 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 111.077 -2.783 . . . . 0.11 109.866 177.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 61.9 mt -108.97 112.23 39.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 114.531 -1.213 . . . . 0.11 107.882 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 34.6 mttt -84.94 129.91 34.72 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 124.474 1.11 . . . . 0.10000000000000001 113.325 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.299 31.4 mt -94.48 175.74 6.56 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-O 122.688 1.233 . . . . 0.089999999999999997 112.315 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . 0.278 0.5 OUTLIER -131.11 160.43 34.75 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 113.51 -1.677 . . . . 0.10000000000000001 114.763 -174.341 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 100.26 -158.83 19.42 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 118.88 2.312 . . . . 0.10000000000000001 118.88 174.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.76 142.15 27.79 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 112.102 -2.049 . . . . 0.11 109.949 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 16.5 m -131.84 159.73 42.9 Favored 'Isoleucine or valine' 0 CA--C 1.459 -2.54 0 CA-C-O 122.834 1.302 . . . . 0.080000000000000002 110.032 -177.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 20.7 m -122.79 123.62 41.47 Favored 'General case' 0 C--N 1.274 -2.709 0 CA-C-N 112.702 -2.044 . . . . 0.11 108.24 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 12.1 p -37.23 123.64 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.63 0 CA-C-O 123.7 1.714 . . . . 0.080000000000000002 113.966 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 61.18 25.83 65.11 Favored Glycine 0 CA--C 1.488 -1.642 0 CA-C-N 112.837 -1.983 . . . . 0.10000000000000001 114.179 175.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.42 -53.26 0.72 Allowed 'General case' 0 C--N 1.287 -2.118 0 CA-C-O 121.929 0.871 . . . . 0.13 111.957 178.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 9.0 m -85.36 123.0 73.59 Favored Pre-proline 0 C--N 1.282 -2.346 0 N-CA-C 114.179 1.177 . . . . 0.10000000000000001 114.179 -175.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -62.5 141.5 86.75 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.003 2.469 . . . . 0.10000000000000001 109.719 177.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 28.6 m -116.65 -27.96 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 121.647 -0.658 . . . . 0.059999999999999998 112.217 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 30.3 mt -141.12 150.98 19.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 N-CA-C 108.527 -0.916 . . . . 0.080000000000000002 108.527 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 5.9 mtt180 -125.78 130.79 52.15 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 105.746 -1.946 . . . . 0.11 105.746 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.724 ' CG1' ' HB ' ' A' ' 20' ' ' ILE . 39.7 pt -128.35 155.6 40.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 C-N-CA 118.987 -1.085 . . . . 0.12 109.771 -178.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 168' ' ' LYS . 1.1 tttt -120.75 154.23 35.93 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.023 -0.732 . . . . 0.17000000000000001 109.023 176.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . 0.638 ' HB3' ' HB2' ' A' ' 147' ' ' LYS . 9.6 tttt . . . . . 0 C--N 1.322 -0.601 0 N-CA-C 108.887 -0.783 . . . . 0.19 108.887 -177.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 301' ' ' MET . . . . . 0.447 ' HB2' ' HG2' ' B' ' 366' ' ' GLU . 4.2 ttm . . . . . 0 C--O 1.218 -0.566 0 N-CA-C 108.459 -0.941 . . . . 0.20999999999999999 108.459 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 302' ' ' PHE . . . . . 0.493 ' CD2' ' HA ' ' B' ' 371' ' ' GLN . 74.6 t80 -142.88 140.93 31.42 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.181 -1.414 . . . . 0.17999999999999999 107.181 178.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -150.83 157.33 42.8 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.037 -1.039 . . . . 0.17000000000000001 109.46 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -153.2 147.6 25.92 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.001 -1.481 . . . . 0.16 107.001 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.92 152.02 19.15 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.319 -0.993 . . . . 0.16 108.319 178.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 7.3 p -149.68 144.29 17.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 107.35 -1.352 . . . . 0.14000000000000001 107.35 174.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 86.5 m -93.84 136.73 33.83 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 121.605 0.717 . . . . 0.17999999999999999 110.119 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 58.9 mt -85.75 114.13 25.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 104.572 -2.381 . . . . 0.16 104.572 177.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 61.1 p -106.45 -3.93 20.41 Favored 'General case' 0 N--CA 1.514 2.746 0 N-CA-C 114.545 1.313 . . . . 0.20999999999999999 114.545 -178.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.65 139.21 83.38 Favored Pre-proline 0 N--CA 1.487 1.422 0 CA-C-N 120.312 1.414 . . . . 0.20000000000000001 110.766 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -46.42 -44.96 19.92 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 123.033 2.488 . . . . 0.25 117.068 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -103.66 29.23 5.89 Favored 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 115.813 -2.355 . . . . 1.3400000000000001 107.127 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 59.52 -148.66 41.1 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 117.624 -2.226 . . . . 0.19 111.007 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 17.1 tp -87.11 74.1 9.69 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 118.331 -1.347 . . . . 0.14999999999999999 108.996 -177.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 315' ' ' HIS . . . . . 0.437 ' H ' ' CD2' ' B' ' 315' ' ' HIS . 7.7 p80 -69.27 -178.06 1.25 Allowed 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 118.667 -1.213 . . . . 0.97999999999999998 112.688 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 3.0 m -48.93 -60.26 2.9 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 118.842 2.904 . . . . 1.05 118.842 -174.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 317' ' ' ARG . . . . . 0.536 HH21 ' CG ' ' A' ' 38' ' ' ASP . 20.9 ttm180 -64.01 -44.19 77.31 Favored Pre-proline 0 C--N 1.282 -2.326 0 CA-C-N 122.599 2.454 . . . . 1.73 113.038 -176.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 318' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' B' ' 317' ' ' ARG . 10.5 Cg_endo -68.09 -28.92 34.22 Favored 'Trans proline' 0 C--N 1.296 -2.185 0 CA-C-N 121.171 1.454 . . . . 0.22 111.934 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -69.45 -35.37 75.57 Favored 'General case' 0 N--CA 1.508 2.473 0 O-C-N 120.836 -1.165 . . . . 0.14999999999999999 108.853 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -71.56 -39.35 70.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.805 -1.185 . . . . 0.17999999999999999 108.855 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -67.77 -36.0 79.7 Favored 'General case' 0 N--CA 1.501 2.093 0 C-N-CA 118.123 -1.431 . . . . 2.3500000000000001 108.714 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -64.28 -44.61 91.17 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.93 -1.106 . . . . 0.13 108.657 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.63 -40.42 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 CA-C-N 115.229 -0.896 . . . . 1.05 110.538 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -64.55 -41.05 96.58 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 120.809 -1.182 . . . . 1.6399999999999999 109.688 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -68.28 -40.16 81.93 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.58 -0.7 . . . . 0.17000000000000001 109.121 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.57 -42.32 92.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.893 -1.129 . . . . 0.14000000000000001 109.287 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -62.82 -15.04 52.55 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.136 -0.977 . . . . 1.9299999999999999 112.905 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -78.34 -11.23 85.53 Favored Glycine 0 N--CA 1.479 1.513 0 N-CA-C 108.847 -1.701 . . . . 0.19 108.847 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . 0.483 ' HE1' ' HE3' ' B' ' 372' ' ' LYS . 82.4 m-85 -103.91 145.08 30.65 Favored 'General case' 0 N--CA 1.506 2.355 0 CA-C-N 118.731 1.266 . . . . 0.17999999999999999 110.083 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 75.4 p -76.95 -28.78 55.32 Favored 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 118.609 -0.71 . . . . 0.23000000000000001 112.477 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 20.3 m -58.87 157.55 9.57 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-O 123.384 1.564 . . . . 0.19 114.893 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.53 128.48 33.42 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 102.25 -3.241 . . . . 0.20000000000000001 102.25 172.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 42.0 mt -125.78 133.98 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 108.18 -1.045 . . . . 0.14999999999999999 108.18 -175.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 97.5 m -124.61 140.64 52.75 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 122.204 1.002 . . . . 0.16 109.229 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 93.1 t -107.37 127.39 63.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 105.349 -2.093 . . . . 0.13 105.349 174.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 88.2 m -124.7 121.04 33.54 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.893 0.854 . . . . 0.17000000000000001 110.432 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 33.4 t -125.59 123.84 39.92 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 118.389 -1.324 . . . . 0.17000000000000001 108.154 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 49.78 40.09 19.49 Favored 'General case' 0 N--CA 1.514 2.747 0 N-CA-C 112.879 0.696 . . . . 0.23000000000000001 112.879 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 81.07 12.26 82.71 Favored Glycine 0 N--CA 1.485 1.961 0 O-C-N 120.442 -1.411 . . . . 0.20999999999999999 113.314 176.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -121.84 136.65 54.94 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 103.55 -2.759 . . . . 3.02 103.55 178.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 68.2 m -121.49 156.09 33.53 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-O 124.348 2.023 . . . . 0.19 115.04 -175.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -151.52 147.98 27.47 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 111.86 -2.427 . . . . 0.16 110.804 177.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 7.6 t -65.65 132.96 50.08 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 106.362 -1.718 . . . . 0.17000000000000001 106.362 173.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -73.46 -6.08 44.11 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.281 -1.512 . . . . 0.12 110.845 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -98.13 12.72 33.55 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.998 -1.064 . . . . 0.17999999999999999 109.224 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.2 105.67 6.77 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 123.146 1.45 . . . . 0.17000000000000001 110.544 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 26.6 tp -57.32 -37.64 72.82 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 113.948 -1.478 . . . . 1.0800000000000001 109.31 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 348' ' ' PHE . . . . . 0.422 ' CB ' ' OE1' ' A' ' 86' ' ' GLU . 67.1 t80 -61.06 -50.48 73.14 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 120.395 -1.44 . . . . 0.42999999999999999 113.018 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -69.51 -31.74 70.16 Favored 'General case' 0 C--N 1.313 -1.01 0 O-C-N 119.589 -1.944 . . . . 1.71 110.526 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 3.1 mt -65.35 -32.02 73.45 Favored 'General case' 0 C--N 1.284 -2.25 0 C-N-CA 119.19 -1.004 . . . . 0.14999999999999999 109.242 -177.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 351' ' ' GLN . . . . . 0.427 ' OE1' ' OG ' ' A' ' 78' ' ' SER . 89.7 mt-30 -68.14 -10.78 56.7 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.938 -0.476 . . . . 0.78000000000000003 109.816 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 2.7 p -91.86 -3.94 55.43 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.385 -1.326 . . . . 1.0 110.815 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 25.6 mt -94.72 157.04 16.13 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.255 -0.903 . . . . 0.17000000000000001 110.094 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -86.28 106.43 3.08 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 104.785 -3.326 . . . . 0.17000000000000001 104.785 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 91.2 mt -122.42 48.4 1.76 Allowed 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 106.133 -1.803 . . . . 0.14999999999999999 106.133 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 18.4 p -83.08 170.99 14.23 Favored 'General case' 0 C--O 1.215 -0.746 0 N-CA-C 109.363 -0.606 . . . . 1.05 109.363 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -57.72 138.48 55.44 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.178 -0.951 . . . . 0.23999999999999999 110.659 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 92.25 -3.15 75.88 Favored Glycine 0 N--CA 1.473 1.108 0 C-N-CA 119.431 -1.366 . . . . 0.19 112.627 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 55.0 m -84.77 132.89 34.38 Favored 'General case' 0 C--N 1.291 -1.966 0 O-C-N 121.497 -1.002 . . . . 0.17000000000000001 111.182 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 95.3 t -94.38 122.91 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 106.972 -1.492 . . . . 0.17000000000000001 106.972 177.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 17.8 m -112.71 161.3 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 C-N-CA 116.922 -1.911 . . . . 0.12 109.955 177.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 84.9 m -110.1 130.48 55.53 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 106.32 -1.733 . . . . 0.14000000000000001 106.32 175.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 54.3 mt -110.29 120.43 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 102.902 -2.999 . . . . 0.11 102.902 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.41 146.43 49.61 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.746 -1.205 . . . . 0.14999999999999999 107.746 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -141.09 153.7 45.57 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 117.549 -1.66 . . . . 0.17000000000000001 108.599 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 366' ' ' GLU . . . . . 0.447 ' HG2' ' HB2' ' B' ' 301' ' ' MET . 0.0 OUTLIER -141.81 111.94 6.88 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.002 -1.481 . . . . 0.23000000000000001 107.002 178.753 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 165.25 -173.45 41.03 Favored Glycine 0 C--N 1.295 -1.734 0 C-N-CA 117.672 -2.204 . . . . 0.22 108.649 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -54.86 -41.49 70.85 Favored 'General case' 0 C--N 1.286 -2.191 0 C-N-CA 124.134 0.974 . . . . 0.27000000000000002 113.24 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 15.1 p30 -116.05 36.75 3.91 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 116.966 -1.894 . . . . 0.20999999999999999 108.114 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -58.99 -30.34 67.89 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 118.961 2.949 . . . . 0.20000000000000001 118.961 -175.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 371' ' ' GLN . . . . . 0.493 ' HA ' ' CD2' ' B' ' 302' ' ' PHE . 0.0 OUTLIER -78.23 -43.43 28.39 Favored 'General case' 0 N--CA 1.513 2.696 0 O-C-N 119.721 -1.862 . . . . 0.22 109.743 -177.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 372' ' ' LYS . . . . . 0.656 ' HZ1' ' CE1' ' B' ' 376' ' ' HIS . 13.2 ttpp -63.65 -40.75 97.63 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 106.948 -1.501 . . . . 0.22 106.948 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.23 -46.78 87.35 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 118.375 -1.33 . . . . 0.16 110.705 -178.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 68.5 t -68.82 -39.57 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 108.525 -0.917 . . . . 0.14000000000000001 108.525 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -58.12 -46.58 85.35 Favored 'General case' 0 N--CA 1.502 2.169 0 CA-C-O 121.839 0.828 . . . . 0.19 109.523 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 376' ' ' HIS . . . . . 0.656 ' CE1' ' HZ1' ' B' ' 372' ' ' LYS . 13.2 m-70 -71.01 -35.87 72.2 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 113.308 0.855 . . . . 0.20999999999999999 113.308 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 95.9 mt -79.84 -25.14 40.86 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 118.443 -1.303 . . . . 0.12 111.788 -175.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 2.1 t -73.11 -38.89 56.13 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 N-CA-C 106.267 -1.753 . . . . 0.14000000000000001 106.267 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -68.84 -48.61 63.07 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.538 -1.282 . . . . 0.22 107.538 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 380' ' ' LEU . . . . . 0.506 ' HG ' ' CD2' ' B' ' 384' ' ' LEU . 28.2 tp -55.55 -47.36 76.48 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.836 -1.165 . . . . 0.17000000000000001 110.717 176.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 2.9 ttm -61.46 -35.04 76.49 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 120.712 -1.242 . . . . 0.14000000000000001 113.51 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -77.48 -29.36 52.59 Favored 'General case' 0 C--N 1.282 -2.341 0 O-C-N 121.183 -0.948 . . . . 0.17999999999999999 108.896 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . 0.266 31.7 mt-10 -76.47 -36.77 57.68 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.81 0.814 . . . . 0.20999999999999999 111.723 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 384' ' ' LEU . . . . . 0.506 ' CD2' ' HG ' ' B' ' 380' ' ' LEU . 0.0 OUTLIER -55.23 127.38 29.05 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 125.934 2.778 . . . . 0.17999999999999999 113.135 -176.119 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.308 -1.214 2 CA-C-N 108.1 -4.136 . . . . 0.23999999999999999 111.168 -178.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.217 -0.613 0 CA-C-O 122.391 1.091 . . . . 0.16 112.81 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.725 ' HB ' ' CG1' ' A' ' 166' ' ' ILE . 2.3 mp -106.02 130.73 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.019 0 CA-C-O 122.663 1.22 . . . . 0.14000000000000001 110.698 177.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -100.46 124.86 46.53 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.229 -1.35 . . . . 0.13 110.318 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.4 mm -94.8 123.44 46.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 105.89 -1.893 . . . . 0.089999999999999997 105.89 176.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.2 mm -92.1 146.79 5.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 122.546 1.165 . . . . 0.10000000000000001 111.834 -178.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.71 121.09 51.22 Favored Pre-proline 0 N--CA 1.428 -1.541 0 N-CA-C 115.379 1.622 . . . . 0.070000000000000007 115.379 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -76.11 -20.02 15.11 Favored 'Trans proline' 0 CA--C 1.559 1.752 0 C-N-CA 121.494 1.463 . . . . 0.050000000000000003 111.396 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . 0.325 0.0 OUTLIER -147.43 161.19 41.54 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 123.815 0.846 . . . . 0.050000000000000003 110.173 175.29 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.9 m -82.61 148.14 28.17 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 121.729 0.776 . . . . 0.10000000000000001 111.099 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 156.81 -155.3 26.24 Favored Glycine 0 N--CA 1.431 -1.688 0 C-N-CA 119.086 -1.531 . . . . 0.080000000000000002 111.041 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.15 134.79 54.34 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.038 -1.081 . . . . 0.10000000000000001 110.063 -177.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.1 mt -74.38 141.45 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 C-N-CA 117.694 -1.602 . . . . 0.080000000000000002 110.383 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.3 t -132.62 155.9 41.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 114.519 -1.219 . . . . 0.089999999999999997 108.786 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.477 ' HB3' ' OE2' ' A' ' 34' ' ' GLU . 13.6 m120 -71.41 138.35 49.04 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-O 121.443 0.639 . . . . 0.11 111.099 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.422 ' CD1' ' CG1' ' A' ' 139' ' ' VAL . 8.2 tt -67.8 -23.67 29.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 C-N-CA 118.65 -1.22 . . . . 0.11 108.724 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.477 ' OE2' ' HB3' ' A' ' 32' ' ' ASN . 0.8 OUTLIER -73.91 -14.09 61.0 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 118.566 -1.254 . . . . 0.14000000000000001 110.543 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -94.9 12.32 28.64 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 113.689 0.996 . . . . 0.13 113.689 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 t -86.42 130.95 47.5 Favored Pre-proline 0 C--N 1.29 -2.011 0 CA-C-O 120.918 0.39 . . . . 0.13 109.963 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -70.46 48.03 0.72 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 122.711 2.274 . . . . 0.14999999999999999 111.781 -173.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.535 ' CG ' HH21 ' B' ' 317' ' ' ARG . 56.3 t0 -150.66 115.83 5.36 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.733 -1.21 . . . . 0.22 107.733 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.2 m -60.36 -37.8 75.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 C-N-CA 119.005 -1.078 . . . . 1.04 111.618 -178.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . 0.405 18.9 m -62.45 -34.94 67.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 116.861 -1.936 . . . . 1.0700000000000001 112.127 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -84.18 -44.15 14.25 Favored 'General case' 0 C--N 1.261 -3.254 0 O-C-N 120.178 -1.576 . . . . 0.25 109.897 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.6 -36.24 78.09 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 108.937 -0.764 . . . . 0.14999999999999999 108.937 -177.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -91.09 7.89 38.24 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 118.173 -1.411 . . . . 1.0800000000000001 110.584 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.514 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 0.3 OUTLIER 52.37 39.78 28.1 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 113.973 1.101 . . . . 0.14999999999999999 113.973 176.62 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.4 mm -67.19 -30.32 48.94 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.958 0 CA-C-O 123.786 1.755 . . . . 1.0700000000000001 110.703 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.293 2.1 t -89.55 -7.71 10.82 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.882 0 CA-C-N 112.375 -2.193 . . . . 1.1899999999999999 111.844 -175.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.514 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . 133.46 -175.57 20.13 Favored Glycine 0 C--O 1.206 -1.627 0 N-CA-C 108.743 -1.743 . . . . 0.14000000000000001 108.743 176.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -119.52 155.45 32.13 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 117.851 -1.539 . . . . 0.12 112.768 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 172.18 -137.77 4.44 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 117.725 -2.179 . . . . 0.089999999999999997 111.158 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 pp -134.98 175.24 11.51 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.716 0 O-C-N 121.592 -0.946 . . . . 0.070000000000000007 108.596 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -121.59 158.51 28.41 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 124.716 1.206 . . . . 0.070000000000000007 108.424 175.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.3 mt -133.33 128.81 55.87 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.826 0 O-C-N 121.641 -0.662 . . . . 0.059999999999999998 111.051 178.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -86.11 108.81 18.71 Favored Pre-proline 0 C--N 1.308 -1.232 0 N-CA-C 101.478 -3.527 . . . . 0.12 101.478 174.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -71.22 150.12 58.8 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 123.725 2.95 . . . . 0.089999999999999997 113.074 -170.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.3 p -138.61 1.6 2.14 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 121.774 -0.579 . . . . 0.11 110.161 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -108.83 -144.5 10.84 Favored Glycine 0 CA--C 1.534 1.238 0 O-C-N 121.444 -0.785 . . . . 0.10000000000000001 114.581 -177.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -142.97 14.48 1.89 Allowed 'General case' 0 CA--C 1.491 -1.291 0 O-C-N 122.363 -0.492 . . . . 0.12 112.079 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -157.28 155.17 30.28 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 115.415 -2.514 . . . . 0.11 113.092 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -114.96 121.44 43.18 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.868 -1.06 . . . . 0.070000000000000007 109.054 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 m -114.15 174.54 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 CA-C-O 122.74 1.257 . . . . 0.080000000000000002 110.964 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.15 126.66 92.92 Favored Pre-proline 0 C--N 1.289 -2.057 0 CA-C-N 113.663 -1.608 . . . . 0.080000000000000002 109.742 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -85.85 -1.5 8.82 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 CA-C-N 120.029 1.046 . . . . 0.070000000000000007 110.429 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.2 m -158.53 164.96 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-O 121.579 0.704 . . . . 0.089999999999999997 111.139 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 115' ' ' VAL . 48.0 m-20 -81.44 127.19 32.54 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 103.595 -2.743 . . . . 0.13 103.595 174.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 80' ' ' GLU . . . 174.0 -157.85 26.2 Favored Glycine 0 C--N 1.301 -1.375 0 N-CA-C 110.78 -0.928 . . . . 0.12 110.78 -175.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.6 m -123.69 134.93 53.64 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 119.814 -0.754 . . . . 0.14000000000000001 111.309 -177.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.7 mm -68.76 140.42 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.041 0 C-N-CA 117.619 -1.632 . . . . 0.12 107.394 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -101.76 -64.21 0.75 Allowed Glycine 0 C--N 1.282 -2.457 0 CA-C-O 121.955 0.753 . . . . 0.14000000000000001 114.291 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.53 ' CD ' ' O ' ' B' ' 351' ' ' GLN . 0.2 OUTLIER -141.35 136.47 31.51 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-O 122.991 1.377 . . . . 2.6400000000000001 111.934 -177.842 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 75.8 mt -116.24 125.46 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 N-CA-C 105.514 -2.032 . . . . 0.14000000000000001 105.514 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -62.72 145.46 54.7 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.164 -1.05 . . . . 0.23000000000000001 108.164 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -61.91 -14.9 38.59 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 123.674 0.79 . . . . 0.70999999999999996 110.488 -178.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.53 ' OG1' ' ND1' ' A' ' 75' ' ' HIS . 25.5 p -97.69 5.02 49.87 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 123.655 1.693 . . . . 1.0600000000000001 109.093 178.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.762 ' ND2' HH21 ' A' ' 105' ' ' ARG . 23.5 m120 50.51 44.31 27.11 Favored 'General case' 0 C--N 1.261 -3.269 0 CA-C-N 113.211 -1.813 . . . . 0.14000000000000001 112.59 175.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.636 ' HE2' ' CE1' ' A' ' 90' ' ' HIS . 13.7 p-80 -126.38 -1.52 6.92 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 113.64 0.978 . . . . 0.33000000000000002 113.64 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.32 152.75 31.47 Favored 'General case' 0 N--CA 1.412 -2.345 0 O-C-N 120.781 -1.2 . . . . 0.11 111.022 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -152.53 166.33 32.36 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 123.072 1.415 . . . . 0.10000000000000001 113.245 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.443 ' HB2' ' H ' ' A' ' 69' ' ' LYS 0.259 15.8 m -118.29 139.72 50.9 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 113.278 -1.783 . . . . 0.12 109.849 -178.894 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.6 tt -143.27 150.03 17.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.585 -1.265 . . . . 0.10000000000000001 107.585 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.476 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 84.6 tt0 -118.42 129.91 55.67 Favored 'General case' 0 C--O 1.201 -1.466 0 N-CA-C 105.628 -1.99 . . . . 0.52000000000000002 105.628 177.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 94.0 p -80.91 167.32 20.0 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 118.457 -1.297 . . . . 0.13 108.28 -176.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.406 ' C ' ' H ' ' A' ' 84' ' ' GLY . 83.0 m-20 -68.11 -31.02 70.33 Favored 'General case' 0 C--N 1.277 -2.569 0 C-N-CA 118.538 -1.265 . . . . 0.14999999999999999 108.264 177.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.22 4.44 2.21 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 125.212 1.405 . . . . 0.14000000000000001 111.998 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 78.73 14.51 81.98 Favored Glycine 0 C--N 1.28 -2.557 0 N-CA-C 117.351 1.7 . . . . 0.14999999999999999 117.351 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.421 HG22 ' CD1' ' A' ' 166' ' ' ILE . 48.8 t -92.42 133.01 35.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 121.189 2.494 . . . . 0.12 110.886 177.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.435 ' OE1' ' CB ' ' B' ' 348' ' ' PHE . 96.5 mt-10 -96.9 121.92 39.3 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.669 -0.645 . . . . 1.73 110.229 176.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -116.32 158.84 22.79 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.986 0.898 . . . . 0.089999999999999997 110.922 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -143.66 111.87 6.27 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 122.988 1.375 . . . . 0.39000000000000001 109.759 177.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.1 t -101.73 115.6 43.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 114.05 -1.432 . . . . 0.070000000000000007 111.41 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.636 ' CE1' ' HE2' ' A' ' 75' ' ' HIS . 2.1 t-80 -123.24 105.07 9.56 Favored 'General case' 0 C--O 1.199 -1.564 0 CA-C-N 115.501 -0.772 . . . . 0.22 111.098 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -63.56 124.13 20.57 Favored 'General case' 0 CA--C 1.558 1.278 0 N-CA-C 116.688 2.107 . . . . 0.10000000000000001 116.688 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.28 -175.84 31.91 Favored Glycine 0 C--O 1.214 -1.123 0 CA-C-O 122.578 1.099 . . . . 0.10000000000000001 114.496 175.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 49.1 mm -118.0 132.62 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-O 123.129 1.442 . . . . 0.14000000000000001 109.158 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 54.69 25.75 6.79 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 114.104 -1.407 . . . . 0.17999999999999999 111.227 -177.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.3 p -64.42 -19.82 65.76 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 115.451 1.648 . . . . 0.14999999999999999 115.451 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.3 p -57.09 -32.83 41.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 O-C-N 120.124 -1.61 . . . . 1.04 109.32 177.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -58.61 -19.99 43.47 Favored 'General case' 0 CA--C 1.566 1.581 0 C-N-CA 119.867 -0.733 . . . . 0.25 112.092 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mp -78.22 -3.24 41.72 Favored 'General case' 0 CA--C 1.564 1.485 0 O-C-N 119.733 -1.855 . . . . 0.17000000000000001 113.913 177.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 32.4 mtmm 48.95 46.23 22.34 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 116.082 1.882 . . . . 3.6099999999999999 116.082 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 90.69 -13.24 66.25 Favored Glycine 0 CA--C 1.543 1.799 0 N-CA-C 115.492 0.957 . . . . 0.16 115.492 176.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.14 121.29 12.71 Favored 'General case' 0 C--N 1.284 -2.263 0 O-C-N 121.36 -1.082 . . . . 0.17999999999999999 112.008 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 122' ' ' PHE . . . 97.68 -7.09 63.1 Favored Glycine 0 C--O 1.201 -1.956 0 N-CA-C 114.902 0.721 . . . . 0.14999999999999999 114.902 178.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -115.67 152.25 33.52 Favored 'General case' 0 C--N 1.284 -2.282 0 C-N-CA 124.121 0.968 . . . . 0.13 111.008 177.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . 0.513 ' NZ ' ' O ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -141.95 113.41 7.71 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 124.625 1.17 . . . . 0.14000000000000001 109.199 176.843 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.762 HH21 ' ND2' ' A' ' 74' ' ' ASN . 5.0 ttm180 -67.19 123.53 20.55 Favored 'General case' 0 CA--C 1.462 -2.416 0 C-N-CA 120.448 -0.501 . . . . 0.14999999999999999 109.946 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.0 mm -106.31 -34.99 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.251 0 C-N-CA 114.928 -2.709 . . . . 0.12 108.119 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.08 178.22 5.62 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 118.682 -1.207 . . . . 0.12 112.235 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -118.31 151.46 37.66 Favored 'General case' 0 C--O 1.213 -0.83 0 N-CA-C 112.594 0.59 . . . . 0.14999999999999999 112.594 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -60.89 137.26 58.23 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 118.498 -1.281 . . . . 1.6799999999999999 108.021 175.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.27 -5.23 84.31 Favored Glycine 0 N--CA 1.475 1.253 0 N-CA-C 111.624 -0.591 . . . . 0.14999999999999999 111.624 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -65.72 138.04 57.69 Favored 'General case' 0 C--N 1.288 -2.07 0 C-N-CA 118.398 -1.321 . . . . 0.13 112.879 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.511 ' CG ' HH11 ' A' ' 112' ' ' ARG . 0.0 OUTLIER -86.23 132.67 33.94 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 114.121 -1.4 . . . . 0.14999999999999999 107.307 175.611 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 m -139.87 160.33 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.023 0 C-N-CA 117.475 -1.69 . . . . 0.11 113.051 -176.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . 0.469 ' HE3' ' OD2' ' A' ' 117' ' ' ASP . 0.5 OUTLIER -110.81 156.7 20.73 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 111.905 -2.407 . . . . 0.14000000000000001 108.406 174.63 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.417 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 43.9 t -45.7 135.74 2.09 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 CA-C-O 121.596 0.712 . . . . 0.11 111.675 176.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.2 -13.05 64.5 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 120.831 -0.699 . . . . 0.10000000000000001 114.38 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . 0.469 ' OD2' ' HE3' ' A' ' 114' ' ' LYS . 91.5 m-20 -63.14 136.38 57.72 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 118.866 1.333 . . . . 0.11 109.797 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.4 m -76.68 132.38 39.33 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-O 122.912 1.339 . . . . 0.11 111.123 -177.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.439 ' O ' HG13 ' A' ' 120' ' ' ILE . 44.8 t -105.83 -48.45 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.684 0 CA-C-N 113.495 -1.684 . . . . 0.089999999999999997 109.315 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 119' ' ' VAL . 10.8 mt -148.37 143.56 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.707 0 N-CA-C 114.085 1.143 . . . . 0.10000000000000001 114.085 -177.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . 0.472 ' O ' ' HD2' ' A' ' 104' ' ' LYS . 49.4 mt-10 -112.28 147.47 36.22 Favored 'General case' 0 CA--C 1.483 -1.627 0 C-N-CA 116.646 -2.022 . . . . 0.12 107.279 175.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.521 ' HA ' ' O ' ' A' ' 102' ' ' GLY . 36.0 p90 -132.94 163.55 28.94 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 122.08 0.943 . . . . 0.11 111.57 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.436 ' OD1' ' HD2' ' A' ' 125' ' ' PRO . 10.3 t0 -100.41 97.85 8.55 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 124.72 1.208 . . . . 0.14999999999999999 109.813 176.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.551 ' HB3' ' HD3' ' A' ' 125' ' ' PRO . 3.1 tp -59.22 -54.79 52.77 Favored Pre-proline 0 C--N 1.292 -1.899 0 N-CA-C 116.061 1.874 . . . . 0.12 116.061 -176.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.551 ' HD3' ' HB3' ' A' ' 124' ' ' LEU . 20.6 Cg_exo -56.92 -44.68 42.37 Favored 'Trans proline' 1 C--N 1.247 -4.804 0 C-N-CA 121.483 1.455 . . . . 0.14999999999999999 109.706 -175.647 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.732 ' CD1' ' HG3' ' A' ' 130' ' ' LYS . 0.5 OUTLIER -57.17 -51.0 71.07 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.134 -0.691 . . . . 0.16 109.134 177.738 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.5 mt -68.36 -31.42 70.79 Favored 'General case' 0 C--N 1.281 -2.394 0 O-C-N 121.092 -1.005 . . . . 0.13 112.098 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -65.13 -37.62 88.03 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 106.727 -1.582 . . . . 0.14999999999999999 106.727 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -75.26 -42.3 55.37 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.218 -0.901 . . . . 0.19 113.33 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . 0.732 ' HG3' ' CD1' ' A' ' 126' ' ' LEU . 0.1 OUTLIER -94.79 -29.28 14.83 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 116.38 1.992 . . . . 0.20000000000000001 116.38 -175.817 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.56 142.96 36.93 Favored 'General case' 0 C--N 1.262 -3.207 0 N-CA-C 115.329 1.603 . . . . 0.14999999999999999 115.329 -176.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.508 ' HD2' ' HA ' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -55.7 -37.82 68.88 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 108.436 -0.95 . . . . 0.19 108.436 178.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.8 t -163.78 143.93 8.44 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 125.037 1.335 . . . . 0.13 110.686 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 76.8 p -95.96 -0.57 50.55 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 114.773 -1.103 . . . . 0.11 110.58 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 17.1 mt -56.33 130.39 44.41 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.263 -1.384 . . . . 0.11 107.263 177.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 93.3 m -118.77 96.92 50.5 Favored Pre-proline 0 N--CA 1.43 -1.432 0 N-CA-C 118.124 2.638 . . . . 0.070000000000000007 118.124 -173.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . 0.415 ' HD2' ' O ' ' A' ' 90' ' ' HIS . 8.5 Cg_exo -67.02 142.94 63.78 Favored 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 117.163 -1.425 . . . . 0.089999999999999997 114.357 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . 0.313 1.6 m -125.83 104.66 13.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 105.192 -2.151 . . . . 0.059999999999999998 105.192 173.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.422 ' CG1' ' CD1' ' A' ' 33' ' ' ILE . 16.3 m -123.51 158.84 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 N-CA-C 116.237 1.939 . . . . 0.10000000000000001 116.237 -176.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.8 mp -97.61 125.51 50.74 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.319 0 N-CA-C 104.566 -2.383 . . . . 0.12 104.566 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 17.2 p -98.41 -4.41 34.75 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 123.158 1.456 . . . . 0.14000000000000001 112.936 -175.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 143' ' ' MET 0.482 0.0 OUTLIER -97.8 15.17 24.53 Favored 'General case' 0 C--N 1.258 -3.386 0 C-N-CA 130.087 3.355 . . . . 0.14999999999999999 114.505 -179.757 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.432 ' C ' ' O ' ' A' ' 142' ' ' ASN 0.251 62.1 mmm -33.68 -45.09 0.17 Allowed 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 115.555 1.687 . . . . 0.16 115.555 -174.261 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -64.11 -11.64 31.85 Favored 'General case' 0 C--N 1.251 -3.682 0 O-C-N 119.891 -1.755 . . . . 0.26000000000000001 113.099 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -106.02 12.68 30.18 Favored 'General case' 0 CA--C 1.479 -1.758 0 CA-C-N 121.225 1.829 . . . . 0.17999999999999999 111.57 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 2.5 pt -120.36 140.81 43.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 C-N-CA 115.906 -2.317 . . . . 0.16 113.983 -177.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . 0.639 ' HB2' ' HB3' ' A' ' 168' ' ' LYS 0.255 12.1 tptt -74.45 -54.73 7.0 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 114.49 -1.232 . . . . 0.20999999999999999 109.794 -179.864 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 166' ' ' ILE . 0.0 OUTLIER -147.31 145.59 29.4 Favored 'General case' 0 C--N 1.289 -2.063 0 O-C-N 119.913 -1.742 . . . . 0.17000000000000001 114.055 177.017 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.68 112.31 21.9 Favored 'General case' 0 N--CA 1.415 -2.177 0 CA-C-N 111.066 -2.788 . . . . 0.13 109.881 177.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 61.8 mt -108.94 112.19 39.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 114.515 -1.221 . . . . 0.14000000000000001 107.92 177.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 34.5 mttt -84.93 129.84 34.74 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 124.492 1.117 . . . . 0.11 113.399 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.299 31.3 mt -94.4 175.78 6.55 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-O 122.732 1.253 . . . . 0.11 112.325 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . 0.276 0.5 OUTLIER -131.09 160.43 34.72 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 113.484 -1.689 . . . . 0.11 114.773 -174.325 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 100.25 -158.82 19.43 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 118.906 2.322 . . . . 0.11 118.906 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.8 142.13 27.83 Favored 'General case' 0 C--O 1.213 -0.841 0 CA-C-N 112.064 -2.068 . . . . 0.12 109.892 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 16.5 m -131.83 159.68 42.93 Favored 'Isoleucine or valine' 0 CA--C 1.46 -2.511 0 CA-C-O 122.783 1.277 . . . . 0.089999999999999997 110.041 -177.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 20.8 m -122.77 123.7 41.66 Favored 'General case' 0 C--N 1.273 -2.734 0 CA-C-N 112.754 -2.021 . . . . 0.12 108.194 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 12.1 p -37.38 123.68 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 CA-C-O 123.725 1.726 . . . . 0.089999999999999997 113.991 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 61.15 25.82 65.03 Favored Glycine 0 CA--C 1.487 -1.68 0 CA-C-N 112.804 -1.998 . . . . 0.10000000000000001 114.232 176.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.43 -53.24 0.72 Allowed 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 119.593 -0.843 . . . . 0.14000000000000001 111.958 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 9.1 m -85.35 122.98 73.61 Favored Pre-proline 0 C--N 1.282 -2.352 0 N-CA-C 114.219 1.192 . . . . 0.11 114.219 -175.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -62.44 141.46 86.92 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.964 2.443 . . . . 0.11 109.766 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 28.9 m -116.64 -27.92 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.625 -0.672 . . . . 0.070000000000000007 112.196 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 30.5 mt -141.17 150.94 19.85 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 108.502 -0.925 . . . . 0.089999999999999997 108.502 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 5.9 mtt180 -125.76 130.83 52.25 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 105.784 -1.932 . . . . 0.13 105.784 176.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.725 ' CG1' ' HB ' ' A' ' 20' ' ' ILE . 39.9 pt -128.36 155.57 40.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 119.075 -1.05 . . . . 0.13 109.813 -177.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 168' ' ' LYS . 1.1 tttt -120.72 154.21 35.92 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.987 -0.746 . . . . 0.19 108.987 176.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . 0.639 ' HB3' ' HB2' ' A' ' 147' ' ' LYS . 9.6 tttt . . . . . 0 C--N 1.322 -0.595 0 N-CA-C 108.87 -0.789 . . . . 0.20000000000000001 108.87 -177.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 301' ' ' MET . . . . . 0.447 ' HB2' ' HG2' ' B' ' 366' ' ' GLU . 4.2 ttm . . . . . 0 C--O 1.219 -0.545 0 N-CA-C 108.473 -0.936 . . . . 0.20000000000000001 108.473 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 302' ' ' PHE . . . . . 0.493 ' CD2' ' HA ' ' B' ' 371' ' ' GLN . 74.9 t80 -142.93 140.91 31.33 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.219 -1.4 . . . . 0.20000000000000001 107.219 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -150.85 157.34 42.8 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 120.998 -1.064 . . . . 0.16 109.461 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -153.18 147.62 25.97 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.024 -1.472 . . . . 0.19 107.024 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.97 151.96 19.17 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.296 -1.001 . . . . 0.17000000000000001 108.296 178.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.62 144.31 17.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 107.345 -1.354 . . . . 0.16 107.345 174.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 87.1 m -93.9 136.69 33.92 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.596 0.712 . . . . 0.20999999999999999 110.107 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 59.0 mt -85.69 114.12 25.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 104.653 -2.351 . . . . 0.19 104.653 177.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 61.1 p -106.44 -3.86 20.49 Favored 'General case' 0 N--CA 1.514 2.729 0 N-CA-C 114.57 1.322 . . . . 0.23000000000000001 114.57 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.74 139.2 83.12 Favored Pre-proline 0 N--CA 1.487 1.396 0 CA-C-N 120.314 1.415 . . . . 0.22 110.701 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -46.45 -44.87 20.18 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 123.012 2.475 . . . . 0.27000000000000002 117.095 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -103.72 29.29 5.88 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 115.758 -2.377 . . . . 1.25 107.145 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 59.49 -148.71 40.94 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 117.615 -2.231 . . . . 0.20000000000000001 110.981 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 17.1 tp -87.07 74.15 9.71 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 118.267 -1.373 . . . . 0.14999999999999999 108.985 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 315' ' ' HIS . . . . . 0.436 ' CD2' ' CG ' ' B' ' 318' ' ' PRO . 2.5 p80 -69.24 -178.04 1.24 Allowed 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 118.656 -1.217 . . . . 0.34999999999999998 112.678 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 26.8 m -49.04 -60.19 2.99 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 118.77 2.878 . . . . 1.1100000000000001 118.77 -174.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 317' ' ' ARG . . . . . 0.535 HH21 ' CG ' ' A' ' 38' ' ' ASP . 18.8 ttm180 -63.93 -44.53 78.98 Favored Pre-proline 0 C--N 1.281 -2.395 0 CA-C-N 122.671 2.487 . . . . 1.5700000000000001 112.902 -176.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 318' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' B' ' 317' ' ' ARG . 9.2 Cg_endo -67.95 -28.89 35.14 Favored 'Trans proline' 0 C--N 1.296 -2.194 0 CA-C-N 121.149 1.446 . . . . 0.20000000000000001 111.937 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -69.44 -35.43 75.65 Favored 'General case' 0 N--CA 1.509 2.5 0 O-C-N 120.824 -1.172 . . . . 0.14000000000000001 108.839 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -71.52 -39.32 70.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.798 -1.189 . . . . 0.17999999999999999 108.867 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -67.84 -35.93 79.44 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 118.084 -1.447 . . . . 2.2599999999999998 108.7 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -64.25 -44.62 91.23 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 122.408 1.099 . . . . 0.12 108.704 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 55.1 t -64.67 -40.45 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-N 115.227 -0.897 . . . . 1.03 110.526 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -64.47 -41.06 96.72 Favored 'General case' 0 C--N 1.293 -1.879 0 O-C-N 120.752 -1.217 . . . . 1.72 109.735 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -68.27 -40.17 81.96 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.152 -0.685 . . . . 0.16 109.152 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.58 -42.31 92.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.945 -1.097 . . . . 0.14000000000000001 109.283 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -62.82 -15.05 52.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.034 -1.041 . . . . 2.1099999999999999 112.875 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -78.36 -11.26 85.5 Favored Glycine 0 N--CA 1.478 1.498 0 N-CA-C 108.85 -1.7 . . . . 0.19 108.85 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . 0.484 ' HE1' ' HE3' ' B' ' 372' ' ' LYS . 82.3 m-85 -103.88 144.99 30.77 Favored 'General case' 0 N--CA 1.507 2.388 0 CA-C-N 118.713 1.257 . . . . 0.17999999999999999 110.129 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 74.4 p -76.9 -28.7 55.44 Favored 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 118.611 -0.709 . . . . 0.23000000000000001 112.503 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 20.3 m -58.92 157.58 9.63 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 123.384 1.564 . . . . 0.19 114.899 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.6 128.49 33.46 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 102.22 -3.252 . . . . 0.19 102.22 172.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 41.7 mt -125.76 133.93 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 108.203 -1.036 . . . . 0.14000000000000001 108.203 -175.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 97.6 m -124.58 140.68 52.72 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 122.267 1.032 . . . . 0.14999999999999999 109.184 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 93.1 t -107.33 127.38 63.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 105.34 -2.096 . . . . 0.12 105.34 174.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 88.3 m -124.73 121.04 33.52 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.881 0.848 . . . . 0.16 110.396 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 33.5 t -125.65 123.83 39.82 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 118.425 -1.31 . . . . 0.17000000000000001 108.129 177.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 49.71 40.19 19.43 Favored 'General case' 0 N--CA 1.514 2.765 0 N-CA-C 112.872 0.693 . . . . 0.23000000000000001 112.872 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 81.05 12.23 82.78 Favored Glycine 0 N--CA 1.485 1.923 0 O-C-N 120.487 -1.383 . . . . 0.20999999999999999 113.334 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -121.8 136.69 54.94 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 103.539 -2.763 . . . . 2.98 103.539 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 68.8 m -121.55 156.1 33.6 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-O 124.321 2.01 . . . . 0.17999999999999999 114.996 -175.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -151.52 148.01 27.52 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 111.848 -2.433 . . . . 0.16 110.82 176.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 7.6 t -65.59 132.93 50.08 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.416 -1.698 . . . . 0.16 106.416 173.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -73.47 -6.02 43.71 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 120.285 -1.509 . . . . 0.11 110.842 178.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -98.23 12.74 33.68 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.966 -1.084 . . . . 0.17999999999999999 109.189 -178.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.23 105.64 6.74 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 123.122 1.439 . . . . 0.17999999999999999 110.557 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 32.6 tp -57.34 -37.59 72.78 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 113.949 -1.478 . . . . 1.0600000000000001 109.303 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 348' ' ' PHE . . . . . 0.435 ' CB ' ' OE1' ' A' ' 86' ' ' GLU . 72.5 t80 -61.18 -50.4 73.32 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 120.355 -1.465 . . . . 0.46999999999999997 112.975 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -69.57 -31.68 70.0 Favored 'General case' 0 C--N 1.314 -0.963 0 O-C-N 119.609 -1.932 . . . . 1.79 110.56 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 3.1 mt -65.29 -32.03 73.47 Favored 'General case' 0 C--N 1.285 -2.236 0 C-N-CA 119.201 -0.999 . . . . 0.14999999999999999 109.309 -177.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 351' ' ' GLN . . . . . 0.53 ' O ' ' CD ' ' A' ' 69' ' ' LYS . 89.6 mt-30 -68.17 -10.72 56.36 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.96 -0.462 . . . . 0.82999999999999996 109.833 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 2.0 p -91.86 -4.02 55.33 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 118.347 -1.341 . . . . 1.04 110.78 -177.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 25.1 mt -94.63 157.05 16.14 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.233 -0.917 . . . . 0.17000000000000001 110.076 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -86.3 106.45 3.09 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 104.713 -3.355 . . . . 0.17999999999999999 104.713 177.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 91.3 mt -122.37 48.39 1.76 Allowed 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 106.153 -1.795 . . . . 0.16 106.153 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 43.0 p -83.12 171.02 14.16 Favored 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 109.335 -0.617 . . . . 1.0600000000000001 109.335 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -57.7 138.52 55.36 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.177 -0.952 . . . . 0.26000000000000001 110.675 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 92.19 -3.13 76.05 Favored Glycine 0 N--CA 1.474 1.173 0 C-N-CA 119.39 -1.385 . . . . 0.22 112.61 177.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 55.3 m -84.82 132.98 34.34 Favored 'General case' 0 C--N 1.291 -1.975 0 O-C-N 121.507 -0.996 . . . . 0.19 111.185 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 94.7 t -94.44 122.86 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 107.031 -1.47 . . . . 0.19 107.031 177.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 17.8 m -112.73 161.33 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 C-N-CA 116.891 -1.923 . . . . 0.13 109.891 178.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 85.4 m -110.06 130.52 55.52 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 106.324 -1.732 . . . . 0.14000000000000001 106.324 175.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 54.5 mt -110.33 120.43 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 102.869 -3.011 . . . . 0.11 102.869 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.42 146.43 49.62 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 107.716 -1.216 . . . . 0.14000000000000001 107.716 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -141.05 153.66 45.6 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 117.566 -1.653 . . . . 0.16 108.63 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 366' ' ' GLU . . . . . 0.447 ' HG2' ' HB2' ' B' ' 301' ' ' MET . 0.0 OUTLIER -141.79 111.91 6.87 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.06 -1.459 . . . . 0.22 107.06 178.701 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 165.25 -173.49 41.04 Favored Glycine 0 C--N 1.294 -1.766 0 C-N-CA 117.651 -2.214 . . . . 0.22 108.64 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -54.78 -41.5 70.62 Favored 'General case' 0 C--N 1.285 -2.213 0 C-N-CA 124.134 0.974 . . . . 0.28000000000000003 113.253 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 15.2 p30 -116.04 36.71 3.93 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 117.002 -1.879 . . . . 0.20999999999999999 108.135 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -58.97 -30.35 67.87 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 119.001 2.963 . . . . 0.20000000000000001 119.001 -175.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 371' ' ' GLN . . . . . 0.493 ' HA ' ' CD2' ' B' ' 302' ' ' PHE . 0.0 OUTLIER -78.2 -43.36 28.72 Favored 'General case' 0 N--CA 1.512 2.66 0 O-C-N 119.647 -1.908 . . . . 0.23999999999999999 109.768 -177.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 372' ' ' LYS . . . . . 0.657 ' HZ1' ' CE1' ' B' ' 376' ' ' HIS . 13.2 ttpp -63.78 -40.71 97.33 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 106.878 -1.527 . . . . 0.23000000000000001 106.878 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.21 -46.89 86.86 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 118.441 -1.303 . . . . 0.16 110.599 -178.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 68.7 t -68.78 -39.54 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 N-CA-C 108.521 -0.918 . . . . 0.14000000000000001 108.521 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -58.21 -46.49 85.75 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.846 0.831 . . . . 0.20999999999999999 109.508 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 376' ' ' HIS . . . . . 0.657 ' CE1' ' HZ1' ' B' ' 372' ' ' LYS . 13.2 m-70 -71.05 -35.81 72.08 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 113.347 0.869 . . . . 0.22 113.347 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 95.8 mt -79.87 -25.11 40.79 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.447 -1.301 . . . . 0.13 111.786 -175.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 2.1 t -73.13 -38.88 56.0 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 N-CA-C 106.288 -1.745 . . . . 0.16 106.288 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -68.83 -48.6 63.13 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 107.563 -1.273 . . . . 0.23000000000000001 107.563 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 380' ' ' LEU . . . . . 0.505 ' HG ' ' CD2' ' B' ' 384' ' ' LEU . 28.2 tp -55.53 -47.37 76.4 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 118.773 -1.171 . . . . 0.16 110.754 176.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 2.9 ttm -61.49 -35.02 76.48 Favored 'General case' 0 C--N 1.309 -1.168 0 O-C-N 120.721 -1.237 . . . . 0.14999999999999999 113.44 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -77.48 -29.46 52.66 Favored 'General case' 0 C--N 1.282 -2.36 0 O-C-N 121.229 -0.919 . . . . 0.19 108.856 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . 0.265 32.3 mt-10 -76.37 -36.76 57.97 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 121.787 0.803 . . . . 0.22 111.757 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 384' ' ' LEU . . . . . 0.505 ' CD2' ' HG ' ' B' ' 380' ' ' LEU . 0.0 OUTLIER -55.21 127.42 29.17 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 125.822 2.725 . . . . 0.17999999999999999 113.15 -176.099 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.307 -1.247 2 CA-C-N 108.129 -4.123 . . . . 0.23000000000000001 111.168 -178.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.217 -0.613 0 CA-C-O 122.391 1.091 . . . . 0.16 112.81 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.687 ' HB ' ' CG1' ' A' ' 166' ' ' ILE . 2.3 mp -106.02 130.73 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.019 0 CA-C-O 122.663 1.22 . . . . 0.14000000000000001 110.698 177.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -100.46 124.86 46.53 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.229 -1.35 . . . . 0.13 110.318 176.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.4 mm -94.8 123.44 46.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 105.89 -1.893 . . . . 0.089999999999999997 105.89 176.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.2 mm -92.1 146.79 5.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 122.546 1.165 . . . . 0.10000000000000001 111.834 -178.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.71 121.09 51.22 Favored Pre-proline 0 N--CA 1.428 -1.541 0 N-CA-C 115.379 1.622 . . . . 0.070000000000000007 115.379 -178.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -76.11 -20.02 15.11 Favored 'Trans proline' 0 CA--C 1.559 1.752 0 C-N-CA 121.494 1.463 . . . . 0.050000000000000003 111.396 -177.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . 0.325 0.0 OUTLIER -147.43 161.19 41.54 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 123.815 0.846 . . . . 0.050000000000000003 110.173 175.29 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.9 m -82.61 148.14 28.17 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 121.729 0.776 . . . . 0.10000000000000001 111.099 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 156.81 -155.3 26.24 Favored Glycine 0 N--CA 1.431 -1.688 0 C-N-CA 119.086 -1.531 . . . . 0.080000000000000002 111.041 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.15 134.79 54.34 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.038 -1.081 . . . . 0.10000000000000001 110.063 -177.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.1 mt -74.38 141.45 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 C-N-CA 117.694 -1.602 . . . . 0.080000000000000002 110.383 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.3 t -132.62 155.9 41.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 114.519 -1.219 . . . . 0.089999999999999997 108.786 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.477 ' HB3' ' OE2' ' A' ' 34' ' ' GLU . 13.6 m120 -71.41 138.35 49.04 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-O 121.443 0.639 . . . . 0.11 111.099 178.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.487 ' CD1' ' CG1' ' A' ' 139' ' ' VAL . 8.2 tt -67.8 -23.67 29.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 C-N-CA 118.65 -1.22 . . . . 0.11 108.724 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.477 ' OE2' ' HB3' ' A' ' 32' ' ' ASN . 0.8 OUTLIER -73.91 -14.09 61.0 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 118.566 -1.254 . . . . 0.14000000000000001 110.543 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -94.9 12.32 28.64 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 113.689 0.996 . . . . 0.13 113.689 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 t -86.42 130.95 47.5 Favored Pre-proline 0 C--N 1.29 -2.011 0 CA-C-O 120.918 0.39 . . . . 0.13 109.963 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -70.46 48.03 0.72 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 122.711 2.274 . . . . 0.14999999999999999 111.781 -173.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.524 ' CG ' HH21 ' B' ' 317' ' ' ARG . 65.3 t0 -150.66 115.83 5.36 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.733 -1.21 . . . . 0.22 107.733 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.8 m -60.34 -37.9 75.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 C-N-CA 119.005 -1.078 . . . . 1.04 111.569 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . 0.404 19.3 m -62.41 -34.89 66.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 C-N-CA 116.864 -1.934 . . . . 1.0700000000000001 112.148 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -84.18 -44.27 14.13 Favored 'General case' 0 C--N 1.262 -3.23 0 O-C-N 120.132 -1.605 . . . . 0.25 109.841 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.52 -36.24 77.9 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 108.937 -0.764 . . . . 0.14999999999999999 108.937 -177.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -91.05 7.81 38.55 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 118.173 -1.411 . . . . 1.0800000000000001 110.585 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.514 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 0.3 OUTLIER 52.42 39.78 28.26 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 113.973 1.101 . . . . 0.14999999999999999 113.973 176.651 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.3 mm -67.18 -30.35 49.04 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.958 0 CA-C-O 123.747 1.737 . . . . 1.0700000000000001 110.696 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.293 2.1 t -89.52 -7.71 10.82 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.898 0 CA-C-N 112.336 -2.211 . . . . 1.1899999999999999 111.844 -175.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.514 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . 133.46 -175.57 20.13 Favored Glycine 0 C--O 1.206 -1.627 0 N-CA-C 108.743 -1.743 . . . . 0.14000000000000001 108.743 176.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -119.52 155.45 32.13 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 117.851 -1.539 . . . . 0.12 112.768 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 172.18 -137.77 4.44 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 117.725 -2.179 . . . . 0.089999999999999997 111.158 177.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 pp -134.98 175.24 11.51 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.716 0 O-C-N 121.592 -0.946 . . . . 0.070000000000000007 108.596 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -121.59 158.51 28.41 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 124.716 1.206 . . . . 0.070000000000000007 108.424 175.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.3 mt -133.33 128.81 55.87 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.826 0 O-C-N 121.641 -0.662 . . . . 0.059999999999999998 111.051 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -86.11 108.81 18.71 Favored Pre-proline 0 C--N 1.308 -1.232 0 N-CA-C 101.478 -3.527 . . . . 0.12 101.478 174.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -71.22 150.12 58.8 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 123.725 2.95 . . . . 0.089999999999999997 113.074 -170.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.3 p -138.61 1.6 2.14 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 121.774 -0.579 . . . . 0.11 110.161 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -108.83 -144.5 10.84 Favored Glycine 0 CA--C 1.534 1.238 0 O-C-N 121.444 -0.785 . . . . 0.10000000000000001 114.581 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -142.97 14.48 1.89 Allowed 'General case' 0 CA--C 1.491 -1.291 0 O-C-N 122.363 -0.492 . . . . 0.12 112.079 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -157.28 155.17 30.28 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 115.415 -2.514 . . . . 0.11 113.092 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -114.96 121.44 43.18 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.868 -1.06 . . . . 0.070000000000000007 109.054 178.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 m -114.15 174.54 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 CA-C-O 122.74 1.257 . . . . 0.080000000000000002 110.964 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.15 126.66 92.92 Favored Pre-proline 0 C--N 1.289 -2.057 0 CA-C-N 113.663 -1.608 . . . . 0.080000000000000002 109.742 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -85.85 -1.5 8.82 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 CA-C-N 120.029 1.046 . . . . 0.070000000000000007 110.429 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.2 m -158.53 164.96 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-O 121.579 0.704 . . . . 0.089999999999999997 111.139 -178.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 115' ' ' VAL . 48.0 m-20 -81.44 127.19 32.54 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 103.595 -2.743 . . . . 0.13 103.595 174.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' A' ' 80' ' ' GLU . . . 174.0 -157.85 26.2 Favored Glycine 0 C--N 1.301 -1.375 0 N-CA-C 110.78 -0.928 . . . . 0.12 110.78 -175.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.6 m -123.69 134.93 53.64 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 119.814 -0.754 . . . . 0.14000000000000001 111.309 -177.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.7 mm -68.76 140.42 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.041 0 C-N-CA 117.619 -1.632 . . . . 0.12 107.394 178.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -101.76 -64.21 0.75 Allowed Glycine 0 C--N 1.282 -2.457 0 CA-C-O 121.955 0.753 . . . . 0.14000000000000001 114.291 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.541 ' CD ' ' O ' ' B' ' 351' ' ' GLN . 0.1 OUTLIER -141.38 136.47 31.46 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-O 123.059 1.409 . . . . 2.6400000000000001 111.925 -177.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 75.8 mt -116.23 125.46 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 N-CA-C 105.514 -2.032 . . . . 0.14000000000000001 105.514 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -62.72 145.46 54.7 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.164 -1.05 . . . . 0.23000000000000001 108.164 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -61.91 -14.9 38.59 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 123.674 0.79 . . . . 0.70999999999999996 110.488 -178.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.542 ' OG1' ' ND1' ' A' ' 75' ' ' HIS . 16.7 p -97.67 4.98 49.95 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 123.593 1.663 . . . . 1.0600000000000001 109.068 178.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.67 ' ND2' HH21 ' A' ' 105' ' ' ARG . 23.5 m120 50.53 44.31 27.19 Favored 'General case' 0 C--N 1.26 -3.305 0 CA-C-N 113.23 -1.805 . . . . 0.14000000000000001 112.59 175.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' HIS . . . . . 0.667 ' HE2' ' CE1' ' A' ' 90' ' ' HIS . 20.1 p-80 -126.41 -1.45 6.9 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 113.661 0.986 . . . . 0.33000000000000002 113.661 -177.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.37 152.75 31.44 Favored 'General case' 0 N--CA 1.412 -2.345 0 O-C-N 120.836 -1.165 . . . . 0.11 111.022 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -152.53 166.33 32.36 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 123.072 1.415 . . . . 0.10000000000000001 113.245 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . 0.443 ' HB2' ' H ' ' A' ' 69' ' ' LYS 0.259 15.8 m -118.29 139.72 50.9 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 113.278 -1.783 . . . . 0.12 109.849 -178.894 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.6 tt -143.27 150.03 17.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.585 -1.265 . . . . 0.10000000000000001 107.585 175.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . 0.475 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 84.6 tt0 -118.42 129.91 55.67 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 105.628 -1.99 . . . . 0.52000000000000002 105.628 177.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 94.0 p -80.91 167.32 20.0 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 118.457 -1.297 . . . . 0.13 108.28 -176.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.406 ' C ' ' H ' ' A' ' 84' ' ' GLY . 83.0 m-20 -68.11 -31.02 70.33 Favored 'General case' 0 C--N 1.277 -2.569 0 C-N-CA 118.538 -1.265 . . . . 0.14999999999999999 108.264 177.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.22 4.44 2.21 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 125.212 1.405 . . . . 0.14000000000000001 111.998 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 78.73 14.51 81.98 Favored Glycine 0 C--N 1.28 -2.557 0 N-CA-C 117.351 1.7 . . . . 0.14999999999999999 117.351 -178.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.8 t -92.42 133.01 35.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 121.189 2.494 . . . . 0.12 110.886 177.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.435 ' OE1' ' CB ' ' B' ' 348' ' ' PHE . 96.5 mt-10 -96.9 121.92 39.3 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.669 -0.645 . . . . 1.73 110.229 176.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -116.32 158.84 22.79 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.986 0.898 . . . . 0.089999999999999997 110.922 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -147.34 140.69 25.35 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.674 -0.694 . . . . 0.39000000000000001 109.919 177.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 45.7 t -131.85 131.98 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.69 -0.631 . . . . 0.070000000000000007 110.003 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.667 ' CE1' ' HE2' ' A' ' 75' ' ' HIS . 2.9 t-80 -120.29 80.72 1.64 Allowed 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 108.462 -0.94 . . . . 0.22 108.462 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PHE . . . . . 0.413 ' C ' ' O ' ' A' ' 90' ' ' HIS . 30.3 t80 -42.84 119.9 1.61 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.239 -0.913 . . . . 0.10000000000000001 110.295 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.34 -175.54 32.64 Favored Glycine 0 C--N 1.303 -1.27 0 CA-C-O 122.885 1.269 . . . . 0.10000000000000001 114.623 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 18.6 mm -118.4 132.61 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-O 122.93 1.348 . . . . 0.14000000000000001 109.132 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 54.65 25.89 6.87 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 114.12 -1.4 . . . . 0.17999999999999999 111.213 -177.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.1 p -64.47 -20.08 65.96 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 115.162 1.541 . . . . 0.14999999999999999 115.162 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.5 p -56.94 -32.82 40.45 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 O-C-N 119.578 -1.951 . . . . 1.04 109.296 178.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -58.61 -19.99 43.5 Favored 'General case' 0 CA--C 1.566 1.581 0 O-C-N 121.524 -0.735 . . . . 0.25 112.092 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.556 ' N ' ' CD1' ' A' ' 98' ' ' LEU . 7.3 mp -78.02 -3.67 43.27 Favored 'General case' 0 CA--C 1.566 1.565 0 O-C-N 119.733 -1.855 . . . . 0.17000000000000001 113.877 177.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm 49.23 46.23 22.99 Favored 'General case' 0 C--N 1.276 -2.624 0 N-CA-C 116.082 1.882 . . . . 3.6099999999999999 116.082 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 90.63 -13.17 66.34 Favored Glycine 0 CA--C 1.544 1.871 0 O-C-N 121.26 -0.9 . . . . 0.16 115.338 176.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -62.21 120.92 11.87 Favored 'General case' 0 C--N 1.28 -2.456 0 O-C-N 121.024 -1.28 . . . . 0.17999999999999999 112.235 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 122' ' ' PHE . . . 98.69 -8.68 61.87 Favored Glycine 0 C--O 1.196 -2.274 0 O-C-N 121.637 -0.664 . . . . 0.14999999999999999 114.597 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -115.02 151.6 33.92 Favored 'General case' 0 C--N 1.278 -2.534 0 C-N-CA 124.136 0.974 . . . . 0.13 111.326 178.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -141.23 112.95 7.67 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 124.43 1.092 . . . . 0.14000000000000001 109.504 177.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ARG . . . . . 0.67 HH21 ' ND2' ' A' ' 74' ' ' ASN . 29.0 ttm180 -67.3 123.26 19.86 Favored 'General case' 0 CA--C 1.453 -2.758 0 C-N-CA 120.337 -0.545 . . . . 0.14999999999999999 109.966 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 29.8 mm -106.22 -34.5 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.251 0 C-N-CA 115.112 -2.635 . . . . 0.12 108.289 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.82 177.66 5.7 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 118.721 -1.191 . . . . 0.12 112.391 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -118.26 150.58 39.2 Favored 'General case' 0 C--O 1.215 -0.754 0 N-CA-C 112.963 0.727 . . . . 0.14999999999999999 112.963 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -60.14 137.26 58.14 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 118.385 -1.326 . . . . 1.6799999999999999 108.021 176.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.54 -5.8 83.58 Favored Glycine 0 N--CA 1.475 1.253 0 N-CA-C 111.455 -0.658 . . . . 0.14999999999999999 111.455 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -65.88 137.17 57.01 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-O 122.843 1.306 . . . . 0.13 113.289 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ARG . . . . . 0.406 ' NH1' ' OD1' ' A' ' 82' ' ' ASP . 0.9 OUTLIER -85.23 133.07 34.19 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 107.095 -1.446 . . . . 0.14999999999999999 107.095 176.153 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.3 m -140.66 159.72 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.042 0 C-N-CA 117.678 -1.609 . . . . 0.11 113.286 -177.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -110.42 156.11 21.27 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 112.032 -2.349 . . . . 0.14000000000000001 108.773 175.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . 0.417 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 28.7 t -45.3 135.43 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.457 0 CA-C-O 121.677 0.751 . . . . 0.11 111.837 176.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.52 -13.2 64.59 Favored Glycine 0 CA--C 1.537 1.42 0 C-N-CA 120.786 -0.721 . . . . 0.10000000000000001 114.285 178.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -63.05 136.24 57.7 Favored 'General case' 0 C--N 1.288 -2.085 0 O-C-N 120.547 -1.561 . . . . 0.11 109.912 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 55.6 m -76.61 132.22 39.32 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 122.915 1.341 . . . . 0.11 111.231 -177.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.403 ' O ' HG13 ' A' ' 120' ' ' ILE . 38.5 t -106.03 -47.83 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.684 0 CA-C-N 113.544 -1.662 . . . . 0.089999999999999997 109.414 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 119' ' ' VAL . 11.5 mt -148.78 143.49 18.67 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.836 0 N-CA-C 114.135 1.161 . . . . 0.10000000000000001 114.135 -177.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -112.71 146.64 38.37 Favored 'General case' 0 CA--C 1.487 -1.457 0 C-N-CA 116.788 -1.965 . . . . 0.12 107.591 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' PHE . . . . . 0.527 ' HA ' ' O ' ' A' ' 102' ' ' GLY . 42.6 p90 -133.0 162.37 31.87 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 122.669 1.223 . . . . 0.11 112.003 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 126' ' ' LEU . 7.9 t70 -99.05 99.59 10.63 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.605 -1.179 . . . . 0.14999999999999999 108.888 177.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LEU . . . . . 0.483 ' HB3' ' HD3' ' A' ' 125' ' ' PRO . 26.9 tp -61.81 -51.54 75.12 Favored Pre-proline 0 C--N 1.292 -1.911 0 N-CA-C 116.929 2.196 . . . . 0.12 116.929 -177.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.483 ' HD3' ' HB3' ' A' ' 124' ' ' LEU . 31.5 Cg_exo -58.97 -45.04 30.62 Favored 'Trans proline' 1 C--N 1.241 -5.116 0 C-N-CA 121.966 1.777 . . . . 0.14999999999999999 109.411 -177.064 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' LEU . . . . . 0.512 ' N ' ' OD1' ' A' ' 123' ' ' ASP . 29.0 tp -57.76 -48.26 80.14 Favored 'General case' 0 C--N 1.308 -1.216 0 O-C-N 121.383 -0.823 . . . . 0.16 110.157 177.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 94.8 mt -69.84 -32.35 70.7 Favored 'General case' 0 C--N 1.282 -2.36 0 O-C-N 121.164 -0.96 . . . . 0.13 111.817 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -64.61 -37.73 88.56 Favored 'General case' 0 C--N 1.278 -2.517 0 N-CA-C 106.538 -1.653 . . . . 0.14999999999999999 106.538 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -75.42 -41.7 55.36 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 113.476 0.917 . . . . 0.19 113.476 177.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 39.4 mmtt -95.8 -27.81 15.05 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 116.582 2.067 . . . . 0.20000000000000001 116.582 -176.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.54 142.73 35.47 Favored 'General case' 0 C--N 1.258 -3.378 0 N-CA-C 115.437 1.643 . . . . 0.14999999999999999 115.437 -177.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 46.3 tptt -55.47 -38.25 68.85 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 108.066 -1.087 . . . . 0.19 108.066 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.3 t -163.71 143.21 8.21 Favored 'General case' 0 C--N 1.287 -2.152 0 C-N-CA 125.004 1.321 . . . . 0.13 111.15 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 10.0 p -94.97 -1.26 52.84 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-N 114.794 -1.093 . . . . 0.11 110.255 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 33.4 mt -54.93 131.85 45.45 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 106.78 -1.563 . . . . 0.11 106.78 177.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 77.2 m -119.79 101.84 47.66 Favored Pre-proline 0 C--N 1.292 -1.893 0 N-CA-C 115.272 1.582 . . . . 0.070000000000000007 115.272 -174.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -71.16 141.68 40.15 Favored 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 117.425 -1.25 . . . . 0.089999999999999997 115.078 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . 0.309 0.6 OUTLIER -124.79 104.61 13.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 105.207 -2.146 . . . . 0.059999999999999998 105.207 174.152 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' VAL . . . . . 0.487 ' CG1' ' CD1' ' A' ' 33' ' ' ILE . 19.8 m -124.02 158.17 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 N-CA-C 116.458 2.021 . . . . 0.10000000000000001 116.458 -176.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.435 ' N ' ' CD1' ' A' ' 140' ' ' ILE . 1.4 mp -96.71 125.55 49.64 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.344 0 N-CA-C 104.618 -2.364 . . . . 0.12 104.618 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 53.6 p -98.44 -4.47 34.49 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-O 123.231 1.491 . . . . 0.14000000000000001 112.956 -175.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ASN . . . . . 0.428 ' O ' ' C ' ' A' ' 143' ' ' MET 0.491 0.8 OUTLIER -98.13 16.05 22.43 Favored 'General case' 0 C--N 1.259 -3.357 0 C-N-CA 130.089 3.356 . . . . 0.14999999999999999 114.344 -179.74 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' MET . . . . . 0.428 ' C ' ' O ' ' A' ' 142' ' ' ASN . 95.3 mmm -34.54 -44.39 0.2 Allowed 'General case' 0 C--N 1.28 -2.452 0 N-CA-C 115.646 1.721 . . . . 0.16 115.646 -174.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -64.51 -11.64 36.09 Favored 'General case' 0 C--N 1.248 -3.811 0 O-C-N 119.762 -1.837 . . . . 0.26000000000000001 113.099 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -106.88 14.56 26.46 Favored 'General case' 0 CA--C 1.475 -1.922 0 CA-C-N 121.225 1.829 . . . . 0.17999999999999999 111.28 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 10.5 pt -121.99 140.29 46.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 C-N-CA 116.082 -2.247 . . . . 0.16 114.056 -178.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . 0.256 49.0 tptt -73.83 -55.12 6.6 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 114.275 -1.329 . . . . 0.20999999999999999 109.584 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' GLU . . . . . 0.512 ' O ' ' HA ' ' A' ' 166' ' ' ILE . 2.6 tt0 -147.64 144.61 28.51 Favored 'General case' 0 C--N 1.286 -2.154 0 O-C-N 119.889 -1.757 . . . . 0.17000000000000001 114.6 177.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.8 tt -114.73 111.66 21.62 Favored 'General case' 0 N--CA 1.415 -2.177 0 CA-C-N 111.309 -2.678 . . . . 0.13 110.262 177.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 70.1 mt -108.1 112.41 40.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 114.567 -1.197 . . . . 0.14000000000000001 107.844 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -85.0 130.32 34.64 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 124.301 1.04 . . . . 0.11 113.113 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.302 39.2 mt -94.67 175.94 6.47 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-O 123.007 1.384 . . . . 0.11 112.371 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' SER . . . . . . . . . . . . 0.293 50.9 m -132.02 159.34 39.07 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 113.416 -1.72 . . . . 0.11 115.145 -174.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 101.4 -158.74 18.73 Favored Glycine 0 C--O 1.214 -1.096 0 N-CA-C 118.92 2.328 . . . . 0.11 118.92 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 64.6 m -94.83 142.51 27.38 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 112.1 -2.05 . . . . 0.12 109.601 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 6.4 m -131.59 160.31 42.46 Favored 'Isoleucine or valine' 0 CA--C 1.462 -2.429 0 CA-C-O 122.995 1.379 . . . . 0.089999999999999997 109.996 -177.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 29.3 m -123.63 122.73 38.89 Favored 'General case' 0 C--N 1.269 -2.903 0 CA-C-N 112.854 -1.975 . . . . 0.12 108.773 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 9.3 p -37.07 122.48 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.736 0 CA-C-O 123.547 1.641 . . . . 0.089999999999999997 114.697 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 62.17 26.34 67.52 Favored Glycine 0 CA--C 1.489 -1.546 0 CA-C-N 112.871 -1.968 . . . . 0.10000000000000001 113.934 176.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -137.43 -51.4 0.64 Allowed 'General case' 0 C--N 1.283 -2.317 0 C-N-CA 119.624 -0.83 . . . . 0.14000000000000001 112.581 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 11.9 m -86.09 123.59 71.6 Favored Pre-proline 0 C--N 1.28 -2.415 0 N-CA-C 113.971 1.1 . . . . 0.11 113.971 -176.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -63.08 141.22 82.48 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.963 2.442 . . . . 0.11 109.957 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 18.4 m -116.25 -28.59 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.306 -0.871 . . . . 0.070000000000000007 111.881 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 34.8 mt -141.36 149.73 20.24 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 CA-C-O 122.064 0.935 . . . . 0.089999999999999997 109.005 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -124.73 130.75 53.02 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 105.78 -1.933 . . . . 0.13 105.78 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ILE . . . . . 0.687 ' CG1' ' HB ' ' A' ' 20' ' ' ILE . 5.8 pt -128.71 155.0 40.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.298 -0.961 . . . . 0.13 109.927 -177.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' LYS . . . . . 0.446 ' O ' ' C ' ' A' ' 168' ' ' LYS . 80.0 tttt -120.1 154.25 34.96 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 109.064 -0.717 . . . . 0.19 109.064 176.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 167' ' ' LYS . 17.1 tttt . . . . . 0 C--N 1.319 -0.732 0 CA-C-N 115.75 -0.659 . . . . 0.20000000000000001 110.044 -177.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 301' ' ' MET . . . . . 0.447 ' HB2' ' HG2' ' B' ' 366' ' ' GLU . 4.2 ttm . . . . . 0 C--O 1.219 -0.545 0 N-CA-C 108.473 -0.936 . . . . 0.20000000000000001 108.473 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 302' ' ' PHE . . . . . 0.493 ' CD2' ' HA ' ' B' ' 371' ' ' GLN . 74.9 t80 -142.93 140.91 31.33 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.219 -1.4 . . . . 0.20000000000000001 107.219 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -150.85 157.34 42.8 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 120.998 -1.064 . . . . 0.16 109.461 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -153.18 147.62 25.97 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.024 -1.472 . . . . 0.19 107.024 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.97 151.96 19.17 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.296 -1.001 . . . . 0.17000000000000001 108.296 178.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.62 144.31 17.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 107.345 -1.354 . . . . 0.16 107.345 174.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 87.1 m -93.9 136.69 33.92 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.596 0.712 . . . . 0.20999999999999999 110.107 178.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 59.0 mt -85.69 114.12 25.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 104.653 -2.351 . . . . 0.19 104.653 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 61.1 p -106.44 -3.86 20.49 Favored 'General case' 0 N--CA 1.514 2.729 0 N-CA-C 114.57 1.322 . . . . 0.23000000000000001 114.57 -178.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.74 139.2 83.12 Favored Pre-proline 0 N--CA 1.487 1.396 0 CA-C-N 120.314 1.415 . . . . 0.22 110.701 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -46.45 -44.87 20.18 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 123.012 2.475 . . . . 0.27000000000000002 117.095 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -103.72 29.29 5.88 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 115.758 -2.377 . . . . 1.25 107.145 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 60.39 -122.47 29.96 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 117.615 -2.231 . . . . 0.20000000000000001 108.839 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 314' ' ' LEU . . . . . 0.422 ' O ' ' O ' ' B' ' 315' ' ' HIS . 4.6 tp -117.51 81.63 1.69 Allowed 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.322 -0.992 . . . . 0.14999999999999999 108.322 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 315' ' ' HIS . . . . . 0.649 ' CG ' ' N ' ' B' ' 316' ' ' THR . 3.5 p80 -66.08 -141.4 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 O-C-N 120.402 -1.436 . . . . 0.34999999999999998 108.211 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 316' ' ' THR . . . . . 0.649 ' N ' ' CG ' ' B' ' 315' ' ' HIS . 8.7 m -84.96 -46.37 11.3 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 115.5 1.667 . . . . 1.1100000000000001 115.5 -176.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 317' ' ' ARG . . . . . 0.646 ' H ' ' CE1' ' B' ' 315' ' ' HIS . 18.9 ttm180 -71.01 -42.96 12.97 Favored Pre-proline 0 N--CA 1.494 1.774 0 C-N-CA 116.091 -2.244 . . . . 1.5700000000000001 113.356 -172.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 318' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' B' ' 317' ' ' ARG . 11.5 Cg_endo -68.9 -28.86 29.01 Favored 'Trans proline' 0 C--N 1.296 -2.233 0 CA-C-N 121.165 1.452 . . . . 0.20000000000000001 111.919 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -69.46 -35.43 75.62 Favored 'General case' 0 N--CA 1.509 2.5 0 O-C-N 120.777 -1.202 . . . . 0.14000000000000001 108.839 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -71.52 -39.32 70.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.798 -1.189 . . . . 0.17999999999999999 108.867 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -67.84 -35.93 79.44 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 118.084 -1.447 . . . . 2.2599999999999998 108.7 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -64.25 -44.62 91.23 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 122.408 1.099 . . . . 0.12 108.704 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.71 -40.37 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-N 115.227 -0.897 . . . . 1.03 110.539 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -64.52 -41.06 96.63 Favored 'General case' 0 C--N 1.292 -1.898 0 O-C-N 120.804 -1.185 . . . . 1.72 109.735 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -68.27 -40.17 81.96 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.152 -0.685 . . . . 0.16 109.152 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.58 -42.31 92.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.945 -1.097 . . . . 0.14000000000000001 109.283 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -62.82 -15.05 52.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.034 -1.041 . . . . 2.1099999999999999 112.875 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -78.36 -11.26 85.5 Favored Glycine 0 N--CA 1.478 1.498 0 N-CA-C 108.85 -1.7 . . . . 0.19 108.85 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 329' ' ' PHE . . . . . 0.484 ' HE1' ' HE3' ' B' ' 372' ' ' LYS . 82.3 m-85 -103.88 144.99 30.77 Favored 'General case' 0 N--CA 1.507 2.388 0 CA-C-N 118.713 1.257 . . . . 0.17999999999999999 110.129 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 74.4 p -76.9 -28.7 55.44 Favored 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 118.611 -0.709 . . . . 0.23000000000000001 112.503 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 20.3 m -58.92 157.58 9.63 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 123.384 1.564 . . . . 0.19 114.899 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.6 128.49 33.46 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 102.22 -3.252 . . . . 0.19 102.22 172.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 41.7 mt -125.76 133.93 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 108.203 -1.036 . . . . 0.14000000000000001 108.203 -175.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 97.6 m -124.58 140.68 52.72 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 122.267 1.032 . . . . 0.14999999999999999 109.184 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 93.1 t -107.33 127.38 63.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 105.34 -2.096 . . . . 0.12 105.34 174.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 88.3 m -124.73 121.04 33.52 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.881 0.848 . . . . 0.16 110.396 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 33.5 t -125.65 123.83 39.82 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 118.425 -1.31 . . . . 0.17000000000000001 108.129 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 49.71 40.19 19.43 Favored 'General case' 0 N--CA 1.514 2.765 0 N-CA-C 112.872 0.693 . . . . 0.23000000000000001 112.872 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 81.05 12.23 82.78 Favored Glycine 0 N--CA 1.485 1.923 0 O-C-N 120.487 -1.383 . . . . 0.20999999999999999 113.334 176.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -121.8 136.69 54.94 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 103.539 -2.763 . . . . 2.98 103.539 178.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 68.8 m -121.55 156.1 33.6 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-O 124.321 2.01 . . . . 0.17999999999999999 114.996 -175.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -151.52 148.01 27.52 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 111.848 -2.433 . . . . 0.16 110.82 176.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 7.6 t -65.59 132.93 50.08 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.416 -1.698 . . . . 0.16 106.416 173.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -73.47 -6.02 43.71 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 120.285 -1.509 . . . . 0.11 110.842 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -98.23 12.74 33.68 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.966 -1.084 . . . . 0.17999999999999999 109.189 -178.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.23 105.64 6.74 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 123.122 1.439 . . . . 0.17999999999999999 110.557 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 28.9 tp -57.34 -37.59 72.78 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 113.949 -1.478 . . . . 1.0600000000000001 109.303 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 348' ' ' PHE . . . . . 0.435 ' CB ' ' OE1' ' A' ' 86' ' ' GLU . 72.5 t80 -61.18 -50.4 73.32 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 120.355 -1.465 . . . . 0.46999999999999997 112.975 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -69.54 -31.75 70.15 Favored 'General case' 0 C--N 1.314 -0.963 0 O-C-N 119.609 -1.932 . . . . 1.79 110.554 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 3.1 mt -65.25 -32.03 73.49 Favored 'General case' 0 C--N 1.285 -2.233 0 C-N-CA 119.177 -1.009 . . . . 0.14999999999999999 109.309 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 351' ' ' GLN . . . . . 0.541 ' O ' ' CD ' ' A' ' 69' ' ' LYS . 89.6 mt-30 -68.21 -10.64 55.93 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.96 -0.462 . . . . 0.82999999999999996 109.819 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 2.7 p -91.95 -3.91 55.31 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 118.292 -1.363 . . . . 1.04 110.804 -177.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 25.5 mt -94.7 157.05 16.13 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.257 -0.902 . . . . 0.17000000000000001 110.076 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -86.3 106.45 3.09 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 104.713 -3.355 . . . . 0.17999999999999999 104.713 177.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 91.3 mt -122.37 48.39 1.76 Allowed 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 106.153 -1.795 . . . . 0.16 106.153 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 24.1 p -83.12 171.02 14.16 Favored 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 109.335 -0.617 . . . . 1.0600000000000001 109.335 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -57.7 138.52 55.36 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.177 -0.952 . . . . 0.26000000000000001 110.675 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 92.19 -3.13 76.05 Favored Glycine 0 N--CA 1.474 1.173 0 C-N-CA 119.39 -1.385 . . . . 0.22 112.61 177.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 55.3 m -84.82 132.98 34.34 Favored 'General case' 0 C--N 1.291 -1.975 0 O-C-N 121.507 -0.996 . . . . 0.19 111.185 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 94.7 t -94.44 122.86 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 107.031 -1.47 . . . . 0.19 107.031 177.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 17.8 m -112.73 161.33 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 C-N-CA 116.891 -1.923 . . . . 0.13 109.891 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 85.4 m -110.06 130.52 55.52 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 106.324 -1.732 . . . . 0.14000000000000001 106.324 175.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 54.5 mt -110.33 120.43 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 102.869 -3.011 . . . . 0.11 102.869 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.42 146.43 49.62 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 107.716 -1.216 . . . . 0.14000000000000001 107.716 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -141.05 153.66 45.6 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 117.566 -1.653 . . . . 0.16 108.63 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 366' ' ' GLU . . . . . 0.447 ' HG2' ' HB2' ' B' ' 301' ' ' MET . 0.0 OUTLIER -141.79 111.91 6.87 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.06 -1.459 . . . . 0.22 107.06 178.701 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 165.25 -173.49 41.04 Favored Glycine 0 C--N 1.294 -1.766 0 C-N-CA 117.651 -2.214 . . . . 0.22 108.64 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -54.78 -41.5 70.62 Favored 'General case' 0 C--N 1.285 -2.213 0 C-N-CA 124.134 0.974 . . . . 0.28000000000000003 113.253 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 15.2 p30 -116.04 36.71 3.93 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 117.002 -1.879 . . . . 0.20999999999999999 108.135 -177.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -58.97 -30.35 67.87 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 119.001 2.963 . . . . 0.20000000000000001 119.001 -175.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 371' ' ' GLN . . . . . 0.493 ' HA ' ' CD2' ' B' ' 302' ' ' PHE . 0.0 OUTLIER -78.2 -43.36 28.72 Favored 'General case' 0 N--CA 1.512 2.66 0 O-C-N 119.647 -1.908 . . . . 0.23999999999999999 109.768 -177.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 372' ' ' LYS . . . . . 0.657 ' HZ1' ' CE1' ' B' ' 376' ' ' HIS . 13.2 ttpp -63.78 -40.71 97.33 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 106.878 -1.527 . . . . 0.23000000000000001 106.878 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.21 -46.89 86.86 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 118.441 -1.303 . . . . 0.16 110.599 -178.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 68.7 t -68.78 -39.54 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 N-CA-C 108.521 -0.918 . . . . 0.14000000000000001 108.521 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -58.21 -46.49 85.75 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.846 0.831 . . . . 0.20999999999999999 109.508 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 376' ' ' HIS . . . . . 0.657 ' CE1' ' HZ1' ' B' ' 372' ' ' LYS . 13.2 m-70 -71.05 -35.81 72.08 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 113.347 0.869 . . . . 0.22 113.347 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 95.8 mt -79.87 -25.11 40.79 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.447 -1.301 . . . . 0.13 111.786 -175.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 2.1 t -73.13 -38.88 56.0 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 N-CA-C 106.288 -1.745 . . . . 0.16 106.288 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -68.83 -48.6 63.13 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 107.563 -1.273 . . . . 0.23000000000000001 107.563 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 380' ' ' LEU . . . . . 0.505 ' HG ' ' CD2' ' B' ' 384' ' ' LEU . 28.2 tp -55.53 -47.37 76.4 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 118.773 -1.171 . . . . 0.16 110.754 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 2.9 ttm -61.49 -35.02 76.48 Favored 'General case' 0 C--N 1.309 -1.168 0 O-C-N 120.721 -1.237 . . . . 0.14999999999999999 113.44 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -77.48 -29.46 52.66 Favored 'General case' 0 C--N 1.282 -2.36 0 O-C-N 121.229 -0.919 . . . . 0.19 108.856 -178.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . 0.265 32.3 mt-10 -76.37 -36.76 57.97 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 121.787 0.803 . . . . 0.22 111.757 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 384' ' ' LEU . . . . . 0.505 ' CD2' ' HG ' ' B' ' 380' ' ' LEU . 0.0 OUTLIER -55.21 127.42 29.17 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 125.822 2.725 . . . . 0.17999999999999999 113.15 -176.099 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.307 -1.247 2 CA-C-N 108.129 -4.123 . . . . 0.23000000000000001 111.168 -178.21 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.217 -0.633 0 CA-C-O 122.405 1.098 . . . . 0.14999999999999999 112.795 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.724 ' HB ' ' CG1' ' A' ' 166' ' ' ILE . 2.3 mp -105.93 130.77 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.023 0 CA-C-O 122.637 1.208 . . . . 0.14000000000000001 110.744 177.46 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -100.49 124.86 46.59 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.225 -1.352 . . . . 0.12 110.302 176.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.4 mm -94.79 123.4 46.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 105.961 -1.866 . . . . 0.089999999999999997 105.961 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.1 mm -92.11 146.77 5.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 CA-C-O 122.553 1.168 . . . . 0.10000000000000001 111.839 -178.369 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.68 121.14 51.52 Favored Pre-proline 0 N--CA 1.429 -1.504 0 N-CA-C 115.336 1.606 . . . . 0.059999999999999998 115.336 -178.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -76.16 -19.99 15.04 Favored 'Trans proline' 0 CA--C 1.558 1.709 0 C-N-CA 121.488 1.458 . . . . 0.040000000000000001 111.386 -177.536 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . 0.324 0.0 OUTLIER -147.44 161.22 41.48 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 123.82 0.848 . . . . 0.059999999999999998 110.185 175.253 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.9 m -82.6 148.13 28.18 Favored 'General case' 0 CA--C 1.498 -1.023 0 CA-C-O 121.709 0.766 . . . . 0.089999999999999997 111.11 177.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 156.84 -155.38 26.31 Favored Glycine 0 N--CA 1.431 -1.682 0 C-N-CA 119.078 -1.534 . . . . 0.089999999999999997 111.003 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.04 134.82 54.27 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 114.002 -1.099 . . . . 0.12 110.156 -177.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.0 mt -74.41 141.5 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 C-N-CA 117.621 -1.632 . . . . 0.089999999999999997 110.333 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.4 t -132.64 155.94 41.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 114.496 -1.229 . . . . 0.11 108.714 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.478 ' HB3' ' OE2' ' A' ' 34' ' ' GLU . 13.6 m120 -71.51 138.37 48.86 Favored 'General case' 0 CA--C 1.497 -1.076 0 CA-C-O 121.477 0.656 . . . . 0.11 111.064 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.422 ' CD1' ' CG1' ' A' ' 139' ' ' VAL . 8.2 tt -67.84 -23.67 29.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 C-N-CA 118.678 -1.209 . . . . 0.12 108.659 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.478 ' OE2' ' HB3' ' A' ' 32' ' ' ASN . 0.8 OUTLIER -73.91 -14.08 61.0 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 118.649 -1.22 . . . . 0.14000000000000001 110.589 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -95.0 12.48 28.29 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 113.694 0.998 . . . . 0.14000000000000001 113.694 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 t -86.5 130.99 47.16 Favored Pre-proline 0 C--N 1.289 -2.045 0 CA-C-O 120.955 0.407 . . . . 0.14999999999999999 109.921 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -70.49 48.01 0.72 Allowed 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 122.695 2.264 . . . . 0.17000000000000001 111.758 -173.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.536 ' CG ' HH21 ' B' ' 317' ' ' ARG . 62.6 t0 -150.68 115.82 5.34 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.662 -1.236 . . . . 0.22 107.662 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.9 m -60.4 -37.81 75.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 C-N-CA 119.016 -1.074 . . . . 1.05 111.601 -178.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . 0.406 16.1 m -62.46 -34.8 66.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 116.907 -1.917 . . . . 1.0700000000000001 112.174 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -84.25 -44.32 13.99 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 120.21 -1.556 . . . . 0.23000000000000001 109.822 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.51 -36.2 77.79 Favored 'General case' 0 CA--C 1.487 -1.461 0 N-CA-C 108.946 -0.761 . . . . 0.16 108.946 -177.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -91.06 7.78 38.73 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 118.219 -1.393 . . . . 0.81000000000000005 110.579 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.515 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 0.3 OUTLIER 52.37 39.82 28.19 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 113.943 1.09 . . . . 0.14999999999999999 113.943 176.665 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.0 mm -67.14 -30.44 49.38 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.963 0 CA-C-O 123.717 1.723 . . . . 1.05 110.676 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.293 2.3 t -89.48 -7.71 10.82 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.916 0 CA-C-N 112.366 -2.197 . . . . 1.25 111.81 -175.524 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.515 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . 133.45 -175.57 20.12 Favored Glycine 0 C--O 1.207 -1.574 0 N-CA-C 108.773 -1.731 . . . . 0.13 108.773 176.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -119.52 155.39 32.24 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 117.835 -1.546 . . . . 0.12 112.797 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 172.22 -137.68 4.39 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 117.703 -2.189 . . . . 0.089999999999999997 111.178 177.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 pp -135.05 175.21 11.53 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.695 0 O-C-N 121.579 -0.954 . . . . 0.070000000000000007 108.596 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -121.58 158.52 28.38 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 124.7 1.2 . . . . 0.080000000000000002 108.428 175.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.3 mt -133.36 128.87 55.85 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.84 0 O-C-N 121.595 -0.691 . . . . 0.070000000000000007 111.005 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -86.23 108.88 19.21 Favored Pre-proline 0 C--N 1.308 -1.224 0 N-CA-C 101.46 -3.533 . . . . 0.14000000000000001 101.46 174.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -71.26 150.1 58.5 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 123.735 2.956 . . . . 0.10000000000000001 113.064 -170.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.7 p -138.66 1.68 2.14 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 121.746 -0.596 . . . . 0.12 110.16 177.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -108.81 -144.48 10.85 Favored Glycine 0 CA--C 1.534 1.268 0 O-C-N 121.485 -0.759 . . . . 0.10000000000000001 114.573 -177.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -142.97 14.52 1.89 Allowed 'General case' 0 CA--C 1.492 -1.265 0 O-C-N 122.351 -0.499 . . . . 0.10000000000000001 112.068 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -157.3 155.12 30.16 Favored 'General case' 0 N--CA 1.415 -2.187 0 C-N-CA 115.405 -2.518 . . . . 0.089999999999999997 113.142 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -114.89 121.4 43.08 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.872 -1.058 . . . . 0.059999999999999998 109.077 178.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 m -114.13 174.58 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.8 0 CA-C-O 122.733 1.254 . . . . 0.070000000000000007 110.998 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.13 126.64 92.89 Favored Pre-proline 0 C--N 1.289 -2.058 0 CA-C-N 113.705 -1.589 . . . . 0.080000000000000002 109.729 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -85.84 -1.52 8.83 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 CA-C-N 120.027 1.045 . . . . 0.070000000000000007 110.439 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.2 m -158.49 164.95 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-O 121.493 0.663 . . . . 0.10000000000000001 111.185 -178.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.422 ' OD1' ' N ' ' A' ' 115' ' ' VAL . 48.5 m-20 -81.45 127.19 32.54 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 103.558 -2.756 . . . . 0.13 103.558 174.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 80' ' ' GLU . . . 174.0 -157.82 26.15 Favored Glycine 0 C--N 1.301 -1.395 0 N-CA-C 110.753 -0.939 . . . . 0.13 110.753 -175.571 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.0 m -123.71 134.85 53.64 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 119.854 -0.739 . . . . 0.14999999999999999 111.316 -177.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.7 mm -68.79 140.42 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.028 0 C-N-CA 117.626 -1.629 . . . . 0.13 107.365 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -101.7 -64.25 0.76 Allowed Glycine 0 C--N 1.282 -2.471 0 CA-C-O 122.029 0.794 . . . . 0.13 114.332 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.445 ' H ' ' HB2' ' A' ' 78' ' ' SER . 2.3 tmtp? -141.4 136.43 31.39 Favored 'General case' 0 C--N 1.279 -2.497 0 CA-C-O 123.053 1.406 . . . . 2.6600000000000001 111.954 -177.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 75.5 mt -116.19 125.45 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 105.532 -2.025 . . . . 0.12 105.532 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -62.65 145.41 54.64 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.172 -1.047 . . . . 0.28000000000000003 108.172 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -61.87 -14.91 38.15 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 123.67 0.788 . . . . 0.40000000000000002 110.454 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.514 ' OG1' ' ND1' ' A' ' 75' ' ' HIS . 41.4 p -97.7 5.03 49.83 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 123.618 1.675 . . . . 1.03 109.055 178.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.762 ' ND2' HH21 ' A' ' 105' ' ' ARG . 23.5 m120 50.41 44.39 26.82 Favored 'General case' 0 C--N 1.26 -3.292 0 CA-C-N 113.24 -1.8 . . . . 0.11 112.608 175.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.514 ' ND1' ' OG1' ' A' ' 73' ' ' THR . 23.7 p-80 -126.38 -1.55 6.91 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 113.652 0.982 . . . . 0.27000000000000002 113.652 -177.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.31 152.69 31.42 Favored 'General case' 0 N--CA 1.411 -2.388 0 O-C-N 120.79 -1.193 . . . . 0.10000000000000001 111.122 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -152.49 166.36 32.23 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 123.077 1.418 . . . . 0.089999999999999997 113.276 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.445 ' HB2' ' H ' ' A' ' 69' ' ' LYS 0.26 15.8 m -118.34 139.74 50.9 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 113.302 -1.772 . . . . 0.12 109.789 -178.877 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.6 tt -143.3 150.0 17.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 107.607 -1.257 . . . . 0.11 107.607 175.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.476 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 84.6 tt0 -118.37 129.89 55.68 Favored 'General case' 0 C--O 1.201 -1.483 0 N-CA-C 105.647 -1.983 . . . . 0.83999999999999997 105.647 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 93.9 p -80.9 167.31 20.02 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 118.441 -1.304 . . . . 0.14000000000000001 108.264 -176.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.406 ' C ' ' H ' ' A' ' 84' ' ' GLY . 83.0 m-20 -68.13 -31.06 70.39 Favored 'General case' 0 C--N 1.276 -2.6 0 C-N-CA 118.572 -1.251 . . . . 0.16 108.232 177.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.16 4.46 2.17 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 125.26 1.424 . . . . 0.16 112.053 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 78.68 14.48 82.03 Favored Glycine 0 C--N 1.28 -2.57 0 N-CA-C 117.386 1.715 . . . . 0.16 117.386 -178.716 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.422 HG22 ' CD1' ' A' ' 166' ' ' ILE . 48.8 t -92.35 133.0 35.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 121.202 2.501 . . . . 0.13 110.863 177.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.422 ' OE1' ' CB ' ' B' ' 348' ' ' PHE . 97.3 mt-10 -96.97 121.97 39.44 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 121.643 -0.661 . . . . 1.7 110.207 176.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -116.32 158.79 22.87 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 122.001 0.905 . . . . 0.10000000000000001 110.851 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -143.65 111.87 6.28 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 122.989 1.376 . . . . 0.22 109.77 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.1 t -101.7 115.56 43.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 114.046 -1.434 . . . . 0.070000000000000007 111.464 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.415 ' O ' ' HD2' ' A' ' 137' ' ' PRO . 18.4 t-80 -123.2 105.1 9.6 Favored 'General case' 0 C--O 1.2 -1.531 0 CA-C-N 115.549 -0.751 . . . . 0.23999999999999999 111.086 -178.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -63.63 124.14 20.64 Favored 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 116.665 2.098 . . . . 0.10000000000000001 116.665 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.35 -175.88 32.07 Favored Glycine 0 C--O 1.215 -1.093 0 CA-C-O 122.572 1.096 . . . . 0.11 114.526 175.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 49.0 mm -118.0 132.59 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-O 123.151 1.453 . . . . 0.14999999999999999 109.2 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 54.65 25.84 6.83 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 114.089 -1.414 . . . . 0.17999999999999999 111.246 -177.123 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.3 p -64.44 -19.9 65.83 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 115.437 1.643 . . . . 0.14000000000000001 115.437 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.3 p -57.06 -32.82 41.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 O-C-N 120.125 -1.609 . . . . 1.04 109.321 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -58.56 -20.07 43.53 Favored 'General case' 0 CA--C 1.566 1.594 0 C-N-CA 119.91 -0.716 . . . . 0.23999999999999999 112.098 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mp -78.19 -3.24 41.61 Favored 'General case' 0 CA--C 1.564 1.488 0 O-C-N 119.716 -1.865 . . . . 0.17000000000000001 113.86 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? 48.91 46.21 22.22 Favored 'General case' 0 C--N 1.278 -2.525 0 N-CA-C 116.077 1.88 . . . . 3.6099999999999999 116.077 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 90.76 -13.3 66.19 Favored Glycine 0 CA--C 1.542 1.77 0 N-CA-C 115.433 0.933 . . . . 0.13 115.433 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.04 121.21 12.45 Favored 'General case' 0 C--N 1.283 -2.284 0 O-C-N 121.296 -1.12 . . . . 0.16 112.016 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 122' ' ' PHE . . . 97.71 -7.03 63.01 Favored Glycine 0 C--O 1.201 -1.926 0 N-CA-C 114.87 0.708 . . . . 0.12 114.87 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -115.73 152.28 33.52 Favored 'General case' 0 C--N 1.283 -2.298 0 C-N-CA 124.117 0.967 . . . . 0.11 111.012 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.517 ' NZ ' ' O ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -141.92 113.47 7.77 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 124.597 1.159 . . . . 0.10000000000000001 109.235 176.83 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.762 HH21 ' ND2' ' A' ' 74' ' ' ASN . 4.9 ttm180 -67.32 123.56 20.68 Favored 'General case' 0 CA--C 1.462 -2.439 0 C-N-CA 120.403 -0.519 . . . . 0.12 109.924 178.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.0 mm -106.27 -35.02 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.256 0 C-N-CA 114.991 -2.684 . . . . 0.089999999999999997 108.1 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.16 178.23 5.61 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 118.675 -1.21 . . . . 0.10000000000000001 112.187 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -118.3 151.52 37.53 Favored 'General case' 0 C--O 1.213 -0.861 0 N-CA-C 112.582 0.586 . . . . 0.14000000000000001 112.582 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -60.92 137.2 58.23 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 118.559 -1.256 . . . . 1.6000000000000001 107.967 175.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.36 -5.27 84.16 Favored Glycine 0 N--CA 1.475 1.272 0 N-CA-C 111.622 -0.591 . . . . 0.14999999999999999 111.622 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -65.76 138.03 57.66 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-O 122.899 1.333 . . . . 0.13 112.888 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.511 ' CG ' HH11 ' A' ' 112' ' ' ARG . 0.0 OUTLIER -86.25 132.7 33.93 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-N 114.111 -1.404 . . . . 0.17999999999999999 107.297 175.64 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.7 m -139.93 160.35 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.04 0 C-N-CA 117.458 -1.697 . . . . 0.12 113.02 -176.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.469 ' HE3' ' OD2' ' A' ' 117' ' ' ASP . 0.5 OUTLIER -110.78 156.73 20.66 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 111.88 -2.418 . . . . 0.14999999999999999 108.398 174.671 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.422 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 44.2 t -45.73 135.73 2.12 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 CA-C-O 121.593 0.711 . . . . 0.11 111.655 176.429 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.14 -12.98 64.62 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 120.853 -0.689 . . . . 0.089999999999999997 114.423 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.469 ' OD2' ' HE3' ' A' ' 114' ' ' LYS . 91.6 m-20 -63.08 136.35 57.74 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 120.926 -1.338 . . . . 0.11 109.812 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.5 m -76.7 132.4 39.31 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-O 122.951 1.358 . . . . 0.089999999999999997 111.084 -177.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.44 ' O ' HG13 ' A' ' 120' ' ' ILE . 44.8 t -105.86 -48.4 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.695 0 CA-C-N 113.42 -1.718 . . . . 0.070000000000000007 109.304 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 119' ' ' VAL . 10.9 mt -148.36 143.51 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.722 0 N-CA-C 114.077 1.139 . . . . 0.070000000000000007 114.077 -177.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.47 ' O ' ' HD2' ' A' ' 104' ' ' LYS . 49.5 mt-10 -112.28 147.41 36.35 Favored 'General case' 0 CA--C 1.484 -1.587 0 C-N-CA 116.685 -2.006 . . . . 0.089999999999999997 107.314 175.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.521 ' HA ' ' O ' ' A' ' 102' ' ' GLY . 36.0 p90 -132.9 163.6 28.79 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 122.059 0.933 . . . . 0.089999999999999997 111.609 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.438 ' OD1' ' HD2' ' A' ' 125' ' ' PRO . 10.3 t0 -100.42 97.84 8.53 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 124.758 1.223 . . . . 0.13 109.799 176.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.553 ' HB3' ' HD3' ' A' ' 125' ' ' PRO . 3.2 tp -59.28 -54.75 53.13 Favored Pre-proline 0 C--N 1.292 -1.913 0 N-CA-C 116.068 1.877 . . . . 0.13 116.068 -176.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' A' ' 124' ' ' LEU . 20.7 Cg_exo -56.9 -44.71 42.17 Favored 'Trans proline' 1 C--N 1.247 -4.812 0 C-N-CA 121.472 1.448 . . . . 0.16 109.698 -175.685 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.731 ' CD1' ' HG3' ' A' ' 130' ' ' LYS . 0.5 OUTLIER -57.17 -50.96 71.21 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.132 -0.692 . . . . 0.16 109.132 177.757 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.4 mt -68.45 -31.37 70.63 Favored 'General case' 0 C--N 1.281 -2.4 0 O-C-N 121.178 -0.951 . . . . 0.14000000000000001 112.068 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -65.16 -37.61 87.93 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 106.699 -1.593 . . . . 0.16 106.699 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -75.32 -42.27 54.91 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.205 -0.907 . . . . 0.20000000000000001 113.335 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.731 ' HG3' ' CD1' ' A' ' 126' ' ' LEU . 0.1 OUTLIER -94.77 -29.3 14.84 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 116.361 1.985 . . . . 0.20000000000000001 116.361 -175.817 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.54 142.93 36.99 Favored 'General case' 0 C--N 1.262 -3.229 0 N-CA-C 115.382 1.623 . . . . 0.16 115.382 -176.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.506 ' HD2' ' HA ' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -55.68 -37.78 68.78 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.428 -0.953 . . . . 0.20000000000000001 108.428 179.025 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.8 t -163.84 143.92 8.35 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 124.986 1.314 . . . . 0.14999999999999999 110.654 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 76.8 p -95.95 -0.6 50.52 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 114.784 -1.098 . . . . 0.13 110.539 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 17.0 mt -56.36 130.43 44.63 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.22 -1.4 . . . . 0.13 107.22 177.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 93.5 m -118.81 96.98 50.57 Favored Pre-proline 0 N--CA 1.431 -1.397 0 N-CA-C 118.121 2.638 . . . . 0.080000000000000002 118.121 -173.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.415 ' HD2' ' O ' ' A' ' 90' ' ' HIS . 8.3 Cg_exo -66.94 142.86 63.94 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 117.192 -1.406 . . . . 0.10000000000000001 114.406 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . 0.313 1.6 m -125.79 104.68 13.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 105.186 -2.153 . . . . 0.059999999999999998 105.186 173.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.422 ' CG1' ' CD1' ' A' ' 33' ' ' ILE . 16.3 m -123.49 158.84 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 N-CA-C 116.258 1.948 . . . . 0.10000000000000001 116.258 -176.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.8 mp -97.57 125.44 50.71 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.294 0 N-CA-C 104.591 -2.374 . . . . 0.12 104.591 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 53.3 p -98.35 -4.42 34.92 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 123.15 1.452 . . . . 0.14000000000000001 112.927 -175.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.431 ' O ' ' C ' ' A' ' 143' ' ' MET 0.483 0.0 OUTLIER -97.86 15.23 24.47 Favored 'General case' 0 C--N 1.258 -3.41 0 C-N-CA 130.114 3.366 . . . . 0.14999999999999999 114.442 -179.679 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.431 ' C ' ' O ' ' A' ' 142' ' ' ASN . 62.1 mmm -33.76 -45.0 0.17 Allowed 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 115.584 1.698 . . . . 0.14999999999999999 115.584 -174.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -64.1 -11.71 32.51 Favored 'General case' 0 C--N 1.252 -3.663 0 O-C-N 119.852 -1.78 . . . . 0.23999999999999999 113.105 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -106.03 12.71 30.11 Favored 'General case' 0 CA--C 1.479 -1.777 0 CA-C-N 121.18 1.809 . . . . 0.17999999999999999 111.546 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 2.5 pt -120.34 140.86 43.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 C-N-CA 115.979 -2.288 . . . . 0.14999999999999999 113.96 -177.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.638 ' HB2' ' HB3' ' A' ' 168' ' ' LYS 0.258 12.0 tptt -74.46 -54.77 6.9 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 114.496 -1.229 . . . . 0.19 109.786 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 166' ' ' ILE . 0.0 OUTLIER -147.33 145.57 29.38 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 123.729 1.728 . . . . 0.14000000000000001 114.017 177.053 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.65 112.35 21.97 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 111.077 -2.783 . . . . 0.11 109.866 177.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 61.9 mt -108.97 112.23 39.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 114.531 -1.213 . . . . 0.11 107.882 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 34.6 mttt -84.94 129.91 34.72 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 124.474 1.11 . . . . 0.10000000000000001 113.325 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.299 31.4 mt -94.48 175.74 6.56 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-O 122.688 1.233 . . . . 0.089999999999999997 112.315 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . 0.278 0.5 OUTLIER -131.11 160.43 34.75 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 113.51 -1.677 . . . . 0.10000000000000001 114.763 -174.341 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 100.26 -158.83 19.42 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 118.88 2.312 . . . . 0.10000000000000001 118.88 174.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.76 142.15 27.79 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 112.102 -2.049 . . . . 0.11 109.949 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 16.5 m -131.84 159.73 42.9 Favored 'Isoleucine or valine' 0 CA--C 1.459 -2.54 0 CA-C-O 122.834 1.302 . . . . 0.080000000000000002 110.032 -177.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 20.7 m -122.79 123.62 41.47 Favored 'General case' 0 C--N 1.274 -2.709 0 CA-C-N 112.702 -2.044 . . . . 0.11 108.24 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 12.1 p -37.23 123.64 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.63 0 CA-C-O 123.7 1.714 . . . . 0.080000000000000002 113.966 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 61.18 25.83 65.11 Favored Glycine 0 CA--C 1.488 -1.642 0 CA-C-N 112.837 -1.983 . . . . 0.10000000000000001 114.179 175.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.42 -53.26 0.72 Allowed 'General case' 0 C--N 1.287 -2.118 0 CA-C-O 121.929 0.871 . . . . 0.13 111.957 178.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 9.0 m -85.36 123.0 73.59 Favored Pre-proline 0 C--N 1.282 -2.346 0 N-CA-C 114.179 1.177 . . . . 0.10000000000000001 114.179 -175.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -62.5 141.5 86.75 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.003 2.469 . . . . 0.10000000000000001 109.719 177.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 28.6 m -116.65 -27.96 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 121.647 -0.658 . . . . 0.059999999999999998 112.217 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 30.3 mt -141.12 150.98 19.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 N-CA-C 108.527 -0.916 . . . . 0.080000000000000002 108.527 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 5.9 mtt180 -125.78 130.79 52.15 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 105.746 -1.946 . . . . 0.11 105.746 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.724 ' CG1' ' HB ' ' A' ' 20' ' ' ILE . 39.7 pt -128.35 155.6 40.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 C-N-CA 118.987 -1.085 . . . . 0.12 109.771 -178.024 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 168' ' ' LYS . 1.1 tttt -120.75 154.23 35.93 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.023 -0.732 . . . . 0.17000000000000001 109.023 176.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.638 ' HB3' ' HB2' ' A' ' 147' ' ' LYS . 9.6 tttt . . . . . 0 C--N 1.322 -0.601 0 N-CA-C 108.887 -0.783 . . . . 0.19 108.887 -177.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 301' ' ' MET . . . . . 0.447 ' HB2' ' HG2' ' B' ' 366' ' ' GLU . 4.2 ttm . . . . . 0 C--O 1.218 -0.566 0 N-CA-C 108.459 -0.941 . . . . 0.20999999999999999 108.459 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 302' ' ' PHE . . . . . 0.493 ' CD2' ' HA ' ' B' ' 371' ' ' GLN . 74.6 t80 -142.88 140.93 31.42 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.181 -1.414 . . . . 0.17999999999999999 107.181 178.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -150.83 157.33 42.8 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.037 -1.039 . . . . 0.17000000000000001 109.46 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -153.2 147.6 25.92 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.001 -1.481 . . . . 0.16 107.001 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.92 152.02 19.15 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.319 -0.993 . . . . 0.16 108.319 178.288 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 7.3 p -149.68 144.29 17.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 107.35 -1.352 . . . . 0.14000000000000001 107.35 174.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 86.5 m -93.84 136.73 33.83 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 121.605 0.717 . . . . 0.17999999999999999 110.119 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 58.9 mt -85.75 114.13 25.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 104.572 -2.381 . . . . 0.16 104.572 177.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 61.1 p -106.45 -3.93 20.41 Favored 'General case' 0 N--CA 1.514 2.746 0 N-CA-C 114.545 1.313 . . . . 0.20999999999999999 114.545 -178.508 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.65 139.21 83.38 Favored Pre-proline 0 N--CA 1.487 1.422 0 CA-C-N 120.312 1.414 . . . . 0.20000000000000001 110.766 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -46.42 -44.96 19.92 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 123.033 2.488 . . . . 0.25 117.068 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -103.66 29.23 5.89 Favored 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 115.813 -2.355 . . . . 1.3400000000000001 107.127 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 59.52 -148.66 41.1 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 117.624 -2.226 . . . . 0.19 111.007 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 17.1 tp -87.11 74.1 9.69 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 118.331 -1.347 . . . . 0.14999999999999999 108.996 -177.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 315' ' ' HIS . . . . . 0.437 ' H ' ' CD2' ' B' ' 315' ' ' HIS . 7.7 p80 -69.27 -178.06 1.25 Allowed 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 118.667 -1.213 . . . . 0.97999999999999998 112.688 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 3.0 m -48.93 -60.26 2.9 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 118.842 2.904 . . . . 1.05 118.842 -174.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 317' ' ' ARG . . . . . 0.536 HH21 ' CG ' ' A' ' 38' ' ' ASP . 20.9 ttm180 -64.01 -44.19 77.31 Favored Pre-proline 0 C--N 1.282 -2.326 0 CA-C-N 122.599 2.454 . . . . 1.73 113.038 -176.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 318' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' B' ' 317' ' ' ARG . 10.5 Cg_endo -68.09 -28.92 34.22 Favored 'Trans proline' 0 C--N 1.296 -2.185 0 CA-C-N 121.171 1.454 . . . . 0.22 111.934 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -69.45 -35.37 75.57 Favored 'General case' 0 N--CA 1.508 2.473 0 O-C-N 120.836 -1.165 . . . . 0.14999999999999999 108.853 179.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -71.56 -39.35 70.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.805 -1.185 . . . . 0.17999999999999999 108.855 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -67.77 -36.0 79.7 Favored 'General case' 0 N--CA 1.501 2.093 0 C-N-CA 118.123 -1.431 . . . . 2.3500000000000001 108.714 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -64.28 -44.61 91.17 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.93 -1.106 . . . . 0.13 108.657 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.63 -40.42 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 CA-C-N 115.229 -0.896 . . . . 1.05 110.538 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -64.55 -41.05 96.58 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 120.809 -1.182 . . . . 1.6399999999999999 109.688 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -68.28 -40.16 81.93 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.58 -0.7 . . . . 0.17000000000000001 109.121 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.57 -42.32 92.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.893 -1.129 . . . . 0.14000000000000001 109.287 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -62.82 -15.04 52.55 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.136 -0.977 . . . . 1.9299999999999999 112.905 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -78.34 -11.23 85.53 Favored Glycine 0 N--CA 1.479 1.513 0 N-CA-C 108.847 -1.701 . . . . 0.19 108.847 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . 0.483 ' HE1' ' HE3' ' B' ' 372' ' ' LYS . 82.4 m-85 -103.91 145.08 30.65 Favored 'General case' 0 N--CA 1.506 2.355 0 CA-C-N 118.731 1.266 . . . . 0.17999999999999999 110.083 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 75.4 p -76.95 -28.78 55.32 Favored 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 118.609 -0.71 . . . . 0.23000000000000001 112.477 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 20.3 m -58.87 157.55 9.57 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-O 123.384 1.564 . . . . 0.19 114.893 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.53 128.48 33.42 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 102.25 -3.241 . . . . 0.20000000000000001 102.25 172.337 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 42.0 mt -125.78 133.98 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 108.18 -1.045 . . . . 0.14999999999999999 108.18 -175.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 97.5 m -124.61 140.64 52.75 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 122.204 1.002 . . . . 0.16 109.229 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 93.1 t -107.37 127.39 63.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 105.349 -2.093 . . . . 0.13 105.349 174.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 88.2 m -124.7 121.04 33.54 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.893 0.854 . . . . 0.17000000000000001 110.432 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 33.4 t -125.59 123.84 39.92 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 118.389 -1.324 . . . . 0.17000000000000001 108.154 177.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 49.78 40.09 19.49 Favored 'General case' 0 N--CA 1.514 2.747 0 N-CA-C 112.879 0.696 . . . . 0.23000000000000001 112.879 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 81.07 12.26 82.71 Favored Glycine 0 N--CA 1.485 1.961 0 O-C-N 120.442 -1.411 . . . . 0.20999999999999999 113.314 176.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -121.84 136.65 54.94 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 103.55 -2.759 . . . . 3.02 103.55 178.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 68.2 m -121.49 156.09 33.53 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-O 124.348 2.023 . . . . 0.19 115.04 -175.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -151.52 147.98 27.47 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 111.86 -2.427 . . . . 0.16 110.804 177.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 7.6 t -65.65 132.96 50.08 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 106.362 -1.718 . . . . 0.17000000000000001 106.362 173.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -73.46 -6.08 44.11 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.281 -1.512 . . . . 0.12 110.845 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -98.13 12.72 33.55 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.998 -1.064 . . . . 0.17999999999999999 109.224 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.2 105.67 6.77 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 123.146 1.45 . . . . 0.17000000000000001 110.544 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 26.6 tp -57.32 -37.64 72.82 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 113.948 -1.478 . . . . 1.0800000000000001 109.31 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 348' ' ' PHE . . . . . 0.422 ' CB ' ' OE1' ' A' ' 86' ' ' GLU . 67.1 t80 -61.06 -50.48 73.14 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 120.395 -1.44 . . . . 0.42999999999999999 113.018 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -69.51 -31.74 70.16 Favored 'General case' 0 C--N 1.313 -1.01 0 O-C-N 119.589 -1.944 . . . . 1.71 110.526 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 3.1 mt -65.35 -32.02 73.45 Favored 'General case' 0 C--N 1.284 -2.25 0 C-N-CA 119.19 -1.004 . . . . 0.14999999999999999 109.242 -177.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . 0.427 ' OE1' ' OG ' ' A' ' 78' ' ' SER . 89.7 mt-30 -68.14 -10.78 56.7 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.938 -0.476 . . . . 0.78000000000000003 109.816 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 2.7 p -91.86 -3.94 55.43 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.385 -1.326 . . . . 1.0 110.815 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 25.6 mt -94.72 157.04 16.13 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.255 -0.903 . . . . 0.17000000000000001 110.094 179.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -86.28 106.43 3.08 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 104.785 -3.326 . . . . 0.17000000000000001 104.785 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 91.2 mt -122.42 48.4 1.76 Allowed 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 106.133 -1.803 . . . . 0.14999999999999999 106.133 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 18.4 p -83.08 170.99 14.23 Favored 'General case' 0 C--O 1.215 -0.746 0 N-CA-C 109.363 -0.606 . . . . 1.05 109.363 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -57.72 138.48 55.44 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.178 -0.951 . . . . 0.23999999999999999 110.659 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 92.25 -3.15 75.88 Favored Glycine 0 N--CA 1.473 1.108 0 C-N-CA 119.431 -1.366 . . . . 0.19 112.627 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 55.0 m -84.77 132.89 34.38 Favored 'General case' 0 C--N 1.291 -1.966 0 O-C-N 121.497 -1.002 . . . . 0.17000000000000001 111.182 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 95.3 t -94.38 122.91 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 106.972 -1.492 . . . . 0.17000000000000001 106.972 177.072 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 17.8 m -112.71 161.3 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 C-N-CA 116.922 -1.911 . . . . 0.12 109.955 177.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 84.9 m -110.1 130.48 55.53 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 106.32 -1.733 . . . . 0.14000000000000001 106.32 175.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 54.3 mt -110.29 120.43 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 102.902 -2.999 . . . . 0.11 102.902 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.41 146.43 49.61 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.746 -1.205 . . . . 0.14999999999999999 107.746 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -141.09 153.7 45.57 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 117.549 -1.66 . . . . 0.17000000000000001 108.599 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 366' ' ' GLU . . . . . 0.447 ' HG2' ' HB2' ' B' ' 301' ' ' MET . 0.0 OUTLIER -141.81 111.94 6.88 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.002 -1.481 . . . . 0.23000000000000001 107.002 178.753 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 165.25 -173.45 41.03 Favored Glycine 0 C--N 1.295 -1.734 0 C-N-CA 117.672 -2.204 . . . . 0.22 108.649 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -54.86 -41.49 70.85 Favored 'General case' 0 C--N 1.286 -2.191 0 C-N-CA 124.134 0.974 . . . . 0.27000000000000002 113.24 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 15.1 p30 -116.05 36.75 3.91 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 116.966 -1.894 . . . . 0.20999999999999999 108.114 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -58.99 -30.34 67.89 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 118.961 2.949 . . . . 0.20000000000000001 118.961 -175.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 371' ' ' GLN . . . . . 0.493 ' HA ' ' CD2' ' B' ' 302' ' ' PHE . 0.0 OUTLIER -78.23 -43.43 28.39 Favored 'General case' 0 N--CA 1.513 2.696 0 O-C-N 119.721 -1.862 . . . . 0.22 109.743 -177.953 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 372' ' ' LYS . . . . . 0.656 ' HZ1' ' CE1' ' B' ' 376' ' ' HIS . 13.2 ttpp -63.65 -40.75 97.63 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 106.948 -1.501 . . . . 0.22 106.948 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.23 -46.78 87.35 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 118.375 -1.33 . . . . 0.16 110.705 -178.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 68.5 t -68.82 -39.57 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 108.525 -0.917 . . . . 0.14000000000000001 108.525 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -58.12 -46.58 85.35 Favored 'General case' 0 N--CA 1.502 2.169 0 CA-C-O 121.839 0.828 . . . . 0.19 109.523 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 376' ' ' HIS . . . . . 0.656 ' CE1' ' HZ1' ' B' ' 372' ' ' LYS . 13.2 m-70 -71.01 -35.87 72.2 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 113.308 0.855 . . . . 0.20999999999999999 113.308 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 95.9 mt -79.84 -25.14 40.86 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 118.443 -1.303 . . . . 0.12 111.788 -175.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 2.1 t -73.11 -38.89 56.13 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 N-CA-C 106.267 -1.753 . . . . 0.14000000000000001 106.267 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -68.84 -48.61 63.07 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.538 -1.282 . . . . 0.22 107.538 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . 0.506 ' HG ' ' CD2' ' B' ' 384' ' ' LEU . 28.2 tp -55.55 -47.36 76.48 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.836 -1.165 . . . . 0.17000000000000001 110.717 176.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 2.9 ttm -61.46 -35.04 76.49 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 120.712 -1.242 . . . . 0.14000000000000001 113.51 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -77.48 -29.36 52.59 Favored 'General case' 0 C--N 1.282 -2.341 0 O-C-N 121.183 -0.948 . . . . 0.17999999999999999 108.896 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . 0.266 31.7 mt-10 -76.47 -36.77 57.68 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.81 0.814 . . . . 0.20999999999999999 111.723 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 384' ' ' LEU . . . . . 0.506 ' CD2' ' HG ' ' B' ' 380' ' ' LEU . 0.0 OUTLIER -55.23 127.38 29.05 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 125.934 2.778 . . . . 0.17999999999999999 113.135 -176.119 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.308 -1.214 2 CA-C-N 108.1 -4.136 . . . . 0.23999999999999999 111.168 -178.233 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 200' ' ' PO3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.217 -0.613 0 CA-C-O 122.391 1.091 . . . . 0.16 112.81 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.725 ' HB ' ' CG1' ' A' ' 166' ' ' ILE . 2.3 mp -106.02 130.73 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.019 0 CA-C-O 122.663 1.22 . . . . 0.14000000000000001 110.698 177.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -100.46 124.86 46.53 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.229 -1.35 . . . . 0.13 110.318 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.4 mm -94.8 123.44 46.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 105.89 -1.893 . . . . 0.089999999999999997 105.89 176.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.2 mm -92.1 146.79 5.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 122.546 1.165 . . . . 0.10000000000000001 111.834 -178.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.71 121.09 51.22 Favored Pre-proline 0 N--CA 1.428 -1.541 0 N-CA-C 115.379 1.622 . . . . 0.070000000000000007 115.379 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -76.11 -20.02 15.11 Favored 'Trans proline' 0 CA--C 1.559 1.752 0 C-N-CA 121.494 1.463 . . . . 0.050000000000000003 111.396 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . 0.325 0.0 OUTLIER -147.43 161.19 41.54 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 123.815 0.846 . . . . 0.050000000000000003 110.173 175.29 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.9 m -82.61 148.14 28.17 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 121.729 0.776 . . . . 0.10000000000000001 111.099 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 156.81 -155.3 26.24 Favored Glycine 0 N--CA 1.431 -1.688 0 C-N-CA 119.086 -1.531 . . . . 0.080000000000000002 111.041 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.15 134.79 54.34 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.038 -1.081 . . . . 0.10000000000000001 110.063 -177.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.1 mt -74.38 141.45 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 C-N-CA 117.694 -1.602 . . . . 0.080000000000000002 110.383 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.3 t -132.62 155.9 41.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 114.519 -1.219 . . . . 0.089999999999999997 108.786 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.477 ' HB3' ' OE2' ' A' ' 34' ' ' GLU . 13.6 m120 -71.41 138.35 49.04 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-O 121.443 0.639 . . . . 0.11 111.099 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.422 ' CD1' ' CG1' ' A' ' 139' ' ' VAL . 8.2 tt -67.8 -23.67 29.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 C-N-CA 118.65 -1.22 . . . . 0.11 108.724 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.477 ' OE2' ' HB3' ' A' ' 32' ' ' ASN . 0.8 OUTLIER -73.91 -14.09 61.0 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 118.566 -1.254 . . . . 0.14000000000000001 110.543 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -94.9 12.32 28.64 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 113.689 0.996 . . . . 0.13 113.689 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 t -86.42 130.95 47.5 Favored Pre-proline 0 C--N 1.29 -2.011 0 CA-C-O 120.918 0.39 . . . . 0.13 109.963 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -70.46 48.03 0.72 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 122.711 2.274 . . . . 0.14999999999999999 111.781 -173.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.535 ' CG ' HH21 ' B' ' 317' ' ' ARG . 56.3 t0 -150.66 115.83 5.36 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.733 -1.21 . . . . 0.22 107.733 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.2 m -60.36 -37.8 75.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 C-N-CA 119.005 -1.078 . . . . 1.04 111.618 -178.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . 0.405 18.9 m -62.45 -34.94 67.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 116.861 -1.936 . . . . 1.0700000000000001 112.127 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -84.18 -44.15 14.25 Favored 'General case' 0 C--N 1.261 -3.254 0 O-C-N 120.178 -1.576 . . . . 0.25 109.897 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.6 -36.24 78.09 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 108.937 -0.764 . . . . 0.14999999999999999 108.937 -177.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -91.09 7.89 38.24 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 118.173 -1.411 . . . . 1.0800000000000001 110.584 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.514 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 0.3 OUTLIER 52.37 39.78 28.1 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 113.973 1.101 . . . . 0.14999999999999999 113.973 176.62 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.4 mm -67.19 -30.32 48.94 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.958 0 CA-C-O 123.786 1.755 . . . . 1.0700000000000001 110.703 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.293 2.1 t -89.55 -7.71 10.82 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.882 0 CA-C-N 112.375 -2.193 . . . . 1.1899999999999999 111.844 -175.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.514 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . 133.46 -175.57 20.13 Favored Glycine 0 C--O 1.206 -1.627 0 N-CA-C 108.743 -1.743 . . . . 0.14000000000000001 108.743 176.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -119.52 155.45 32.13 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 117.851 -1.539 . . . . 0.12 112.768 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 172.18 -137.77 4.44 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 117.725 -2.179 . . . . 0.089999999999999997 111.158 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 pp -134.98 175.24 11.51 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.716 0 O-C-N 121.592 -0.946 . . . . 0.070000000000000007 108.596 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -121.59 158.51 28.41 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 124.716 1.206 . . . . 0.070000000000000007 108.424 175.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.3 mt -133.33 128.81 55.87 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.826 0 O-C-N 121.641 -0.662 . . . . 0.059999999999999998 111.051 178.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -86.11 108.81 18.71 Favored Pre-proline 0 C--N 1.308 -1.232 0 N-CA-C 101.478 -3.527 . . . . 0.12 101.478 174.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -71.22 150.12 58.8 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 123.725 2.95 . . . . 0.089999999999999997 113.074 -170.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.3 p -138.61 1.6 2.14 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 121.774 -0.579 . . . . 0.11 110.161 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -108.83 -144.5 10.84 Favored Glycine 0 CA--C 1.534 1.238 0 O-C-N 121.444 -0.785 . . . . 0.10000000000000001 114.581 -177.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -142.97 14.48 1.89 Allowed 'General case' 0 CA--C 1.491 -1.291 0 O-C-N 122.363 -0.492 . . . . 0.12 112.079 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -157.28 155.17 30.28 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 115.415 -2.514 . . . . 0.11 113.092 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -114.96 121.44 43.18 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.868 -1.06 . . . . 0.070000000000000007 109.054 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 m -114.15 174.54 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 CA-C-O 122.74 1.257 . . . . 0.080000000000000002 110.964 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.15 126.66 92.92 Favored Pre-proline 0 C--N 1.289 -2.057 0 CA-C-N 113.663 -1.608 . . . . 0.080000000000000002 109.742 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -85.85 -1.5 8.82 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 CA-C-N 120.029 1.046 . . . . 0.070000000000000007 110.429 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.2 m -158.53 164.96 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-O 121.579 0.704 . . . . 0.089999999999999997 111.139 -178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 115' ' ' VAL . 48.0 m-20 -81.44 127.19 32.54 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 103.595 -2.743 . . . . 0.13 103.595 174.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 80' ' ' GLU . . . 174.0 -157.85 26.2 Favored Glycine 0 C--N 1.301 -1.375 0 N-CA-C 110.78 -0.928 . . . . 0.12 110.78 -175.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.6 m -123.69 134.93 53.64 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 119.814 -0.754 . . . . 0.14000000000000001 111.309 -177.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.7 mm -68.76 140.42 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.041 0 C-N-CA 117.619 -1.632 . . . . 0.12 107.394 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -101.76 -64.21 0.75 Allowed Glycine 0 C--N 1.282 -2.457 0 CA-C-O 121.955 0.753 . . . . 0.14000000000000001 114.291 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.53 ' CD ' ' O ' ' B' ' 351' ' ' GLN . 0.2 OUTLIER -141.35 136.47 31.51 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-O 122.991 1.377 . . . . 2.6400000000000001 111.934 -177.842 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 75.8 mt -116.24 125.46 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 N-CA-C 105.514 -2.032 . . . . 0.14000000000000001 105.514 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -62.72 145.46 54.7 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.164 -1.05 . . . . 0.23000000000000001 108.164 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -61.91 -14.9 38.59 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 123.674 0.79 . . . . 0.70999999999999996 110.488 -178.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.53 ' OG1' ' ND1' ' A' ' 75' ' ' HIS . 25.5 p -97.69 5.02 49.87 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 123.655 1.693 . . . . 1.0600000000000001 109.093 178.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.762 ' ND2' HH21 ' A' ' 105' ' ' ARG . 23.5 m120 50.51 44.31 27.11 Favored 'General case' 0 C--N 1.261 -3.269 0 CA-C-N 113.211 -1.813 . . . . 0.14000000000000001 112.59 175.449 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.636 ' HE2' ' CE1' ' A' ' 90' ' ' HIS . 13.7 p-80 -126.38 -1.52 6.92 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 113.64 0.978 . . . . 0.33000000000000002 113.64 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.32 152.75 31.47 Favored 'General case' 0 N--CA 1.412 -2.345 0 O-C-N 120.781 -1.2 . . . . 0.11 111.022 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -152.53 166.33 32.36 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 123.072 1.415 . . . . 0.10000000000000001 113.245 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.443 ' HB2' ' H ' ' A' ' 69' ' ' LYS 0.259 15.8 m -118.29 139.72 50.9 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 113.278 -1.783 . . . . 0.12 109.849 -178.894 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.6 tt -143.27 150.03 17.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.585 -1.265 . . . . 0.10000000000000001 107.585 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.476 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 84.6 tt0 -118.42 129.91 55.67 Favored 'General case' 0 C--O 1.201 -1.466 0 N-CA-C 105.628 -1.99 . . . . 0.52000000000000002 105.628 177.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 94.0 p -80.91 167.32 20.0 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 118.457 -1.297 . . . . 0.13 108.28 -176.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.406 ' C ' ' H ' ' A' ' 84' ' ' GLY . 83.0 m-20 -68.11 -31.02 70.33 Favored 'General case' 0 C--N 1.277 -2.569 0 C-N-CA 118.538 -1.265 . . . . 0.14999999999999999 108.264 177.714 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.22 4.44 2.21 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 125.212 1.405 . . . . 0.14000000000000001 111.998 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 78.73 14.51 81.98 Favored Glycine 0 C--N 1.28 -2.557 0 N-CA-C 117.351 1.7 . . . . 0.14999999999999999 117.351 -178.755 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.421 HG22 ' CD1' ' A' ' 166' ' ' ILE . 48.8 t -92.42 133.01 35.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 121.189 2.494 . . . . 0.12 110.886 177.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.435 ' OE1' ' CB ' ' B' ' 348' ' ' PHE . 96.5 mt-10 -96.9 121.92 39.3 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.669 -0.645 . . . . 1.73 110.229 176.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -116.32 158.84 22.79 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.986 0.898 . . . . 0.089999999999999997 110.922 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -143.66 111.87 6.27 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 122.988 1.375 . . . . 0.39000000000000001 109.759 177.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.1 t -101.73 115.6 43.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 114.05 -1.432 . . . . 0.070000000000000007 111.41 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.636 ' CE1' ' HE2' ' A' ' 75' ' ' HIS . 2.1 t-80 -123.24 105.07 9.56 Favored 'General case' 0 C--O 1.199 -1.564 0 CA-C-N 115.501 -0.772 . . . . 0.22 111.098 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -63.56 124.13 20.57 Favored 'General case' 0 CA--C 1.558 1.278 0 N-CA-C 116.688 2.107 . . . . 0.10000000000000001 116.688 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.28 -175.84 31.91 Favored Glycine 0 C--O 1.214 -1.123 0 CA-C-O 122.578 1.099 . . . . 0.10000000000000001 114.496 175.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 49.1 mm -118.0 132.62 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-O 123.129 1.442 . . . . 0.14000000000000001 109.158 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 54.69 25.75 6.79 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 114.104 -1.407 . . . . 0.17999999999999999 111.227 -177.17 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.3 p -64.42 -19.82 65.76 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 115.451 1.648 . . . . 0.14999999999999999 115.451 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.3 p -57.09 -32.83 41.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 O-C-N 120.124 -1.61 . . . . 1.04 109.32 177.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -58.61 -19.99 43.47 Favored 'General case' 0 CA--C 1.566 1.581 0 C-N-CA 119.867 -0.733 . . . . 0.25 112.092 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mp -78.22 -3.24 41.72 Favored 'General case' 0 CA--C 1.564 1.485 0 O-C-N 119.733 -1.855 . . . . 0.17000000000000001 113.913 177.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 32.4 mtmm 48.95 46.23 22.34 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 116.082 1.882 . . . . 3.6099999999999999 116.082 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 90.69 -13.24 66.25 Favored Glycine 0 CA--C 1.543 1.799 0 N-CA-C 115.492 0.957 . . . . 0.16 115.492 176.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.14 121.29 12.71 Favored 'General case' 0 C--N 1.284 -2.263 0 O-C-N 121.36 -1.082 . . . . 0.17999999999999999 112.008 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.521 ' O ' ' HA ' ' A' ' 122' ' ' PHE . . . 97.68 -7.09 63.1 Favored Glycine 0 C--O 1.201 -1.956 0 N-CA-C 114.902 0.721 . . . . 0.14999999999999999 114.902 178.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -115.67 152.25 33.52 Favored 'General case' 0 C--N 1.284 -2.282 0 C-N-CA 124.121 0.968 . . . . 0.13 111.008 177.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . 0.513 ' NZ ' ' O ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -141.95 113.41 7.71 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 124.625 1.17 . . . . 0.14000000000000001 109.199 176.843 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.762 HH21 ' ND2' ' A' ' 74' ' ' ASN . 5.0 ttm180 -67.19 123.53 20.55 Favored 'General case' 0 CA--C 1.462 -2.416 0 C-N-CA 120.448 -0.501 . . . . 0.14999999999999999 109.946 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 24.0 mm -106.31 -34.99 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.251 0 C-N-CA 114.928 -2.709 . . . . 0.12 108.119 -179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.08 178.22 5.62 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 118.682 -1.207 . . . . 0.12 112.235 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -118.31 151.46 37.66 Favored 'General case' 0 C--O 1.213 -0.83 0 N-CA-C 112.594 0.59 . . . . 0.14999999999999999 112.594 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -60.89 137.26 58.23 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 118.498 -1.281 . . . . 1.6799999999999999 108.021 175.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.27 -5.23 84.31 Favored Glycine 0 N--CA 1.475 1.253 0 N-CA-C 111.624 -0.591 . . . . 0.14999999999999999 111.624 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -65.72 138.04 57.69 Favored 'General case' 0 C--N 1.288 -2.07 0 C-N-CA 118.398 -1.321 . . . . 0.13 112.879 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.511 ' CG ' HH11 ' A' ' 112' ' ' ARG . 0.0 OUTLIER -86.23 132.67 33.94 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 114.121 -1.4 . . . . 0.14999999999999999 107.307 175.611 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 m -139.87 160.33 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.023 0 C-N-CA 117.475 -1.69 . . . . 0.11 113.051 -176.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.469 ' HE3' ' OD2' ' A' ' 117' ' ' ASP . 0.5 OUTLIER -110.81 156.7 20.73 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 111.905 -2.407 . . . . 0.14000000000000001 108.406 174.63 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.417 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 43.9 t -45.7 135.74 2.09 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 CA-C-O 121.596 0.712 . . . . 0.11 111.675 176.438 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.2 -13.05 64.5 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 120.831 -0.699 . . . . 0.10000000000000001 114.38 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.469 ' OD2' ' HE3' ' A' ' 114' ' ' LYS . 91.5 m-20 -63.14 136.38 57.72 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 118.866 1.333 . . . . 0.11 109.797 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.4 m -76.68 132.38 39.33 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-O 122.912 1.339 . . . . 0.11 111.123 -177.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.439 ' O ' HG13 ' A' ' 120' ' ' ILE . 44.8 t -105.83 -48.45 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.684 0 CA-C-N 113.495 -1.684 . . . . 0.089999999999999997 109.315 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 119' ' ' VAL . 10.8 mt -148.37 143.56 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.707 0 N-CA-C 114.085 1.143 . . . . 0.10000000000000001 114.085 -177.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . 0.472 ' O ' ' HD2' ' A' ' 104' ' ' LYS . 49.4 mt-10 -112.28 147.47 36.22 Favored 'General case' 0 CA--C 1.483 -1.627 0 C-N-CA 116.646 -2.022 . . . . 0.12 107.279 175.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.521 ' HA ' ' O ' ' A' ' 102' ' ' GLY . 36.0 p90 -132.94 163.55 28.94 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 122.08 0.943 . . . . 0.11 111.57 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.436 ' OD1' ' HD2' ' A' ' 125' ' ' PRO . 10.3 t0 -100.41 97.85 8.55 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 124.72 1.208 . . . . 0.14999999999999999 109.813 176.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.551 ' HB3' ' HD3' ' A' ' 125' ' ' PRO . 3.1 tp -59.22 -54.79 52.77 Favored Pre-proline 0 C--N 1.292 -1.899 0 N-CA-C 116.061 1.874 . . . . 0.12 116.061 -176.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.551 ' HD3' ' HB3' ' A' ' 124' ' ' LEU . 20.6 Cg_exo -56.92 -44.68 42.37 Favored 'Trans proline' 1 C--N 1.247 -4.804 0 C-N-CA 121.483 1.455 . . . . 0.14999999999999999 109.706 -175.647 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.732 ' CD1' ' HG3' ' A' ' 130' ' ' LYS . 0.5 OUTLIER -57.17 -51.0 71.07 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.134 -0.691 . . . . 0.16 109.134 177.738 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.5 mt -68.36 -31.42 70.79 Favored 'General case' 0 C--N 1.281 -2.394 0 O-C-N 121.092 -1.005 . . . . 0.13 112.098 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -65.13 -37.62 88.03 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 106.727 -1.582 . . . . 0.14999999999999999 106.727 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -75.26 -42.3 55.37 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.218 -0.901 . . . . 0.19 113.33 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.732 ' HG3' ' CD1' ' A' ' 126' ' ' LEU . 0.1 OUTLIER -94.79 -29.28 14.83 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 116.38 1.992 . . . . 0.20000000000000001 116.38 -175.817 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.56 142.96 36.93 Favored 'General case' 0 C--N 1.262 -3.207 0 N-CA-C 115.329 1.603 . . . . 0.14999999999999999 115.329 -176.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.508 ' HD2' ' HA ' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -55.7 -37.82 68.88 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 108.436 -0.95 . . . . 0.19 108.436 178.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.8 t -163.78 143.93 8.44 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 125.037 1.335 . . . . 0.13 110.686 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 76.8 p -95.96 -0.57 50.55 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 114.773 -1.103 . . . . 0.11 110.58 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 17.1 mt -56.33 130.39 44.41 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.263 -1.384 . . . . 0.11 107.263 177.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 93.3 m -118.77 96.92 50.5 Favored Pre-proline 0 N--CA 1.43 -1.432 0 N-CA-C 118.124 2.638 . . . . 0.070000000000000007 118.124 -173.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . 0.415 ' HD2' ' O ' ' A' ' 90' ' ' HIS . 8.5 Cg_exo -67.02 142.94 63.78 Favored 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 117.163 -1.425 . . . . 0.089999999999999997 114.357 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . 0.313 1.6 m -125.83 104.66 13.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 105.192 -2.151 . . . . 0.059999999999999998 105.192 173.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.422 ' CG1' ' CD1' ' A' ' 33' ' ' ILE . 16.3 m -123.51 158.84 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 N-CA-C 116.237 1.939 . . . . 0.10000000000000001 116.237 -176.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.8 mp -97.61 125.51 50.74 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.319 0 N-CA-C 104.566 -2.383 . . . . 0.12 104.566 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 17.2 p -98.41 -4.41 34.75 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 123.158 1.456 . . . . 0.14000000000000001 112.936 -175.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 143' ' ' MET 0.482 0.0 OUTLIER -97.8 15.17 24.53 Favored 'General case' 0 C--N 1.258 -3.386 0 C-N-CA 130.087 3.355 . . . . 0.14999999999999999 114.505 -179.757 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.432 ' C ' ' O ' ' A' ' 142' ' ' ASN 0.251 62.1 mmm -33.68 -45.09 0.17 Allowed 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 115.555 1.687 . . . . 0.16 115.555 -174.261 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -64.11 -11.64 31.85 Favored 'General case' 0 C--N 1.251 -3.682 0 O-C-N 119.891 -1.755 . . . . 0.26000000000000001 113.099 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -106.02 12.68 30.18 Favored 'General case' 0 CA--C 1.479 -1.758 0 CA-C-N 121.225 1.829 . . . . 0.17999999999999999 111.57 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 2.5 pt -120.36 140.81 43.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 C-N-CA 115.906 -2.317 . . . . 0.16 113.983 -177.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . 0.639 ' HB2' ' HB3' ' A' ' 168' ' ' LYS 0.255 12.1 tptt -74.45 -54.73 7.0 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 114.49 -1.232 . . . . 0.20999999999999999 109.794 -179.864 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.506 ' O ' ' HA ' ' A' ' 166' ' ' ILE . 0.0 OUTLIER -147.31 145.59 29.4 Favored 'General case' 0 C--N 1.289 -2.063 0 O-C-N 119.913 -1.742 . . . . 0.17000000000000001 114.055 177.017 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.68 112.31 21.9 Favored 'General case' 0 N--CA 1.415 -2.177 0 CA-C-N 111.066 -2.788 . . . . 0.13 109.881 177.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 61.8 mt -108.94 112.19 39.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 114.515 -1.221 . . . . 0.14000000000000001 107.92 177.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 34.5 mttt -84.93 129.84 34.74 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 124.492 1.117 . . . . 0.11 113.399 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.299 31.3 mt -94.4 175.78 6.55 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-O 122.732 1.253 . . . . 0.11 112.325 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . 0.276 0.5 OUTLIER -131.09 160.43 34.72 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 113.484 -1.689 . . . . 0.11 114.773 -174.325 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 100.25 -158.82 19.43 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 118.906 2.322 . . . . 0.11 118.906 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.8 142.13 27.83 Favored 'General case' 0 C--O 1.213 -0.841 0 CA-C-N 112.064 -2.068 . . . . 0.12 109.892 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 16.5 m -131.83 159.68 42.93 Favored 'Isoleucine or valine' 0 CA--C 1.46 -2.511 0 CA-C-O 122.783 1.277 . . . . 0.089999999999999997 110.041 -177.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 20.8 m -122.77 123.7 41.66 Favored 'General case' 0 C--N 1.273 -2.734 0 CA-C-N 112.754 -2.021 . . . . 0.12 108.194 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 12.1 p -37.38 123.68 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 CA-C-O 123.725 1.726 . . . . 0.089999999999999997 113.991 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 61.15 25.82 65.03 Favored Glycine 0 CA--C 1.487 -1.68 0 CA-C-N 112.804 -1.998 . . . . 0.10000000000000001 114.232 176.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.43 -53.24 0.72 Allowed 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 119.593 -0.843 . . . . 0.14000000000000001 111.958 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 9.1 m -85.35 122.98 73.61 Favored Pre-proline 0 C--N 1.282 -2.352 0 N-CA-C 114.219 1.192 . . . . 0.11 114.219 -175.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -62.44 141.46 86.92 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.964 2.443 . . . . 0.11 109.766 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 28.9 m -116.64 -27.92 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.625 -0.672 . . . . 0.070000000000000007 112.196 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 30.5 mt -141.17 150.94 19.85 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 108.502 -0.925 . . . . 0.089999999999999997 108.502 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 5.9 mtt180 -125.76 130.83 52.25 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 105.784 -1.932 . . . . 0.13 105.784 176.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.725 ' CG1' ' HB ' ' A' ' 20' ' ' ILE . 39.9 pt -128.36 155.57 40.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 119.075 -1.05 . . . . 0.13 109.813 -177.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 168' ' ' LYS . 1.1 tttt -120.72 154.21 35.92 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.987 -0.746 . . . . 0.19 108.987 176.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.639 ' HB3' ' HB2' ' A' ' 147' ' ' LYS . 9.6 tttt . . . . . 0 C--N 1.322 -0.595 0 N-CA-C 108.87 -0.789 . . . . 0.20000000000000001 108.87 -177.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 301' ' ' MET . . . . . 0.447 ' HB2' ' HG2' ' B' ' 366' ' ' GLU . 4.2 ttm . . . . . 0 C--O 1.219 -0.545 0 N-CA-C 108.473 -0.936 . . . . 0.20000000000000001 108.473 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 302' ' ' PHE . . . . . 0.493 ' CD2' ' HA ' ' B' ' 371' ' ' GLN . 74.9 t80 -142.93 140.91 31.33 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.219 -1.4 . . . . 0.20000000000000001 107.219 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -150.85 157.34 42.8 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 120.998 -1.064 . . . . 0.16 109.461 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -153.18 147.62 25.97 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.024 -1.472 . . . . 0.19 107.024 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.97 151.96 19.17 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.296 -1.001 . . . . 0.17000000000000001 108.296 178.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.62 144.31 17.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 107.345 -1.354 . . . . 0.16 107.345 174.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 87.1 m -93.9 136.69 33.92 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.596 0.712 . . . . 0.20999999999999999 110.107 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 59.0 mt -85.69 114.12 25.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 104.653 -2.351 . . . . 0.19 104.653 177.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 61.1 p -106.44 -3.86 20.49 Favored 'General case' 0 N--CA 1.514 2.729 0 N-CA-C 114.57 1.322 . . . . 0.23000000000000001 114.57 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.74 139.2 83.12 Favored Pre-proline 0 N--CA 1.487 1.396 0 CA-C-N 120.314 1.415 . . . . 0.22 110.701 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -46.45 -44.87 20.18 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 123.012 2.475 . . . . 0.27000000000000002 117.095 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -103.72 29.29 5.88 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 115.758 -2.377 . . . . 1.25 107.145 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 59.49 -148.71 40.94 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 117.615 -2.231 . . . . 0.20000000000000001 110.981 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . . . . . . . . . 17.1 tp -87.07 74.15 9.71 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 118.267 -1.373 . . . . 0.14999999999999999 108.985 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 315' ' ' HIS . . . . . 0.436 ' CD2' ' CG ' ' B' ' 318' ' ' PRO . 2.5 p80 -69.24 -178.04 1.24 Allowed 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 118.656 -1.217 . . . . 0.34999999999999998 112.678 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 26.8 m -49.04 -60.19 2.99 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 118.77 2.878 . . . . 1.1100000000000001 118.77 -174.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 317' ' ' ARG . . . . . 0.535 HH21 ' CG ' ' A' ' 38' ' ' ASP . 18.8 ttm180 -63.93 -44.53 78.98 Favored Pre-proline 0 C--N 1.281 -2.395 0 CA-C-N 122.671 2.487 . . . . 1.5700000000000001 112.902 -176.628 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 318' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' B' ' 317' ' ' ARG . 9.2 Cg_endo -67.95 -28.89 35.14 Favored 'Trans proline' 0 C--N 1.296 -2.194 0 CA-C-N 121.149 1.446 . . . . 0.20000000000000001 111.937 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -69.44 -35.43 75.65 Favored 'General case' 0 N--CA 1.509 2.5 0 O-C-N 120.824 -1.172 . . . . 0.14000000000000001 108.839 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -71.52 -39.32 70.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.798 -1.189 . . . . 0.17999999999999999 108.867 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -67.84 -35.93 79.44 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 118.084 -1.447 . . . . 2.2599999999999998 108.7 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -64.25 -44.62 91.23 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 122.408 1.099 . . . . 0.12 108.704 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 55.1 t -64.67 -40.45 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-N 115.227 -0.897 . . . . 1.03 110.526 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -64.47 -41.06 96.72 Favored 'General case' 0 C--N 1.293 -1.879 0 O-C-N 120.752 -1.217 . . . . 1.72 109.735 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -68.27 -40.17 81.96 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.152 -0.685 . . . . 0.16 109.152 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.58 -42.31 92.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.945 -1.097 . . . . 0.14000000000000001 109.283 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -62.82 -15.05 52.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.034 -1.041 . . . . 2.1099999999999999 112.875 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -78.36 -11.26 85.5 Favored Glycine 0 N--CA 1.478 1.498 0 N-CA-C 108.85 -1.7 . . . . 0.19 108.85 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . 0.484 ' HE1' ' HE3' ' B' ' 372' ' ' LYS . 82.3 m-85 -103.88 144.99 30.77 Favored 'General case' 0 N--CA 1.507 2.388 0 CA-C-N 118.713 1.257 . . . . 0.17999999999999999 110.129 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 74.4 p -76.9 -28.7 55.44 Favored 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 118.611 -0.709 . . . . 0.23000000000000001 112.503 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 20.3 m -58.92 157.58 9.63 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 123.384 1.564 . . . . 0.19 114.899 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.6 128.49 33.46 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 102.22 -3.252 . . . . 0.19 102.22 172.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 41.7 mt -125.76 133.93 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 108.203 -1.036 . . . . 0.14000000000000001 108.203 -175.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 97.6 m -124.58 140.68 52.72 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 122.267 1.032 . . . . 0.14999999999999999 109.184 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 93.1 t -107.33 127.38 63.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 105.34 -2.096 . . . . 0.12 105.34 174.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 88.3 m -124.73 121.04 33.52 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.881 0.848 . . . . 0.16 110.396 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 33.5 t -125.65 123.83 39.82 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 118.425 -1.31 . . . . 0.17000000000000001 108.129 177.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 49.71 40.19 19.43 Favored 'General case' 0 N--CA 1.514 2.765 0 N-CA-C 112.872 0.693 . . . . 0.23000000000000001 112.872 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 81.05 12.23 82.78 Favored Glycine 0 N--CA 1.485 1.923 0 O-C-N 120.487 -1.383 . . . . 0.20999999999999999 113.334 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -121.8 136.69 54.94 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 103.539 -2.763 . . . . 2.98 103.539 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 68.8 m -121.55 156.1 33.6 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-O 124.321 2.01 . . . . 0.17999999999999999 114.996 -175.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -151.52 148.01 27.52 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 111.848 -2.433 . . . . 0.16 110.82 176.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 7.6 t -65.59 132.93 50.08 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.416 -1.698 . . . . 0.16 106.416 173.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -73.47 -6.02 43.71 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 120.285 -1.509 . . . . 0.11 110.842 178.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -98.23 12.74 33.68 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.966 -1.084 . . . . 0.17999999999999999 109.189 -178.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.23 105.64 6.74 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 123.122 1.439 . . . . 0.17999999999999999 110.557 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 32.6 tp -57.34 -37.59 72.78 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 113.949 -1.478 . . . . 1.0600000000000001 109.303 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 348' ' ' PHE . . . . . 0.435 ' CB ' ' OE1' ' A' ' 86' ' ' GLU . 72.5 t80 -61.18 -50.4 73.32 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 120.355 -1.465 . . . . 0.46999999999999997 112.975 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -69.57 -31.68 70.0 Favored 'General case' 0 C--N 1.314 -0.963 0 O-C-N 119.609 -1.932 . . . . 1.79 110.56 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 3.1 mt -65.29 -32.03 73.47 Favored 'General case' 0 C--N 1.285 -2.236 0 C-N-CA 119.201 -0.999 . . . . 0.14999999999999999 109.309 -177.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . 0.53 ' O ' ' CD ' ' A' ' 69' ' ' LYS . 89.6 mt-30 -68.17 -10.72 56.36 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.96 -0.462 . . . . 0.82999999999999996 109.833 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 2.0 p -91.86 -4.02 55.33 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 118.347 -1.341 . . . . 1.04 110.78 -177.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 25.1 mt -94.63 157.05 16.14 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.233 -0.917 . . . . 0.17000000000000001 110.076 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -86.3 106.45 3.09 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 104.713 -3.355 . . . . 0.17999999999999999 104.713 177.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 91.3 mt -122.37 48.39 1.76 Allowed 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 106.153 -1.795 . . . . 0.16 106.153 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 43.0 p -83.12 171.02 14.16 Favored 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 109.335 -0.617 . . . . 1.0600000000000001 109.335 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -57.7 138.52 55.36 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.177 -0.952 . . . . 0.26000000000000001 110.675 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 92.19 -3.13 76.05 Favored Glycine 0 N--CA 1.474 1.173 0 C-N-CA 119.39 -1.385 . . . . 0.22 112.61 177.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 55.3 m -84.82 132.98 34.34 Favored 'General case' 0 C--N 1.291 -1.975 0 O-C-N 121.507 -0.996 . . . . 0.19 111.185 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 94.7 t -94.44 122.86 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 107.031 -1.47 . . . . 0.19 107.031 177.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 17.8 m -112.73 161.33 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 C-N-CA 116.891 -1.923 . . . . 0.13 109.891 178.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 85.4 m -110.06 130.52 55.52 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 106.324 -1.732 . . . . 0.14000000000000001 106.324 175.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 54.5 mt -110.33 120.43 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 102.869 -3.011 . . . . 0.11 102.869 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.42 146.43 49.62 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 107.716 -1.216 . . . . 0.14000000000000001 107.716 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -141.05 153.66 45.6 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 117.566 -1.653 . . . . 0.16 108.63 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 366' ' ' GLU . . . . . 0.447 ' HG2' ' HB2' ' B' ' 301' ' ' MET . 0.0 OUTLIER -141.79 111.91 6.87 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.06 -1.459 . . . . 0.22 107.06 178.701 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 165.25 -173.49 41.04 Favored Glycine 0 C--N 1.294 -1.766 0 C-N-CA 117.651 -2.214 . . . . 0.22 108.64 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -54.78 -41.5 70.62 Favored 'General case' 0 C--N 1.285 -2.213 0 C-N-CA 124.134 0.974 . . . . 0.28000000000000003 113.253 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 15.2 p30 -116.04 36.71 3.93 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 117.002 -1.879 . . . . 0.20999999999999999 108.135 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -58.97 -30.35 67.87 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 119.001 2.963 . . . . 0.20000000000000001 119.001 -175.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 371' ' ' GLN . . . . . 0.493 ' HA ' ' CD2' ' B' ' 302' ' ' PHE . 0.0 OUTLIER -78.2 -43.36 28.72 Favored 'General case' 0 N--CA 1.512 2.66 0 O-C-N 119.647 -1.908 . . . . 0.23999999999999999 109.768 -177.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 372' ' ' LYS . . . . . 0.657 ' HZ1' ' CE1' ' B' ' 376' ' ' HIS . 13.2 ttpp -63.78 -40.71 97.33 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 106.878 -1.527 . . . . 0.23000000000000001 106.878 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.21 -46.89 86.86 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 118.441 -1.303 . . . . 0.16 110.599 -178.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 68.7 t -68.78 -39.54 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 N-CA-C 108.521 -0.918 . . . . 0.14000000000000001 108.521 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -58.21 -46.49 85.75 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.846 0.831 . . . . 0.20999999999999999 109.508 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 376' ' ' HIS . . . . . 0.657 ' CE1' ' HZ1' ' B' ' 372' ' ' LYS . 13.2 m-70 -71.05 -35.81 72.08 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 113.347 0.869 . . . . 0.22 113.347 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 95.8 mt -79.87 -25.11 40.79 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.447 -1.301 . . . . 0.13 111.786 -175.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 2.1 t -73.13 -38.88 56.0 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 N-CA-C 106.288 -1.745 . . . . 0.16 106.288 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -68.83 -48.6 63.13 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 107.563 -1.273 . . . . 0.23000000000000001 107.563 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . 0.505 ' HG ' ' CD2' ' B' ' 384' ' ' LEU . 28.2 tp -55.53 -47.37 76.4 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 118.773 -1.171 . . . . 0.16 110.754 176.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 2.9 ttm -61.49 -35.02 76.48 Favored 'General case' 0 C--N 1.309 -1.168 0 O-C-N 120.721 -1.237 . . . . 0.14999999999999999 113.44 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -77.48 -29.46 52.66 Favored 'General case' 0 C--N 1.282 -2.36 0 O-C-N 121.229 -0.919 . . . . 0.19 108.856 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . 0.265 32.3 mt-10 -76.37 -36.76 57.97 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 121.787 0.803 . . . . 0.22 111.757 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 384' ' ' LEU . . . . . 0.505 ' CD2' ' HG ' ' B' ' 380' ' ' LEU . 0.0 OUTLIER -55.21 127.42 29.17 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 125.822 2.725 . . . . 0.17999999999999999 113.15 -176.099 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.307 -1.247 2 CA-C-N 108.129 -4.123 . . . . 0.23000000000000001 111.168 -178.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 200' ' ' PO3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.217 -0.613 0 CA-C-O 122.391 1.091 . . . . 0.16 112.81 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.687 ' HB ' ' CG1' ' A' ' 166' ' ' ILE . 2.3 mp -106.02 130.73 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.019 0 CA-C-O 122.663 1.22 . . . . 0.14000000000000001 110.698 177.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -100.46 124.86 46.53 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.229 -1.35 . . . . 0.13 110.318 176.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.4 mm -94.8 123.44 46.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 105.89 -1.893 . . . . 0.089999999999999997 105.89 176.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.2 mm -92.1 146.79 5.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 122.546 1.165 . . . . 0.10000000000000001 111.834 -178.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.71 121.09 51.22 Favored Pre-proline 0 N--CA 1.428 -1.541 0 N-CA-C 115.379 1.622 . . . . 0.070000000000000007 115.379 -178.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -76.11 -20.02 15.11 Favored 'Trans proline' 0 CA--C 1.559 1.752 0 C-N-CA 121.494 1.463 . . . . 0.050000000000000003 111.396 -177.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . 0.325 0.0 OUTLIER -147.43 161.19 41.54 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 123.815 0.846 . . . . 0.050000000000000003 110.173 175.29 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.9 m -82.61 148.14 28.17 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 121.729 0.776 . . . . 0.10000000000000001 111.099 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 156.81 -155.3 26.24 Favored Glycine 0 N--CA 1.431 -1.688 0 C-N-CA 119.086 -1.531 . . . . 0.080000000000000002 111.041 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.15 134.79 54.34 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.038 -1.081 . . . . 0.10000000000000001 110.063 -177.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.1 mt -74.38 141.45 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 C-N-CA 117.694 -1.602 . . . . 0.080000000000000002 110.383 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.3 t -132.62 155.9 41.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 114.519 -1.219 . . . . 0.089999999999999997 108.786 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.477 ' HB3' ' OE2' ' A' ' 34' ' ' GLU . 13.6 m120 -71.41 138.35 49.04 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-O 121.443 0.639 . . . . 0.11 111.099 178.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.487 ' CD1' ' CG1' ' A' ' 139' ' ' VAL . 8.2 tt -67.8 -23.67 29.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 C-N-CA 118.65 -1.22 . . . . 0.11 108.724 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.477 ' OE2' ' HB3' ' A' ' 32' ' ' ASN . 0.8 OUTLIER -73.91 -14.09 61.0 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 118.566 -1.254 . . . . 0.14000000000000001 110.543 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -94.9 12.32 28.64 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 113.689 0.996 . . . . 0.13 113.689 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 t -86.42 130.95 47.5 Favored Pre-proline 0 C--N 1.29 -2.011 0 CA-C-O 120.918 0.39 . . . . 0.13 109.963 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -70.46 48.03 0.72 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 122.711 2.274 . . . . 0.14999999999999999 111.781 -173.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.524 ' CG ' HH21 ' B' ' 317' ' ' ARG . 65.3 t0 -150.66 115.83 5.36 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.733 -1.21 . . . . 0.22 107.733 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.8 m -60.34 -37.9 75.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 C-N-CA 119.005 -1.078 . . . . 1.04 111.569 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . 0.404 19.3 m -62.41 -34.89 66.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 C-N-CA 116.864 -1.934 . . . . 1.0700000000000001 112.148 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -84.18 -44.27 14.13 Favored 'General case' 0 C--N 1.262 -3.23 0 O-C-N 120.132 -1.605 . . . . 0.25 109.841 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.52 -36.24 77.9 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 108.937 -0.764 . . . . 0.14999999999999999 108.937 -177.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -91.05 7.81 38.55 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 118.173 -1.411 . . . . 1.0800000000000001 110.585 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.514 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 0.3 OUTLIER 52.42 39.78 28.26 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 113.973 1.101 . . . . 0.14999999999999999 113.973 176.651 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.3 mm -67.18 -30.35 49.04 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.958 0 CA-C-O 123.747 1.737 . . . . 1.0700000000000001 110.696 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.293 2.1 t -89.52 -7.71 10.82 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.898 0 CA-C-N 112.336 -2.211 . . . . 1.1899999999999999 111.844 -175.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.514 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . 133.46 -175.57 20.13 Favored Glycine 0 C--O 1.206 -1.627 0 N-CA-C 108.743 -1.743 . . . . 0.14000000000000001 108.743 176.57 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -119.52 155.45 32.13 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 117.851 -1.539 . . . . 0.12 112.768 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 172.18 -137.77 4.44 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 117.725 -2.179 . . . . 0.089999999999999997 111.158 177.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.8 pp -134.98 175.24 11.51 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.716 0 O-C-N 121.592 -0.946 . . . . 0.070000000000000007 108.596 178.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -121.59 158.51 28.41 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 124.716 1.206 . . . . 0.070000000000000007 108.424 175.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.3 mt -133.33 128.81 55.87 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.826 0 O-C-N 121.641 -0.662 . . . . 0.059999999999999998 111.051 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -86.11 108.81 18.71 Favored Pre-proline 0 C--N 1.308 -1.232 0 N-CA-C 101.478 -3.527 . . . . 0.12 101.478 174.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -71.22 150.12 58.8 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 123.725 2.95 . . . . 0.089999999999999997 113.074 -170.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.3 p -138.61 1.6 2.14 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 121.774 -0.579 . . . . 0.11 110.161 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -108.83 -144.5 10.84 Favored Glycine 0 CA--C 1.534 1.238 0 O-C-N 121.444 -0.785 . . . . 0.10000000000000001 114.581 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -142.97 14.48 1.89 Allowed 'General case' 0 CA--C 1.491 -1.291 0 O-C-N 122.363 -0.492 . . . . 0.12 112.079 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -157.28 155.17 30.28 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 115.415 -2.514 . . . . 0.11 113.092 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -114.96 121.44 43.18 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.868 -1.06 . . . . 0.070000000000000007 109.054 178.744 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 m -114.15 174.54 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 CA-C-O 122.74 1.257 . . . . 0.080000000000000002 110.964 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.15 126.66 92.92 Favored Pre-proline 0 C--N 1.289 -2.057 0 CA-C-N 113.663 -1.608 . . . . 0.080000000000000002 109.742 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -85.85 -1.5 8.82 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 CA-C-N 120.029 1.046 . . . . 0.070000000000000007 110.429 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . . . . . . . . . 17.2 m -158.53 164.96 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-O 121.579 0.704 . . . . 0.089999999999999997 111.139 -178.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 115' ' ' VAL . 48.0 m-20 -81.44 127.19 32.54 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 103.595 -2.743 . . . . 0.13 103.595 174.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.475 ' HA3' ' O ' ' A' ' 80' ' ' GLU . . . 174.0 -157.85 26.2 Favored Glycine 0 C--N 1.301 -1.375 0 N-CA-C 110.78 -0.928 . . . . 0.12 110.78 -175.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.6 m -123.69 134.93 53.64 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 119.814 -0.754 . . . . 0.14000000000000001 111.309 -177.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.7 mm -68.76 140.42 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.041 0 C-N-CA 117.619 -1.632 . . . . 0.12 107.394 178.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -101.76 -64.21 0.75 Allowed Glycine 0 C--N 1.282 -2.457 0 CA-C-O 121.955 0.753 . . . . 0.14000000000000001 114.291 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.541 ' CD ' ' O ' ' B' ' 351' ' ' GLN . 0.1 OUTLIER -141.38 136.47 31.46 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-O 123.059 1.409 . . . . 2.6400000000000001 111.925 -177.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 75.8 mt -116.23 125.46 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 N-CA-C 105.514 -2.032 . . . . 0.14000000000000001 105.514 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -62.72 145.46 54.7 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.164 -1.05 . . . . 0.23000000000000001 108.164 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -61.91 -14.9 38.59 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 123.674 0.79 . . . . 0.70999999999999996 110.488 -178.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.542 ' OG1' ' ND1' ' A' ' 75' ' ' HIS . 16.7 p -97.67 4.98 49.95 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 123.593 1.663 . . . . 1.0600000000000001 109.068 178.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.67 ' ND2' HH21 ' A' ' 105' ' ' ARG . 23.5 m120 50.53 44.31 27.19 Favored 'General case' 0 C--N 1.26 -3.305 0 CA-C-N 113.23 -1.805 . . . . 0.14000000000000001 112.59 175.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' HIS . . . . . 0.667 ' HE2' ' CE1' ' A' ' 90' ' ' HIS . 20.1 p-80 -126.41 -1.45 6.9 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 113.661 0.986 . . . . 0.33000000000000002 113.661 -177.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.37 152.75 31.44 Favored 'General case' 0 N--CA 1.412 -2.345 0 O-C-N 120.836 -1.165 . . . . 0.11 111.022 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -152.53 166.33 32.36 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 123.072 1.415 . . . . 0.10000000000000001 113.245 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . 0.443 ' HB2' ' H ' ' A' ' 69' ' ' LYS 0.259 15.8 m -118.29 139.72 50.9 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 113.278 -1.783 . . . . 0.12 109.849 -178.894 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.6 tt -143.27 150.03 17.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.585 -1.265 . . . . 0.10000000000000001 107.585 175.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . 0.475 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 84.6 tt0 -118.42 129.91 55.67 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 105.628 -1.99 . . . . 0.52000000000000002 105.628 177.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 94.0 p -80.91 167.32 20.0 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 118.457 -1.297 . . . . 0.13 108.28 -176.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.406 ' C ' ' H ' ' A' ' 84' ' ' GLY . 83.0 m-20 -68.11 -31.02 70.33 Favored 'General case' 0 C--N 1.277 -2.569 0 C-N-CA 118.538 -1.265 . . . . 0.14999999999999999 108.264 177.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.22 4.44 2.21 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 125.212 1.405 . . . . 0.14000000000000001 111.998 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.406 ' H ' ' C ' ' A' ' 82' ' ' ASP . . . 78.73 14.51 81.98 Favored Glycine 0 C--N 1.28 -2.557 0 N-CA-C 117.351 1.7 . . . . 0.14999999999999999 117.351 -178.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 48.8 t -92.42 133.01 35.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 121.189 2.494 . . . . 0.12 110.886 177.8 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.435 ' OE1' ' CB ' ' B' ' 348' ' ' PHE . 96.5 mt-10 -96.9 121.92 39.3 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.669 -0.645 . . . . 1.73 110.229 176.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -116.32 158.84 22.79 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.986 0.898 . . . . 0.089999999999999997 110.922 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -147.34 140.69 25.35 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.674 -0.694 . . . . 0.39000000000000001 109.919 177.549 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 45.7 t -131.85 131.98 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.69 -0.631 . . . . 0.070000000000000007 110.003 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 1.236 ' NE2' ' P ' ' B' ' 200' ' ' PO3 . 2.9 t-80 -120.29 80.72 1.64 Allowed 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 108.462 -0.94 . . . . 0.22 108.462 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PHE . . . . . 0.413 ' C ' ' O ' ' A' ' 90' ' ' HIS . 30.3 t80 -42.84 119.9 1.61 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.239 -0.913 . . . . 0.10000000000000001 110.295 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.34 -175.54 32.64 Favored Glycine 0 C--N 1.303 -1.27 0 CA-C-O 122.885 1.269 . . . . 0.10000000000000001 114.623 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 18.6 mm -118.4 132.61 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-O 122.93 1.348 . . . . 0.14000000000000001 109.132 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 54.65 25.89 6.87 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 114.12 -1.4 . . . . 0.17999999999999999 111.213 -177.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.1 p -64.47 -20.08 65.96 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 115.162 1.541 . . . . 0.14999999999999999 115.162 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.5 p -56.94 -32.82 40.45 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 O-C-N 119.578 -1.951 . . . . 1.04 109.296 178.05 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -58.61 -19.99 43.5 Favored 'General case' 0 CA--C 1.566 1.581 0 O-C-N 121.524 -0.735 . . . . 0.25 112.092 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.556 ' N ' ' CD1' ' A' ' 98' ' ' LEU . 7.3 mp -78.02 -3.67 43.27 Favored 'General case' 0 CA--C 1.566 1.565 0 O-C-N 119.733 -1.855 . . . . 0.17000000000000001 113.877 177.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm 49.23 46.23 22.99 Favored 'General case' 0 C--N 1.276 -2.624 0 N-CA-C 116.082 1.882 . . . . 3.6099999999999999 116.082 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 90.63 -13.17 66.34 Favored Glycine 0 CA--C 1.544 1.871 0 O-C-N 121.26 -0.9 . . . . 0.16 115.338 176.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -62.21 120.92 11.87 Favored 'General case' 0 C--N 1.28 -2.456 0 O-C-N 121.024 -1.28 . . . . 0.17999999999999999 112.235 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.527 ' O ' ' HA ' ' A' ' 122' ' ' PHE . . . 98.69 -8.68 61.87 Favored Glycine 0 C--O 1.196 -2.274 0 O-C-N 121.637 -0.664 . . . . 0.14999999999999999 114.597 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -115.02 151.6 33.92 Favored 'General case' 0 C--N 1.278 -2.534 0 C-N-CA 124.136 0.974 . . . . 0.13 111.326 178.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -141.23 112.95 7.67 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 124.43 1.092 . . . . 0.14000000000000001 109.504 177.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ARG . . . . . 0.67 HH21 ' ND2' ' A' ' 74' ' ' ASN . 29.0 ttm180 -67.3 123.26 19.86 Favored 'General case' 0 CA--C 1.453 -2.758 0 C-N-CA 120.337 -0.545 . . . . 0.14999999999999999 109.966 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 29.8 mm -106.22 -34.5 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.251 0 C-N-CA 115.112 -2.635 . . . . 0.12 108.289 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.82 177.66 5.7 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 118.721 -1.191 . . . . 0.12 112.391 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -118.26 150.58 39.2 Favored 'General case' 0 C--O 1.215 -0.754 0 N-CA-C 112.963 0.727 . . . . 0.14999999999999999 112.963 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -60.14 137.26 58.14 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 118.385 -1.326 . . . . 1.6799999999999999 108.021 176.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.54 -5.8 83.58 Favored Glycine 0 N--CA 1.475 1.253 0 N-CA-C 111.455 -0.658 . . . . 0.14999999999999999 111.455 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -65.88 137.17 57.01 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-O 122.843 1.306 . . . . 0.13 113.289 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ARG . . . . . 0.406 ' NH1' ' OD1' ' A' ' 82' ' ' ASP . 0.9 OUTLIER -85.23 133.07 34.19 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 107.095 -1.446 . . . . 0.14999999999999999 107.095 176.153 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.3 m -140.66 159.72 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.042 0 C-N-CA 117.678 -1.609 . . . . 0.11 113.286 -177.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -110.42 156.11 21.27 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 112.032 -2.349 . . . . 0.14000000000000001 108.773 175.03 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . 0.417 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 28.7 t -45.3 135.43 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.457 0 CA-C-O 121.677 0.751 . . . . 0.11 111.837 176.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.52 -13.2 64.59 Favored Glycine 0 CA--C 1.537 1.42 0 C-N-CA 120.786 -0.721 . . . . 0.10000000000000001 114.285 178.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -63.05 136.24 57.7 Favored 'General case' 0 C--N 1.288 -2.085 0 O-C-N 120.547 -1.561 . . . . 0.11 109.912 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 55.6 m -76.61 132.22 39.32 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 122.915 1.341 . . . . 0.11 111.231 -177.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.403 ' O ' HG13 ' A' ' 120' ' ' ILE . 38.5 t -106.03 -47.83 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.684 0 CA-C-N 113.544 -1.662 . . . . 0.089999999999999997 109.414 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 119' ' ' VAL . 11.5 mt -148.78 143.49 18.67 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.836 0 N-CA-C 114.135 1.161 . . . . 0.10000000000000001 114.135 -177.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -112.71 146.64 38.37 Favored 'General case' 0 CA--C 1.487 -1.457 0 C-N-CA 116.788 -1.965 . . . . 0.12 107.591 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' PHE . . . . . 0.527 ' HA ' ' O ' ' A' ' 102' ' ' GLY . 42.6 p90 -133.0 162.37 31.87 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 122.669 1.223 . . . . 0.11 112.003 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.512 ' OD1' ' N ' ' A' ' 126' ' ' LEU . 7.9 t70 -99.05 99.59 10.63 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.605 -1.179 . . . . 0.14999999999999999 108.888 177.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.483 ' HB3' ' HD3' ' A' ' 125' ' ' PRO . 26.9 tp -61.81 -51.54 75.12 Favored Pre-proline 0 C--N 1.292 -1.911 0 N-CA-C 116.929 2.196 . . . . 0.12 116.929 -177.161 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.483 ' HD3' ' HB3' ' A' ' 124' ' ' LEU . 31.5 Cg_exo -58.97 -45.04 30.62 Favored 'Trans proline' 1 C--N 1.241 -5.116 0 C-N-CA 121.966 1.777 . . . . 0.14999999999999999 109.411 -177.064 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LEU . . . . . 0.512 ' N ' ' OD1' ' A' ' 123' ' ' ASP . 29.0 tp -57.76 -48.26 80.14 Favored 'General case' 0 C--N 1.308 -1.216 0 O-C-N 121.383 -0.823 . . . . 0.16 110.157 177.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 94.8 mt -69.84 -32.35 70.7 Favored 'General case' 0 C--N 1.282 -2.36 0 O-C-N 121.164 -0.96 . . . . 0.13 111.817 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -64.61 -37.73 88.56 Favored 'General case' 0 C--N 1.278 -2.517 0 N-CA-C 106.538 -1.653 . . . . 0.14999999999999999 106.538 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -75.42 -41.7 55.36 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 113.476 0.917 . . . . 0.19 113.476 177.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 39.4 mmtt -95.8 -27.81 15.05 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 116.582 2.067 . . . . 0.20000000000000001 116.582 -176.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.54 142.73 35.47 Favored 'General case' 0 C--N 1.258 -3.378 0 N-CA-C 115.437 1.643 . . . . 0.14999999999999999 115.437 -177.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 46.3 tptt -55.47 -38.25 68.85 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 108.066 -1.087 . . . . 0.19 108.066 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.3 t -163.71 143.21 8.21 Favored 'General case' 0 C--N 1.287 -2.152 0 C-N-CA 125.004 1.321 . . . . 0.13 111.15 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 10.0 p -94.97 -1.26 52.84 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-N 114.794 -1.093 . . . . 0.11 110.255 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 33.4 mt -54.93 131.85 45.45 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 106.78 -1.563 . . . . 0.11 106.78 177.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 77.2 m -119.79 101.84 47.66 Favored Pre-proline 0 C--N 1.292 -1.893 0 N-CA-C 115.272 1.582 . . . . 0.070000000000000007 115.272 -174.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -71.16 141.68 40.15 Favored 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 117.425 -1.25 . . . . 0.089999999999999997 115.078 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . 0.309 0.6 OUTLIER -124.79 104.61 13.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 105.207 -2.146 . . . . 0.059999999999999998 105.207 174.152 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' VAL . . . . . 0.487 ' CG1' ' CD1' ' A' ' 33' ' ' ILE . 19.8 m -124.02 158.17 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 N-CA-C 116.458 2.021 . . . . 0.10000000000000001 116.458 -176.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.435 ' N ' ' CD1' ' A' ' 140' ' ' ILE . 1.4 mp -96.71 125.55 49.64 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.344 0 N-CA-C 104.618 -2.364 . . . . 0.12 104.618 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 53.6 p -98.44 -4.47 34.49 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-O 123.231 1.491 . . . . 0.14000000000000001 112.956 -175.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ASN . . . . . 0.428 ' O ' ' C ' ' A' ' 143' ' ' MET 0.491 0.8 OUTLIER -98.13 16.05 22.43 Favored 'General case' 0 C--N 1.259 -3.357 0 C-N-CA 130.089 3.356 . . . . 0.14999999999999999 114.344 -179.74 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' MET . . . . . 0.428 ' C ' ' O ' ' A' ' 142' ' ' ASN . 95.3 mmm -34.54 -44.39 0.2 Allowed 'General case' 0 C--N 1.28 -2.452 0 N-CA-C 115.646 1.721 . . . . 0.16 115.646 -174.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -64.51 -11.64 36.09 Favored 'General case' 0 C--N 1.248 -3.811 0 O-C-N 119.762 -1.837 . . . . 0.26000000000000001 113.099 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 80.4 mt-10 -106.88 14.56 26.46 Favored 'General case' 0 CA--C 1.475 -1.922 0 CA-C-N 121.225 1.829 . . . . 0.17999999999999999 111.28 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 10.5 pt -121.99 140.29 46.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 C-N-CA 116.082 -2.247 . . . . 0.16 114.056 -178.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . 0.256 49.0 tptt -73.83 -55.12 6.6 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 114.275 -1.329 . . . . 0.20999999999999999 109.584 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' GLU . . . . . 0.512 ' O ' ' HA ' ' A' ' 166' ' ' ILE . 2.6 tt0 -147.64 144.61 28.51 Favored 'General case' 0 C--N 1.286 -2.154 0 O-C-N 119.889 -1.757 . . . . 0.17000000000000001 114.6 177.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.8 tt -114.73 111.66 21.62 Favored 'General case' 0 N--CA 1.415 -2.177 0 CA-C-N 111.309 -2.678 . . . . 0.13 110.262 177.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 70.1 mt -108.1 112.41 40.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 114.567 -1.197 . . . . 0.14000000000000001 107.844 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -85.0 130.32 34.64 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 124.301 1.04 . . . . 0.11 113.113 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.302 39.2 mt -94.67 175.94 6.47 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-O 123.007 1.384 . . . . 0.11 112.371 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . 0.293 50.9 m -132.02 159.34 39.07 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 113.416 -1.72 . . . . 0.11 115.145 -174.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 101.4 -158.74 18.73 Favored Glycine 0 C--O 1.214 -1.096 0 N-CA-C 118.92 2.328 . . . . 0.11 118.92 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 64.6 m -94.83 142.51 27.38 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 112.1 -2.05 . . . . 0.12 109.601 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' VAL . . . . . . . . . . . . . 6.4 m -131.59 160.31 42.46 Favored 'Isoleucine or valine' 0 CA--C 1.462 -2.429 0 CA-C-O 122.995 1.379 . . . . 0.089999999999999997 109.996 -177.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 29.3 m -123.63 122.73 38.89 Favored 'General case' 0 C--N 1.269 -2.903 0 CA-C-N 112.854 -1.975 . . . . 0.12 108.773 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 9.3 p -37.07 122.48 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.736 0 CA-C-O 123.547 1.641 . . . . 0.089999999999999997 114.697 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 62.17 26.34 67.52 Favored Glycine 0 CA--C 1.489 -1.546 0 CA-C-N 112.871 -1.968 . . . . 0.10000000000000001 113.934 176.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -137.43 -51.4 0.64 Allowed 'General case' 0 C--N 1.283 -2.317 0 C-N-CA 119.624 -0.83 . . . . 0.14000000000000001 112.581 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 11.9 m -86.09 123.59 71.6 Favored Pre-proline 0 C--N 1.28 -2.415 0 N-CA-C 113.971 1.1 . . . . 0.11 113.971 -176.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -63.08 141.22 82.48 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.963 2.442 . . . . 0.11 109.957 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' VAL . . . . . . . . . . . . . 18.4 m -116.25 -28.59 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.306 -0.871 . . . . 0.070000000000000007 111.881 -179.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 34.8 mt -141.36 149.73 20.24 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 CA-C-O 122.064 0.935 . . . . 0.089999999999999997 109.005 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -124.73 130.75 53.02 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 105.78 -1.933 . . . . 0.13 105.78 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ILE . . . . . 0.687 ' CG1' ' HB ' ' A' ' 20' ' ' ILE . 5.8 pt -128.71 155.0 40.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.298 -0.961 . . . . 0.13 109.927 -177.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' LYS . . . . . 0.446 ' O ' ' C ' ' A' ' 168' ' ' LYS . 80.0 tttt -120.1 154.25 34.96 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 109.064 -0.717 . . . . 0.19 109.064 176.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 167' ' ' LYS . 17.1 tttt . . . . . 0 C--N 1.319 -0.732 0 CA-C-N 115.75 -0.659 . . . . 0.20000000000000001 110.044 -177.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 301' ' ' MET . . . . . 0.447 ' HB2' ' HG2' ' B' ' 366' ' ' GLU . 4.2 ttm . . . . . 0 C--O 1.219 -0.545 0 N-CA-C 108.473 -0.936 . . . . 0.20000000000000001 108.473 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 302' ' ' PHE . . . . . 0.493 ' CD2' ' HA ' ' B' ' 371' ' ' GLN . 74.9 t80 -142.93 140.91 31.33 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.219 -1.4 . . . . 0.20000000000000001 107.219 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -150.85 157.34 42.8 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 120.998 -1.064 . . . . 0.16 109.461 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -153.18 147.62 25.97 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.024 -1.472 . . . . 0.19 107.024 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.97 151.96 19.17 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.296 -1.001 . . . . 0.17000000000000001 108.296 178.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.62 144.31 17.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 107.345 -1.354 . . . . 0.16 107.345 174.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 87.1 m -93.9 136.69 33.92 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.596 0.712 . . . . 0.20999999999999999 110.107 178.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 59.0 mt -85.69 114.12 25.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 104.653 -2.351 . . . . 0.19 104.653 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 61.1 p -106.44 -3.86 20.49 Favored 'General case' 0 N--CA 1.514 2.729 0 N-CA-C 114.57 1.322 . . . . 0.23000000000000001 114.57 -178.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 310' ' ' ALA . . . . . . . . . . . . . . . -71.74 139.2 83.12 Favored Pre-proline 0 N--CA 1.487 1.396 0 CA-C-N 120.314 1.415 . . . . 0.22 110.701 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -46.45 -44.87 20.18 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 123.012 2.475 . . . . 0.27000000000000002 117.095 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -103.72 29.29 5.88 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 115.758 -2.377 . . . . 1.25 107.145 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 60.39 -122.47 29.96 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 117.615 -2.231 . . . . 0.20000000000000001 108.839 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 314' ' ' LEU . . . . . 0.422 ' O ' ' O ' ' B' ' 315' ' ' HIS . 4.6 tp -117.51 81.63 1.69 Allowed 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.322 -0.992 . . . . 0.14999999999999999 108.322 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 315' ' ' HIS . . . . . 1.22 ' ND1' ' P ' ' B' ' 200' ' ' PO3 . 3.5 p80 -66.08 -141.4 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 O-C-N 120.402 -1.436 . . . . 0.34999999999999998 108.211 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 316' ' ' THR . . . . . 0.649 ' N ' ' CG ' ' B' ' 315' ' ' HIS . 8.7 m -84.96 -46.37 11.3 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 115.5 1.667 . . . . 1.1100000000000001 115.5 -176.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 317' ' ' ARG . . . . . 0.646 ' H ' ' CE1' ' B' ' 315' ' ' HIS . 18.9 ttm180 -71.01 -42.96 12.97 Favored Pre-proline 0 N--CA 1.494 1.774 0 C-N-CA 116.091 -2.244 . . . . 1.5700000000000001 113.356 -172.404 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 318' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' B' ' 317' ' ' ARG . 11.5 Cg_endo -68.9 -28.86 29.01 Favored 'Trans proline' 0 C--N 1.296 -2.233 0 CA-C-N 121.165 1.452 . . . . 0.20000000000000001 111.919 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -69.46 -35.43 75.62 Favored 'General case' 0 N--CA 1.509 2.5 0 O-C-N 120.777 -1.202 . . . . 0.14000000000000001 108.839 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -71.52 -39.32 70.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.798 -1.189 . . . . 0.17999999999999999 108.867 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -67.84 -35.93 79.44 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 118.084 -1.447 . . . . 2.2599999999999998 108.7 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -64.25 -44.62 91.23 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 122.408 1.099 . . . . 0.12 108.704 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.71 -40.37 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-N 115.227 -0.897 . . . . 1.03 110.539 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -64.52 -41.06 96.63 Favored 'General case' 0 C--N 1.292 -1.898 0 O-C-N 120.804 -1.185 . . . . 1.72 109.735 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -68.27 -40.17 81.96 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.152 -0.685 . . . . 0.16 109.152 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.58 -42.31 92.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.945 -1.097 . . . . 0.14000000000000001 109.283 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -62.82 -15.05 52.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.034 -1.041 . . . . 2.1099999999999999 112.875 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -78.36 -11.26 85.5 Favored Glycine 0 N--CA 1.478 1.498 0 N-CA-C 108.85 -1.7 . . . . 0.19 108.85 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 329' ' ' PHE . . . . . 0.484 ' HE1' ' HE3' ' B' ' 372' ' ' LYS . 82.3 m-85 -103.88 144.99 30.77 Favored 'General case' 0 N--CA 1.507 2.388 0 CA-C-N 118.713 1.257 . . . . 0.17999999999999999 110.129 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 74.4 p -76.9 -28.7 55.44 Favored 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 118.611 -0.709 . . . . 0.23000000000000001 112.503 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 20.3 m -58.92 157.58 9.63 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 123.384 1.564 . . . . 0.19 114.899 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.6 128.49 33.46 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 102.22 -3.252 . . . . 0.19 102.22 172.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 41.7 mt -125.76 133.93 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 108.203 -1.036 . . . . 0.14000000000000001 108.203 -175.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 97.6 m -124.58 140.68 52.72 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 122.267 1.032 . . . . 0.14999999999999999 109.184 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 335' ' ' VAL . . . . . . . . . . . . . 93.1 t -107.33 127.38 63.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 105.34 -2.096 . . . . 0.12 105.34 174.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 88.3 m -124.73 121.04 33.52 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.881 0.848 . . . . 0.16 110.396 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 337' ' ' SER . . . . . . . . . . . . . 33.5 t -125.65 123.83 39.82 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 118.425 -1.31 . . . . 0.17000000000000001 108.129 177.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 49.71 40.19 19.43 Favored 'General case' 0 N--CA 1.514 2.765 0 N-CA-C 112.872 0.693 . . . . 0.23000000000000001 112.872 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 81.05 12.23 82.78 Favored Glycine 0 N--CA 1.485 1.923 0 O-C-N 120.487 -1.383 . . . . 0.20999999999999999 113.334 176.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -121.8 136.69 54.94 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 103.539 -2.763 . . . . 2.98 103.539 178.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 68.8 m -121.55 156.1 33.6 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-O 124.321 2.01 . . . . 0.17999999999999999 114.996 -175.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -151.52 148.01 27.52 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 111.848 -2.433 . . . . 0.16 110.82 176.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 7.6 t -65.59 132.93 50.08 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.416 -1.698 . . . . 0.16 106.416 173.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 344' ' ' ALA . . . . . . . . . . . . . . . -73.47 -6.02 43.71 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 120.285 -1.509 . . . . 0.11 110.842 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -98.23 12.74 33.68 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.966 -1.084 . . . . 0.17999999999999999 109.189 -178.035 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.23 105.64 6.74 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 123.122 1.439 . . . . 0.17999999999999999 110.557 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 28.9 tp -57.34 -37.59 72.78 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 113.949 -1.478 . . . . 1.0600000000000001 109.303 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 348' ' ' PHE . . . . . 0.435 ' CB ' ' OE1' ' A' ' 86' ' ' GLU . 72.5 t80 -61.18 -50.4 73.32 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 120.355 -1.465 . . . . 0.46999999999999997 112.975 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -69.54 -31.75 70.15 Favored 'General case' 0 C--N 1.314 -0.963 0 O-C-N 119.609 -1.932 . . . . 1.79 110.554 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 3.1 mt -65.25 -32.03 73.49 Favored 'General case' 0 C--N 1.285 -2.233 0 C-N-CA 119.177 -1.009 . . . . 0.14999999999999999 109.309 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 351' ' ' GLN . . . . . 0.541 ' O ' ' CD ' ' A' ' 69' ' ' LYS . 89.6 mt-30 -68.21 -10.64 55.93 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.96 -0.462 . . . . 0.82999999999999996 109.819 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 2.7 p -91.95 -3.91 55.31 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 118.292 -1.363 . . . . 1.04 110.804 -177.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 353' ' ' LEU . . . . . . . . . . . . . 25.5 mt -94.7 157.05 16.13 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.257 -0.902 . . . . 0.17000000000000001 110.076 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -86.3 106.45 3.09 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 104.713 -3.355 . . . . 0.17999999999999999 104.713 177.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 91.3 mt -122.37 48.39 1.76 Allowed 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 106.153 -1.795 . . . . 0.16 106.153 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 24.1 p -83.12 171.02 14.16 Favored 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 109.335 -0.617 . . . . 1.0600000000000001 109.335 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -57.7 138.52 55.36 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.177 -0.952 . . . . 0.26000000000000001 110.675 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 92.19 -3.13 76.05 Favored Glycine 0 N--CA 1.474 1.173 0 C-N-CA 119.39 -1.385 . . . . 0.22 112.61 177.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 55.3 m -84.82 132.98 34.34 Favored 'General case' 0 C--N 1.291 -1.975 0 O-C-N 121.507 -0.996 . . . . 0.19 111.185 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 94.7 t -94.44 122.86 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 107.031 -1.47 . . . . 0.19 107.031 177.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 361' ' ' VAL . . . . . . . . . . . . . 17.8 m -112.73 161.33 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 C-N-CA 116.891 -1.923 . . . . 0.13 109.891 178.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 85.4 m -110.06 130.52 55.52 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 106.324 -1.732 . . . . 0.14000000000000001 106.324 175.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 54.5 mt -110.33 120.43 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 102.869 -3.011 . . . . 0.11 102.869 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.42 146.43 49.62 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 107.716 -1.216 . . . . 0.14000000000000001 107.716 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -141.05 153.66 45.6 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 117.566 -1.653 . . . . 0.16 108.63 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 366' ' ' GLU . . . . . 0.447 ' HG2' ' HB2' ' B' ' 301' ' ' MET . 0.0 OUTLIER -141.79 111.91 6.87 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.06 -1.459 . . . . 0.22 107.06 178.701 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 165.25 -173.49 41.04 Favored Glycine 0 C--N 1.294 -1.766 0 C-N-CA 117.651 -2.214 . . . . 0.22 108.64 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -54.78 -41.5 70.62 Favored 'General case' 0 C--N 1.285 -2.213 0 C-N-CA 124.134 0.974 . . . . 0.28000000000000003 113.253 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 15.2 p30 -116.04 36.71 3.93 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 117.002 -1.879 . . . . 0.20999999999999999 108.135 -177.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -58.97 -30.35 67.87 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 119.001 2.963 . . . . 0.20000000000000001 119.001 -175.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 371' ' ' GLN . . . . . 0.493 ' HA ' ' CD2' ' B' ' 302' ' ' PHE . 0.0 OUTLIER -78.2 -43.36 28.72 Favored 'General case' 0 N--CA 1.512 2.66 0 O-C-N 119.647 -1.908 . . . . 0.23999999999999999 109.768 -177.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 372' ' ' LYS . . . . . 0.657 ' HZ1' ' CE1' ' B' ' 376' ' ' HIS . 13.2 ttpp -63.78 -40.71 97.33 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 106.878 -1.527 . . . . 0.23000000000000001 106.878 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.21 -46.89 86.86 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 118.441 -1.303 . . . . 0.16 110.599 -178.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 68.7 t -68.78 -39.54 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 N-CA-C 108.521 -0.918 . . . . 0.14000000000000001 108.521 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -58.21 -46.49 85.75 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.846 0.831 . . . . 0.20999999999999999 109.508 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 376' ' ' HIS . . . . . 0.657 ' CE1' ' HZ1' ' B' ' 372' ' ' LYS . 13.2 m-70 -71.05 -35.81 72.08 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 113.347 0.869 . . . . 0.22 113.347 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 95.8 mt -79.87 -25.11 40.79 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.447 -1.301 . . . . 0.13 111.786 -175.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 2.1 t -73.13 -38.88 56.0 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 N-CA-C 106.288 -1.745 . . . . 0.16 106.288 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -68.83 -48.6 63.13 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 107.563 -1.273 . . . . 0.23000000000000001 107.563 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 380' ' ' LEU . . . . . 0.505 ' HG ' ' CD2' ' B' ' 384' ' ' LEU . 28.2 tp -55.53 -47.37 76.4 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 118.773 -1.171 . . . . 0.16 110.754 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 2.9 ttm -61.49 -35.02 76.48 Favored 'General case' 0 C--N 1.309 -1.168 0 O-C-N 120.721 -1.237 . . . . 0.14999999999999999 113.44 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -77.48 -29.46 52.66 Favored 'General case' 0 C--N 1.282 -2.36 0 O-C-N 121.229 -0.919 . . . . 0.19 108.856 -178.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . 0.265 32.3 mt-10 -76.37 -36.76 57.97 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 121.787 0.803 . . . . 0.22 111.757 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 384' ' ' LEU . . . . . 0.505 ' CD2' ' HG ' ' B' ' 380' ' ' LEU . 0.0 OUTLIER -55.21 127.42 29.17 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 125.822 2.725 . . . . 0.17999999999999999 113.15 -176.099 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 385' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.307 -1.247 2 CA-C-N 108.129 -4.123 . . . . 0.23000000000000001 111.168 -178.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 200' ' ' PO3 . . . . . 1.236 ' P ' ' NE2' ' A' ' 90' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.217 -0.633 0 CA-C-O 122.405 1.098 . . . . 0.14999999999999999 112.795 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.814 ' HB ' ' CG1' ' A' ' 166' ' ' ILE . 2.3 mp -105.93 130.77 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.023 0 CA-C-O 122.637 1.208 . . . . 0.13 110.744 177.46 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -100.49 124.86 46.59 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.225 -1.352 . . . . 0.12 110.302 176.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.4 mm -94.79 123.4 46.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 105.961 -1.866 . . . . 0.080000000000000002 105.961 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.1 mm -92.11 146.77 5.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 CA-C-O 122.553 1.168 . . . . 0.089999999999999997 111.839 -178.369 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.68 121.14 51.52 Favored Pre-proline 0 N--CA 1.429 -1.504 0 N-CA-C 115.336 1.606 . . . . 0.050000000000000003 115.336 -178.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -76.16 -19.99 15.04 Favored 'Trans proline' 0 CA--C 1.558 1.709 0 C-N-CA 121.488 1.458 . . . . 0.040000000000000001 111.386 -177.536 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.466 ' N ' HD12 ' A' ' 26' ' ' LEU 0.324 0.0 OUTLIER -147.44 161.22 41.48 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 123.82 0.848 . . . . 0.050000000000000003 110.185 175.253 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.9 m -82.6 148.13 28.18 Favored 'General case' 0 CA--C 1.498 -1.023 0 CA-C-O 121.709 0.766 . . . . 0.080000000000000002 111.11 177.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 156.84 -155.38 26.31 Favored Glycine 0 N--CA 1.431 -1.682 0 C-N-CA 119.078 -1.534 . . . . 0.080000000000000002 111.003 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.04 134.82 54.27 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 114.002 -1.099 . . . . 0.12 110.156 -177.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.0 mt -74.41 141.5 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 C-N-CA 117.621 -1.632 . . . . 0.089999999999999997 110.333 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.4 t -132.64 155.94 41.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 114.496 -1.229 . . . . 0.10000000000000001 108.714 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.502 ' HB3' ' OE2' ' A' ' 34' ' ' GLU . 86.0 m-20 -71.51 138.37 48.86 Favored 'General case' 0 CA--C 1.497 -1.076 0 CA-C-O 121.477 0.656 . . . . 0.11 111.064 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.422 ' CD1' ' CG1' ' A' ' 139' ' ' VAL . 8.2 tt -67.84 -23.67 29.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 C-N-CA 118.678 -1.209 . . . . 0.12 108.659 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.502 ' OE2' ' HB3' ' A' ' 32' ' ' ASN . 0.8 OUTLIER -73.91 -14.08 61.0 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 118.649 -1.22 . . . . 0.14000000000000001 110.589 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -95.0 12.48 28.29 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 113.694 0.998 . . . . 0.14000000000000001 113.694 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 t -86.5 130.99 47.16 Favored Pre-proline 0 C--N 1.289 -2.045 0 CA-C-O 120.955 0.407 . . . . 0.14999999999999999 109.921 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -70.49 48.01 0.72 Allowed 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 122.695 2.264 . . . . 0.16 111.758 -173.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.555 ' CG ' HH21 ' B' ' 317' ' ' ARG . 62.6 t0 -150.68 115.82 5.34 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.662 -1.236 . . . . 0.22 107.662 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.9 m -60.4 -37.81 75.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 C-N-CA 119.016 -1.074 . . . . 0.19 111.601 -178.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . 0.406 16.1 m -62.46 -34.8 66.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 116.907 -1.917 . . . . 0.27000000000000002 112.174 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -84.25 -44.32 13.99 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 120.21 -1.556 . . . . 0.19 109.822 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.51 -36.2 77.79 Favored 'General case' 0 CA--C 1.487 -1.461 0 N-CA-C 108.946 -0.761 . . . . 0.14999999999999999 108.946 -177.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -91.06 7.78 38.73 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 118.219 -1.393 . . . . 0.81000000000000005 110.579 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.54 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 0.3 OUTLIER 52.37 39.82 28.19 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 113.943 1.09 . . . . 0.14999999999999999 113.943 176.665 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.0 mm -67.14 -30.44 49.38 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.963 0 CA-C-O 123.717 1.723 . . . . 0.17000000000000001 110.676 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.293 2.3 t -89.48 -7.71 10.82 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.916 0 CA-C-N 112.366 -2.197 . . . . 0.5 111.81 -175.524 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.54 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . 133.45 -175.57 20.12 Favored Glycine 0 C--O 1.207 -1.574 0 N-CA-C 108.773 -1.731 . . . . 0.13 108.773 176.572 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -119.52 155.39 32.24 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 117.835 -1.546 . . . . 0.11 112.797 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 172.22 -137.68 4.39 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 117.703 -2.189 . . . . 0.089999999999999997 111.178 177.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.444 ' C ' HD12 ' A' ' 50' ' ' ILE . 2.8 pp -135.05 175.21 11.53 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.695 0 O-C-N 121.579 -0.954 . . . . 0.070000000000000007 108.596 178.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -121.58 158.52 28.38 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 124.7 1.2 . . . . 0.080000000000000002 108.428 175.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.3 mt -133.36 128.87 55.85 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.84 0 O-C-N 121.595 -0.691 . . . . 0.070000000000000007 111.005 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -86.23 108.88 19.21 Favored Pre-proline 0 C--N 1.308 -1.224 0 N-CA-C 101.46 -3.533 . . . . 0.13 101.46 174.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.429 ' HB3' HD22 ' A' ' 26' ' ' LEU . 2.0 Cg_endo -71.26 150.1 58.5 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 123.735 2.956 . . . . 0.10000000000000001 113.064 -170.849 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.7 p -138.66 1.68 2.14 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 121.746 -0.596 . . . . 0.11 110.16 177.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -108.81 -144.48 10.85 Favored Glycine 0 CA--C 1.534 1.268 0 O-C-N 121.485 -0.759 . . . . 0.089999999999999997 114.573 -177.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -142.97 14.52 1.89 Allowed 'General case' 0 CA--C 1.492 -1.265 0 O-C-N 122.351 -0.499 . . . . 0.10000000000000001 112.068 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -157.3 155.12 30.16 Favored 'General case' 0 N--CA 1.415 -2.187 0 C-N-CA 115.405 -2.518 . . . . 0.089999999999999997 113.142 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -114.89 121.4 43.08 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.872 -1.058 . . . . 0.059999999999999998 109.077 178.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 m -114.13 174.58 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.8 0 CA-C-O 122.733 1.254 . . . . 0.059999999999999998 110.998 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.13 126.64 92.89 Favored Pre-proline 0 C--N 1.289 -2.058 0 CA-C-N 113.705 -1.589 . . . . 0.080000000000000002 109.729 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -85.84 -1.52 8.83 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 CA-C-N 120.027 1.045 . . . . 0.070000000000000007 110.439 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.449 HG21 ' HB3' ' A' ' 81' ' ' SER . 17.2 m -158.49 164.95 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-O 121.493 0.663 . . . . 0.10000000000000001 111.185 -178.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.8 ' OD1' HG23 ' A' ' 115' ' ' VAL . 48.5 m-20 -81.45 127.19 32.54 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 103.558 -2.756 . . . . 0.13 103.558 174.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 80' ' ' GLU . . . 174.0 -157.82 26.15 Favored Glycine 0 C--N 1.301 -1.395 0 N-CA-C 110.753 -0.939 . . . . 0.12 110.753 -175.571 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.0 m -123.71 134.85 53.64 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 119.854 -0.739 . . . . 0.14999999999999999 111.316 -177.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.7 mm -68.79 140.42 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.028 0 C-N-CA 117.626 -1.629 . . . . 0.13 107.365 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -101.7 -64.25 0.76 Allowed Glycine 0 C--N 1.282 -2.471 0 CA-C-O 122.029 0.794 . . . . 0.13 114.332 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.5 ' H ' ' HB2' ' A' ' 78' ' ' SER . 2.3 tmtp? -141.4 136.43 31.39 Favored 'General case' 0 C--N 1.279 -2.497 0 CA-C-O 123.053 1.406 . . . . 2.1600000000000001 111.954 -177.853 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 75.5 mt -116.19 125.45 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 105.532 -2.025 . . . . 0.12 105.532 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -62.65 145.41 54.64 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.172 -1.047 . . . . 0.20999999999999999 108.172 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -61.87 -14.91 38.15 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 123.67 0.788 . . . . 0.40000000000000002 110.454 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.508 ' OG1' ' ND1' ' A' ' 75' ' ' HIS . 41.4 p -97.7 5.03 49.83 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 123.618 1.675 . . . . 0.14999999999999999 109.055 178.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 50.41 44.39 26.82 Favored 'General case' 0 C--N 1.26 -3.292 0 CA-C-N 113.24 -1.8 . . . . 0.11 112.608 175.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.508 ' ND1' ' OG1' ' A' ' 73' ' ' THR . 23.7 p-80 -126.38 -1.55 6.91 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 113.652 0.982 . . . . 0.17999999999999999 113.652 -177.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.31 152.69 31.42 Favored 'General case' 0 N--CA 1.411 -2.388 0 O-C-N 120.79 -1.193 . . . . 0.089999999999999997 111.122 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -152.49 166.36 32.23 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 123.077 1.418 . . . . 0.089999999999999997 113.276 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.5 ' HB2' ' H ' ' A' ' 69' ' ' LYS 0.26 15.8 m -118.34 139.74 50.9 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 113.302 -1.772 . . . . 0.11 109.789 -178.877 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.6 tt -143.3 150.0 17.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 107.607 -1.257 . . . . 0.11 107.607 175.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.489 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 84.6 tt0 -118.37 129.89 55.68 Favored 'General case' 0 C--O 1.201 -1.483 0 N-CA-C 105.647 -1.983 . . . . 0.83999999999999997 105.647 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.449 ' HB3' HG21 ' A' ' 63' ' ' VAL . 93.9 p -80.9 167.31 20.02 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 118.441 -1.304 . . . . 0.14000000000000001 108.264 -176.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -68.13 -31.06 70.39 Favored 'General case' 0 C--N 1.276 -2.6 0 C-N-CA 118.572 -1.251 . . . . 0.16 108.232 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.16 4.46 2.17 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 125.26 1.424 . . . . 0.14999999999999999 112.053 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.68 14.48 82.03 Favored Glycine 0 C--N 1.28 -2.57 0 N-CA-C 117.386 1.715 . . . . 0.14999999999999999 117.386 -178.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.762 HG21 HD11 ' A' ' 166' ' ' ILE . 48.8 t -92.35 133.0 35.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 121.202 2.501 . . . . 0.13 110.863 177.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.422 ' OE1' ' CB ' ' B' ' 348' ' ' PHE . 97.3 mt-10 -96.97 121.97 39.44 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 121.643 -0.661 . . . . 1.7 110.207 176.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -116.32 158.79 22.87 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 122.001 0.905 . . . . 0.10000000000000001 110.851 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -143.65 111.87 6.28 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 122.989 1.376 . . . . 0.17999999999999999 109.77 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.1 t -101.7 115.56 43.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 114.046 -1.434 . . . . 0.070000000000000007 111.464 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.449 ' O ' ' HD2' ' A' ' 137' ' ' PRO . 18.4 t-80 -123.2 105.1 9.6 Favored 'General case' 0 C--O 1.2 -1.531 0 CA-C-N 115.549 -0.751 . . . . 0.16 111.086 -178.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -63.63 124.14 20.64 Favored 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 116.665 2.098 . . . . 0.10000000000000001 116.665 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.35 -175.88 32.07 Favored Glycine 0 C--O 1.215 -1.093 0 CA-C-O 122.572 1.096 . . . . 0.11 114.526 175.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 49.0 mm -118.0 132.59 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-O 123.151 1.453 . . . . 0.14999999999999999 109.2 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 54.65 25.84 6.83 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 114.089 -1.414 . . . . 0.17999999999999999 111.246 -177.123 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.3 p -64.44 -19.9 65.83 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 115.437 1.643 . . . . 0.14000000000000001 115.437 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.3 p -57.06 -32.82 41.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 O-C-N 120.125 -1.609 . . . . 0.17000000000000001 109.321 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -58.56 -20.07 43.53 Favored 'General case' 0 CA--C 1.566 1.594 0 C-N-CA 119.91 -0.716 . . . . 0.23999999999999999 112.098 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mp -78.19 -3.24 41.61 Favored 'General case' 0 CA--C 1.564 1.488 0 O-C-N 119.716 -1.865 . . . . 0.16 113.86 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? 48.91 46.21 22.22 Favored 'General case' 0 C--N 1.278 -2.525 0 N-CA-C 116.077 1.88 . . . . 3.21 116.077 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 90.76 -13.3 66.19 Favored Glycine 0 CA--C 1.542 1.77 0 N-CA-C 115.433 0.933 . . . . 0.13 115.433 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.04 121.21 12.45 Favored 'General case' 0 C--N 1.283 -2.284 0 O-C-N 121.296 -1.12 . . . . 0.16 112.016 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.517 ' O ' ' NZ ' ' A' ' 104' ' ' LYS . . . 97.71 -7.03 63.01 Favored Glycine 0 C--O 1.201 -1.926 0 N-CA-C 114.87 0.708 . . . . 0.12 114.87 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -115.73 152.28 33.52 Favored 'General case' 0 C--N 1.283 -2.298 0 C-N-CA 124.117 0.967 . . . . 0.10000000000000001 111.012 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.517 ' NZ ' ' O ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -141.92 113.47 7.77 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 124.597 1.159 . . . . 0.10000000000000001 109.235 176.83 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.9 ttm180 -67.32 123.56 20.68 Favored 'General case' 0 CA--C 1.462 -2.439 0 C-N-CA 120.403 -0.519 . . . . 0.12 109.924 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.403 HG13 ' HG3' ' A' ' 121' ' ' GLU . 24.0 mm -106.27 -35.02 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.256 0 C-N-CA 114.991 -2.684 . . . . 0.089999999999999997 108.1 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.16 178.23 5.61 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 118.675 -1.21 . . . . 0.10000000000000001 112.187 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -118.3 151.52 37.53 Favored 'General case' 0 C--O 1.213 -0.861 0 N-CA-C 112.582 0.586 . . . . 0.14000000000000001 112.582 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -60.92 137.2 58.23 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 118.559 -1.256 . . . . 1.6000000000000001 107.967 175.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.36 -5.27 84.16 Favored Glycine 0 N--CA 1.475 1.272 0 N-CA-C 111.622 -0.591 . . . . 0.14000000000000001 111.622 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -65.76 138.03 57.66 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-O 122.899 1.333 . . . . 0.13 112.888 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.519 ' CG ' HH11 ' A' ' 112' ' ' ARG . 0.0 OUTLIER -86.25 132.7 33.93 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-N 114.111 -1.404 . . . . 0.17000000000000001 107.297 175.64 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.7 m -139.93 160.35 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.04 0 C-N-CA 117.458 -1.697 . . . . 0.12 113.02 -176.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.494 ' HE3' ' OD2' ' A' ' 117' ' ' ASP . 0.5 OUTLIER -110.78 156.73 20.66 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 111.88 -2.418 . . . . 0.14000000000000001 108.398 174.671 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.8 HG23 ' OD1' ' A' ' 64' ' ' ASP . 44.2 t -45.73 135.73 2.12 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 CA-C-O 121.593 0.711 . . . . 0.11 111.655 176.429 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.14 -12.98 64.62 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 120.853 -0.689 . . . . 0.089999999999999997 114.423 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.494 ' OD2' ' HE3' ' A' ' 114' ' ' LYS . 91.6 m-20 -63.08 136.35 57.74 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 120.926 -1.338 . . . . 0.11 109.812 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.5 m -76.7 132.4 39.31 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-O 122.951 1.358 . . . . 0.080000000000000002 111.084 -177.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.475 ' O ' HG13 ' A' ' 120' ' ' ILE . 44.8 t -105.86 -48.4 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.695 0 CA-C-N 113.42 -1.718 . . . . 0.070000000000000007 109.304 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 119' ' ' VAL . 10.9 mt -148.36 143.51 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.722 0 N-CA-C 114.077 1.139 . . . . 0.070000000000000007 114.077 -177.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.502 ' O ' ' HD2' ' A' ' 104' ' ' LYS . 49.5 mt-10 -112.28 147.41 36.35 Favored 'General case' 0 CA--C 1.484 -1.587 0 C-N-CA 116.685 -2.006 . . . . 0.089999999999999997 107.314 175.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.516 ' HA ' ' O ' ' A' ' 102' ' ' GLY . 36.0 p90 -132.9 163.6 28.79 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 122.059 0.933 . . . . 0.089999999999999997 111.609 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.438 ' OD1' ' HD2' ' A' ' 125' ' ' PRO . 10.3 t0 -100.42 97.84 8.53 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 124.758 1.223 . . . . 0.13 109.799 176.912 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.62 ' HB3' ' HD3' ' A' ' 125' ' ' PRO . 3.2 tp -59.28 -54.75 53.13 Favored Pre-proline 0 C--N 1.292 -1.913 0 N-CA-C 116.068 1.877 . . . . 0.13 116.068 -176.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.62 ' HD3' ' HB3' ' A' ' 124' ' ' LEU . 20.7 Cg_exo -56.9 -44.71 42.17 Favored 'Trans proline' 1 C--N 1.247 -4.812 0 C-N-CA 121.472 1.448 . . . . 0.14999999999999999 109.698 -175.685 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.811 ' CD1' ' HG3' ' A' ' 130' ' ' LYS . 0.5 OUTLIER -57.17 -50.96 71.21 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.132 -0.692 . . . . 0.14999999999999999 109.132 177.757 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.4 mt -68.45 -31.37 70.63 Favored 'General case' 0 C--N 1.281 -2.4 0 O-C-N 121.178 -0.951 . . . . 0.14000000000000001 112.068 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -65.16 -37.61 87.93 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 106.699 -1.593 . . . . 0.16 106.699 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -75.32 -42.27 54.91 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.205 -0.907 . . . . 0.20000000000000001 113.335 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.811 ' HG3' ' CD1' ' A' ' 126' ' ' LEU . 0.1 OUTLIER -94.77 -29.3 14.84 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 116.361 1.985 . . . . 0.20000000000000001 116.361 -175.817 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.54 142.93 36.99 Favored 'General case' 0 C--N 1.262 -3.229 0 N-CA-C 115.382 1.623 . . . . 0.16 115.382 -176.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.493 ' HD2' ' HA ' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -55.68 -37.78 68.78 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.428 -0.953 . . . . 0.19 108.428 179.025 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.8 t -163.84 143.92 8.35 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 124.986 1.314 . . . . 0.14999999999999999 110.654 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 76.8 p -95.95 -0.6 50.52 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 114.784 -1.098 . . . . 0.12 110.539 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.507 ' HA ' HD23 ' A' ' 135' ' ' LEU . 17.0 mt -56.36 130.43 44.63 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.22 -1.4 . . . . 0.12 107.22 177.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 93.5 m -118.81 96.98 50.57 Favored Pre-proline 0 N--CA 1.431 -1.397 0 N-CA-C 118.121 2.638 . . . . 0.080000000000000002 118.121 -173.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.449 ' HD2' ' O ' ' A' ' 90' ' ' HIS . 8.3 Cg_exo -66.94 142.86 63.94 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 117.192 -1.406 . . . . 0.089999999999999997 114.406 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . 0.313 1.6 m -125.79 104.68 13.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 105.186 -2.153 . . . . 0.059999999999999998 105.186 173.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.422 ' CG1' ' CD1' ' A' ' 33' ' ' ILE . 16.3 m -123.49 158.84 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 N-CA-C 116.258 1.948 . . . . 0.10000000000000001 116.258 -176.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.8 mp -97.57 125.44 50.71 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.294 0 N-CA-C 104.591 -2.374 . . . . 0.11 104.591 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 53.3 p -98.35 -4.42 34.92 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 123.15 1.452 . . . . 0.14000000000000001 112.927 -175.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.431 ' O ' ' C ' ' A' ' 143' ' ' MET 0.483 1.1 t-20 -97.86 15.23 24.47 Favored 'General case' 0 C--N 1.258 -3.41 0 C-N-CA 130.114 3.366 . . . . 0.14999999999999999 114.442 -179.679 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.431 ' C ' ' O ' ' A' ' 142' ' ' ASN . 62.1 mmm -33.76 -45.0 0.17 Allowed 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 115.584 1.698 . . . . 0.14999999999999999 115.584 -174.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -64.1 -11.71 32.51 Favored 'General case' 0 C--N 1.252 -3.663 0 O-C-N 119.852 -1.78 . . . . 0.23999999999999999 113.105 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -106.03 12.71 30.11 Favored 'General case' 0 CA--C 1.479 -1.777 0 CA-C-N 121.18 1.809 . . . . 0.17000000000000001 111.546 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 2.5 pt -120.34 140.86 43.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 C-N-CA 115.979 -2.288 . . . . 0.14999999999999999 113.96 -177.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.747 ' HB2' ' HB3' ' A' ' 168' ' ' LYS 0.258 12.0 tptt -74.46 -54.77 6.9 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 114.496 -1.229 . . . . 0.17999999999999999 109.786 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' ' 166' ' ' ILE . 0.0 OUTLIER -147.33 145.57 29.38 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 123.729 1.728 . . . . 0.14000000000000001 114.017 177.053 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.65 112.35 21.97 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 111.077 -2.783 . . . . 0.11 109.866 177.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 61.9 mt -108.97 112.23 39.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 114.531 -1.213 . . . . 0.11 107.882 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 34.6 mttt -84.94 129.91 34.72 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 124.474 1.11 . . . . 0.089999999999999997 113.325 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.299 31.4 mt -94.48 175.74 6.56 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-O 122.688 1.233 . . . . 0.080000000000000002 112.315 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . 0.278 0.5 OUTLIER -131.11 160.43 34.75 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 113.51 -1.677 . . . . 0.089999999999999997 114.763 -174.341 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 100.26 -158.83 19.42 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 118.88 2.312 . . . . 0.089999999999999997 118.88 174.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.76 142.15 27.79 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 112.102 -2.049 . . . . 0.11 109.949 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.555 HG11 HG12 ' A' ' 163' ' ' VAL . 16.5 m -131.84 159.73 42.9 Favored 'Isoleucine or valine' 0 CA--C 1.459 -2.54 0 CA-C-O 122.834 1.302 . . . . 0.080000000000000002 110.032 -177.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 20.7 m -122.79 123.62 41.47 Favored 'General case' 0 C--N 1.274 -2.709 0 CA-C-N 112.702 -2.044 . . . . 0.11 108.24 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 12.1 p -37.23 123.64 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.63 0 CA-C-O 123.7 1.714 . . . . 0.080000000000000002 113.966 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 61.18 25.83 65.11 Favored Glycine 0 CA--C 1.488 -1.642 0 CA-C-N 112.837 -1.983 . . . . 0.10000000000000001 114.179 175.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.42 -53.26 0.72 Allowed 'General case' 0 C--N 1.287 -2.118 0 CA-C-O 121.929 0.871 . . . . 0.13 111.957 178.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.463 ' CG2' HG12 ' A' ' 156' ' ' VAL . 9.0 m -85.36 123.0 73.59 Favored Pre-proline 0 C--N 1.282 -2.346 0 N-CA-C 114.179 1.177 . . . . 0.089999999999999997 114.179 -175.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -62.5 141.5 86.75 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.003 2.469 . . . . 0.089999999999999997 109.719 177.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.555 HG12 HG11 ' A' ' 156' ' ' VAL . 28.6 m -116.65 -27.96 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 121.647 -0.658 . . . . 0.059999999999999998 112.217 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 30.3 mt -141.12 150.98 19.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 N-CA-C 108.527 -0.916 . . . . 0.080000000000000002 108.527 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 5.9 mtt180 -125.78 130.79 52.15 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 105.746 -1.946 . . . . 0.11 105.746 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.814 ' CG1' ' HB ' ' A' ' 20' ' ' ILE . 39.7 pt -128.35 155.6 40.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 C-N-CA 118.987 -1.085 . . . . 0.12 109.771 -178.024 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 168' ' ' LYS . 1.1 tttt -120.75 154.23 35.93 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.023 -0.732 . . . . 0.16 109.023 176.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.747 ' HB3' ' HB2' ' A' ' 147' ' ' LYS . 9.6 tttt . . . . . 0 C--N 1.322 -0.601 0 N-CA-C 108.887 -0.783 . . . . 0.17999999999999999 108.887 -177.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 301' ' ' MET . . . . . 0.514 ' HB2' ' HG2' ' B' ' 366' ' ' GLU . 4.2 ttm . . . . . 0 C--O 1.218 -0.566 0 N-CA-C 108.459 -0.941 . . . . 0.20999999999999999 108.459 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 302' ' ' PHE . . . . . 0.533 ' CD2' ' HA ' ' B' ' 371' ' ' GLN . 74.6 t80 -142.88 140.93 31.42 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.181 -1.414 . . . . 0.17000000000000001 107.181 178.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -150.83 157.33 42.8 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.037 -1.039 . . . . 0.17000000000000001 109.46 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -153.2 147.6 25.92 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.001 -1.481 . . . . 0.16 107.001 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.92 152.02 19.15 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.319 -0.993 . . . . 0.16 108.319 178.288 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 7.3 p -149.68 144.29 17.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 107.35 -1.352 . . . . 0.13 107.35 174.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 86.5 m -93.84 136.73 33.83 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 121.605 0.717 . . . . 0.17000000000000001 110.119 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 58.9 mt -85.75 114.13 25.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 104.572 -2.381 . . . . 0.16 104.572 177.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 61.1 p -106.45 -3.93 20.41 Favored 'General case' 0 N--CA 1.514 2.746 0 N-CA-C 114.545 1.313 . . . . 0.20999999999999999 114.545 -178.508 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 310' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' B' ' 384' ' ' LEU . . . -71.65 139.21 83.38 Favored Pre-proline 0 N--CA 1.487 1.422 0 CA-C-N 120.312 1.414 . . . . 0.20000000000000001 110.766 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -46.42 -44.96 19.92 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 123.033 2.488 . . . . 0.23999999999999999 117.068 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -103.66 29.23 5.89 Favored 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 115.813 -2.355 . . . . 1.0800000000000001 107.127 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 59.52 -148.66 41.1 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 117.624 -2.226 . . . . 0.17999999999999999 111.007 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.452 ' HG ' ' HB2' ' B' ' 319' ' ' ALA . 17.1 tp -87.11 74.1 9.69 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 118.331 -1.347 . . . . 0.14999999999999999 108.996 -177.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 315' ' ' HIS . . . . . 0.513 ' CE1' ' HG3' ' B' ' 318' ' ' PRO . 29.4 p-80 -69.27 -178.06 1.25 Allowed 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 118.667 -1.213 . . . . 0.81000000000000005 112.688 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 3.0 m -48.93 -60.26 2.9 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 118.842 2.904 . . . . 0.20999999999999999 118.842 -174.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 317' ' ' ARG . . . . . 0.555 HH21 ' CG ' ' A' ' 38' ' ' ASP . 20.9 ttm180 -64.01 -44.19 77.31 Favored Pre-proline 0 C--N 1.282 -2.326 0 CA-C-N 122.599 2.454 . . . . 1.24 113.038 -176.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 318' ' ' PRO . . . . . 0.513 ' HG3' ' CE1' ' B' ' 315' ' ' HIS . 10.5 Cg_endo -68.09 -28.92 34.22 Favored 'Trans proline' 0 C--N 1.296 -2.185 0 CA-C-N 121.171 1.454 . . . . 0.17999999999999999 111.934 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 319' ' ' ALA . . . . . 0.452 ' HB2' ' HG ' ' B' ' 314' ' ' LEU . . . -69.45 -35.37 75.57 Favored 'General case' 0 N--CA 1.508 2.473 0 O-C-N 120.836 -1.165 . . . . 0.14000000000000001 108.853 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -71.56 -39.35 70.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.805 -1.185 . . . . 0.17000000000000001 108.855 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -67.77 -36.0 79.7 Favored 'General case' 0 N--CA 1.501 2.093 0 C-N-CA 118.123 -1.431 . . . . 1.74 108.714 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -64.28 -44.61 91.17 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.93 -1.106 . . . . 0.13 108.657 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.63 -40.42 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 CA-C-N 115.229 -0.896 . . . . 0.14000000000000001 110.538 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -64.55 -41.05 96.58 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 120.809 -1.182 . . . . 1.22 109.688 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -68.28 -40.16 81.93 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.58 -0.7 . . . . 0.17000000000000001 109.121 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.57 -42.32 92.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.893 -1.129 . . . . 0.14000000000000001 109.287 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -62.82 -15.04 52.55 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.136 -0.977 . . . . 1.4299999999999999 112.905 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -78.34 -11.23 85.53 Favored Glycine 0 N--CA 1.479 1.513 0 N-CA-C 108.847 -1.701 . . . . 0.19 108.847 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 329' ' ' PHE . . . . . 0.542 ' HE1' ' HE3' ' B' ' 372' ' ' LYS . 82.4 m-85 -103.91 145.08 30.65 Favored 'General case' 0 N--CA 1.506 2.355 0 CA-C-N 118.731 1.266 . . . . 0.17999999999999999 110.083 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 75.4 p -76.95 -28.78 55.32 Favored 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 118.609 -0.71 . . . . 0.22 112.477 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 20.3 m -58.87 157.55 9.57 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-O 123.384 1.564 . . . . 0.17999999999999999 114.893 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.53 128.48 33.42 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 102.25 -3.241 . . . . 0.19 102.25 172.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 42.0 mt -125.78 133.98 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 108.18 -1.045 . . . . 0.14999999999999999 108.18 -175.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 97.5 m -124.61 140.64 52.75 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 122.204 1.002 . . . . 0.16 109.229 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 335' ' ' VAL . . . . . 0.437 HG23 ' HB2' ' B' ' 344' ' ' ALA . 93.1 t -107.37 127.39 63.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 105.349 -2.093 . . . . 0.13 105.349 174.297 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 88.2 m -124.7 121.04 33.54 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.893 0.854 . . . . 0.16 110.432 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 337' ' ' SER . . . . . 0.498 ' HB2' HG12 ' B' ' 361' ' ' VAL . 33.4 t -125.59 123.84 39.92 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 118.389 -1.324 . . . . 0.17000000000000001 108.154 177.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 58.4 t30 49.78 40.09 19.49 Favored 'General case' 0 N--CA 1.514 2.747 0 N-CA-C 112.879 0.696 . . . . 0.22 112.879 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 81.07 12.26 82.71 Favored Glycine 0 N--CA 1.485 1.961 0 O-C-N 120.442 -1.411 . . . . 0.20999999999999999 113.314 176.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -121.84 136.65 54.94 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 103.55 -2.759 . . . . 2.5899999999999999 103.55 178.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 68.2 m -121.49 156.09 33.53 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-O 124.348 2.023 . . . . 0.17999999999999999 115.04 -175.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -151.52 147.98 27.47 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 111.86 -2.427 . . . . 0.14999999999999999 110.804 177.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 7.6 t -65.65 132.96 50.08 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 106.362 -1.718 . . . . 0.16 106.362 173.02 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 344' ' ' ALA . . . . . 0.437 ' HB2' HG23 ' B' ' 335' ' ' VAL . . . -73.46 -6.08 44.11 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.281 -1.512 . . . . 0.12 110.845 178.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -98.13 12.72 33.55 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.998 -1.064 . . . . 0.17000000000000001 109.224 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.2 105.67 6.77 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 123.146 1.45 . . . . 0.17000000000000001 110.544 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 26.6 tp -57.32 -37.64 72.82 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 113.948 -1.478 . . . . 0.19 109.31 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 348' ' ' PHE . . . . . 0.422 ' CB ' ' OE1' ' A' ' 86' ' ' GLU . 67.1 t80 -61.06 -50.48 73.14 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 120.395 -1.44 . . . . 0.34000000000000002 113.018 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -69.51 -31.74 70.16 Favored 'General case' 0 C--N 1.313 -1.01 0 O-C-N 119.589 -1.944 . . . . 1.1299999999999999 110.526 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 3.1 mt -65.35 -32.02 73.45 Favored 'General case' 0 C--N 1.284 -2.25 0 C-N-CA 119.19 -1.004 . . . . 0.14999999999999999 109.242 -177.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 351' ' ' GLN . . . . . 0.427 ' OE1' ' OG ' ' A' ' 78' ' ' SER . 89.7 mt-30 -68.14 -10.78 56.7 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.938 -0.476 . . . . 0.78000000000000003 109.816 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 2.7 p -91.86 -3.94 55.43 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.385 -1.326 . . . . 0.22 110.815 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 353' ' ' LEU . . . . . 0.48 HD22 ' HB3' ' B' ' 337' ' ' SER . 25.6 mt -94.72 157.04 16.13 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.255 -0.903 . . . . 0.16 110.094 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -86.28 106.43 3.08 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 104.785 -3.326 . . . . 0.16 104.785 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 91.2 mt -122.42 48.4 1.76 Allowed 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 106.133 -1.803 . . . . 0.14999999999999999 106.133 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 18.4 p -83.08 170.99 14.23 Favored 'General case' 0 C--O 1.215 -0.746 0 N-CA-C 109.363 -0.606 . . . . 0.20999999999999999 109.363 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -57.72 138.48 55.44 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.178 -0.951 . . . . 0.23000000000000001 110.659 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 92.25 -3.15 75.88 Favored Glycine 0 N--CA 1.473 1.108 0 C-N-CA 119.431 -1.366 . . . . 0.17999999999999999 112.627 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 55.0 m -84.77 132.89 34.38 Favored 'General case' 0 C--N 1.291 -1.966 0 O-C-N 121.497 -1.002 . . . . 0.16 111.182 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 95.3 t -94.38 122.91 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 106.972 -1.492 . . . . 0.16 106.972 177.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 361' ' ' VAL . . . . . 0.498 HG12 ' HB2' ' B' ' 337' ' ' SER . 17.8 m -112.71 161.3 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 C-N-CA 116.922 -1.911 . . . . 0.12 109.955 177.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 84.9 m -110.1 130.48 55.53 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 106.32 -1.733 . . . . 0.14000000000000001 106.32 175.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 54.3 mt -110.29 120.43 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 102.902 -2.999 . . . . 0.11 102.902 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.41 146.43 49.61 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.746 -1.205 . . . . 0.14000000000000001 107.746 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -141.09 153.7 45.57 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 117.549 -1.66 . . . . 0.17000000000000001 108.599 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 366' ' ' GLU . . . . . 0.514 ' HG2' ' HB2' ' B' ' 301' ' ' MET . 0.0 OUTLIER -141.81 111.94 6.88 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.002 -1.481 . . . . 0.23000000000000001 107.002 178.753 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 165.25 -173.45 41.03 Favored Glycine 0 C--N 1.295 -1.734 0 C-N-CA 117.672 -2.204 . . . . 0.20999999999999999 108.649 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -54.86 -41.49 70.85 Favored 'General case' 0 C--N 1.286 -2.191 0 C-N-CA 124.134 0.974 . . . . 0.27000000000000002 113.24 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 15.1 p30 -116.05 36.75 3.91 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 116.966 -1.894 . . . . 0.20000000000000001 108.114 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -58.99 -30.34 67.89 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 118.961 2.949 . . . . 0.20000000000000001 118.961 -175.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 371' ' ' GLN . . . . . 0.533 ' HA ' ' CD2' ' B' ' 302' ' ' PHE . 0.0 OUTLIER -78.23 -43.43 28.39 Favored 'General case' 0 N--CA 1.513 2.696 0 O-C-N 119.721 -1.862 . . . . 0.20999999999999999 109.743 -177.953 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 372' ' ' LYS . . . . . 0.542 ' HE3' ' HE1' ' B' ' 329' ' ' PHE . 13.2 ttpp -63.65 -40.75 97.63 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 106.948 -1.501 . . . . 0.20999999999999999 106.948 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.23 -46.78 87.35 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 118.375 -1.33 . . . . 0.14999999999999999 110.705 -178.163 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 68.5 t -68.82 -39.57 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 108.525 -0.917 . . . . 0.13 108.525 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -58.12 -46.58 85.35 Favored 'General case' 0 N--CA 1.502 2.169 0 CA-C-O 121.839 0.828 . . . . 0.19 109.523 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 376' ' ' HIS . . . . . 0.463 ' CE1' ' HZ2' ' B' ' 372' ' ' LYS . 3.5 m80 -71.01 -35.87 72.2 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 113.308 0.855 . . . . 0.19 113.308 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 95.9 mt -79.84 -25.14 40.86 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 118.443 -1.303 . . . . 0.12 111.788 -175.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 2.1 t -73.11 -38.89 56.13 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 N-CA-C 106.267 -1.753 . . . . 0.13 106.267 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -68.84 -48.61 63.07 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.538 -1.282 . . . . 0.20999999999999999 107.538 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 380' ' ' LEU . . . . . 0.572 ' HG ' ' CD2' ' B' ' 384' ' ' LEU . 28.2 tp -55.55 -47.36 76.48 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.836 -1.165 . . . . 0.16 110.717 176.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 2.9 ttm -61.46 -35.04 76.49 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 120.712 -1.242 . . . . 0.14000000000000001 113.51 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -77.48 -29.36 52.59 Favored 'General case' 0 C--N 1.282 -2.341 0 O-C-N 121.183 -0.948 . . . . 0.17999999999999999 108.896 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . 0.266 31.7 mt-10 -76.47 -36.77 57.68 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.81 0.814 . . . . 0.20999999999999999 111.723 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 384' ' ' LEU . . . . . 0.572 ' CD2' ' HG ' ' B' ' 380' ' ' LEU . 0.0 OUTLIER -55.23 127.38 29.05 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 125.934 2.778 . . . . 0.17999999999999999 113.135 -176.119 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 385' ' ' GLU . . . . . 0.402 ' CD ' ' H ' ' B' ' 385' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.308 -1.214 2 CA-C-N 108.1 -4.136 . . . . 0.22 111.168 -178.233 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.217 -0.613 0 CA-C-O 122.391 1.091 . . . . 0.16 112.81 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.815 ' HB ' ' CG1' ' A' ' 166' ' ' ILE . 2.3 mp -106.02 130.73 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.019 0 CA-C-O 122.663 1.22 . . . . 0.13 110.698 177.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -100.46 124.86 46.53 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.229 -1.35 . . . . 0.13 110.318 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.4 mm -94.8 123.44 46.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 105.89 -1.893 . . . . 0.080000000000000002 105.89 176.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.2 mm -92.1 146.79 5.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 122.546 1.165 . . . . 0.089999999999999997 111.834 -178.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.71 121.09 51.22 Favored Pre-proline 0 N--CA 1.428 -1.541 0 N-CA-C 115.379 1.622 . . . . 0.059999999999999998 115.379 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -76.11 -20.02 15.11 Favored 'Trans proline' 0 CA--C 1.559 1.752 0 C-N-CA 121.494 1.463 . . . . 0.050000000000000003 111.396 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.465 ' N ' HD12 ' A' ' 26' ' ' LEU 0.325 0.0 OUTLIER -147.43 161.19 41.54 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 123.815 0.846 . . . . 0.050000000000000003 110.173 175.29 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.9 m -82.61 148.14 28.17 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 121.729 0.776 . . . . 0.089999999999999997 111.099 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 156.81 -155.3 26.24 Favored Glycine 0 N--CA 1.431 -1.688 0 C-N-CA 119.086 -1.531 . . . . 0.080000000000000002 111.041 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.15 134.79 54.34 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.038 -1.081 . . . . 0.10000000000000001 110.063 -177.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.1 mt -74.38 141.45 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 C-N-CA 117.694 -1.602 . . . . 0.080000000000000002 110.383 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.3 t -132.62 155.9 41.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 114.519 -1.219 . . . . 0.089999999999999997 108.786 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.501 ' HB3' ' OE2' ' A' ' 34' ' ' GLU . 86.0 m-20 -71.41 138.35 49.04 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-O 121.443 0.639 . . . . 0.11 111.099 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.422 ' CD1' ' CG1' ' A' ' 139' ' ' VAL . 8.2 tt -67.8 -23.67 29.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 C-N-CA 118.65 -1.22 . . . . 0.11 108.724 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.501 ' OE2' ' HB3' ' A' ' 32' ' ' ASN . 0.8 OUTLIER -73.91 -14.09 61.0 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 118.566 -1.254 . . . . 0.13 110.543 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -94.9 12.32 28.64 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 113.689 0.996 . . . . 0.12 113.689 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 t -86.42 130.95 47.5 Favored Pre-proline 0 C--N 1.29 -2.011 0 CA-C-O 120.918 0.39 . . . . 0.13 109.963 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -70.46 48.03 0.72 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 122.711 2.274 . . . . 0.14999999999999999 111.781 -173.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.555 ' CG ' HH21 ' B' ' 317' ' ' ARG . 56.3 t0 -150.66 115.83 5.36 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.733 -1.21 . . . . 0.22 107.733 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.2 m -60.36 -37.8 75.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 C-N-CA 119.005 -1.078 . . . . 0.20000000000000001 111.618 -178.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . 0.405 18.9 m -62.45 -34.94 67.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 116.861 -1.936 . . . . 0.25 112.127 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -84.18 -44.15 14.25 Favored 'General case' 0 C--N 1.261 -3.254 0 O-C-N 120.178 -1.576 . . . . 0.20000000000000001 109.897 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.6 -36.24 78.09 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 108.937 -0.764 . . . . 0.14000000000000001 108.937 -177.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -91.09 7.89 38.24 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 118.173 -1.411 . . . . 1.0800000000000001 110.584 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.54 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 0.3 OUTLIER 52.37 39.78 28.1 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 113.973 1.101 . . . . 0.14999999999999999 113.973 176.62 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.4 mm -67.19 -30.32 48.94 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.958 0 CA-C-O 123.786 1.755 . . . . 0.17999999999999999 110.703 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.293 2.1 t -89.55 -7.71 10.82 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.882 0 CA-C-N 112.375 -2.193 . . . . 0.48999999999999999 111.844 -175.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.54 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . 133.46 -175.57 20.13 Favored Glycine 0 C--O 1.206 -1.627 0 N-CA-C 108.743 -1.743 . . . . 0.13 108.743 176.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -119.52 155.45 32.13 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 117.851 -1.539 . . . . 0.12 112.768 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 172.18 -137.77 4.44 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 117.725 -2.179 . . . . 0.089999999999999997 111.158 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.444 ' C ' HD12 ' A' ' 50' ' ' ILE . 2.8 pp -134.98 175.24 11.51 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.716 0 O-C-N 121.592 -0.946 . . . . 0.070000000000000007 108.596 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -121.59 158.51 28.41 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 124.716 1.206 . . . . 0.070000000000000007 108.424 175.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.3 mt -133.33 128.81 55.87 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.826 0 O-C-N 121.641 -0.662 . . . . 0.059999999999999998 111.051 178.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -86.11 108.81 18.71 Favored Pre-proline 0 C--N 1.308 -1.232 0 N-CA-C 101.478 -3.527 . . . . 0.11 101.478 174.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.428 ' HB3' HD22 ' A' ' 26' ' ' LEU . 2.0 Cg_endo -71.22 150.12 58.8 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 123.725 2.95 . . . . 0.089999999999999997 113.074 -170.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.3 p -138.61 1.6 2.14 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 121.774 -0.579 . . . . 0.11 110.161 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -108.83 -144.5 10.84 Favored Glycine 0 CA--C 1.534 1.238 0 O-C-N 121.444 -0.785 . . . . 0.10000000000000001 114.581 -177.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -142.97 14.48 1.89 Allowed 'General case' 0 CA--C 1.491 -1.291 0 O-C-N 122.363 -0.492 . . . . 0.12 112.079 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -157.28 155.17 30.28 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 115.415 -2.514 . . . . 0.10000000000000001 113.092 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -114.96 121.44 43.18 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.868 -1.06 . . . . 0.070000000000000007 109.054 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 m -114.15 174.54 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 CA-C-O 122.74 1.257 . . . . 0.070000000000000007 110.964 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.15 126.66 92.92 Favored Pre-proline 0 C--N 1.289 -2.057 0 CA-C-N 113.663 -1.608 . . . . 0.070000000000000007 109.742 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -85.85 -1.5 8.82 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 CA-C-N 120.029 1.046 . . . . 0.070000000000000007 110.429 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.449 ' HA ' HG22 ' A' ' 115' ' ' VAL . 17.2 m -158.53 164.96 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-O 121.579 0.704 . . . . 0.089999999999999997 111.139 -178.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.799 ' OD1' HG23 ' A' ' 115' ' ' VAL . 48.0 m-20 -81.44 127.19 32.54 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 103.595 -2.743 . . . . 0.13 103.595 174.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 80' ' ' GLU . . . 174.0 -157.85 26.2 Favored Glycine 0 C--N 1.301 -1.375 0 N-CA-C 110.78 -0.928 . . . . 0.11 110.78 -175.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.6 m -123.69 134.93 53.64 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 119.814 -0.754 . . . . 0.13 111.309 -177.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.7 mm -68.76 140.42 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.041 0 C-N-CA 117.619 -1.632 . . . . 0.12 107.394 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -101.76 -64.21 0.75 Allowed Glycine 0 C--N 1.282 -2.457 0 CA-C-O 121.955 0.753 . . . . 0.14000000000000001 114.291 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.53 ' CD ' ' O ' ' B' ' 351' ' ' GLN . 0.2 OUTLIER -141.35 136.47 31.51 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-O 122.991 1.377 . . . . 2.1800000000000002 111.934 -177.842 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 75.8 mt -116.24 125.46 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 N-CA-C 105.514 -2.032 . . . . 0.14000000000000001 105.514 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -62.72 145.46 54.7 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.164 -1.05 . . . . 0.17999999999999999 108.164 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -61.91 -14.9 38.59 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 123.674 0.79 . . . . 0.70999999999999996 110.488 -178.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.526 ' OG1' ' ND1' ' A' ' 75' ' ' HIS . 25.5 p -97.69 5.02 49.87 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 123.655 1.693 . . . . 0.20000000000000001 109.093 178.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 50.51 44.31 27.11 Favored 'General case' 0 C--N 1.261 -3.269 0 CA-C-N 113.211 -1.813 . . . . 0.14000000000000001 112.59 175.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.526 ' ND1' ' OG1' ' A' ' 73' ' ' THR . 13.7 p-80 -126.38 -1.52 6.92 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 113.64 0.978 . . . . 0.20999999999999999 113.64 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.32 152.75 31.47 Favored 'General case' 0 N--CA 1.412 -2.345 0 O-C-N 120.781 -1.2 . . . . 0.10000000000000001 111.022 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -152.53 166.33 32.36 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 123.072 1.415 . . . . 0.089999999999999997 113.245 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.501 ' HB2' ' H ' ' A' ' 69' ' ' LYS 0.259 15.8 m -118.29 139.72 50.9 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 113.278 -1.783 . . . . 0.12 109.849 -178.894 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.6 tt -143.27 150.03 17.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.585 -1.265 . . . . 0.10000000000000001 107.585 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.489 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 84.6 tt0 -118.42 129.91 55.67 Favored 'General case' 0 C--O 1.201 -1.466 0 N-CA-C 105.628 -1.99 . . . . 0.52000000000000002 105.628 177.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.447 ' HB3' HG21 ' A' ' 63' ' ' VAL . 94.0 p -80.91 167.32 20.0 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 118.457 -1.297 . . . . 0.13 108.28 -176.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -68.11 -31.02 70.33 Favored 'General case' 0 C--N 1.277 -2.569 0 C-N-CA 118.538 -1.265 . . . . 0.14999999999999999 108.264 177.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.22 4.44 2.21 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 125.212 1.405 . . . . 0.14000000000000001 111.998 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.73 14.51 81.98 Favored Glycine 0 C--N 1.28 -2.557 0 N-CA-C 117.351 1.7 . . . . 0.14000000000000001 117.351 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.761 HG21 HD11 ' A' ' 166' ' ' ILE . 48.8 t -92.42 133.01 35.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 121.189 2.494 . . . . 0.12 110.886 177.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.435 ' OE1' ' CB ' ' B' ' 348' ' ' PHE . 96.5 mt-10 -96.9 121.92 39.3 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.669 -0.645 . . . . 1.73 110.229 176.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -116.32 158.84 22.79 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.986 0.898 . . . . 0.089999999999999997 110.922 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -143.66 111.87 6.27 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 122.988 1.375 . . . . 0.31 109.759 177.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.1 t -101.73 115.6 43.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 114.05 -1.432 . . . . 0.070000000000000007 111.41 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.45 ' O ' ' HD2' ' A' ' 137' ' ' PRO . 3.4 t-160 -123.24 105.07 9.56 Favored 'General case' 0 C--O 1.199 -1.564 0 CA-C-N 115.501 -0.772 . . . . 0.16 111.098 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -63.56 124.13 20.57 Favored 'General case' 0 CA--C 1.558 1.278 0 N-CA-C 116.688 2.107 . . . . 0.10000000000000001 116.688 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.28 -175.84 31.91 Favored Glycine 0 C--O 1.214 -1.123 0 CA-C-O 122.578 1.099 . . . . 0.10000000000000001 114.496 175.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 49.1 mm -118.0 132.62 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-O 123.129 1.442 . . . . 0.14000000000000001 109.158 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 54.69 25.75 6.79 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 114.104 -1.407 . . . . 0.17999999999999999 111.227 -177.17 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.3 p -64.42 -19.82 65.76 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 115.451 1.648 . . . . 0.14999999999999999 115.451 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.3 p -57.09 -32.83 41.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 O-C-N 120.124 -1.61 . . . . 0.17000000000000001 109.32 177.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -58.61 -19.99 43.47 Favored 'General case' 0 CA--C 1.566 1.581 0 C-N-CA 119.867 -0.733 . . . . 0.25 112.092 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mp -78.22 -3.24 41.72 Favored 'General case' 0 CA--C 1.564 1.485 0 O-C-N 119.733 -1.855 . . . . 0.17000000000000001 113.913 177.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 32.4 mtmm 48.95 46.23 22.34 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 116.082 1.882 . . . . 3.1899999999999999 116.082 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 90.69 -13.24 66.25 Favored Glycine 0 CA--C 1.543 1.799 0 N-CA-C 115.492 0.957 . . . . 0.16 115.492 176.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.14 121.29 12.71 Favored 'General case' 0 C--N 1.284 -2.263 0 O-C-N 121.36 -1.082 . . . . 0.17999999999999999 112.008 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 122' ' ' PHE . . . 97.68 -7.09 63.1 Favored Glycine 0 C--O 1.201 -1.956 0 N-CA-C 114.902 0.721 . . . . 0.14000000000000001 114.902 178.369 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -115.67 152.25 33.52 Favored 'General case' 0 C--N 1.284 -2.282 0 C-N-CA 124.121 0.968 . . . . 0.13 111.008 177.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' LYS . . . . . 0.513 ' NZ ' ' O ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -141.95 113.41 7.71 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 124.625 1.17 . . . . 0.13 109.199 176.843 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -67.19 123.53 20.55 Favored 'General case' 0 CA--C 1.462 -2.416 0 C-N-CA 120.448 -0.501 . . . . 0.14000000000000001 109.946 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ILE . . . . . 0.405 HG13 ' HG3' ' A' ' 121' ' ' GLU . 24.0 mm -106.31 -34.99 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.251 0 C-N-CA 114.928 -2.709 . . . . 0.12 108.119 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.08 178.22 5.62 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 118.682 -1.207 . . . . 0.12 112.235 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -118.31 151.46 37.66 Favored 'General case' 0 C--O 1.213 -0.83 0 N-CA-C 112.594 0.59 . . . . 0.14999999999999999 112.594 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -60.89 137.26 58.23 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 118.498 -1.281 . . . . 1.6799999999999999 108.021 175.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.27 -5.23 84.31 Favored Glycine 0 N--CA 1.475 1.253 0 N-CA-C 111.624 -0.591 . . . . 0.14000000000000001 111.624 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -65.72 138.04 57.69 Favored 'General case' 0 C--N 1.288 -2.07 0 C-N-CA 118.398 -1.321 . . . . 0.13 112.879 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.52 ' CG ' HH11 ' A' ' 112' ' ' ARG . 0.0 OUTLIER -86.23 132.67 33.94 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 114.121 -1.4 . . . . 0.14999999999999999 107.307 175.611 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 m -139.87 160.33 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.023 0 C-N-CA 117.475 -1.69 . . . . 0.11 113.051 -176.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.493 ' HE3' ' OD2' ' A' ' 117' ' ' ASP . 0.5 OUTLIER -110.81 156.7 20.73 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 111.905 -2.407 . . . . 0.14000000000000001 108.406 174.63 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.799 HG23 ' OD1' ' A' ' 64' ' ' ASP . 43.9 t -45.7 135.74 2.09 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 CA-C-O 121.596 0.712 . . . . 0.11 111.675 176.438 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.2 -13.05 64.5 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 120.831 -0.699 . . . . 0.089999999999999997 114.38 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASP . . . . . 0.493 ' OD2' ' HE3' ' A' ' 114' ' ' LYS . 91.5 m-20 -63.14 136.38 57.72 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 118.866 1.333 . . . . 0.11 109.797 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.4 m -76.68 132.38 39.33 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-O 122.912 1.339 . . . . 0.10000000000000001 111.123 -177.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.474 ' O ' HG13 ' A' ' 120' ' ' ILE . 44.8 t -105.83 -48.45 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.684 0 CA-C-N 113.495 -1.684 . . . . 0.089999999999999997 109.315 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 119' ' ' VAL . 10.8 mt -148.37 143.56 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.707 0 N-CA-C 114.085 1.143 . . . . 0.089999999999999997 114.085 -177.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLU . . . . . 0.503 ' O ' ' HD2' ' A' ' 104' ' ' LYS . 49.4 mt-10 -112.28 147.47 36.22 Favored 'General case' 0 CA--C 1.483 -1.627 0 C-N-CA 116.646 -2.022 . . . . 0.12 107.279 175.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.518 ' HA ' ' O ' ' A' ' 102' ' ' GLY . 36.0 p90 -132.94 163.55 28.94 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 122.08 0.943 . . . . 0.11 111.57 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.437 ' OD1' ' HD2' ' A' ' 125' ' ' PRO . 10.3 t0 -100.41 97.85 8.55 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 124.72 1.208 . . . . 0.14999999999999999 109.813 176.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.62 ' HB3' ' HD3' ' A' ' 125' ' ' PRO . 3.1 tp -59.22 -54.79 52.77 Favored Pre-proline 0 C--N 1.292 -1.899 0 N-CA-C 116.061 1.874 . . . . 0.12 116.061 -176.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.62 ' HD3' ' HB3' ' A' ' 124' ' ' LEU . 20.6 Cg_exo -56.92 -44.68 42.37 Favored 'Trans proline' 1 C--N 1.247 -4.804 0 C-N-CA 121.483 1.455 . . . . 0.14999999999999999 109.706 -175.647 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.813 ' CD1' ' HG3' ' A' ' 130' ' ' LYS . 0.5 OUTLIER -57.17 -51.0 71.07 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.134 -0.691 . . . . 0.16 109.134 177.738 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.5 mt -68.36 -31.42 70.79 Favored 'General case' 0 C--N 1.281 -2.394 0 O-C-N 121.092 -1.005 . . . . 0.13 112.098 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -65.13 -37.62 88.03 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 106.727 -1.582 . . . . 0.14999999999999999 106.727 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -75.26 -42.3 55.37 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.218 -0.901 . . . . 0.19 113.33 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LYS . . . . . 0.813 ' HG3' ' CD1' ' A' ' 126' ' ' LEU . 0.1 OUTLIER -94.79 -29.28 14.83 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 116.38 1.992 . . . . 0.20000000000000001 116.38 -175.817 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.56 142.96 36.93 Favored 'General case' 0 C--N 1.262 -3.207 0 N-CA-C 115.329 1.603 . . . . 0.14999999999999999 115.329 -176.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.491 ' HD2' ' HA ' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -55.7 -37.82 68.88 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 108.436 -0.95 . . . . 0.17999999999999999 108.436 178.989 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.8 t -163.78 143.93 8.44 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 125.037 1.335 . . . . 0.13 110.686 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 76.8 p -95.96 -0.57 50.55 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 114.773 -1.103 . . . . 0.11 110.58 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.508 ' HA ' HD23 ' A' ' 135' ' ' LEU . 17.1 mt -56.33 130.39 44.41 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.263 -1.384 . . . . 0.10000000000000001 107.263 177.15 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 93.3 m -118.77 96.92 50.5 Favored Pre-proline 0 N--CA 1.43 -1.432 0 N-CA-C 118.124 2.638 . . . . 0.070000000000000007 118.124 -173.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' PRO . . . . . 0.45 ' HD2' ' O ' ' A' ' 90' ' ' HIS . 8.5 Cg_exo -67.02 142.94 63.78 Favored 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 117.163 -1.425 . . . . 0.089999999999999997 114.357 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . 0.313 1.6 m -125.83 104.66 13.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 105.192 -2.151 . . . . 0.059999999999999998 105.192 173.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.422 ' CG1' ' CD1' ' A' ' 33' ' ' ILE . 16.3 m -123.51 158.84 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 N-CA-C 116.237 1.939 . . . . 0.089999999999999997 116.237 -176.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.8 mp -97.61 125.51 50.74 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.319 0 N-CA-C 104.566 -2.383 . . . . 0.11 104.566 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 17.2 p -98.41 -4.41 34.75 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 123.158 1.456 . . . . 0.14000000000000001 112.936 -175.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 143' ' ' MET 0.482 1.1 t-20 -97.8 15.17 24.53 Favored 'General case' 0 C--N 1.258 -3.386 0 C-N-CA 130.087 3.355 . . . . 0.14999999999999999 114.505 -179.757 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.432 ' C ' ' O ' ' A' ' 142' ' ' ASN 0.251 62.1 mmm -33.68 -45.09 0.17 Allowed 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 115.555 1.687 . . . . 0.16 115.555 -174.261 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -64.11 -11.64 31.85 Favored 'General case' 0 C--N 1.251 -3.682 0 O-C-N 119.891 -1.755 . . . . 0.26000000000000001 113.099 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -106.02 12.68 30.18 Favored 'General case' 0 CA--C 1.479 -1.758 0 CA-C-N 121.225 1.829 . . . . 0.17000000000000001 111.57 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 2.5 pt -120.36 140.81 43.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 C-N-CA 115.906 -2.317 . . . . 0.16 113.983 -177.149 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LYS . . . . . 0.75 ' HB2' ' HB3' ' A' ' 168' ' ' LYS 0.255 12.1 tptt -74.45 -54.73 7.0 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 114.49 -1.232 . . . . 0.20000000000000001 109.794 -179.864 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' ' 166' ' ' ILE . 0.0 OUTLIER -147.31 145.59 29.4 Favored 'General case' 0 C--N 1.289 -2.063 0 O-C-N 119.913 -1.742 . . . . 0.17000000000000001 114.055 177.017 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.68 112.31 21.9 Favored 'General case' 0 N--CA 1.415 -2.177 0 CA-C-N 111.066 -2.788 . . . . 0.13 109.881 177.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 61.8 mt -108.94 112.19 39.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 114.515 -1.221 . . . . 0.14000000000000001 107.92 177.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 34.5 mttt -84.93 129.84 34.74 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 124.492 1.117 . . . . 0.11 113.399 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.299 31.3 mt -94.4 175.78 6.55 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-O 122.732 1.253 . . . . 0.11 112.325 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . 0.276 0.5 OUTLIER -131.09 160.43 34.72 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 113.484 -1.689 . . . . 0.11 114.773 -174.325 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 100.25 -158.82 19.43 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 118.906 2.322 . . . . 0.10000000000000001 118.906 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.8 142.13 27.83 Favored 'General case' 0 C--O 1.213 -0.841 0 CA-C-N 112.064 -2.068 . . . . 0.12 109.892 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.555 HG11 HG12 ' A' ' 163' ' ' VAL . 16.5 m -131.83 159.68 42.93 Favored 'Isoleucine or valine' 0 CA--C 1.46 -2.511 0 CA-C-O 122.783 1.277 . . . . 0.089999999999999997 110.041 -177.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 20.8 m -122.77 123.7 41.66 Favored 'General case' 0 C--N 1.273 -2.734 0 CA-C-N 112.754 -2.021 . . . . 0.12 108.194 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 12.1 p -37.38 123.68 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 CA-C-O 123.725 1.726 . . . . 0.089999999999999997 113.991 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 61.15 25.82 65.03 Favored Glycine 0 CA--C 1.487 -1.68 0 CA-C-N 112.804 -1.998 . . . . 0.10000000000000001 114.232 176.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.43 -53.24 0.72 Allowed 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 119.593 -0.843 . . . . 0.14000000000000001 111.958 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.462 ' CG2' HG12 ' A' ' 156' ' ' VAL . 9.1 m -85.35 122.98 73.61 Favored Pre-proline 0 C--N 1.282 -2.352 0 N-CA-C 114.219 1.192 . . . . 0.10000000000000001 114.219 -175.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -62.44 141.46 86.92 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.964 2.443 . . . . 0.11 109.766 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.555 HG12 HG11 ' A' ' 156' ' ' VAL . 28.9 m -116.64 -27.92 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.625 -0.672 . . . . 0.070000000000000007 112.196 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 30.5 mt -141.17 150.94 19.85 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 108.502 -0.925 . . . . 0.089999999999999997 108.502 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 5.9 mtt180 -125.76 130.83 52.25 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 105.784 -1.932 . . . . 0.13 105.784 176.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.815 ' CG1' ' HB ' ' A' ' 20' ' ' ILE . 39.9 pt -128.36 155.57 40.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 119.075 -1.05 . . . . 0.13 109.813 -177.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 168' ' ' LYS . 1.1 tttt -120.72 154.21 35.92 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.987 -0.746 . . . . 0.17999999999999999 108.987 176.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.75 ' HB3' ' HB2' ' A' ' 147' ' ' LYS . 9.6 tttt . . . . . 0 C--N 1.322 -0.595 0 N-CA-C 108.87 -0.789 . . . . 0.19 108.87 -177.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 301' ' ' MET . . . . . 0.513 ' HB2' ' HG2' ' B' ' 366' ' ' GLU . 4.2 ttm . . . . . 0 C--O 1.219 -0.545 0 N-CA-C 108.473 -0.936 . . . . 0.20000000000000001 108.473 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 302' ' ' PHE . . . . . 0.534 ' CD2' ' HA ' ' B' ' 371' ' ' GLN . 74.9 t80 -142.93 140.91 31.33 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.219 -1.4 . . . . 0.19 107.219 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -150.85 157.34 42.8 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 120.998 -1.064 . . . . 0.16 109.461 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -153.18 147.62 25.97 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.024 -1.472 . . . . 0.17999999999999999 107.024 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.97 151.96 19.17 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.296 -1.001 . . . . 0.17000000000000001 108.296 178.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.62 144.31 17.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 107.345 -1.354 . . . . 0.14999999999999999 107.345 174.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 87.1 m -93.9 136.69 33.92 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.596 0.712 . . . . 0.19 110.107 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 59.0 mt -85.69 114.12 25.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 104.653 -2.351 . . . . 0.19 104.653 177.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 61.1 p -106.44 -3.86 20.49 Favored 'General case' 0 N--CA 1.514 2.729 0 N-CA-C 114.57 1.322 . . . . 0.23000000000000001 114.57 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 310' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' B' ' 384' ' ' LEU . . . -71.74 139.2 83.12 Favored Pre-proline 0 N--CA 1.487 1.396 0 CA-C-N 120.314 1.415 . . . . 0.20999999999999999 110.701 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -46.45 -44.87 20.18 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 123.012 2.475 . . . . 0.26000000000000001 117.095 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -103.72 29.29 5.88 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 115.758 -2.377 . . . . 1.04 107.145 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 59.49 -148.71 40.94 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 117.615 -2.231 . . . . 0.19 110.981 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.452 ' HG ' ' HB2' ' B' ' 319' ' ' ALA . 17.1 tp -87.07 74.15 9.71 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 118.267 -1.373 . . . . 0.14999999999999999 108.985 -177.687 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 315' ' ' HIS . . . . . 0.436 ' CD2' ' CG ' ' B' ' 318' ' ' PRO . 2.5 p80 -69.24 -178.04 1.24 Allowed 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 118.656 -1.217 . . . . 0.32000000000000001 112.678 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 26.8 m -49.04 -60.19 2.99 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 118.77 2.878 . . . . 0.28000000000000003 118.77 -174.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 317' ' ' ARG . . . . . 0.555 HH21 ' CG ' ' A' ' 38' ' ' ASP . 18.8 ttm180 -63.93 -44.53 78.98 Favored Pre-proline 0 C--N 1.281 -2.395 0 CA-C-N 122.671 2.487 . . . . 1.1000000000000001 112.902 -176.628 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 318' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' B' ' 317' ' ' ARG . 9.2 Cg_endo -67.95 -28.89 35.14 Favored 'Trans proline' 0 C--N 1.296 -2.194 0 CA-C-N 121.149 1.446 . . . . 0.17000000000000001 111.937 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 319' ' ' ALA . . . . . 0.452 ' HB2' ' HG ' ' B' ' 314' ' ' LEU . . . -69.44 -35.43 75.65 Favored 'General case' 0 N--CA 1.509 2.5 0 O-C-N 120.824 -1.172 . . . . 0.13 108.839 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -71.52 -39.32 70.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.798 -1.189 . . . . 0.16 108.867 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -67.84 -35.93 79.44 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 118.084 -1.447 . . . . 1.7 108.7 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -64.25 -44.62 91.23 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 122.408 1.099 . . . . 0.12 108.704 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 55.1 t -64.67 -40.45 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-N 115.227 -0.897 . . . . 0.13 110.526 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -64.47 -41.06 96.72 Favored 'General case' 0 C--N 1.293 -1.879 0 O-C-N 120.752 -1.217 . . . . 1.1799999999999999 109.735 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -68.27 -40.17 81.96 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.152 -0.685 . . . . 0.16 109.152 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.58 -42.31 92.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.945 -1.097 . . . . 0.14000000000000001 109.283 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -62.82 -15.05 52.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.034 -1.041 . . . . 1.6000000000000001 112.875 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -78.36 -11.26 85.5 Favored Glycine 0 N--CA 1.478 1.498 0 N-CA-C 108.85 -1.7 . . . . 0.19 108.85 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 329' ' ' PHE . . . . . 0.541 ' HE1' ' HE3' ' B' ' 372' ' ' LYS . 82.3 m-85 -103.88 144.99 30.77 Favored 'General case' 0 N--CA 1.507 2.388 0 CA-C-N 118.713 1.257 . . . . 0.17000000000000001 110.129 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 74.4 p -76.9 -28.7 55.44 Favored 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 118.611 -0.709 . . . . 0.22 112.503 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 20.3 m -58.92 157.58 9.63 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 123.384 1.564 . . . . 0.17999999999999999 114.899 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.6 128.49 33.46 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 102.22 -3.252 . . . . 0.17999999999999999 102.22 172.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 41.7 mt -125.76 133.93 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 108.203 -1.036 . . . . 0.14000000000000001 108.203 -175.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 97.6 m -124.58 140.68 52.72 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 122.267 1.032 . . . . 0.14000000000000001 109.184 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 335' ' ' VAL . . . . . 0.436 HG23 ' HB2' ' B' ' 344' ' ' ALA . 93.1 t -107.33 127.38 63.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 105.34 -2.096 . . . . 0.12 105.34 174.282 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 88.3 m -124.73 121.04 33.52 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.881 0.848 . . . . 0.14999999999999999 110.396 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 337' ' ' SER . . . . . 0.498 ' HB2' HG12 ' B' ' 361' ' ' VAL . 33.5 t -125.65 123.83 39.82 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 118.425 -1.31 . . . . 0.17000000000000001 108.129 177.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 58.5 t30 49.71 40.19 19.43 Favored 'General case' 0 N--CA 1.514 2.765 0 N-CA-C 112.872 0.693 . . . . 0.22 112.872 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 81.05 12.23 82.78 Favored Glycine 0 N--CA 1.485 1.923 0 O-C-N 120.487 -1.383 . . . . 0.20000000000000001 113.334 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -121.8 136.69 54.94 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 103.539 -2.763 . . . . 2.48 103.539 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 68.8 m -121.55 156.1 33.6 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-O 124.321 2.01 . . . . 0.17000000000000001 114.996 -175.15 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -151.52 148.01 27.52 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 111.848 -2.433 . . . . 0.14999999999999999 110.82 176.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 7.6 t -65.59 132.93 50.08 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.416 -1.698 . . . . 0.14999999999999999 106.416 173.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 344' ' ' ALA . . . . . 0.436 ' HB2' HG23 ' B' ' 335' ' ' VAL . . . -73.47 -6.02 43.71 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 120.285 -1.509 . . . . 0.11 110.842 178.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -98.23 12.74 33.68 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.966 -1.084 . . . . 0.17000000000000001 109.189 -178.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.23 105.64 6.74 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 123.122 1.439 . . . . 0.17999999999999999 110.557 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 32.6 tp -57.34 -37.59 72.78 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 113.949 -1.478 . . . . 0.19 109.303 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 348' ' ' PHE . . . . . 0.435 ' CB ' ' OE1' ' A' ' 86' ' ' GLU . 72.5 t80 -61.18 -50.4 73.32 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 120.355 -1.465 . . . . 0.38 112.975 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -69.57 -31.68 70.0 Favored 'General case' 0 C--N 1.314 -0.963 0 O-C-N 119.609 -1.932 . . . . 1.1699999999999999 110.56 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 3.1 mt -65.29 -32.03 73.47 Favored 'General case' 0 C--N 1.285 -2.236 0 C-N-CA 119.201 -0.999 . . . . 0.14999999999999999 109.309 -177.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 351' ' ' GLN . . . . . 0.53 ' O ' ' CD ' ' A' ' 69' ' ' LYS . 89.6 mt-30 -68.17 -10.72 56.36 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.96 -0.462 . . . . 0.82999999999999996 109.833 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 2.0 p -91.86 -4.02 55.33 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 118.347 -1.341 . . . . 0.23000000000000001 110.78 -177.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 353' ' ' LEU . . . . . 0.484 HD22 ' HB3' ' B' ' 337' ' ' SER . 25.1 mt -94.63 157.05 16.14 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.233 -0.917 . . . . 0.17000000000000001 110.076 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -86.3 106.45 3.09 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 104.713 -3.355 . . . . 0.17999999999999999 104.713 177.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 91.3 mt -122.37 48.39 1.76 Allowed 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 106.153 -1.795 . . . . 0.16 106.153 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 43.0 p -83.12 171.02 14.16 Favored 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 109.335 -0.617 . . . . 0.25 109.335 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -57.7 138.52 55.36 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.177 -0.952 . . . . 0.25 110.675 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 92.19 -3.13 76.05 Favored Glycine 0 N--CA 1.474 1.173 0 C-N-CA 119.39 -1.385 . . . . 0.20999999999999999 112.61 177.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 55.3 m -84.82 132.98 34.34 Favored 'General case' 0 C--N 1.291 -1.975 0 O-C-N 121.507 -0.996 . . . . 0.17999999999999999 111.185 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 94.7 t -94.44 122.86 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 107.031 -1.47 . . . . 0.17999999999999999 107.031 177.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 361' ' ' VAL . . . . . 0.498 HG12 ' HB2' ' B' ' 337' ' ' SER . 17.8 m -112.73 161.33 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 C-N-CA 116.891 -1.923 . . . . 0.13 109.891 178.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 85.4 m -110.06 130.52 55.52 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 106.324 -1.732 . . . . 0.13 106.324 175.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 54.5 mt -110.33 120.43 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 102.869 -3.011 . . . . 0.11 102.869 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.42 146.43 49.62 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 107.716 -1.216 . . . . 0.13 107.716 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -141.05 153.66 45.6 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 117.566 -1.653 . . . . 0.16 108.63 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 366' ' ' GLU . . . . . 0.513 ' HG2' ' HB2' ' B' ' 301' ' ' MET . 0.0 OUTLIER -141.79 111.91 6.87 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.06 -1.459 . . . . 0.22 107.06 178.701 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 165.25 -173.49 41.04 Favored Glycine 0 C--N 1.294 -1.766 0 C-N-CA 117.651 -2.214 . . . . 0.20999999999999999 108.64 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -54.78 -41.5 70.62 Favored 'General case' 0 C--N 1.285 -2.213 0 C-N-CA 124.134 0.974 . . . . 0.28000000000000003 113.253 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 15.2 p30 -116.04 36.71 3.93 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 117.002 -1.879 . . . . 0.20999999999999999 108.135 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -58.97 -30.35 67.87 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 119.001 2.963 . . . . 0.20000000000000001 119.001 -175.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 371' ' ' GLN . . . . . 0.534 ' HA ' ' CD2' ' B' ' 302' ' ' PHE . 0.0 OUTLIER -78.2 -43.36 28.72 Favored 'General case' 0 N--CA 1.512 2.66 0 O-C-N 119.647 -1.908 . . . . 0.23000000000000001 109.768 -177.953 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 372' ' ' LYS . . . . . 0.541 ' HE3' ' HE1' ' B' ' 329' ' ' PHE . 13.2 ttpp -63.78 -40.71 97.33 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 106.878 -1.527 . . . . 0.22 106.878 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.21 -46.89 86.86 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 118.441 -1.303 . . . . 0.16 110.599 -178.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 68.7 t -68.78 -39.54 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 N-CA-C 108.521 -0.918 . . . . 0.14000000000000001 108.521 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -58.21 -46.49 85.75 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.846 0.831 . . . . 0.20999999999999999 109.508 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 376' ' ' HIS . . . . . 0.462 ' CE1' ' HZ2' ' B' ' 372' ' ' LYS . 3.5 m80 -71.05 -35.81 72.08 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 113.347 0.869 . . . . 0.20000000000000001 113.347 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 95.8 mt -79.87 -25.11 40.79 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.447 -1.301 . . . . 0.13 111.786 -175.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 2.1 t -73.13 -38.88 56.0 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 N-CA-C 106.288 -1.745 . . . . 0.14999999999999999 106.288 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -68.83 -48.6 63.13 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 107.563 -1.273 . . . . 0.22 107.563 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 380' ' ' LEU . . . . . 0.569 ' HG ' ' CD2' ' B' ' 384' ' ' LEU . 28.2 tp -55.53 -47.37 76.4 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 118.773 -1.171 . . . . 0.14999999999999999 110.754 176.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 2.9 ttm -61.49 -35.02 76.48 Favored 'General case' 0 C--N 1.309 -1.168 0 O-C-N 120.721 -1.237 . . . . 0.14999999999999999 113.44 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -77.48 -29.46 52.66 Favored 'General case' 0 C--N 1.282 -2.36 0 O-C-N 121.229 -0.919 . . . . 0.19 108.856 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . 0.265 32.3 mt-10 -76.37 -36.76 57.97 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 121.787 0.803 . . . . 0.22 111.757 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 384' ' ' LEU . . . . . 0.569 ' CD2' ' HG ' ' B' ' 380' ' ' LEU . 0.0 OUTLIER -55.21 127.42 29.17 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 125.822 2.725 . . . . 0.17999999999999999 113.15 -176.099 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 385' ' ' GLU . . . . . 0.401 ' CD ' ' H ' ' B' ' 385' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.307 -1.247 2 CA-C-N 108.129 -4.123 . . . . 0.22 111.168 -178.21 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.217 -0.613 0 CA-C-O 122.391 1.091 . . . . 0.16 112.81 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.825 ' HB ' HG13 ' A' ' 166' ' ' ILE . 2.3 mp -106.02 130.73 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.019 0 CA-C-O 122.663 1.22 . . . . 0.13 110.698 177.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -100.46 124.86 46.53 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.229 -1.35 . . . . 0.13 110.318 176.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.4 mm -94.8 123.44 46.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 105.89 -1.893 . . . . 0.080000000000000002 105.89 176.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.2 mm -92.1 146.79 5.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 122.546 1.165 . . . . 0.089999999999999997 111.834 -178.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.71 121.09 51.22 Favored Pre-proline 0 N--CA 1.428 -1.541 0 N-CA-C 115.379 1.622 . . . . 0.059999999999999998 115.379 -178.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -76.11 -20.02 15.11 Favored 'Trans proline' 0 CA--C 1.559 1.752 0 C-N-CA 121.494 1.463 . . . . 0.050000000000000003 111.396 -177.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.465 ' N ' HD12 ' A' ' 26' ' ' LEU 0.325 0.0 OUTLIER -147.43 161.19 41.54 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 123.815 0.846 . . . . 0.050000000000000003 110.173 175.29 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.9 m -82.61 148.14 28.17 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 121.729 0.776 . . . . 0.089999999999999997 111.099 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 156.81 -155.3 26.24 Favored Glycine 0 N--CA 1.431 -1.688 0 C-N-CA 119.086 -1.531 . . . . 0.080000000000000002 111.041 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.15 134.79 54.34 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.038 -1.081 . . . . 0.10000000000000001 110.063 -177.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.1 mt -74.38 141.45 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 C-N-CA 117.694 -1.602 . . . . 0.080000000000000002 110.383 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.3 t -132.62 155.9 41.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 114.519 -1.219 . . . . 0.089999999999999997 108.786 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.501 ' HB3' ' OE2' ' A' ' 34' ' ' GLU . 86.0 m-20 -71.41 138.35 49.04 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-O 121.443 0.639 . . . . 0.11 111.099 178.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.487 ' CD1' ' CG1' ' A' ' 139' ' ' VAL . 8.2 tt -67.8 -23.67 29.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 C-N-CA 118.65 -1.22 . . . . 0.11 108.724 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.501 ' OE2' ' HB3' ' A' ' 32' ' ' ASN . 0.8 OUTLIER -73.91 -14.09 61.0 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 118.566 -1.254 . . . . 0.13 110.543 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -94.9 12.32 28.64 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 113.689 0.996 . . . . 0.12 113.689 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 t -86.42 130.95 47.5 Favored Pre-proline 0 C--N 1.29 -2.011 0 CA-C-O 120.918 0.39 . . . . 0.13 109.963 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -70.46 48.03 0.72 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 122.711 2.274 . . . . 0.14999999999999999 111.781 -173.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.543 ' CG ' HH21 ' B' ' 317' ' ' ARG . 65.3 t0 -150.66 115.83 5.36 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.733 -1.21 . . . . 0.22 107.733 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.8 m -60.34 -37.9 75.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 C-N-CA 119.005 -1.078 . . . . 0.20000000000000001 111.569 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . 0.404 19.3 m -62.41 -34.89 66.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 C-N-CA 116.864 -1.934 . . . . 0.25 112.148 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -84.18 -44.27 14.13 Favored 'General case' 0 C--N 1.262 -3.23 0 O-C-N 120.132 -1.605 . . . . 0.20000000000000001 109.841 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.52 -36.24 77.9 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 108.937 -0.764 . . . . 0.14000000000000001 108.937 -177.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -91.05 7.81 38.55 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 118.173 -1.411 . . . . 1.0800000000000001 110.585 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.54 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 0.3 OUTLIER 52.42 39.78 28.26 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 113.973 1.101 . . . . 0.14999999999999999 113.973 176.651 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.3 mm -67.18 -30.35 49.04 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.958 0 CA-C-O 123.747 1.737 . . . . 0.17999999999999999 110.696 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.293 2.1 t -89.52 -7.71 10.82 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.898 0 CA-C-N 112.336 -2.211 . . . . 0.48999999999999999 111.844 -175.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.54 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . 133.46 -175.57 20.13 Favored Glycine 0 C--O 1.206 -1.627 0 N-CA-C 108.743 -1.743 . . . . 0.13 108.743 176.57 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -119.52 155.45 32.13 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 117.851 -1.539 . . . . 0.12 112.768 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 172.18 -137.77 4.44 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 117.725 -2.179 . . . . 0.089999999999999997 111.158 177.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.444 ' C ' HD12 ' A' ' 50' ' ' ILE . 2.8 pp -134.98 175.24 11.51 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.716 0 O-C-N 121.592 -0.946 . . . . 0.070000000000000007 108.596 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -121.59 158.51 28.41 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 124.716 1.206 . . . . 0.070000000000000007 108.424 175.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.3 mt -133.33 128.81 55.87 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.826 0 O-C-N 121.641 -0.662 . . . . 0.059999999999999998 111.051 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -86.11 108.81 18.71 Favored Pre-proline 0 C--N 1.308 -1.232 0 N-CA-C 101.478 -3.527 . . . . 0.11 101.478 174.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.428 ' HB3' HD22 ' A' ' 26' ' ' LEU . 2.0 Cg_endo -71.22 150.12 58.8 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 123.725 2.95 . . . . 0.089999999999999997 113.074 -170.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.3 p -138.61 1.6 2.14 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 121.774 -0.579 . . . . 0.11 110.161 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -108.83 -144.5 10.84 Favored Glycine 0 CA--C 1.534 1.238 0 O-C-N 121.444 -0.785 . . . . 0.10000000000000001 114.581 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -142.97 14.48 1.89 Allowed 'General case' 0 CA--C 1.491 -1.291 0 O-C-N 122.363 -0.492 . . . . 0.12 112.079 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -157.28 155.17 30.28 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 115.415 -2.514 . . . . 0.10000000000000001 113.092 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -114.96 121.44 43.18 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.868 -1.06 . . . . 0.070000000000000007 109.054 178.744 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 m -114.15 174.54 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 CA-C-O 122.74 1.257 . . . . 0.070000000000000007 110.964 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.15 126.66 92.92 Favored Pre-proline 0 C--N 1.289 -2.057 0 CA-C-N 113.663 -1.608 . . . . 0.070000000000000007 109.742 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -85.85 -1.5 8.82 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 CA-C-N 120.029 1.046 . . . . 0.070000000000000007 110.429 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.447 HG21 ' HB3' ' A' ' 81' ' ' SER . 17.2 m -158.53 164.96 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-O 121.579 0.704 . . . . 0.089999999999999997 111.139 -178.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.862 ' OD1' HG23 ' A' ' 115' ' ' VAL . 48.0 m-20 -81.44 127.19 32.54 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 103.595 -2.743 . . . . 0.13 103.595 174.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 80' ' ' GLU . . . 174.0 -157.85 26.2 Favored Glycine 0 C--N 1.301 -1.375 0 N-CA-C 110.78 -0.928 . . . . 0.11 110.78 -175.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.6 m -123.69 134.93 53.64 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 119.814 -0.754 . . . . 0.13 111.309 -177.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.7 mm -68.76 140.42 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.041 0 C-N-CA 117.619 -1.632 . . . . 0.12 107.394 178.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -101.76 -64.21 0.75 Allowed Glycine 0 C--N 1.282 -2.457 0 CA-C-O 121.955 0.753 . . . . 0.14000000000000001 114.291 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.541 ' CD ' ' O ' ' B' ' 351' ' ' GLN . 0.1 OUTLIER -141.38 136.47 31.46 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-O 123.059 1.409 . . . . 2.1800000000000002 111.925 -177.842 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 75.8 mt -116.23 125.46 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 N-CA-C 105.514 -2.032 . . . . 0.14000000000000001 105.514 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -62.72 145.46 54.7 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.164 -1.05 . . . . 0.17999999999999999 108.164 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -61.91 -14.9 38.59 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 123.674 0.79 . . . . 0.70999999999999996 110.488 -178.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.509 ' HG1' ' CE1' ' A' ' 75' ' ' HIS . 16.7 p -97.67 4.98 49.95 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 123.593 1.663 . . . . 0.20000000000000001 109.068 178.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.402 ' OD1' ' NH2' ' A' ' 105' ' ' ARG . 69.6 m-20 50.53 44.31 27.19 Favored 'General case' 0 C--N 1.26 -3.305 0 CA-C-N 113.23 -1.805 . . . . 0.14000000000000001 112.59 175.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' HIS . . . . . 0.509 ' CE1' ' HG1' ' A' ' 73' ' ' THR . 20.1 p-80 -126.41 -1.45 6.9 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 113.661 0.986 . . . . 0.20999999999999999 113.661 -177.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.37 152.75 31.44 Favored 'General case' 0 N--CA 1.412 -2.345 0 O-C-N 120.836 -1.165 . . . . 0.10000000000000001 111.022 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -152.53 166.33 32.36 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 123.072 1.415 . . . . 0.089999999999999997 113.245 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . 0.501 ' HB2' ' H ' ' A' ' 69' ' ' LYS 0.259 15.8 m -118.29 139.72 50.9 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 113.278 -1.783 . . . . 0.12 109.849 -178.894 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.6 tt -143.27 150.03 17.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.585 -1.265 . . . . 0.10000000000000001 107.585 175.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . 0.489 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 84.6 tt0 -118.42 129.91 55.67 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 105.628 -1.99 . . . . 0.52000000000000002 105.628 177.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' SER . . . . . 0.447 ' HB3' HG21 ' A' ' 63' ' ' VAL . 94.0 p -80.91 167.32 20.0 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 118.457 -1.297 . . . . 0.13 108.28 -176.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.406 ' OD1' ' NH1' ' A' ' 112' ' ' ARG . 83.0 m-20 -68.11 -31.02 70.33 Favored 'General case' 0 C--N 1.277 -2.569 0 C-N-CA 118.538 -1.265 . . . . 0.14999999999999999 108.264 177.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.22 4.44 2.21 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 125.212 1.405 . . . . 0.14000000000000001 111.998 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.73 14.51 81.98 Favored Glycine 0 C--N 1.28 -2.557 0 N-CA-C 117.351 1.7 . . . . 0.14000000000000001 117.351 -178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.671 HG21 ' CD1' ' A' ' 166' ' ' ILE . 48.8 t -92.42 133.01 35.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 121.189 2.494 . . . . 0.12 110.886 177.8 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.435 ' OE1' ' CB ' ' B' ' 348' ' ' PHE . 96.5 mt-10 -96.9 121.92 39.3 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.669 -0.645 . . . . 1.73 110.229 176.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -116.32 158.84 22.79 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.986 0.898 . . . . 0.089999999999999997 110.922 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -147.34 140.69 25.35 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.674 -0.694 . . . . 0.31 109.919 177.549 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 45.7 t -131.85 131.98 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.69 -0.631 . . . . 0.070000000000000007 110.003 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.413 ' O ' ' C ' ' A' ' 91' ' ' PHE . 3.0 t-160 -120.29 80.72 1.64 Allowed 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 108.462 -0.94 . . . . 0.16 108.462 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PHE . . . . . 0.413 ' C ' ' O ' ' A' ' 90' ' ' HIS . 30.3 t80 -42.84 119.9 1.61 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.239 -0.913 . . . . 0.10000000000000001 110.295 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.34 -175.54 32.64 Favored Glycine 0 C--N 1.303 -1.27 0 CA-C-O 122.885 1.269 . . . . 0.10000000000000001 114.623 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 18.6 mm -118.4 132.61 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-O 122.93 1.348 . . . . 0.14000000000000001 109.132 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 54.65 25.89 6.87 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 114.12 -1.4 . . . . 0.17999999999999999 111.213 -177.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.1 p -64.47 -20.08 65.96 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 115.162 1.541 . . . . 0.14999999999999999 115.162 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.5 p -56.94 -32.82 40.45 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 O-C-N 119.578 -1.951 . . . . 0.17000000000000001 109.296 178.05 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -58.61 -19.99 43.5 Favored 'General case' 0 CA--C 1.566 1.581 0 O-C-N 121.524 -0.735 . . . . 0.25 112.092 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.635 ' N ' HD12 ' A' ' 98' ' ' LEU . 7.3 mp -78.02 -3.67 43.27 Favored 'General case' 0 CA--C 1.566 1.565 0 O-C-N 119.733 -1.855 . . . . 0.17000000000000001 113.877 177.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm 49.23 46.23 22.99 Favored 'General case' 0 C--N 1.276 -2.624 0 N-CA-C 116.082 1.882 . . . . 3.1899999999999999 116.082 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 90.63 -13.17 66.34 Favored Glycine 0 CA--C 1.544 1.871 0 O-C-N 121.26 -0.9 . . . . 0.16 115.338 176.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -62.21 120.92 11.87 Favored 'General case' 0 C--N 1.28 -2.456 0 O-C-N 121.024 -1.28 . . . . 0.17999999999999999 112.235 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 122' ' ' PHE . . . 98.69 -8.68 61.87 Favored Glycine 0 C--O 1.196 -2.274 0 O-C-N 121.637 -0.664 . . . . 0.14000000000000001 114.597 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -115.02 151.6 33.92 Favored 'General case' 0 C--N 1.278 -2.534 0 C-N-CA 124.136 0.974 . . . . 0.13 111.326 178.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -141.23 112.95 7.67 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 124.43 1.092 . . . . 0.13 109.504 177.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ARG . . . . . 0.402 ' NH2' ' OD1' ' A' ' 74' ' ' ASN . 29.0 ttm180 -67.3 123.26 19.86 Favored 'General case' 0 CA--C 1.453 -2.758 0 C-N-CA 120.337 -0.545 . . . . 0.14000000000000001 109.966 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 29.8 mm -106.22 -34.5 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.251 0 C-N-CA 115.112 -2.635 . . . . 0.12 108.289 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.82 177.66 5.7 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 118.721 -1.191 . . . . 0.12 112.391 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -118.26 150.58 39.2 Favored 'General case' 0 C--O 1.215 -0.754 0 N-CA-C 112.963 0.727 . . . . 0.14999999999999999 112.963 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -60.14 137.26 58.14 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 118.385 -1.326 . . . . 1.6799999999999999 108.021 176.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.54 -5.8 83.58 Favored Glycine 0 N--CA 1.475 1.253 0 N-CA-C 111.455 -0.658 . . . . 0.14000000000000001 111.455 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -65.88 137.17 57.01 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-O 122.843 1.306 . . . . 0.13 113.289 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ARG . . . . . 0.406 ' NH1' ' OD1' ' A' ' 82' ' ' ASP . 0.9 OUTLIER -85.23 133.07 34.19 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 107.095 -1.446 . . . . 0.14999999999999999 107.095 176.153 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.3 m -140.66 159.72 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.042 0 C-N-CA 117.678 -1.609 . . . . 0.11 113.286 -177.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -110.42 156.11 21.27 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 112.032 -2.349 . . . . 0.14000000000000001 108.773 175.03 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.862 HG23 ' OD1' ' A' ' 64' ' ' ASP . 28.7 t -45.3 135.43 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.457 0 CA-C-O 121.677 0.751 . . . . 0.11 111.837 176.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.52 -13.2 64.59 Favored Glycine 0 CA--C 1.537 1.42 0 C-N-CA 120.786 -0.721 . . . . 0.089999999999999997 114.285 178.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -63.05 136.24 57.7 Favored 'General case' 0 C--N 1.288 -2.085 0 O-C-N 120.547 -1.561 . . . . 0.11 109.912 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 55.6 m -76.61 132.22 39.32 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 122.915 1.341 . . . . 0.10000000000000001 111.231 -177.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 120' ' ' ILE . 38.5 t -106.03 -47.83 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.684 0 CA-C-N 113.544 -1.662 . . . . 0.089999999999999997 109.414 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 119' ' ' VAL . 11.5 mt -148.78 143.49 18.67 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.836 0 N-CA-C 114.135 1.161 . . . . 0.089999999999999997 114.135 -177.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -112.71 146.64 38.37 Favored 'General case' 0 CA--C 1.487 -1.457 0 C-N-CA 116.788 -1.965 . . . . 0.12 107.591 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' PHE . . . . . 0.517 ' HA ' ' O ' ' A' ' 102' ' ' GLY . 42.6 p90 -133.0 162.37 31.87 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 122.669 1.223 . . . . 0.11 112.003 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 126' ' ' LEU . 7.9 t70 -99.05 99.59 10.63 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.605 -1.179 . . . . 0.14999999999999999 108.888 177.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LEU . . . . . 0.553 ' HB3' ' HD3' ' A' ' 125' ' ' PRO . 26.9 tp -61.81 -51.54 75.12 Favored Pre-proline 0 C--N 1.292 -1.911 0 N-CA-C 116.929 2.196 . . . . 0.12 116.929 -177.161 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' A' ' 124' ' ' LEU . 31.5 Cg_exo -58.97 -45.04 30.62 Favored 'Trans proline' 1 C--N 1.241 -5.116 0 C-N-CA 121.966 1.777 . . . . 0.14999999999999999 109.411 -177.064 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 126' ' ' LEU . . . . . 0.508 ' N ' ' OD1' ' A' ' 123' ' ' ASP . 29.0 tp -57.76 -48.26 80.14 Favored 'General case' 0 C--N 1.308 -1.216 0 O-C-N 121.383 -0.823 . . . . 0.16 110.157 177.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 94.8 mt -69.84 -32.35 70.7 Favored 'General case' 0 C--N 1.282 -2.36 0 O-C-N 121.164 -0.96 . . . . 0.13 111.817 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -64.61 -37.73 88.56 Favored 'General case' 0 C--N 1.278 -2.517 0 N-CA-C 106.538 -1.653 . . . . 0.14999999999999999 106.538 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -75.42 -41.7 55.36 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 113.476 0.917 . . . . 0.19 113.476 177.828 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 39.4 mmtt -95.8 -27.81 15.05 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 116.582 2.067 . . . . 0.20000000000000001 116.582 -176.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.54 142.73 35.47 Favored 'General case' 0 C--N 1.258 -3.378 0 N-CA-C 115.437 1.643 . . . . 0.14999999999999999 115.437 -177.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 46.3 tptt -55.47 -38.25 68.85 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 108.066 -1.087 . . . . 0.17999999999999999 108.066 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.3 t -163.71 143.21 8.21 Favored 'General case' 0 C--N 1.287 -2.152 0 C-N-CA 125.004 1.321 . . . . 0.13 111.15 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 10.0 p -94.97 -1.26 52.84 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-N 114.794 -1.093 . . . . 0.11 110.255 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 33.4 mt -54.93 131.85 45.45 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 106.78 -1.563 . . . . 0.10000000000000001 106.78 177.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 77.2 m -119.79 101.84 47.66 Favored Pre-proline 0 C--N 1.292 -1.893 0 N-CA-C 115.272 1.582 . . . . 0.070000000000000007 115.272 -174.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -71.16 141.68 40.15 Favored 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 117.425 -1.25 . . . . 0.089999999999999997 115.078 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . 0.309 0.6 OUTLIER -124.79 104.61 13.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 105.207 -2.146 . . . . 0.059999999999999998 105.207 174.152 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 139' ' ' VAL . . . . . 0.487 ' CG1' ' CD1' ' A' ' 33' ' ' ILE . 19.8 m -124.02 158.17 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 N-CA-C 116.458 2.021 . . . . 0.089999999999999997 116.458 -176.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.584 ' N ' HD12 ' A' ' 140' ' ' ILE . 1.4 mp -96.71 125.55 49.64 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.344 0 N-CA-C 104.618 -2.364 . . . . 0.11 104.618 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 53.6 p -98.44 -4.47 34.49 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-O 123.231 1.491 . . . . 0.14000000000000001 112.956 -175.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ASN . . . . . 0.428 ' O ' ' C ' ' A' ' 143' ' ' MET 0.491 42.1 t30 -98.13 16.05 22.43 Favored 'General case' 0 C--N 1.259 -3.357 0 C-N-CA 130.089 3.356 . . . . 0.14999999999999999 114.344 -179.74 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 143' ' ' MET . . . . . 0.428 ' C ' ' O ' ' A' ' 142' ' ' ASN . 95.3 mmm -34.54 -44.39 0.2 Allowed 'General case' 0 C--N 1.28 -2.452 0 N-CA-C 115.646 1.721 . . . . 0.16 115.646 -174.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -64.51 -11.64 36.09 Favored 'General case' 0 C--N 1.248 -3.811 0 O-C-N 119.762 -1.837 . . . . 0.26000000000000001 113.099 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLU . . . . . 0.402 ' HB2' ' ND2' ' A' ' 142' ' ' ASN . 80.4 mt-10 -106.88 14.56 26.46 Favored 'General case' 0 CA--C 1.475 -1.922 0 CA-C-N 121.225 1.829 . . . . 0.17000000000000001 111.28 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 10.5 pt -121.99 140.29 46.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 C-N-CA 116.082 -2.247 . . . . 0.16 114.056 -178.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . 0.256 49.0 tptt -73.83 -55.12 6.6 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 114.275 -1.329 . . . . 0.20000000000000001 109.584 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 166' ' ' ILE . 2.6 tt0 -147.64 144.61 28.51 Favored 'General case' 0 C--N 1.286 -2.154 0 O-C-N 119.889 -1.757 . . . . 0.17000000000000001 114.6 177.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.8 tt -114.73 111.66 21.62 Favored 'General case' 0 N--CA 1.415 -2.177 0 CA-C-N 111.309 -2.678 . . . . 0.13 110.262 177.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 70.1 mt -108.1 112.41 40.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 114.567 -1.197 . . . . 0.14000000000000001 107.844 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -85.0 130.32 34.64 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 124.301 1.04 . . . . 0.11 113.113 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 152' ' ' LEU 0.302 39.2 mt -94.67 175.94 6.47 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-O 123.007 1.384 . . . . 0.11 112.371 -179.618 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 153' ' ' SER . . . . . . . . . . . . 0.293 50.9 m -132.02 159.34 39.07 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 113.416 -1.72 . . . . 0.11 115.145 -174.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 101.4 -158.74 18.73 Favored Glycine 0 C--O 1.214 -1.096 0 N-CA-C 118.92 2.328 . . . . 0.10000000000000001 118.92 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 64.6 m -94.83 142.51 27.38 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 112.1 -2.05 . . . . 0.12 109.601 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' VAL . . . . . 0.624 HG11 HG12 ' A' ' 163' ' ' VAL . 6.4 m -131.59 160.31 42.46 Favored 'Isoleucine or valine' 0 CA--C 1.462 -2.429 0 CA-C-O 122.995 1.379 . . . . 0.089999999999999997 109.996 -177.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 29.3 m -123.63 122.73 38.89 Favored 'General case' 0 C--N 1.269 -2.903 0 CA-C-N 112.854 -1.975 . . . . 0.12 108.773 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 9.3 p -37.07 122.48 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.736 0 CA-C-O 123.547 1.641 . . . . 0.089999999999999997 114.697 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 62.17 26.34 67.52 Favored Glycine 0 CA--C 1.489 -1.546 0 CA-C-N 112.871 -1.968 . . . . 0.10000000000000001 113.934 176.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -137.43 -51.4 0.64 Allowed 'General case' 0 C--N 1.283 -2.317 0 C-N-CA 119.624 -0.83 . . . . 0.14000000000000001 112.581 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.599 ' CG2' HG12 ' A' ' 156' ' ' VAL . 11.9 m -86.09 123.59 71.6 Favored Pre-proline 0 C--N 1.28 -2.415 0 N-CA-C 113.971 1.1 . . . . 0.10000000000000001 113.971 -176.618 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -63.08 141.22 82.48 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.963 2.442 . . . . 0.11 109.957 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' VAL . . . . . 0.624 HG12 HG11 ' A' ' 156' ' ' VAL . 18.4 m -116.25 -28.59 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.306 -0.871 . . . . 0.070000000000000007 111.881 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 34.8 mt -141.36 149.73 20.24 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 CA-C-O 122.064 0.935 . . . . 0.089999999999999997 109.005 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -124.73 130.75 53.02 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 105.78 -1.933 . . . . 0.13 105.78 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ILE . . . . . 0.825 HG13 ' HB ' ' A' ' 20' ' ' ILE . 5.8 pt -128.71 155.0 40.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.298 -0.961 . . . . 0.13 109.927 -177.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' LYS . . . . . 0.446 ' O ' ' C ' ' A' ' 168' ' ' LYS . 80.0 tttt -120.1 154.25 34.96 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 109.064 -0.717 . . . . 0.17999999999999999 109.064 176.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 167' ' ' LYS . 17.1 tttt . . . . . 0 C--N 1.319 -0.732 0 CA-C-N 115.75 -0.659 . . . . 0.19 110.044 -177.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 301' ' ' MET . . . . . 0.513 ' HB2' ' HG2' ' B' ' 366' ' ' GLU . 4.2 ttm . . . . . 0 C--O 1.219 -0.545 0 N-CA-C 108.473 -0.936 . . . . 0.20000000000000001 108.473 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 302' ' ' PHE . . . . . 0.534 ' CD2' ' HA ' ' B' ' 371' ' ' GLN . 74.9 t80 -142.93 140.91 31.33 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.219 -1.4 . . . . 0.19 107.219 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -150.85 157.34 42.8 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 120.998 -1.064 . . . . 0.16 109.461 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -153.18 147.62 25.97 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.024 -1.472 . . . . 0.17999999999999999 107.024 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.97 151.96 19.17 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.296 -1.001 . . . . 0.17000000000000001 108.296 178.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.62 144.31 17.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 107.345 -1.354 . . . . 0.14999999999999999 107.345 174.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 87.1 m -93.9 136.69 33.92 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.596 0.712 . . . . 0.19 110.107 178.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 59.0 mt -85.69 114.12 25.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 104.653 -2.351 . . . . 0.19 104.653 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 61.1 p -106.44 -3.86 20.49 Favored 'General case' 0 N--CA 1.514 2.729 0 N-CA-C 114.57 1.322 . . . . 0.23000000000000001 114.57 -178.479 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 310' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' B' ' 384' ' ' LEU . . . -71.74 139.2 83.12 Favored Pre-proline 0 N--CA 1.487 1.396 0 CA-C-N 120.314 1.415 . . . . 0.20999999999999999 110.701 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -46.45 -44.87 20.18 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 123.012 2.475 . . . . 0.26000000000000001 117.095 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -103.72 29.29 5.88 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 115.758 -2.377 . . . . 1.04 107.145 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 60.39 -122.47 29.96 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 117.615 -2.231 . . . . 0.19 108.839 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 314' ' ' LEU . . . . . 0.422 ' O ' ' O ' ' B' ' 315' ' ' HIS . 4.6 tp -117.51 81.63 1.69 Allowed 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.322 -0.992 . . . . 0.14999999999999999 108.322 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 315' ' ' HIS . . . . . 0.674 ' CE1' ' H ' ' B' ' 317' ' ' ARG . 3.5 p80 -66.08 -141.4 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 O-C-N 120.402 -1.436 . . . . 0.32000000000000001 108.211 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 316' ' ' THR . . . . . 0.652 ' H ' ' CG ' ' B' ' 315' ' ' HIS . 8.7 m -84.96 -46.37 11.3 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 115.5 1.667 . . . . 0.28000000000000003 115.5 -176.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 317' ' ' ARG . . . . . 0.674 ' H ' ' CE1' ' B' ' 315' ' ' HIS . 18.9 ttm180 -71.01 -42.96 12.97 Favored Pre-proline 0 N--CA 1.494 1.774 0 C-N-CA 116.091 -2.244 . . . . 1.1000000000000001 113.356 -172.404 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 318' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' B' ' 317' ' ' ARG . 11.5 Cg_endo -68.9 -28.86 29.01 Favored 'Trans proline' 0 C--N 1.296 -2.233 0 CA-C-N 121.165 1.452 . . . . 0.17000000000000001 111.919 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -69.46 -35.43 75.62 Favored 'General case' 0 N--CA 1.509 2.5 0 O-C-N 120.777 -1.202 . . . . 0.13 108.839 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -71.52 -39.32 70.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.798 -1.189 . . . . 0.16 108.867 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -67.84 -35.93 79.44 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 118.084 -1.447 . . . . 1.7 108.7 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -64.25 -44.62 91.23 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 122.408 1.099 . . . . 0.12 108.704 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.71 -40.37 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-N 115.227 -0.897 . . . . 0.13 110.539 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -64.52 -41.06 96.63 Favored 'General case' 0 C--N 1.292 -1.898 0 O-C-N 120.804 -1.185 . . . . 1.1799999999999999 109.735 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -68.27 -40.17 81.96 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.152 -0.685 . . . . 0.16 109.152 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.58 -42.31 92.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.945 -1.097 . . . . 0.14000000000000001 109.283 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -62.82 -15.05 52.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.034 -1.041 . . . . 1.6000000000000001 112.875 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -78.36 -11.26 85.5 Favored Glycine 0 N--CA 1.478 1.498 0 N-CA-C 108.85 -1.7 . . . . 0.19 108.85 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 329' ' ' PHE . . . . . 0.541 ' HE1' ' HE3' ' B' ' 372' ' ' LYS . 82.3 m-85 -103.88 144.99 30.77 Favored 'General case' 0 N--CA 1.507 2.388 0 CA-C-N 118.713 1.257 . . . . 0.17000000000000001 110.129 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 74.4 p -76.9 -28.7 55.44 Favored 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 118.611 -0.709 . . . . 0.22 112.503 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 20.3 m -58.92 157.58 9.63 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 123.384 1.564 . . . . 0.17999999999999999 114.899 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.6 128.49 33.46 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 102.22 -3.252 . . . . 0.17999999999999999 102.22 172.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 41.7 mt -125.76 133.93 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 108.203 -1.036 . . . . 0.14000000000000001 108.203 -175.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 97.6 m -124.58 140.68 52.72 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 122.267 1.032 . . . . 0.14000000000000001 109.184 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 335' ' ' VAL . . . . . 0.436 HG23 ' HB2' ' B' ' 344' ' ' ALA . 93.1 t -107.33 127.38 63.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 105.34 -2.096 . . . . 0.12 105.34 174.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 88.3 m -124.73 121.04 33.52 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.881 0.848 . . . . 0.14999999999999999 110.396 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 337' ' ' SER . . . . . 0.498 ' HB2' HG12 ' B' ' 361' ' ' VAL . 33.5 t -125.65 123.83 39.82 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 118.425 -1.31 . . . . 0.17000000000000001 108.129 177.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 58.5 t30 49.71 40.19 19.43 Favored 'General case' 0 N--CA 1.514 2.765 0 N-CA-C 112.872 0.693 . . . . 0.22 112.872 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 81.05 12.23 82.78 Favored Glycine 0 N--CA 1.485 1.923 0 O-C-N 120.487 -1.383 . . . . 0.20000000000000001 113.334 176.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -121.8 136.69 54.94 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 103.539 -2.763 . . . . 2.48 103.539 178.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 68.8 m -121.55 156.1 33.6 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-O 124.321 2.01 . . . . 0.17000000000000001 114.996 -175.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -151.52 148.01 27.52 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 111.848 -2.433 . . . . 0.14999999999999999 110.82 176.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 7.6 t -65.59 132.93 50.08 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.416 -1.698 . . . . 0.14999999999999999 106.416 173.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 344' ' ' ALA . . . . . 0.436 ' HB2' HG23 ' B' ' 335' ' ' VAL . . . -73.47 -6.02 43.71 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 120.285 -1.509 . . . . 0.11 110.842 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -98.23 12.74 33.68 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.966 -1.084 . . . . 0.17000000000000001 109.189 -178.035 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.23 105.64 6.74 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 123.122 1.439 . . . . 0.17999999999999999 110.557 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 28.9 tp -57.34 -37.59 72.78 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 113.949 -1.478 . . . . 0.19 109.303 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 348' ' ' PHE . . . . . 0.435 ' CB ' ' OE1' ' A' ' 86' ' ' GLU . 72.5 t80 -61.18 -50.4 73.32 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 120.355 -1.465 . . . . 0.38 112.975 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -69.54 -31.75 70.15 Favored 'General case' 0 C--N 1.314 -0.963 0 O-C-N 119.609 -1.932 . . . . 1.1699999999999999 110.554 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 3.1 mt -65.25 -32.03 73.49 Favored 'General case' 0 C--N 1.285 -2.233 0 C-N-CA 119.177 -1.009 . . . . 0.14999999999999999 109.309 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 351' ' ' GLN . . . . . 0.541 ' O ' ' CD ' ' A' ' 69' ' ' LYS . 89.6 mt-30 -68.21 -10.64 55.93 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.96 -0.462 . . . . 0.82999999999999996 109.819 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 2.7 p -91.95 -3.91 55.31 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 118.292 -1.363 . . . . 0.23000000000000001 110.804 -177.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 353' ' ' LEU . . . . . 0.482 HD22 ' HB3' ' B' ' 337' ' ' SER . 25.5 mt -94.7 157.05 16.13 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.257 -0.902 . . . . 0.17000000000000001 110.076 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -86.3 106.45 3.09 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 104.713 -3.355 . . . . 0.17999999999999999 104.713 177.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 91.3 mt -122.37 48.39 1.76 Allowed 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 106.153 -1.795 . . . . 0.16 106.153 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 24.1 p -83.12 171.02 14.16 Favored 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 109.335 -0.617 . . . . 0.25 109.335 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -57.7 138.52 55.36 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.177 -0.952 . . . . 0.25 110.675 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 92.19 -3.13 76.05 Favored Glycine 0 N--CA 1.474 1.173 0 C-N-CA 119.39 -1.385 . . . . 0.20999999999999999 112.61 177.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 55.3 m -84.82 132.98 34.34 Favored 'General case' 0 C--N 1.291 -1.975 0 O-C-N 121.507 -0.996 . . . . 0.17999999999999999 111.185 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 94.7 t -94.44 122.86 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 107.031 -1.47 . . . . 0.17999999999999999 107.031 177.091 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 361' ' ' VAL . . . . . 0.498 HG12 ' HB2' ' B' ' 337' ' ' SER . 17.8 m -112.73 161.33 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 C-N-CA 116.891 -1.923 . . . . 0.13 109.891 178.039 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 85.4 m -110.06 130.52 55.52 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 106.324 -1.732 . . . . 0.13 106.324 175.744 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 54.5 mt -110.33 120.43 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 102.869 -3.011 . . . . 0.11 102.869 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.42 146.43 49.62 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 107.716 -1.216 . . . . 0.13 107.716 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -141.05 153.66 45.6 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 117.566 -1.653 . . . . 0.16 108.63 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 366' ' ' GLU . . . . . 0.513 ' HG2' ' HB2' ' B' ' 301' ' ' MET . 0.0 OUTLIER -141.79 111.91 6.87 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.06 -1.459 . . . . 0.22 107.06 178.701 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 165.25 -173.49 41.04 Favored Glycine 0 C--N 1.294 -1.766 0 C-N-CA 117.651 -2.214 . . . . 0.20999999999999999 108.64 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -54.78 -41.5 70.62 Favored 'General case' 0 C--N 1.285 -2.213 0 C-N-CA 124.134 0.974 . . . . 0.28000000000000003 113.253 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 15.2 p30 -116.04 36.71 3.93 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 117.002 -1.879 . . . . 0.20999999999999999 108.135 -177.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -58.97 -30.35 67.87 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 119.001 2.963 . . . . 0.20000000000000001 119.001 -175.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 371' ' ' GLN . . . . . 0.534 ' HA ' ' CD2' ' B' ' 302' ' ' PHE . 0.0 OUTLIER -78.2 -43.36 28.72 Favored 'General case' 0 N--CA 1.512 2.66 0 O-C-N 119.647 -1.908 . . . . 0.23000000000000001 109.768 -177.953 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 372' ' ' LYS . . . . . 0.541 ' HE3' ' HE1' ' B' ' 329' ' ' PHE . 13.2 ttpp -63.78 -40.71 97.33 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 106.878 -1.527 . . . . 0.22 106.878 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.21 -46.89 86.86 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 118.441 -1.303 . . . . 0.16 110.599 -178.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 68.7 t -68.78 -39.54 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 N-CA-C 108.521 -0.918 . . . . 0.14000000000000001 108.521 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -58.21 -46.49 85.75 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.846 0.831 . . . . 0.20999999999999999 109.508 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 376' ' ' HIS . . . . . 0.462 ' CE1' ' HZ2' ' B' ' 372' ' ' LYS . 3.5 m80 -71.05 -35.81 72.08 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 113.347 0.869 . . . . 0.20000000000000001 113.347 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 95.8 mt -79.87 -25.11 40.79 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.447 -1.301 . . . . 0.13 111.786 -175.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 2.1 t -73.13 -38.88 56.0 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 N-CA-C 106.288 -1.745 . . . . 0.14999999999999999 106.288 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -68.83 -48.6 63.13 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 107.563 -1.273 . . . . 0.22 107.563 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 380' ' ' LEU . . . . . 0.569 ' HG ' ' CD2' ' B' ' 384' ' ' LEU . 28.2 tp -55.53 -47.37 76.4 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 118.773 -1.171 . . . . 0.14999999999999999 110.754 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 2.9 ttm -61.49 -35.02 76.48 Favored 'General case' 0 C--N 1.309 -1.168 0 O-C-N 120.721 -1.237 . . . . 0.14999999999999999 113.44 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -77.48 -29.46 52.66 Favored 'General case' 0 C--N 1.282 -2.36 0 O-C-N 121.229 -0.919 . . . . 0.19 108.856 -178.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . 0.265 32.3 mt-10 -76.37 -36.76 57.97 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 121.787 0.803 . . . . 0.22 111.757 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 384' ' ' LEU . . . . . 0.569 ' CD2' ' HG ' ' B' ' 380' ' ' LEU . 0.0 OUTLIER -55.21 127.42 29.17 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 125.822 2.725 . . . . 0.17999999999999999 113.15 -176.099 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 385' ' ' GLU . . . . . 0.401 ' CD ' ' H ' ' B' ' 385' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.307 -1.247 2 CA-C-N 108.129 -4.123 . . . . 0.22 111.168 -178.21 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.217 -0.633 0 CA-C-O 122.405 1.098 . . . . 0.14999999999999999 112.795 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.814 ' HB ' ' CG1' ' A' ' 166' ' ' ILE . 2.3 mp -105.93 130.77 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.023 0 CA-C-O 122.637 1.208 . . . . 0.13 110.744 177.46 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -100.49 124.86 46.59 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.225 -1.352 . . . . 0.12 110.302 176.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.4 mm -94.79 123.4 46.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 105.961 -1.866 . . . . 0.080000000000000002 105.961 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.1 mm -92.11 146.77 5.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 CA-C-O 122.553 1.168 . . . . 0.089999999999999997 111.839 -178.369 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.68 121.14 51.52 Favored Pre-proline 0 N--CA 1.429 -1.504 0 N-CA-C 115.336 1.606 . . . . 0.050000000000000003 115.336 -178.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -76.16 -19.99 15.04 Favored 'Trans proline' 0 CA--C 1.558 1.709 0 C-N-CA 121.488 1.458 . . . . 0.040000000000000001 111.386 -177.536 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.466 ' N ' HD12 ' A' ' 26' ' ' LEU 0.324 0.0 OUTLIER -147.44 161.22 41.48 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 123.82 0.848 . . . . 0.050000000000000003 110.185 175.253 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.9 m -82.6 148.13 28.18 Favored 'General case' 0 CA--C 1.498 -1.023 0 CA-C-O 121.709 0.766 . . . . 0.080000000000000002 111.11 177.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 156.84 -155.38 26.31 Favored Glycine 0 N--CA 1.431 -1.682 0 C-N-CA 119.078 -1.534 . . . . 0.080000000000000002 111.003 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.04 134.82 54.27 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 114.002 -1.099 . . . . 0.12 110.156 -177.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.0 mt -74.41 141.5 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 C-N-CA 117.621 -1.632 . . . . 0.089999999999999997 110.333 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.4 t -132.64 155.94 41.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 114.496 -1.229 . . . . 0.10000000000000001 108.714 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.502 ' HB3' ' OE2' ' A' ' 34' ' ' GLU . 86.0 m-20 -71.51 138.37 48.86 Favored 'General case' 0 CA--C 1.497 -1.076 0 CA-C-O 121.477 0.656 . . . . 0.11 111.064 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.422 ' CD1' ' CG1' ' A' ' 139' ' ' VAL . 8.2 tt -67.84 -23.67 29.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 C-N-CA 118.678 -1.209 . . . . 0.12 108.659 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.502 ' OE2' ' HB3' ' A' ' 32' ' ' ASN . 0.8 OUTLIER -73.91 -14.08 61.0 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 118.649 -1.22 . . . . 0.14000000000000001 110.589 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -95.0 12.48 28.29 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 113.694 0.998 . . . . 0.14000000000000001 113.694 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 t -86.5 130.99 47.16 Favored Pre-proline 0 C--N 1.289 -2.045 0 CA-C-O 120.955 0.407 . . . . 0.14999999999999999 109.921 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -70.49 48.01 0.72 Allowed 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 122.695 2.264 . . . . 0.16 111.758 -173.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.555 ' CG ' HH21 ' B' ' 317' ' ' ARG . 62.6 t0 -150.68 115.82 5.34 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.662 -1.236 . . . . 0.22 107.662 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.9 m -60.4 -37.81 75.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 C-N-CA 119.016 -1.074 . . . . 0.19 111.601 -178.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . 0.406 16.1 m -62.46 -34.8 66.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 116.907 -1.917 . . . . 0.27000000000000002 112.174 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -84.25 -44.32 13.99 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 120.21 -1.556 . . . . 0.19 109.822 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.51 -36.2 77.79 Favored 'General case' 0 CA--C 1.487 -1.461 0 N-CA-C 108.946 -0.761 . . . . 0.14999999999999999 108.946 -177.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -91.06 7.78 38.73 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 118.219 -1.393 . . . . 0.81000000000000005 110.579 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.54 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 0.3 OUTLIER 52.37 39.82 28.19 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 113.943 1.09 . . . . 0.14999999999999999 113.943 176.665 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.0 mm -67.14 -30.44 49.38 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.963 0 CA-C-O 123.717 1.723 . . . . 0.17000000000000001 110.676 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.293 2.3 t -89.48 -7.71 10.82 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.916 0 CA-C-N 112.366 -2.197 . . . . 0.5 111.81 -175.524 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.54 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . 133.45 -175.57 20.12 Favored Glycine 0 C--O 1.207 -1.574 0 N-CA-C 108.773 -1.731 . . . . 0.13 108.773 176.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -119.52 155.39 32.24 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 117.835 -1.546 . . . . 0.11 112.797 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 172.22 -137.68 4.39 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 117.703 -2.189 . . . . 0.089999999999999997 111.178 177.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.444 ' C ' HD12 ' A' ' 50' ' ' ILE . 2.8 pp -135.05 175.21 11.53 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.695 0 O-C-N 121.579 -0.954 . . . . 0.070000000000000007 108.596 178.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -121.58 158.52 28.38 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 124.7 1.2 . . . . 0.080000000000000002 108.428 175.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.3 mt -133.36 128.87 55.85 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.84 0 O-C-N 121.595 -0.691 . . . . 0.070000000000000007 111.005 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -86.23 108.88 19.21 Favored Pre-proline 0 C--N 1.308 -1.224 0 N-CA-C 101.46 -3.533 . . . . 0.13 101.46 174.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.429 ' HB3' HD22 ' A' ' 26' ' ' LEU . 2.0 Cg_endo -71.26 150.1 58.5 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 123.735 2.956 . . . . 0.10000000000000001 113.064 -170.849 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.7 p -138.66 1.68 2.14 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 121.746 -0.596 . . . . 0.11 110.16 177.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -108.81 -144.48 10.85 Favored Glycine 0 CA--C 1.534 1.268 0 O-C-N 121.485 -0.759 . . . . 0.089999999999999997 114.573 -177.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -142.97 14.52 1.89 Allowed 'General case' 0 CA--C 1.492 -1.265 0 O-C-N 122.351 -0.499 . . . . 0.10000000000000001 112.068 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -157.3 155.12 30.16 Favored 'General case' 0 N--CA 1.415 -2.187 0 C-N-CA 115.405 -2.518 . . . . 0.089999999999999997 113.142 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -114.89 121.4 43.08 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.872 -1.058 . . . . 0.059999999999999998 109.077 178.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 m -114.13 174.58 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.8 0 CA-C-O 122.733 1.254 . . . . 0.059999999999999998 110.998 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.13 126.64 92.89 Favored Pre-proline 0 C--N 1.289 -2.058 0 CA-C-N 113.705 -1.589 . . . . 0.080000000000000002 109.729 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -85.84 -1.52 8.83 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 CA-C-N 120.027 1.045 . . . . 0.070000000000000007 110.439 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.449 HG21 ' HB3' ' A' ' 81' ' ' SER . 17.2 m -158.49 164.95 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-O 121.493 0.663 . . . . 0.10000000000000001 111.185 -178.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.8 ' OD1' HG23 ' A' ' 115' ' ' VAL . 48.5 m-20 -81.45 127.19 32.54 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 103.558 -2.756 . . . . 0.13 103.558 174.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 80' ' ' GLU . . . 174.0 -157.82 26.15 Favored Glycine 0 C--N 1.301 -1.395 0 N-CA-C 110.753 -0.939 . . . . 0.12 110.753 -175.571 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.0 m -123.71 134.85 53.64 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 119.854 -0.739 . . . . 0.14999999999999999 111.316 -177.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.7 mm -68.79 140.42 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.028 0 C-N-CA 117.626 -1.629 . . . . 0.13 107.365 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -101.7 -64.25 0.76 Allowed Glycine 0 C--N 1.282 -2.471 0 CA-C-O 122.029 0.794 . . . . 0.13 114.332 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.5 ' H ' ' HB2' ' A' ' 78' ' ' SER . 2.3 tmtp? -141.4 136.43 31.39 Favored 'General case' 0 C--N 1.279 -2.497 0 CA-C-O 123.053 1.406 . . . . 2.1600000000000001 111.954 -177.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 75.5 mt -116.19 125.45 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 105.532 -2.025 . . . . 0.12 105.532 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -62.65 145.41 54.64 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.172 -1.047 . . . . 0.20999999999999999 108.172 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -61.87 -14.91 38.15 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 123.67 0.788 . . . . 0.40000000000000002 110.454 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.508 ' OG1' ' ND1' ' A' ' 75' ' ' HIS . 41.4 p -97.7 5.03 49.83 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 123.618 1.675 . . . . 0.14999999999999999 109.055 178.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 69.7 m-20 50.41 44.39 26.82 Favored 'General case' 0 C--N 1.26 -3.292 0 CA-C-N 113.24 -1.8 . . . . 0.11 112.608 175.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.508 ' ND1' ' OG1' ' A' ' 73' ' ' THR . 23.7 p-80 -126.38 -1.55 6.91 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 113.652 0.982 . . . . 0.17999999999999999 113.652 -177.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.31 152.69 31.42 Favored 'General case' 0 N--CA 1.411 -2.388 0 O-C-N 120.79 -1.193 . . . . 0.089999999999999997 111.122 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -152.49 166.36 32.23 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 123.077 1.418 . . . . 0.089999999999999997 113.276 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.5 ' HB2' ' H ' ' A' ' 69' ' ' LYS 0.26 15.8 m -118.34 139.74 50.9 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 113.302 -1.772 . . . . 0.11 109.789 -178.877 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.6 tt -143.3 150.0 17.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 107.607 -1.257 . . . . 0.11 107.607 175.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.489 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 84.6 tt0 -118.37 129.89 55.68 Favored 'General case' 0 C--O 1.201 -1.483 0 N-CA-C 105.647 -1.983 . . . . 0.83999999999999997 105.647 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.449 ' HB3' HG21 ' A' ' 63' ' ' VAL . 93.9 p -80.9 167.31 20.02 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 118.441 -1.304 . . . . 0.14000000000000001 108.264 -176.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -68.13 -31.06 70.39 Favored 'General case' 0 C--N 1.276 -2.6 0 C-N-CA 118.572 -1.251 . . . . 0.16 108.232 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.16 4.46 2.17 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 125.26 1.424 . . . . 0.14999999999999999 112.053 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.68 14.48 82.03 Favored Glycine 0 C--N 1.28 -2.57 0 N-CA-C 117.386 1.715 . . . . 0.14999999999999999 117.386 -178.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.762 HG21 HD11 ' A' ' 166' ' ' ILE . 48.8 t -92.35 133.0 35.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 121.202 2.501 . . . . 0.13 110.863 177.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.422 ' OE1' ' CB ' ' B' ' 348' ' ' PHE . 97.3 mt-10 -96.97 121.97 39.44 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 121.643 -0.661 . . . . 1.7 110.207 176.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -116.32 158.79 22.87 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 122.001 0.905 . . . . 0.10000000000000001 110.851 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -143.65 111.87 6.28 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 122.989 1.376 . . . . 0.17999999999999999 109.77 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.1 t -101.7 115.56 43.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 114.046 -1.434 . . . . 0.070000000000000007 111.464 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.449 ' O ' ' HD2' ' A' ' 137' ' ' PRO . 18.4 t-80 -123.2 105.1 9.6 Favored 'General case' 0 C--O 1.2 -1.531 0 CA-C-N 115.549 -0.751 . . . . 0.16 111.086 -178.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -63.63 124.14 20.64 Favored 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 116.665 2.098 . . . . 0.10000000000000001 116.665 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.35 -175.88 32.07 Favored Glycine 0 C--O 1.215 -1.093 0 CA-C-O 122.572 1.096 . . . . 0.11 114.526 175.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 49.0 mm -118.0 132.59 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-O 123.151 1.453 . . . . 0.14999999999999999 109.2 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 54.65 25.84 6.83 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 114.089 -1.414 . . . . 0.17999999999999999 111.246 -177.123 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.3 p -64.44 -19.9 65.83 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 115.437 1.643 . . . . 0.14000000000000001 115.437 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.3 p -57.06 -32.82 41.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 O-C-N 120.125 -1.609 . . . . 0.17000000000000001 109.321 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -58.56 -20.07 43.53 Favored 'General case' 0 CA--C 1.566 1.594 0 C-N-CA 119.91 -0.716 . . . . 0.23999999999999999 112.098 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mp -78.19 -3.24 41.61 Favored 'General case' 0 CA--C 1.564 1.488 0 O-C-N 119.716 -1.865 . . . . 0.16 113.86 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? 48.91 46.21 22.22 Favored 'General case' 0 C--N 1.278 -2.525 0 N-CA-C 116.077 1.88 . . . . 3.21 116.077 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 90.76 -13.3 66.19 Favored Glycine 0 CA--C 1.542 1.77 0 N-CA-C 115.433 0.933 . . . . 0.13 115.433 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.04 121.21 12.45 Favored 'General case' 0 C--N 1.283 -2.284 0 O-C-N 121.296 -1.12 . . . . 0.16 112.016 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.517 ' O ' ' NZ ' ' A' ' 104' ' ' LYS . . . 97.71 -7.03 63.01 Favored Glycine 0 C--O 1.201 -1.926 0 N-CA-C 114.87 0.708 . . . . 0.12 114.87 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -115.73 152.28 33.52 Favored 'General case' 0 C--N 1.283 -2.298 0 C-N-CA 124.117 0.967 . . . . 0.10000000000000001 111.012 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.517 ' NZ ' ' O ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -141.92 113.47 7.77 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 124.597 1.159 . . . . 0.10000000000000001 109.235 176.83 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 4.9 ttm180 -67.32 123.56 20.68 Favored 'General case' 0 CA--C 1.462 -2.439 0 C-N-CA 120.403 -0.519 . . . . 0.12 109.924 178.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.403 HG13 ' HG3' ' A' ' 121' ' ' GLU . 24.0 mm -106.27 -35.02 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.256 0 C-N-CA 114.991 -2.684 . . . . 0.089999999999999997 108.1 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.16 178.23 5.61 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 118.675 -1.21 . . . . 0.10000000000000001 112.187 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -118.3 151.52 37.53 Favored 'General case' 0 C--O 1.213 -0.861 0 N-CA-C 112.582 0.586 . . . . 0.14000000000000001 112.582 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -60.92 137.2 58.23 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 118.559 -1.256 . . . . 1.6000000000000001 107.967 175.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.36 -5.27 84.16 Favored Glycine 0 N--CA 1.475 1.272 0 N-CA-C 111.622 -0.591 . . . . 0.14000000000000001 111.622 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -65.76 138.03 57.66 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-O 122.899 1.333 . . . . 0.13 112.888 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.519 ' CG ' HH11 ' A' ' 112' ' ' ARG . 0.0 OUTLIER -86.25 132.7 33.93 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-N 114.111 -1.404 . . . . 0.17000000000000001 107.297 175.64 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.7 m -139.93 160.35 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.04 0 C-N-CA 117.458 -1.697 . . . . 0.12 113.02 -176.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.494 ' HE3' ' OD2' ' A' ' 117' ' ' ASP . 0.5 OUTLIER -110.78 156.73 20.66 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 111.88 -2.418 . . . . 0.14000000000000001 108.398 174.671 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.8 HG23 ' OD1' ' A' ' 64' ' ' ASP . 44.2 t -45.73 135.73 2.12 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 CA-C-O 121.593 0.711 . . . . 0.11 111.655 176.429 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.14 -12.98 64.62 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 120.853 -0.689 . . . . 0.089999999999999997 114.423 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.494 ' OD2' ' HE3' ' A' ' 114' ' ' LYS . 91.6 m-20 -63.08 136.35 57.74 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 120.926 -1.338 . . . . 0.11 109.812 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.5 m -76.7 132.4 39.31 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-O 122.951 1.358 . . . . 0.080000000000000002 111.084 -177.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.475 ' O ' HG13 ' A' ' 120' ' ' ILE . 44.8 t -105.86 -48.4 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.695 0 CA-C-N 113.42 -1.718 . . . . 0.070000000000000007 109.304 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 119' ' ' VAL . 10.9 mt -148.36 143.51 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.722 0 N-CA-C 114.077 1.139 . . . . 0.070000000000000007 114.077 -177.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.502 ' O ' ' HD2' ' A' ' 104' ' ' LYS . 49.5 mt-10 -112.28 147.41 36.35 Favored 'General case' 0 CA--C 1.484 -1.587 0 C-N-CA 116.685 -2.006 . . . . 0.089999999999999997 107.314 175.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.516 ' HA ' ' O ' ' A' ' 102' ' ' GLY . 36.0 p90 -132.9 163.6 28.79 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 122.059 0.933 . . . . 0.089999999999999997 111.609 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.438 ' OD1' ' HD2' ' A' ' 125' ' ' PRO . 10.3 t0 -100.42 97.84 8.53 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 124.758 1.223 . . . . 0.13 109.799 176.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.62 ' HB3' ' HD3' ' A' ' 125' ' ' PRO . 3.2 tp -59.28 -54.75 53.13 Favored Pre-proline 0 C--N 1.292 -1.913 0 N-CA-C 116.068 1.877 . . . . 0.13 116.068 -176.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.62 ' HD3' ' HB3' ' A' ' 124' ' ' LEU . 20.7 Cg_exo -56.9 -44.71 42.17 Favored 'Trans proline' 1 C--N 1.247 -4.812 0 C-N-CA 121.472 1.448 . . . . 0.14999999999999999 109.698 -175.685 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.811 ' CD1' ' HG3' ' A' ' 130' ' ' LYS . 0.5 OUTLIER -57.17 -50.96 71.21 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.132 -0.692 . . . . 0.14999999999999999 109.132 177.757 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.4 mt -68.45 -31.37 70.63 Favored 'General case' 0 C--N 1.281 -2.4 0 O-C-N 121.178 -0.951 . . . . 0.14000000000000001 112.068 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -65.16 -37.61 87.93 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 106.699 -1.593 . . . . 0.16 106.699 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -75.32 -42.27 54.91 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.205 -0.907 . . . . 0.20000000000000001 113.335 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.811 ' HG3' ' CD1' ' A' ' 126' ' ' LEU . 0.1 OUTLIER -94.77 -29.3 14.84 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 116.361 1.985 . . . . 0.20000000000000001 116.361 -175.817 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.54 142.93 36.99 Favored 'General case' 0 C--N 1.262 -3.229 0 N-CA-C 115.382 1.623 . . . . 0.16 115.382 -176.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.493 ' HD2' ' HA ' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -55.68 -37.78 68.78 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.428 -0.953 . . . . 0.19 108.428 179.025 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.8 t -163.84 143.92 8.35 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 124.986 1.314 . . . . 0.14999999999999999 110.654 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 76.8 p -95.95 -0.6 50.52 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 114.784 -1.098 . . . . 0.12 110.539 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.507 ' HA ' HD23 ' A' ' 135' ' ' LEU . 17.0 mt -56.36 130.43 44.63 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.22 -1.4 . . . . 0.12 107.22 177.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 93.5 m -118.81 96.98 50.57 Favored Pre-proline 0 N--CA 1.431 -1.397 0 N-CA-C 118.121 2.638 . . . . 0.080000000000000002 118.121 -173.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.449 ' HD2' ' O ' ' A' ' 90' ' ' HIS . 8.3 Cg_exo -66.94 142.86 63.94 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 117.192 -1.406 . . . . 0.089999999999999997 114.406 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . 0.313 1.6 m -125.79 104.68 13.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 105.186 -2.153 . . . . 0.059999999999999998 105.186 173.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.422 ' CG1' ' CD1' ' A' ' 33' ' ' ILE . 16.3 m -123.49 158.84 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 N-CA-C 116.258 1.948 . . . . 0.10000000000000001 116.258 -176.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.8 mp -97.57 125.44 50.71 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.294 0 N-CA-C 104.591 -2.374 . . . . 0.11 104.591 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 53.3 p -98.35 -4.42 34.92 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 123.15 1.452 . . . . 0.14000000000000001 112.927 -175.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.431 ' O ' ' C ' ' A' ' 143' ' ' MET 0.483 1.1 t-20 -97.86 15.23 24.47 Favored 'General case' 0 C--N 1.258 -3.41 0 C-N-CA 130.114 3.366 . . . . 0.14999999999999999 114.442 -179.679 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.431 ' C ' ' O ' ' A' ' 142' ' ' ASN . 62.1 mmm -33.76 -45.0 0.17 Allowed 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 115.584 1.698 . . . . 0.14999999999999999 115.584 -174.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -64.1 -11.71 32.51 Favored 'General case' 0 C--N 1.252 -3.663 0 O-C-N 119.852 -1.78 . . . . 0.23999999999999999 113.105 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -106.03 12.71 30.11 Favored 'General case' 0 CA--C 1.479 -1.777 0 CA-C-N 121.18 1.809 . . . . 0.17000000000000001 111.546 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 2.5 pt -120.34 140.86 43.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 C-N-CA 115.979 -2.288 . . . . 0.14999999999999999 113.96 -177.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.747 ' HB2' ' HB3' ' A' ' 168' ' ' LYS 0.258 12.0 tptt -74.46 -54.77 6.9 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 114.496 -1.229 . . . . 0.17999999999999999 109.786 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' ' 166' ' ' ILE . 0.0 OUTLIER -147.33 145.57 29.38 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 123.729 1.728 . . . . 0.14000000000000001 114.017 177.053 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.65 112.35 21.97 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 111.077 -2.783 . . . . 0.11 109.866 177.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 61.9 mt -108.97 112.23 39.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 114.531 -1.213 . . . . 0.11 107.882 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 34.6 mttt -84.94 129.91 34.72 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 124.474 1.11 . . . . 0.089999999999999997 113.325 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.299 31.4 mt -94.48 175.74 6.56 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-O 122.688 1.233 . . . . 0.080000000000000002 112.315 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . 0.278 0.5 OUTLIER -131.11 160.43 34.75 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 113.51 -1.677 . . . . 0.089999999999999997 114.763 -174.341 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 100.26 -158.83 19.42 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 118.88 2.312 . . . . 0.089999999999999997 118.88 174.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.76 142.15 27.79 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 112.102 -2.049 . . . . 0.11 109.949 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.555 HG11 HG12 ' A' ' 163' ' ' VAL . 16.5 m -131.84 159.73 42.9 Favored 'Isoleucine or valine' 0 CA--C 1.459 -2.54 0 CA-C-O 122.834 1.302 . . . . 0.080000000000000002 110.032 -177.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 20.7 m -122.79 123.62 41.47 Favored 'General case' 0 C--N 1.274 -2.709 0 CA-C-N 112.702 -2.044 . . . . 0.11 108.24 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 12.1 p -37.23 123.64 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.63 0 CA-C-O 123.7 1.714 . . . . 0.080000000000000002 113.966 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 61.18 25.83 65.11 Favored Glycine 0 CA--C 1.488 -1.642 0 CA-C-N 112.837 -1.983 . . . . 0.10000000000000001 114.179 175.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.42 -53.26 0.72 Allowed 'General case' 0 C--N 1.287 -2.118 0 CA-C-O 121.929 0.871 . . . . 0.13 111.957 178.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.463 ' CG2' HG12 ' A' ' 156' ' ' VAL . 9.0 m -85.36 123.0 73.59 Favored Pre-proline 0 C--N 1.282 -2.346 0 N-CA-C 114.179 1.177 . . . . 0.089999999999999997 114.179 -175.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -62.5 141.5 86.75 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.003 2.469 . . . . 0.089999999999999997 109.719 177.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.555 HG12 HG11 ' A' ' 156' ' ' VAL . 28.6 m -116.65 -27.96 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 121.647 -0.658 . . . . 0.059999999999999998 112.217 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 30.3 mt -141.12 150.98 19.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 N-CA-C 108.527 -0.916 . . . . 0.080000000000000002 108.527 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 5.9 mtt180 -125.78 130.79 52.15 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 105.746 -1.946 . . . . 0.11 105.746 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.814 ' CG1' ' HB ' ' A' ' 20' ' ' ILE . 39.7 pt -128.35 155.6 40.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 C-N-CA 118.987 -1.085 . . . . 0.12 109.771 -178.024 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 168' ' ' LYS . 1.1 tttt -120.75 154.23 35.93 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.023 -0.732 . . . . 0.16 109.023 176.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.747 ' HB3' ' HB2' ' A' ' 147' ' ' LYS . 9.6 tttt . . . . . 0 C--N 1.322 -0.601 0 N-CA-C 108.887 -0.783 . . . . 0.17999999999999999 108.887 -177.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 301' ' ' MET . . . . . 0.514 ' HB2' ' HG2' ' B' ' 366' ' ' GLU . 4.2 ttm . . . . . 0 C--O 1.218 -0.566 0 N-CA-C 108.459 -0.941 . . . . 0.20999999999999999 108.459 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 302' ' ' PHE . . . . . 0.533 ' CD2' ' HA ' ' B' ' 371' ' ' GLN . 74.6 t80 -142.88 140.93 31.42 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.181 -1.414 . . . . 0.17000000000000001 107.181 178.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -150.83 157.33 42.8 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.037 -1.039 . . . . 0.17000000000000001 109.46 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -153.2 147.6 25.92 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.001 -1.481 . . . . 0.16 107.001 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.92 152.02 19.15 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.319 -0.993 . . . . 0.16 108.319 178.288 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 7.3 p -149.68 144.29 17.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 107.35 -1.352 . . . . 0.13 107.35 174.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 86.5 m -93.84 136.73 33.83 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 121.605 0.717 . . . . 0.17000000000000001 110.119 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 58.9 mt -85.75 114.13 25.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 104.572 -2.381 . . . . 0.16 104.572 177.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 61.1 p -106.45 -3.93 20.41 Favored 'General case' 0 N--CA 1.514 2.746 0 N-CA-C 114.545 1.313 . . . . 0.20999999999999999 114.545 -178.508 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 310' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' B' ' 384' ' ' LEU . . . -71.65 139.21 83.38 Favored Pre-proline 0 N--CA 1.487 1.422 0 CA-C-N 120.312 1.414 . . . . 0.20000000000000001 110.766 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -46.42 -44.96 19.92 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 123.033 2.488 . . . . 0.23999999999999999 117.068 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -103.66 29.23 5.89 Favored 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 115.813 -2.355 . . . . 1.0800000000000001 107.127 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 59.52 -148.66 41.1 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 117.624 -2.226 . . . . 0.17999999999999999 111.007 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.452 ' HG ' ' HB2' ' B' ' 319' ' ' ALA . 17.1 tp -87.11 74.1 9.69 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 118.331 -1.347 . . . . 0.14999999999999999 108.996 -177.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 315' ' ' HIS . . . . . 0.513 ' CE1' ' HG3' ' B' ' 318' ' ' PRO . 29.4 p-80 -69.27 -178.06 1.25 Allowed 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 118.667 -1.213 . . . . 0.81000000000000005 112.688 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 3.0 m -48.93 -60.26 2.9 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 118.842 2.904 . . . . 0.20999999999999999 118.842 -174.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 317' ' ' ARG . . . . . 0.555 HH21 ' CG ' ' A' ' 38' ' ' ASP . 20.9 ttm180 -64.01 -44.19 77.31 Favored Pre-proline 0 C--N 1.282 -2.326 0 CA-C-N 122.599 2.454 . . . . 1.24 113.038 -176.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 318' ' ' PRO . . . . . 0.513 ' HG3' ' CE1' ' B' ' 315' ' ' HIS . 10.5 Cg_endo -68.09 -28.92 34.22 Favored 'Trans proline' 0 C--N 1.296 -2.185 0 CA-C-N 121.171 1.454 . . . . 0.17999999999999999 111.934 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 319' ' ' ALA . . . . . 0.452 ' HB2' ' HG ' ' B' ' 314' ' ' LEU . . . -69.45 -35.37 75.57 Favored 'General case' 0 N--CA 1.508 2.473 0 O-C-N 120.836 -1.165 . . . . 0.14000000000000001 108.853 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -71.56 -39.35 70.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.805 -1.185 . . . . 0.17000000000000001 108.855 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -67.77 -36.0 79.7 Favored 'General case' 0 N--CA 1.501 2.093 0 C-N-CA 118.123 -1.431 . . . . 1.74 108.714 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -64.28 -44.61 91.17 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.93 -1.106 . . . . 0.13 108.657 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.63 -40.42 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 CA-C-N 115.229 -0.896 . . . . 0.14000000000000001 110.538 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -64.55 -41.05 96.58 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 120.809 -1.182 . . . . 1.22 109.688 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -68.28 -40.16 81.93 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.58 -0.7 . . . . 0.17000000000000001 109.121 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.57 -42.32 92.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.893 -1.129 . . . . 0.14000000000000001 109.287 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -62.82 -15.04 52.55 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.136 -0.977 . . . . 1.4299999999999999 112.905 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -78.34 -11.23 85.53 Favored Glycine 0 N--CA 1.479 1.513 0 N-CA-C 108.847 -1.701 . . . . 0.19 108.847 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 329' ' ' PHE . . . . . 0.542 ' HE1' ' HE3' ' B' ' 372' ' ' LYS . 82.4 m-85 -103.91 145.08 30.65 Favored 'General case' 0 N--CA 1.506 2.355 0 CA-C-N 118.731 1.266 . . . . 0.17999999999999999 110.083 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 75.4 p -76.95 -28.78 55.32 Favored 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 118.609 -0.71 . . . . 0.22 112.477 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 20.3 m -58.87 157.55 9.57 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-O 123.384 1.564 . . . . 0.17999999999999999 114.893 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.53 128.48 33.42 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 102.25 -3.241 . . . . 0.19 102.25 172.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 42.0 mt -125.78 133.98 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 108.18 -1.045 . . . . 0.14999999999999999 108.18 -175.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 97.5 m -124.61 140.64 52.75 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 122.204 1.002 . . . . 0.16 109.229 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 335' ' ' VAL . . . . . 0.437 HG23 ' HB2' ' B' ' 344' ' ' ALA . 93.1 t -107.37 127.39 63.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 105.349 -2.093 . . . . 0.13 105.349 174.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 88.2 m -124.7 121.04 33.54 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.893 0.854 . . . . 0.16 110.432 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 337' ' ' SER . . . . . 0.498 ' HB2' HG12 ' B' ' 361' ' ' VAL . 33.4 t -125.59 123.84 39.92 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 118.389 -1.324 . . . . 0.17000000000000001 108.154 177.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 58.4 t30 49.78 40.09 19.49 Favored 'General case' 0 N--CA 1.514 2.747 0 N-CA-C 112.879 0.696 . . . . 0.22 112.879 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 81.07 12.26 82.71 Favored Glycine 0 N--CA 1.485 1.961 0 O-C-N 120.442 -1.411 . . . . 0.20999999999999999 113.314 176.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -121.84 136.65 54.94 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 103.55 -2.759 . . . . 2.5899999999999999 103.55 178.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 68.2 m -121.49 156.09 33.53 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-O 124.348 2.023 . . . . 0.17999999999999999 115.04 -175.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -151.52 147.98 27.47 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 111.86 -2.427 . . . . 0.14999999999999999 110.804 177.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 7.6 t -65.65 132.96 50.08 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 106.362 -1.718 . . . . 0.16 106.362 173.02 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 344' ' ' ALA . . . . . 0.437 ' HB2' HG23 ' B' ' 335' ' ' VAL . . . -73.46 -6.08 44.11 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.281 -1.512 . . . . 0.12 110.845 178.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -98.13 12.72 33.55 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.998 -1.064 . . . . 0.17000000000000001 109.224 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.2 105.67 6.77 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 123.146 1.45 . . . . 0.17000000000000001 110.544 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 26.6 tp -57.32 -37.64 72.82 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 113.948 -1.478 . . . . 0.19 109.31 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 348' ' ' PHE . . . . . 0.422 ' CB ' ' OE1' ' A' ' 86' ' ' GLU . 67.1 t80 -61.06 -50.48 73.14 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 120.395 -1.44 . . . . 0.34000000000000002 113.018 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -69.51 -31.74 70.16 Favored 'General case' 0 C--N 1.313 -1.01 0 O-C-N 119.589 -1.944 . . . . 1.1299999999999999 110.526 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 3.1 mt -65.35 -32.02 73.45 Favored 'General case' 0 C--N 1.284 -2.25 0 C-N-CA 119.19 -1.004 . . . . 0.14999999999999999 109.242 -177.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 351' ' ' GLN . . . . . 0.427 ' OE1' ' OG ' ' A' ' 78' ' ' SER . 89.7 mt-30 -68.14 -10.78 56.7 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.938 -0.476 . . . . 0.78000000000000003 109.816 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 2.7 p -91.86 -3.94 55.43 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.385 -1.326 . . . . 0.22 110.815 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 353' ' ' LEU . . . . . 0.48 HD22 ' HB3' ' B' ' 337' ' ' SER . 25.6 mt -94.72 157.04 16.13 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.255 -0.903 . . . . 0.16 110.094 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -86.28 106.43 3.08 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 104.785 -3.326 . . . . 0.16 104.785 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 91.2 mt -122.42 48.4 1.76 Allowed 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 106.133 -1.803 . . . . 0.14999999999999999 106.133 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 18.4 p -83.08 170.99 14.23 Favored 'General case' 0 C--O 1.215 -0.746 0 N-CA-C 109.363 -0.606 . . . . 0.20999999999999999 109.363 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -57.72 138.48 55.44 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.178 -0.951 . . . . 0.23000000000000001 110.659 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 92.25 -3.15 75.88 Favored Glycine 0 N--CA 1.473 1.108 0 C-N-CA 119.431 -1.366 . . . . 0.17999999999999999 112.627 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 55.0 m -84.77 132.89 34.38 Favored 'General case' 0 C--N 1.291 -1.966 0 O-C-N 121.497 -1.002 . . . . 0.16 111.182 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 95.3 t -94.38 122.91 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 106.972 -1.492 . . . . 0.16 106.972 177.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 361' ' ' VAL . . . . . 0.498 HG12 ' HB2' ' B' ' 337' ' ' SER . 17.8 m -112.71 161.3 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 C-N-CA 116.922 -1.911 . . . . 0.12 109.955 177.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 84.9 m -110.1 130.48 55.53 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 106.32 -1.733 . . . . 0.14000000000000001 106.32 175.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 54.3 mt -110.29 120.43 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 102.902 -2.999 . . . . 0.11 102.902 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.41 146.43 49.61 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.746 -1.205 . . . . 0.14000000000000001 107.746 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -141.09 153.7 45.57 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 117.549 -1.66 . . . . 0.17000000000000001 108.599 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 366' ' ' GLU . . . . . 0.514 ' HG2' ' HB2' ' B' ' 301' ' ' MET . 0.0 OUTLIER -141.81 111.94 6.88 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.002 -1.481 . . . . 0.23000000000000001 107.002 178.753 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 165.25 -173.45 41.03 Favored Glycine 0 C--N 1.295 -1.734 0 C-N-CA 117.672 -2.204 . . . . 0.20999999999999999 108.649 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -54.86 -41.49 70.85 Favored 'General case' 0 C--N 1.286 -2.191 0 C-N-CA 124.134 0.974 . . . . 0.27000000000000002 113.24 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 15.1 p30 -116.05 36.75 3.91 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 116.966 -1.894 . . . . 0.20000000000000001 108.114 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -58.99 -30.34 67.89 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 118.961 2.949 . . . . 0.20000000000000001 118.961 -175.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 371' ' ' GLN . . . . . 0.533 ' HA ' ' CD2' ' B' ' 302' ' ' PHE . 0.0 OUTLIER -78.23 -43.43 28.39 Favored 'General case' 0 N--CA 1.513 2.696 0 O-C-N 119.721 -1.862 . . . . 0.20999999999999999 109.743 -177.953 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 372' ' ' LYS . . . . . 0.542 ' HE3' ' HE1' ' B' ' 329' ' ' PHE . 13.2 ttpp -63.65 -40.75 97.63 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 106.948 -1.501 . . . . 0.20999999999999999 106.948 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.23 -46.78 87.35 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 118.375 -1.33 . . . . 0.14999999999999999 110.705 -178.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 68.5 t -68.82 -39.57 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 108.525 -0.917 . . . . 0.13 108.525 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -58.12 -46.58 85.35 Favored 'General case' 0 N--CA 1.502 2.169 0 CA-C-O 121.839 0.828 . . . . 0.19 109.523 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 376' ' ' HIS . . . . . 0.463 ' CE1' ' HZ2' ' B' ' 372' ' ' LYS . 3.5 m80 -71.01 -35.87 72.2 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 113.308 0.855 . . . . 0.19 113.308 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 95.9 mt -79.84 -25.14 40.86 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 118.443 -1.303 . . . . 0.12 111.788 -175.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 2.1 t -73.11 -38.89 56.13 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 N-CA-C 106.267 -1.753 . . . . 0.13 106.267 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -68.84 -48.61 63.07 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.538 -1.282 . . . . 0.20999999999999999 107.538 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 380' ' ' LEU . . . . . 0.572 ' HG ' ' CD2' ' B' ' 384' ' ' LEU . 28.2 tp -55.55 -47.36 76.48 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.836 -1.165 . . . . 0.16 110.717 176.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 2.9 ttm -61.46 -35.04 76.49 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 120.712 -1.242 . . . . 0.14000000000000001 113.51 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -77.48 -29.36 52.59 Favored 'General case' 0 C--N 1.282 -2.341 0 O-C-N 121.183 -0.948 . . . . 0.17999999999999999 108.896 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . 0.266 31.7 mt-10 -76.47 -36.77 57.68 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.81 0.814 . . . . 0.20999999999999999 111.723 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 384' ' ' LEU . . . . . 0.572 ' CD2' ' HG ' ' B' ' 380' ' ' LEU . 0.0 OUTLIER -55.23 127.38 29.05 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 125.934 2.778 . . . . 0.17999999999999999 113.135 -176.119 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 385' ' ' GLU . . . . . 0.402 ' CD ' ' H ' ' B' ' 385' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.308 -1.214 2 CA-C-N 108.1 -4.136 . . . . 0.22 111.168 -178.233 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 200' ' ' PO3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.217 -0.613 0 CA-C-O 122.391 1.091 . . . . 0.16 112.81 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.815 ' HB ' ' CG1' ' A' ' 166' ' ' ILE . 2.3 mp -106.02 130.73 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.019 0 CA-C-O 122.663 1.22 . . . . 0.13 110.698 177.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -100.46 124.86 46.53 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.229 -1.35 . . . . 0.13 110.318 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.4 mm -94.8 123.44 46.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 105.89 -1.893 . . . . 0.080000000000000002 105.89 176.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.2 mm -92.1 146.79 5.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 122.546 1.165 . . . . 0.089999999999999997 111.834 -178.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.71 121.09 51.22 Favored Pre-proline 0 N--CA 1.428 -1.541 0 N-CA-C 115.379 1.622 . . . . 0.059999999999999998 115.379 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -76.11 -20.02 15.11 Favored 'Trans proline' 0 CA--C 1.559 1.752 0 C-N-CA 121.494 1.463 . . . . 0.050000000000000003 111.396 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.465 ' N ' HD12 ' A' ' 26' ' ' LEU 0.325 0.0 OUTLIER -147.43 161.19 41.54 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 123.815 0.846 . . . . 0.050000000000000003 110.173 175.29 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.9 m -82.61 148.14 28.17 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 121.729 0.776 . . . . 0.089999999999999997 111.099 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 156.81 -155.3 26.24 Favored Glycine 0 N--CA 1.431 -1.688 0 C-N-CA 119.086 -1.531 . . . . 0.080000000000000002 111.041 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.15 134.79 54.34 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.038 -1.081 . . . . 0.10000000000000001 110.063 -177.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.1 mt -74.38 141.45 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 C-N-CA 117.694 -1.602 . . . . 0.080000000000000002 110.383 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.3 t -132.62 155.9 41.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 114.519 -1.219 . . . . 0.089999999999999997 108.786 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.501 ' HB3' ' OE2' ' A' ' 34' ' ' GLU . 86.0 m-20 -71.41 138.35 49.04 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-O 121.443 0.639 . . . . 0.11 111.099 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.422 ' CD1' ' CG1' ' A' ' 139' ' ' VAL . 8.2 tt -67.8 -23.67 29.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 C-N-CA 118.65 -1.22 . . . . 0.11 108.724 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.501 ' OE2' ' HB3' ' A' ' 32' ' ' ASN . 0.8 OUTLIER -73.91 -14.09 61.0 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 118.566 -1.254 . . . . 0.13 110.543 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -94.9 12.32 28.64 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 113.689 0.996 . . . . 0.12 113.689 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 t -86.42 130.95 47.5 Favored Pre-proline 0 C--N 1.29 -2.011 0 CA-C-O 120.918 0.39 . . . . 0.13 109.963 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -70.46 48.03 0.72 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 122.711 2.274 . . . . 0.14999999999999999 111.781 -173.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.555 ' CG ' HH21 ' B' ' 317' ' ' ARG . 56.3 t0 -150.66 115.83 5.36 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.733 -1.21 . . . . 0.22 107.733 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.2 m -60.36 -37.8 75.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 C-N-CA 119.005 -1.078 . . . . 0.20000000000000001 111.618 -178.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . 0.405 18.9 m -62.45 -34.94 67.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 116.861 -1.936 . . . . 0.25 112.127 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -84.18 -44.15 14.25 Favored 'General case' 0 C--N 1.261 -3.254 0 O-C-N 120.178 -1.576 . . . . 0.20000000000000001 109.897 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.6 -36.24 78.09 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 108.937 -0.764 . . . . 0.14000000000000001 108.937 -177.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -91.09 7.89 38.24 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 118.173 -1.411 . . . . 1.0800000000000001 110.584 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.54 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 0.3 OUTLIER 52.37 39.78 28.1 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 113.973 1.101 . . . . 0.14999999999999999 113.973 176.62 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.4 mm -67.19 -30.32 48.94 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.958 0 CA-C-O 123.786 1.755 . . . . 0.17999999999999999 110.703 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.293 2.1 t -89.55 -7.71 10.82 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.882 0 CA-C-N 112.375 -2.193 . . . . 0.48999999999999999 111.844 -175.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.54 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . 133.46 -175.57 20.13 Favored Glycine 0 C--O 1.206 -1.627 0 N-CA-C 108.743 -1.743 . . . . 0.13 108.743 176.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -119.52 155.45 32.13 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 117.851 -1.539 . . . . 0.12 112.768 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 172.18 -137.77 4.44 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 117.725 -2.179 . . . . 0.089999999999999997 111.158 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.444 ' C ' HD12 ' A' ' 50' ' ' ILE . 2.8 pp -134.98 175.24 11.51 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.716 0 O-C-N 121.592 -0.946 . . . . 0.070000000000000007 108.596 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -121.59 158.51 28.41 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 124.716 1.206 . . . . 0.070000000000000007 108.424 175.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.3 mt -133.33 128.81 55.87 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.826 0 O-C-N 121.641 -0.662 . . . . 0.059999999999999998 111.051 178.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -86.11 108.81 18.71 Favored Pre-proline 0 C--N 1.308 -1.232 0 N-CA-C 101.478 -3.527 . . . . 0.11 101.478 174.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.428 ' HB3' HD22 ' A' ' 26' ' ' LEU . 2.0 Cg_endo -71.22 150.12 58.8 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 123.725 2.95 . . . . 0.089999999999999997 113.074 -170.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.3 p -138.61 1.6 2.14 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 121.774 -0.579 . . . . 0.11 110.161 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -108.83 -144.5 10.84 Favored Glycine 0 CA--C 1.534 1.238 0 O-C-N 121.444 -0.785 . . . . 0.10000000000000001 114.581 -177.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -142.97 14.48 1.89 Allowed 'General case' 0 CA--C 1.491 -1.291 0 O-C-N 122.363 -0.492 . . . . 0.12 112.079 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -157.28 155.17 30.28 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 115.415 -2.514 . . . . 0.10000000000000001 113.092 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -114.96 121.44 43.18 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.868 -1.06 . . . . 0.070000000000000007 109.054 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 m -114.15 174.54 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 CA-C-O 122.74 1.257 . . . . 0.070000000000000007 110.964 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.15 126.66 92.92 Favored Pre-proline 0 C--N 1.289 -2.057 0 CA-C-N 113.663 -1.608 . . . . 0.070000000000000007 109.742 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -85.85 -1.5 8.82 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 CA-C-N 120.029 1.046 . . . . 0.070000000000000007 110.429 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.449 ' HA ' HG22 ' A' ' 115' ' ' VAL . 17.2 m -158.53 164.96 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-O 121.579 0.704 . . . . 0.089999999999999997 111.139 -178.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.799 ' OD1' HG23 ' A' ' 115' ' ' VAL . 48.0 m-20 -81.44 127.19 32.54 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 103.595 -2.743 . . . . 0.13 103.595 174.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 80' ' ' GLU . . . 174.0 -157.85 26.2 Favored Glycine 0 C--N 1.301 -1.375 0 N-CA-C 110.78 -0.928 . . . . 0.11 110.78 -175.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.6 m -123.69 134.93 53.64 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 119.814 -0.754 . . . . 0.13 111.309 -177.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.7 mm -68.76 140.42 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.041 0 C-N-CA 117.619 -1.632 . . . . 0.12 107.394 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -101.76 -64.21 0.75 Allowed Glycine 0 C--N 1.282 -2.457 0 CA-C-O 121.955 0.753 . . . . 0.14000000000000001 114.291 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.53 ' CD ' ' O ' ' B' ' 351' ' ' GLN . 0.2 OUTLIER -141.35 136.47 31.51 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-O 122.991 1.377 . . . . 2.1800000000000002 111.934 -177.842 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 75.8 mt -116.24 125.46 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 N-CA-C 105.514 -2.032 . . . . 0.14000000000000001 105.514 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -62.72 145.46 54.7 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.164 -1.05 . . . . 0.17999999999999999 108.164 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -61.91 -14.9 38.59 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 123.674 0.79 . . . . 0.70999999999999996 110.488 -178.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.482 ' OG1' ' ND1' ' A' ' 75' ' ' HIS . 25.5 p -97.69 5.02 49.87 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 123.655 1.693 . . . . 0.20000000000000001 109.093 178.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 69.6 m-20 50.51 44.31 27.11 Favored 'General case' 0 C--N 1.261 -3.269 0 CA-C-N 113.211 -1.813 . . . . 0.14000000000000001 112.59 175.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.649 ' HE2' ' CE1' ' A' ' 90' ' ' HIS . 13.7 p-80 -126.38 -1.52 6.92 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 113.64 0.978 . . . . 0.20999999999999999 113.64 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.32 152.75 31.47 Favored 'General case' 0 N--CA 1.412 -2.345 0 O-C-N 120.781 -1.2 . . . . 0.10000000000000001 111.022 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -152.53 166.33 32.36 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 123.072 1.415 . . . . 0.089999999999999997 113.245 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.501 ' HB2' ' H ' ' A' ' 69' ' ' LYS 0.259 15.8 m -118.29 139.72 50.9 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 113.278 -1.783 . . . . 0.12 109.849 -178.894 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.6 tt -143.27 150.03 17.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.585 -1.265 . . . . 0.10000000000000001 107.585 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.489 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 84.6 tt0 -118.42 129.91 55.67 Favored 'General case' 0 C--O 1.201 -1.466 0 N-CA-C 105.628 -1.99 . . . . 0.52000000000000002 105.628 177.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.447 ' HB3' HG21 ' A' ' 63' ' ' VAL . 94.0 p -80.91 167.32 20.0 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 118.457 -1.297 . . . . 0.13 108.28 -176.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -68.11 -31.02 70.33 Favored 'General case' 0 C--N 1.277 -2.569 0 C-N-CA 118.538 -1.265 . . . . 0.14999999999999999 108.264 177.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.22 4.44 2.21 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 125.212 1.405 . . . . 0.14000000000000001 111.998 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.73 14.51 81.98 Favored Glycine 0 C--N 1.28 -2.557 0 N-CA-C 117.351 1.7 . . . . 0.14000000000000001 117.351 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.761 HG21 HD11 ' A' ' 166' ' ' ILE . 48.8 t -92.42 133.01 35.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 121.189 2.494 . . . . 0.12 110.886 177.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.435 ' OE1' ' CB ' ' B' ' 348' ' ' PHE . 96.5 mt-10 -96.9 121.92 39.3 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.669 -0.645 . . . . 1.73 110.229 176.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -116.32 158.84 22.79 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.986 0.898 . . . . 0.089999999999999997 110.922 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -143.66 111.87 6.27 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 122.988 1.375 . . . . 0.31 109.759 177.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.1 t -101.73 115.6 43.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 114.05 -1.432 . . . . 0.070000000000000007 111.41 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.649 ' CE1' ' HE2' ' A' ' 75' ' ' HIS . 2.1 t-80 -123.24 105.07 9.56 Favored 'General case' 0 C--O 1.199 -1.564 0 CA-C-N 115.501 -0.772 . . . . 0.16 111.098 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -63.56 124.13 20.57 Favored 'General case' 0 CA--C 1.558 1.278 0 N-CA-C 116.688 2.107 . . . . 0.10000000000000001 116.688 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.28 -175.84 31.91 Favored Glycine 0 C--O 1.214 -1.123 0 CA-C-O 122.578 1.099 . . . . 0.10000000000000001 114.496 175.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 49.1 mm -118.0 132.62 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-O 123.129 1.442 . . . . 0.14000000000000001 109.158 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 54.69 25.75 6.79 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 114.104 -1.407 . . . . 0.17999999999999999 111.227 -177.17 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.3 p -64.42 -19.82 65.76 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 115.451 1.648 . . . . 0.14999999999999999 115.451 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.3 p -57.09 -32.83 41.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 O-C-N 120.124 -1.61 . . . . 0.17000000000000001 109.32 177.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -58.61 -19.99 43.47 Favored 'General case' 0 CA--C 1.566 1.581 0 C-N-CA 119.867 -0.733 . . . . 0.25 112.092 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mp -78.22 -3.24 41.72 Favored 'General case' 0 CA--C 1.564 1.485 0 O-C-N 119.733 -1.855 . . . . 0.17000000000000001 113.913 177.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 32.4 mtmm 48.95 46.23 22.34 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 116.082 1.882 . . . . 3.1899999999999999 116.082 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 90.69 -13.24 66.25 Favored Glycine 0 CA--C 1.543 1.799 0 N-CA-C 115.492 0.957 . . . . 0.16 115.492 176.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.14 121.29 12.71 Favored 'General case' 0 C--N 1.284 -2.263 0 O-C-N 121.36 -1.082 . . . . 0.17999999999999999 112.008 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 122' ' ' PHE . . . 97.68 -7.09 63.1 Favored Glycine 0 C--O 1.201 -1.956 0 N-CA-C 114.902 0.721 . . . . 0.14000000000000001 114.902 178.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -115.67 152.25 33.52 Favored 'General case' 0 C--N 1.284 -2.282 0 C-N-CA 124.121 0.968 . . . . 0.13 111.008 177.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' LYS . . . . . 0.513 ' NZ ' ' O ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -141.95 113.41 7.71 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 124.625 1.17 . . . . 0.13 109.199 176.843 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -67.19 123.53 20.55 Favored 'General case' 0 CA--C 1.462 -2.416 0 C-N-CA 120.448 -0.501 . . . . 0.14000000000000001 109.946 178.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ILE . . . . . 0.405 HG13 ' HG3' ' A' ' 121' ' ' GLU . 24.0 mm -106.31 -34.99 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.251 0 C-N-CA 114.928 -2.709 . . . . 0.12 108.119 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.08 178.22 5.62 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 118.682 -1.207 . . . . 0.12 112.235 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -118.31 151.46 37.66 Favored 'General case' 0 C--O 1.213 -0.83 0 N-CA-C 112.594 0.59 . . . . 0.14999999999999999 112.594 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -60.89 137.26 58.23 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 118.498 -1.281 . . . . 1.6799999999999999 108.021 175.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.27 -5.23 84.31 Favored Glycine 0 N--CA 1.475 1.253 0 N-CA-C 111.624 -0.591 . . . . 0.14000000000000001 111.624 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -65.72 138.04 57.69 Favored 'General case' 0 C--N 1.288 -2.07 0 C-N-CA 118.398 -1.321 . . . . 0.13 112.879 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.52 ' CG ' HH11 ' A' ' 112' ' ' ARG . 0.0 OUTLIER -86.23 132.67 33.94 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 114.121 -1.4 . . . . 0.14999999999999999 107.307 175.611 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 m -139.87 160.33 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.023 0 C-N-CA 117.475 -1.69 . . . . 0.11 113.051 -176.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.493 ' HE3' ' OD2' ' A' ' 117' ' ' ASP . 0.5 OUTLIER -110.81 156.7 20.73 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 111.905 -2.407 . . . . 0.14000000000000001 108.406 174.63 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.799 HG23 ' OD1' ' A' ' 64' ' ' ASP . 43.9 t -45.7 135.74 2.09 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 CA-C-O 121.596 0.712 . . . . 0.11 111.675 176.438 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.2 -13.05 64.5 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 120.831 -0.699 . . . . 0.089999999999999997 114.38 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.493 ' OD2' ' HE3' ' A' ' 114' ' ' LYS . 91.5 m-20 -63.14 136.38 57.72 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 118.866 1.333 . . . . 0.11 109.797 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.4 m -76.68 132.38 39.33 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-O 122.912 1.339 . . . . 0.10000000000000001 111.123 -177.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.474 ' O ' HG13 ' A' ' 120' ' ' ILE . 44.8 t -105.83 -48.45 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.684 0 CA-C-N 113.495 -1.684 . . . . 0.089999999999999997 109.315 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 119' ' ' VAL . 10.8 mt -148.37 143.56 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.707 0 N-CA-C 114.085 1.143 . . . . 0.089999999999999997 114.085 -177.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLU . . . . . 0.503 ' O ' ' HD2' ' A' ' 104' ' ' LYS . 49.4 mt-10 -112.28 147.47 36.22 Favored 'General case' 0 CA--C 1.483 -1.627 0 C-N-CA 116.646 -2.022 . . . . 0.12 107.279 175.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.518 ' HA ' ' O ' ' A' ' 102' ' ' GLY . 36.0 p90 -132.94 163.55 28.94 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 122.08 0.943 . . . . 0.11 111.57 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.437 ' OD1' ' HD2' ' A' ' 125' ' ' PRO . 10.3 t0 -100.41 97.85 8.55 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 124.72 1.208 . . . . 0.14999999999999999 109.813 176.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.62 ' HB3' ' HD3' ' A' ' 125' ' ' PRO . 3.1 tp -59.22 -54.79 52.77 Favored Pre-proline 0 C--N 1.292 -1.899 0 N-CA-C 116.061 1.874 . . . . 0.12 116.061 -176.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.62 ' HD3' ' HB3' ' A' ' 124' ' ' LEU . 20.6 Cg_exo -56.92 -44.68 42.37 Favored 'Trans proline' 1 C--N 1.247 -4.804 0 C-N-CA 121.483 1.455 . . . . 0.14999999999999999 109.706 -175.647 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.813 ' CD1' ' HG3' ' A' ' 130' ' ' LYS . 0.5 OUTLIER -57.17 -51.0 71.07 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.134 -0.691 . . . . 0.16 109.134 177.738 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.5 mt -68.36 -31.42 70.79 Favored 'General case' 0 C--N 1.281 -2.394 0 O-C-N 121.092 -1.005 . . . . 0.13 112.098 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -65.13 -37.62 88.03 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 106.727 -1.582 . . . . 0.14999999999999999 106.727 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -75.26 -42.3 55.37 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.218 -0.901 . . . . 0.19 113.33 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.813 ' HG3' ' CD1' ' A' ' 126' ' ' LEU . 0.1 OUTLIER -94.79 -29.28 14.83 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 116.38 1.992 . . . . 0.20000000000000001 116.38 -175.817 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.56 142.96 36.93 Favored 'General case' 0 C--N 1.262 -3.207 0 N-CA-C 115.329 1.603 . . . . 0.14999999999999999 115.329 -176.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.491 ' HD2' ' HA ' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -55.7 -37.82 68.88 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 108.436 -0.95 . . . . 0.17999999999999999 108.436 178.989 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.8 t -163.78 143.93 8.44 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 125.037 1.335 . . . . 0.13 110.686 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 76.8 p -95.96 -0.57 50.55 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 114.773 -1.103 . . . . 0.11 110.58 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.508 ' HA ' HD23 ' A' ' 135' ' ' LEU . 17.1 mt -56.33 130.39 44.41 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.263 -1.384 . . . . 0.10000000000000001 107.263 177.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 93.3 m -118.77 96.92 50.5 Favored Pre-proline 0 N--CA 1.43 -1.432 0 N-CA-C 118.124 2.638 . . . . 0.070000000000000007 118.124 -173.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' PRO . . . . . 0.45 ' HD2' ' O ' ' A' ' 90' ' ' HIS . 8.5 Cg_exo -67.02 142.94 63.78 Favored 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 117.163 -1.425 . . . . 0.089999999999999997 114.357 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . 0.313 1.6 m -125.83 104.66 13.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 105.192 -2.151 . . . . 0.059999999999999998 105.192 173.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.422 ' CG1' ' CD1' ' A' ' 33' ' ' ILE . 16.3 m -123.51 158.84 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 N-CA-C 116.237 1.939 . . . . 0.089999999999999997 116.237 -176.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.8 mp -97.61 125.51 50.74 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.319 0 N-CA-C 104.566 -2.383 . . . . 0.11 104.566 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 17.2 p -98.41 -4.41 34.75 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 123.158 1.456 . . . . 0.14000000000000001 112.936 -175.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.432 ' O ' ' C ' ' A' ' 143' ' ' MET 0.482 1.1 t-20 -97.8 15.17 24.53 Favored 'General case' 0 C--N 1.258 -3.386 0 C-N-CA 130.087 3.355 . . . . 0.14999999999999999 114.505 -179.757 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.432 ' C ' ' O ' ' A' ' 142' ' ' ASN 0.251 62.1 mmm -33.68 -45.09 0.17 Allowed 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 115.555 1.687 . . . . 0.16 115.555 -174.261 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -64.11 -11.64 31.85 Favored 'General case' 0 C--N 1.251 -3.682 0 O-C-N 119.891 -1.755 . . . . 0.26000000000000001 113.099 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -106.02 12.68 30.18 Favored 'General case' 0 CA--C 1.479 -1.758 0 CA-C-N 121.225 1.829 . . . . 0.17000000000000001 111.57 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 2.5 pt -120.36 140.81 43.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 C-N-CA 115.906 -2.317 . . . . 0.16 113.983 -177.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LYS . . . . . 0.75 ' HB2' ' HB3' ' A' ' 168' ' ' LYS 0.255 12.1 tptt -74.45 -54.73 7.0 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 114.49 -1.232 . . . . 0.20000000000000001 109.794 -179.864 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' ' 166' ' ' ILE . 0.0 OUTLIER -147.31 145.59 29.4 Favored 'General case' 0 C--N 1.289 -2.063 0 O-C-N 119.913 -1.742 . . . . 0.17000000000000001 114.055 177.017 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.68 112.31 21.9 Favored 'General case' 0 N--CA 1.415 -2.177 0 CA-C-N 111.066 -2.788 . . . . 0.13 109.881 177.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 61.8 mt -108.94 112.19 39.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 114.515 -1.221 . . . . 0.14000000000000001 107.92 177.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 34.5 mttt -84.93 129.84 34.74 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 124.492 1.117 . . . . 0.11 113.399 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.299 31.3 mt -94.4 175.78 6.55 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-O 122.732 1.253 . . . . 0.11 112.325 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . 0.276 0.5 OUTLIER -131.09 160.43 34.72 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 113.484 -1.689 . . . . 0.11 114.773 -174.325 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 100.25 -158.82 19.43 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 118.906 2.322 . . . . 0.10000000000000001 118.906 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.8 142.13 27.83 Favored 'General case' 0 C--O 1.213 -0.841 0 CA-C-N 112.064 -2.068 . . . . 0.12 109.892 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.555 HG11 HG12 ' A' ' 163' ' ' VAL . 16.5 m -131.83 159.68 42.93 Favored 'Isoleucine or valine' 0 CA--C 1.46 -2.511 0 CA-C-O 122.783 1.277 . . . . 0.089999999999999997 110.041 -177.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 20.8 m -122.77 123.7 41.66 Favored 'General case' 0 C--N 1.273 -2.734 0 CA-C-N 112.754 -2.021 . . . . 0.12 108.194 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 12.1 p -37.38 123.68 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 CA-C-O 123.725 1.726 . . . . 0.089999999999999997 113.991 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 61.15 25.82 65.03 Favored Glycine 0 CA--C 1.487 -1.68 0 CA-C-N 112.804 -1.998 . . . . 0.10000000000000001 114.232 176.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.43 -53.24 0.72 Allowed 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 119.593 -0.843 . . . . 0.14000000000000001 111.958 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.462 ' CG2' HG12 ' A' ' 156' ' ' VAL . 9.1 m -85.35 122.98 73.61 Favored Pre-proline 0 C--N 1.282 -2.352 0 N-CA-C 114.219 1.192 . . . . 0.10000000000000001 114.219 -175.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -62.44 141.46 86.92 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.964 2.443 . . . . 0.11 109.766 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.555 HG12 HG11 ' A' ' 156' ' ' VAL . 28.9 m -116.64 -27.92 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.625 -0.672 . . . . 0.070000000000000007 112.196 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 30.5 mt -141.17 150.94 19.85 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 108.502 -0.925 . . . . 0.089999999999999997 108.502 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 5.9 mtt180 -125.76 130.83 52.25 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 105.784 -1.932 . . . . 0.13 105.784 176.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.815 ' CG1' ' HB ' ' A' ' 20' ' ' ILE . 39.9 pt -128.36 155.57 40.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 119.075 -1.05 . . . . 0.13 109.813 -177.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 168' ' ' LYS . 1.1 tttt -120.72 154.21 35.92 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.987 -0.746 . . . . 0.17999999999999999 108.987 176.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.75 ' HB3' ' HB2' ' A' ' 147' ' ' LYS . 9.6 tttt . . . . . 0 C--N 1.322 -0.595 0 N-CA-C 108.87 -0.789 . . . . 0.19 108.87 -177.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 301' ' ' MET . . . . . 0.513 ' HB2' ' HG2' ' B' ' 366' ' ' GLU . 4.2 ttm . . . . . 0 C--O 1.219 -0.545 0 N-CA-C 108.473 -0.936 . . . . 0.20000000000000001 108.473 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 302' ' ' PHE . . . . . 0.534 ' CD2' ' HA ' ' B' ' 371' ' ' GLN . 74.9 t80 -142.93 140.91 31.33 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.219 -1.4 . . . . 0.19 107.219 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -150.85 157.34 42.8 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 120.998 -1.064 . . . . 0.16 109.461 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -153.18 147.62 25.97 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.024 -1.472 . . . . 0.17999999999999999 107.024 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.97 151.96 19.17 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.296 -1.001 . . . . 0.17000000000000001 108.296 178.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.62 144.31 17.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 107.345 -1.354 . . . . 0.14999999999999999 107.345 174.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 87.1 m -93.9 136.69 33.92 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.596 0.712 . . . . 0.19 110.107 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 59.0 mt -85.69 114.12 25.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 104.653 -2.351 . . . . 0.19 104.653 177.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 61.1 p -106.44 -3.86 20.49 Favored 'General case' 0 N--CA 1.514 2.729 0 N-CA-C 114.57 1.322 . . . . 0.23000000000000001 114.57 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 310' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' B' ' 384' ' ' LEU . . . -71.74 139.2 83.12 Favored Pre-proline 0 N--CA 1.487 1.396 0 CA-C-N 120.314 1.415 . . . . 0.20999999999999999 110.701 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -46.45 -44.87 20.18 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 123.012 2.475 . . . . 0.26000000000000001 117.095 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -103.72 29.29 5.88 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 115.758 -2.377 . . . . 1.04 107.145 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 59.49 -148.71 40.94 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 117.615 -2.231 . . . . 0.19 110.981 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.452 ' HG ' ' HB2' ' B' ' 319' ' ' ALA . 17.1 tp -87.07 74.15 9.71 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 118.267 -1.373 . . . . 0.14999999999999999 108.985 -177.687 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 315' ' ' HIS . . . . . 0.436 ' CD2' ' CG ' ' B' ' 318' ' ' PRO . 2.5 p80 -69.24 -178.04 1.24 Allowed 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 118.656 -1.217 . . . . 0.32000000000000001 112.678 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 26.8 m -49.04 -60.19 2.99 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 118.77 2.878 . . . . 0.28000000000000003 118.77 -174.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 317' ' ' ARG . . . . . 0.555 HH21 ' CG ' ' A' ' 38' ' ' ASP . 18.8 ttm180 -63.93 -44.53 78.98 Favored Pre-proline 0 C--N 1.281 -2.395 0 CA-C-N 122.671 2.487 . . . . 1.1000000000000001 112.902 -176.628 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 318' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' B' ' 317' ' ' ARG . 9.2 Cg_endo -67.95 -28.89 35.14 Favored 'Trans proline' 0 C--N 1.296 -2.194 0 CA-C-N 121.149 1.446 . . . . 0.17000000000000001 111.937 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 319' ' ' ALA . . . . . 0.452 ' HB2' ' HG ' ' B' ' 314' ' ' LEU . . . -69.44 -35.43 75.65 Favored 'General case' 0 N--CA 1.509 2.5 0 O-C-N 120.824 -1.172 . . . . 0.13 108.839 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -71.52 -39.32 70.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.798 -1.189 . . . . 0.16 108.867 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -67.84 -35.93 79.44 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 118.084 -1.447 . . . . 1.7 108.7 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -64.25 -44.62 91.23 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 122.408 1.099 . . . . 0.12 108.704 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 55.1 t -64.67 -40.45 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-N 115.227 -0.897 . . . . 0.13 110.526 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -64.47 -41.06 96.72 Favored 'General case' 0 C--N 1.293 -1.879 0 O-C-N 120.752 -1.217 . . . . 1.1799999999999999 109.735 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -68.27 -40.17 81.96 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.152 -0.685 . . . . 0.16 109.152 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.58 -42.31 92.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.945 -1.097 . . . . 0.14000000000000001 109.283 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -62.82 -15.05 52.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.034 -1.041 . . . . 1.6000000000000001 112.875 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -78.36 -11.26 85.5 Favored Glycine 0 N--CA 1.478 1.498 0 N-CA-C 108.85 -1.7 . . . . 0.19 108.85 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 329' ' ' PHE . . . . . 0.541 ' HE1' ' HE3' ' B' ' 372' ' ' LYS . 82.3 m-85 -103.88 144.99 30.77 Favored 'General case' 0 N--CA 1.507 2.388 0 CA-C-N 118.713 1.257 . . . . 0.17000000000000001 110.129 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 74.4 p -76.9 -28.7 55.44 Favored 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 118.611 -0.709 . . . . 0.22 112.503 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 20.3 m -58.92 157.58 9.63 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 123.384 1.564 . . . . 0.17999999999999999 114.899 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.6 128.49 33.46 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 102.22 -3.252 . . . . 0.17999999999999999 102.22 172.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 41.7 mt -125.76 133.93 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 108.203 -1.036 . . . . 0.14000000000000001 108.203 -175.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 97.6 m -124.58 140.68 52.72 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 122.267 1.032 . . . . 0.14000000000000001 109.184 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 335' ' ' VAL . . . . . 0.436 HG23 ' HB2' ' B' ' 344' ' ' ALA . 93.1 t -107.33 127.38 63.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 105.34 -2.096 . . . . 0.12 105.34 174.282 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 88.3 m -124.73 121.04 33.52 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.881 0.848 . . . . 0.14999999999999999 110.396 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 337' ' ' SER . . . . . 0.498 ' HB2' HG12 ' B' ' 361' ' ' VAL . 33.5 t -125.65 123.83 39.82 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 118.425 -1.31 . . . . 0.17000000000000001 108.129 177.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 58.5 t30 49.71 40.19 19.43 Favored 'General case' 0 N--CA 1.514 2.765 0 N-CA-C 112.872 0.693 . . . . 0.22 112.872 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 81.05 12.23 82.78 Favored Glycine 0 N--CA 1.485 1.923 0 O-C-N 120.487 -1.383 . . . . 0.20000000000000001 113.334 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -121.8 136.69 54.94 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 103.539 -2.763 . . . . 2.48 103.539 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 68.8 m -121.55 156.1 33.6 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-O 124.321 2.01 . . . . 0.17000000000000001 114.996 -175.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -151.52 148.01 27.52 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 111.848 -2.433 . . . . 0.14999999999999999 110.82 176.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 7.6 t -65.59 132.93 50.08 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.416 -1.698 . . . . 0.14999999999999999 106.416 173.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 344' ' ' ALA . . . . . 0.436 ' HB2' HG23 ' B' ' 335' ' ' VAL . . . -73.47 -6.02 43.71 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 120.285 -1.509 . . . . 0.11 110.842 178.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -98.23 12.74 33.68 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.966 -1.084 . . . . 0.17000000000000001 109.189 -178.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.23 105.64 6.74 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 123.122 1.439 . . . . 0.17999999999999999 110.557 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 32.6 tp -57.34 -37.59 72.78 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 113.949 -1.478 . . . . 0.19 109.303 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 348' ' ' PHE . . . . . 0.435 ' CB ' ' OE1' ' A' ' 86' ' ' GLU . 72.5 t80 -61.18 -50.4 73.32 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 120.355 -1.465 . . . . 0.38 112.975 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -69.57 -31.68 70.0 Favored 'General case' 0 C--N 1.314 -0.963 0 O-C-N 119.609 -1.932 . . . . 1.1699999999999999 110.56 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 3.1 mt -65.29 -32.03 73.47 Favored 'General case' 0 C--N 1.285 -2.236 0 C-N-CA 119.201 -0.999 . . . . 0.14999999999999999 109.309 -177.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 351' ' ' GLN . . . . . 0.53 ' O ' ' CD ' ' A' ' 69' ' ' LYS . 89.6 mt-30 -68.17 -10.72 56.36 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.96 -0.462 . . . . 0.82999999999999996 109.833 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 2.0 p -91.86 -4.02 55.33 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 118.347 -1.341 . . . . 0.23000000000000001 110.78 -177.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 353' ' ' LEU . . . . . 0.484 HD22 ' HB3' ' B' ' 337' ' ' SER . 25.1 mt -94.63 157.05 16.14 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.233 -0.917 . . . . 0.17000000000000001 110.076 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -86.3 106.45 3.09 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 104.713 -3.355 . . . . 0.17999999999999999 104.713 177.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 91.3 mt -122.37 48.39 1.76 Allowed 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 106.153 -1.795 . . . . 0.16 106.153 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 43.0 p -83.12 171.02 14.16 Favored 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 109.335 -0.617 . . . . 0.25 109.335 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -57.7 138.52 55.36 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.177 -0.952 . . . . 0.25 110.675 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 92.19 -3.13 76.05 Favored Glycine 0 N--CA 1.474 1.173 0 C-N-CA 119.39 -1.385 . . . . 0.20999999999999999 112.61 177.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 55.3 m -84.82 132.98 34.34 Favored 'General case' 0 C--N 1.291 -1.975 0 O-C-N 121.507 -0.996 . . . . 0.17999999999999999 111.185 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 94.7 t -94.44 122.86 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 107.031 -1.47 . . . . 0.17999999999999999 107.031 177.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 361' ' ' VAL . . . . . 0.498 HG12 ' HB2' ' B' ' 337' ' ' SER . 17.8 m -112.73 161.33 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 C-N-CA 116.891 -1.923 . . . . 0.13 109.891 178.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 85.4 m -110.06 130.52 55.52 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 106.324 -1.732 . . . . 0.13 106.324 175.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 54.5 mt -110.33 120.43 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 102.869 -3.011 . . . . 0.11 102.869 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.42 146.43 49.62 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 107.716 -1.216 . . . . 0.13 107.716 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -141.05 153.66 45.6 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 117.566 -1.653 . . . . 0.16 108.63 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 366' ' ' GLU . . . . . 0.513 ' HG2' ' HB2' ' B' ' 301' ' ' MET . 0.0 OUTLIER -141.79 111.91 6.87 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.06 -1.459 . . . . 0.22 107.06 178.701 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 165.25 -173.49 41.04 Favored Glycine 0 C--N 1.294 -1.766 0 C-N-CA 117.651 -2.214 . . . . 0.20999999999999999 108.64 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -54.78 -41.5 70.62 Favored 'General case' 0 C--N 1.285 -2.213 0 C-N-CA 124.134 0.974 . . . . 0.28000000000000003 113.253 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 15.2 p30 -116.04 36.71 3.93 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 117.002 -1.879 . . . . 0.20999999999999999 108.135 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -58.97 -30.35 67.87 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 119.001 2.963 . . . . 0.20000000000000001 119.001 -175.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 371' ' ' GLN . . . . . 0.534 ' HA ' ' CD2' ' B' ' 302' ' ' PHE . 0.0 OUTLIER -78.2 -43.36 28.72 Favored 'General case' 0 N--CA 1.512 2.66 0 O-C-N 119.647 -1.908 . . . . 0.23000000000000001 109.768 -177.953 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 372' ' ' LYS . . . . . 0.541 ' HE3' ' HE1' ' B' ' 329' ' ' PHE . 13.2 ttpp -63.78 -40.71 97.33 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 106.878 -1.527 . . . . 0.22 106.878 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.21 -46.89 86.86 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 118.441 -1.303 . . . . 0.16 110.599 -178.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 68.7 t -68.78 -39.54 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 N-CA-C 108.521 -0.918 . . . . 0.14000000000000001 108.521 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -58.21 -46.49 85.75 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.846 0.831 . . . . 0.20999999999999999 109.508 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 376' ' ' HIS . . . . . 0.462 ' CE1' ' HZ2' ' B' ' 372' ' ' LYS . 3.5 m80 -71.05 -35.81 72.08 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 113.347 0.869 . . . . 0.20000000000000001 113.347 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 95.8 mt -79.87 -25.11 40.79 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.447 -1.301 . . . . 0.13 111.786 -175.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 2.1 t -73.13 -38.88 56.0 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 N-CA-C 106.288 -1.745 . . . . 0.14999999999999999 106.288 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -68.83 -48.6 63.13 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 107.563 -1.273 . . . . 0.22 107.563 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 380' ' ' LEU . . . . . 0.569 ' HG ' ' CD2' ' B' ' 384' ' ' LEU . 28.2 tp -55.53 -47.37 76.4 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 118.773 -1.171 . . . . 0.14999999999999999 110.754 176.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 2.9 ttm -61.49 -35.02 76.48 Favored 'General case' 0 C--N 1.309 -1.168 0 O-C-N 120.721 -1.237 . . . . 0.14999999999999999 113.44 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -77.48 -29.46 52.66 Favored 'General case' 0 C--N 1.282 -2.36 0 O-C-N 121.229 -0.919 . . . . 0.19 108.856 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . 0.265 32.3 mt-10 -76.37 -36.76 57.97 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 121.787 0.803 . . . . 0.22 111.757 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 384' ' ' LEU . . . . . 0.569 ' CD2' ' HG ' ' B' ' 380' ' ' LEU . 0.0 OUTLIER -55.21 127.42 29.17 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 125.822 2.725 . . . . 0.17999999999999999 113.15 -176.099 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 385' ' ' GLU . . . . . 0.401 ' CD ' ' H ' ' B' ' 385' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.307 -1.247 2 CA-C-N 108.129 -4.123 . . . . 0.22 111.168 -178.21 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 200' ' ' PO3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.217 -0.613 0 CA-C-O 122.391 1.091 . . . . 0.16 112.81 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.825 ' HB ' HG13 ' A' ' 166' ' ' ILE . 2.3 mp -106.02 130.73 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.019 0 CA-C-O 122.663 1.22 . . . . 0.13 110.698 177.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -100.46 124.86 46.53 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.229 -1.35 . . . . 0.13 110.318 176.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.4 mm -94.8 123.44 46.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 105.89 -1.893 . . . . 0.080000000000000002 105.89 176.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.2 mm -92.1 146.79 5.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 122.546 1.165 . . . . 0.089999999999999997 111.834 -178.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.71 121.09 51.22 Favored Pre-proline 0 N--CA 1.428 -1.541 0 N-CA-C 115.379 1.622 . . . . 0.059999999999999998 115.379 -178.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -76.11 -20.02 15.11 Favored 'Trans proline' 0 CA--C 1.559 1.752 0 C-N-CA 121.494 1.463 . . . . 0.050000000000000003 111.396 -177.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.465 ' N ' HD12 ' A' ' 26' ' ' LEU 0.325 0.0 OUTLIER -147.43 161.19 41.54 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 123.815 0.846 . . . . 0.050000000000000003 110.173 175.29 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.9 m -82.61 148.14 28.17 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 121.729 0.776 . . . . 0.089999999999999997 111.099 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 156.81 -155.3 26.24 Favored Glycine 0 N--CA 1.431 -1.688 0 C-N-CA 119.086 -1.531 . . . . 0.080000000000000002 111.041 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.15 134.79 54.34 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.038 -1.081 . . . . 0.10000000000000001 110.063 -177.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.1 mt -74.38 141.45 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 C-N-CA 117.694 -1.602 . . . . 0.080000000000000002 110.383 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.3 t -132.62 155.9 41.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 114.519 -1.219 . . . . 0.089999999999999997 108.786 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.501 ' HB3' ' OE2' ' A' ' 34' ' ' GLU . 86.0 m-20 -71.41 138.35 49.04 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-O 121.443 0.639 . . . . 0.11 111.099 178.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.487 ' CD1' ' CG1' ' A' ' 139' ' ' VAL . 8.2 tt -67.8 -23.67 29.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 C-N-CA 118.65 -1.22 . . . . 0.11 108.724 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.501 ' OE2' ' HB3' ' A' ' 32' ' ' ASN . 0.8 OUTLIER -73.91 -14.09 61.0 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 118.566 -1.254 . . . . 0.13 110.543 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -94.9 12.32 28.64 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 113.689 0.996 . . . . 0.12 113.689 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 t -86.42 130.95 47.5 Favored Pre-proline 0 C--N 1.29 -2.011 0 CA-C-O 120.918 0.39 . . . . 0.13 109.963 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -70.46 48.03 0.72 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 122.711 2.274 . . . . 0.14999999999999999 111.781 -173.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.543 ' CG ' HH21 ' B' ' 317' ' ' ARG . 65.3 t0 -150.66 115.83 5.36 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.733 -1.21 . . . . 0.22 107.733 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.8 m -60.34 -37.9 75.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 C-N-CA 119.005 -1.078 . . . . 0.20000000000000001 111.569 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . 0.404 19.3 m -62.41 -34.89 66.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 C-N-CA 116.864 -1.934 . . . . 0.25 112.148 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -84.18 -44.27 14.13 Favored 'General case' 0 C--N 1.262 -3.23 0 O-C-N 120.132 -1.605 . . . . 0.20000000000000001 109.841 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.52 -36.24 77.9 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 108.937 -0.764 . . . . 0.14000000000000001 108.937 -177.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -91.05 7.81 38.55 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 118.173 -1.411 . . . . 1.0800000000000001 110.585 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.54 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 0.3 OUTLIER 52.42 39.78 28.26 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 113.973 1.101 . . . . 0.14999999999999999 113.973 176.651 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.3 mm -67.18 -30.35 49.04 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.958 0 CA-C-O 123.747 1.737 . . . . 0.17999999999999999 110.696 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.293 2.1 t -89.52 -7.71 10.82 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.898 0 CA-C-N 112.336 -2.211 . . . . 0.48999999999999999 111.844 -175.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.54 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . 133.46 -175.57 20.13 Favored Glycine 0 C--O 1.206 -1.627 0 N-CA-C 108.743 -1.743 . . . . 0.13 108.743 176.57 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -119.52 155.45 32.13 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 117.851 -1.539 . . . . 0.12 112.768 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 172.18 -137.77 4.44 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 117.725 -2.179 . . . . 0.089999999999999997 111.158 177.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.444 ' C ' HD12 ' A' ' 50' ' ' ILE . 2.8 pp -134.98 175.24 11.51 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.716 0 O-C-N 121.592 -0.946 . . . . 0.070000000000000007 108.596 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -121.59 158.51 28.41 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 124.716 1.206 . . . . 0.070000000000000007 108.424 175.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.3 mt -133.33 128.81 55.87 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.826 0 O-C-N 121.641 -0.662 . . . . 0.059999999999999998 111.051 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -86.11 108.81 18.71 Favored Pre-proline 0 C--N 1.308 -1.232 0 N-CA-C 101.478 -3.527 . . . . 0.11 101.478 174.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.428 ' HB3' HD22 ' A' ' 26' ' ' LEU . 2.0 Cg_endo -71.22 150.12 58.8 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 123.725 2.95 . . . . 0.089999999999999997 113.074 -170.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.3 p -138.61 1.6 2.14 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 121.774 -0.579 . . . . 0.11 110.161 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -108.83 -144.5 10.84 Favored Glycine 0 CA--C 1.534 1.238 0 O-C-N 121.444 -0.785 . . . . 0.10000000000000001 114.581 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -142.97 14.48 1.89 Allowed 'General case' 0 CA--C 1.491 -1.291 0 O-C-N 122.363 -0.492 . . . . 0.12 112.079 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -157.28 155.17 30.28 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 115.415 -2.514 . . . . 0.10000000000000001 113.092 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -114.96 121.44 43.18 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.868 -1.06 . . . . 0.070000000000000007 109.054 178.744 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 m -114.15 174.54 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 CA-C-O 122.74 1.257 . . . . 0.070000000000000007 110.964 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.15 126.66 92.92 Favored Pre-proline 0 C--N 1.289 -2.057 0 CA-C-N 113.663 -1.608 . . . . 0.070000000000000007 109.742 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -85.85 -1.5 8.82 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 CA-C-N 120.029 1.046 . . . . 0.070000000000000007 110.429 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.447 HG21 ' HB3' ' A' ' 81' ' ' SER . 17.2 m -158.53 164.96 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-O 121.579 0.704 . . . . 0.089999999999999997 111.139 -178.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.862 ' OD1' HG23 ' A' ' 115' ' ' VAL . 48.0 m-20 -81.44 127.19 32.54 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 103.595 -2.743 . . . . 0.13 103.595 174.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 80' ' ' GLU . . . 174.0 -157.85 26.2 Favored Glycine 0 C--N 1.301 -1.375 0 N-CA-C 110.78 -0.928 . . . . 0.11 110.78 -175.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.6 m -123.69 134.93 53.64 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 119.814 -0.754 . . . . 0.13 111.309 -177.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.7 mm -68.76 140.42 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.041 0 C-N-CA 117.619 -1.632 . . . . 0.12 107.394 178.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -101.76 -64.21 0.75 Allowed Glycine 0 C--N 1.282 -2.457 0 CA-C-O 121.955 0.753 . . . . 0.14000000000000001 114.291 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.541 ' CD ' ' O ' ' B' ' 351' ' ' GLN . 0.1 OUTLIER -141.38 136.47 31.46 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-O 123.059 1.409 . . . . 2.1800000000000002 111.925 -177.842 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 75.8 mt -116.23 125.46 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 N-CA-C 105.514 -2.032 . . . . 0.14000000000000001 105.514 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -62.72 145.46 54.7 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.164 -1.05 . . . . 0.17999999999999999 108.164 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -61.91 -14.9 38.59 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 123.674 0.79 . . . . 0.70999999999999996 110.488 -178.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.535 ' OG1' ' ND1' ' A' ' 75' ' ' HIS . 16.7 p -97.67 4.98 49.95 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 123.593 1.663 . . . . 0.20000000000000001 109.068 178.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.402 ' OD1' ' NH2' ' A' ' 105' ' ' ARG . 69.6 m-20 50.53 44.31 27.19 Favored 'General case' 0 C--N 1.26 -3.305 0 CA-C-N 113.23 -1.805 . . . . 0.14000000000000001 112.59 175.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' HIS . . . . . 0.559 ' NE2' ' CE1' ' A' ' 90' ' ' HIS . 20.1 p-80 -126.41 -1.45 6.9 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 113.661 0.986 . . . . 0.20999999999999999 113.661 -177.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.37 152.75 31.44 Favored 'General case' 0 N--CA 1.412 -2.345 0 O-C-N 120.836 -1.165 . . . . 0.10000000000000001 111.022 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -152.53 166.33 32.36 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 123.072 1.415 . . . . 0.089999999999999997 113.245 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.501 ' HB2' ' H ' ' A' ' 69' ' ' LYS 0.259 15.8 m -118.29 139.72 50.9 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 113.278 -1.783 . . . . 0.12 109.849 -178.894 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.6 tt -143.27 150.03 17.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.585 -1.265 . . . . 0.10000000000000001 107.585 175.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . 0.489 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 84.6 tt0 -118.42 129.91 55.67 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 105.628 -1.99 . . . . 0.52000000000000002 105.628 177.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.447 ' HB3' HG21 ' A' ' 63' ' ' VAL . 94.0 p -80.91 167.32 20.0 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 118.457 -1.297 . . . . 0.13 108.28 -176.942 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.406 ' OD1' ' NH1' ' A' ' 112' ' ' ARG . 83.0 m-20 -68.11 -31.02 70.33 Favored 'General case' 0 C--N 1.277 -2.569 0 C-N-CA 118.538 -1.265 . . . . 0.14999999999999999 108.264 177.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.22 4.44 2.21 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 125.212 1.405 . . . . 0.14000000000000001 111.998 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.73 14.51 81.98 Favored Glycine 0 C--N 1.28 -2.557 0 N-CA-C 117.351 1.7 . . . . 0.14000000000000001 117.351 -178.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.671 HG21 ' CD1' ' A' ' 166' ' ' ILE . 48.8 t -92.42 133.01 35.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 121.189 2.494 . . . . 0.12 110.886 177.8 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.435 ' OE1' ' CB ' ' B' ' 348' ' ' PHE . 96.5 mt-10 -96.9 121.92 39.3 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.669 -0.645 . . . . 1.73 110.229 176.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -116.32 158.84 22.79 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.986 0.898 . . . . 0.089999999999999997 110.922 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -147.34 140.69 25.35 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.674 -0.694 . . . . 0.31 109.919 177.549 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 45.7 t -131.85 131.98 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.69 -0.631 . . . . 0.070000000000000007 110.003 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 1.236 ' NE2' ' P ' ' B' ' 200' ' ' PO3 . 2.9 t-80 -120.29 80.72 1.64 Allowed 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 108.462 -0.94 . . . . 0.16 108.462 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PHE . . . . . 0.413 ' C ' ' O ' ' A' ' 90' ' ' HIS . 30.3 t80 -42.84 119.9 1.61 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.239 -0.913 . . . . 0.10000000000000001 110.295 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.34 -175.54 32.64 Favored Glycine 0 C--N 1.303 -1.27 0 CA-C-O 122.885 1.269 . . . . 0.10000000000000001 114.623 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 18.6 mm -118.4 132.61 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-O 122.93 1.348 . . . . 0.14000000000000001 109.132 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 54.65 25.89 6.87 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 114.12 -1.4 . . . . 0.17999999999999999 111.213 -177.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.1 p -64.47 -20.08 65.96 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 115.162 1.541 . . . . 0.14999999999999999 115.162 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.5 p -56.94 -32.82 40.45 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 O-C-N 119.578 -1.951 . . . . 0.17000000000000001 109.296 178.05 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -58.61 -19.99 43.5 Favored 'General case' 0 CA--C 1.566 1.581 0 O-C-N 121.524 -0.735 . . . . 0.25 112.092 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.635 ' N ' HD12 ' A' ' 98' ' ' LEU . 7.3 mp -78.02 -3.67 43.27 Favored 'General case' 0 CA--C 1.566 1.565 0 O-C-N 119.733 -1.855 . . . . 0.17000000000000001 113.877 177.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm 49.23 46.23 22.99 Favored 'General case' 0 C--N 1.276 -2.624 0 N-CA-C 116.082 1.882 . . . . 3.1899999999999999 116.082 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 90.63 -13.17 66.34 Favored Glycine 0 CA--C 1.544 1.871 0 O-C-N 121.26 -0.9 . . . . 0.16 115.338 176.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -62.21 120.92 11.87 Favored 'General case' 0 C--N 1.28 -2.456 0 O-C-N 121.024 -1.28 . . . . 0.17999999999999999 112.235 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 122' ' ' PHE . . . 98.69 -8.68 61.87 Favored Glycine 0 C--O 1.196 -2.274 0 O-C-N 121.637 -0.664 . . . . 0.14000000000000001 114.597 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -115.02 151.6 33.92 Favored 'General case' 0 C--N 1.278 -2.534 0 C-N-CA 124.136 0.974 . . . . 0.13 111.326 178.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -141.23 112.95 7.67 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 124.43 1.092 . . . . 0.13 109.504 177.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ARG . . . . . 0.402 ' NH2' ' OD1' ' A' ' 74' ' ' ASN . 29.0 ttm180 -67.3 123.26 19.86 Favored 'General case' 0 CA--C 1.453 -2.758 0 C-N-CA 120.337 -0.545 . . . . 0.14000000000000001 109.966 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 29.8 mm -106.22 -34.5 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.251 0 C-N-CA 115.112 -2.635 . . . . 0.12 108.289 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.82 177.66 5.7 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 118.721 -1.191 . . . . 0.12 112.391 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -118.26 150.58 39.2 Favored 'General case' 0 C--O 1.215 -0.754 0 N-CA-C 112.963 0.727 . . . . 0.14999999999999999 112.963 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -60.14 137.26 58.14 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 118.385 -1.326 . . . . 1.6799999999999999 108.021 176.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.54 -5.8 83.58 Favored Glycine 0 N--CA 1.475 1.253 0 N-CA-C 111.455 -0.658 . . . . 0.14000000000000001 111.455 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -65.88 137.17 57.01 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-O 122.843 1.306 . . . . 0.13 113.289 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ARG . . . . . 0.406 ' NH1' ' OD1' ' A' ' 82' ' ' ASP . 0.9 OUTLIER -85.23 133.07 34.19 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 107.095 -1.446 . . . . 0.14999999999999999 107.095 176.153 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.3 m -140.66 159.72 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.042 0 C-N-CA 117.678 -1.609 . . . . 0.11 113.286 -177.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -110.42 156.11 21.27 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 112.032 -2.349 . . . . 0.14000000000000001 108.773 175.03 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.862 HG23 ' OD1' ' A' ' 64' ' ' ASP . 28.7 t -45.3 135.43 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.457 0 CA-C-O 121.677 0.751 . . . . 0.11 111.837 176.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.52 -13.2 64.59 Favored Glycine 0 CA--C 1.537 1.42 0 C-N-CA 120.786 -0.721 . . . . 0.089999999999999997 114.285 178.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -63.05 136.24 57.7 Favored 'General case' 0 C--N 1.288 -2.085 0 O-C-N 120.547 -1.561 . . . . 0.11 109.912 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 55.6 m -76.61 132.22 39.32 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 122.915 1.341 . . . . 0.10000000000000001 111.231 -177.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 120' ' ' ILE . 38.5 t -106.03 -47.83 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.684 0 CA-C-N 113.544 -1.662 . . . . 0.089999999999999997 109.414 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 119' ' ' VAL . 11.5 mt -148.78 143.49 18.67 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.836 0 N-CA-C 114.135 1.161 . . . . 0.089999999999999997 114.135 -177.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -112.71 146.64 38.37 Favored 'General case' 0 CA--C 1.487 -1.457 0 C-N-CA 116.788 -1.965 . . . . 0.12 107.591 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' PHE . . . . . 0.517 ' HA ' ' O ' ' A' ' 102' ' ' GLY . 42.6 p90 -133.0 162.37 31.87 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 122.669 1.223 . . . . 0.11 112.003 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 126' ' ' LEU . 7.9 t70 -99.05 99.59 10.63 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.605 -1.179 . . . . 0.14999999999999999 108.888 177.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.553 ' HB3' ' HD3' ' A' ' 125' ' ' PRO . 26.9 tp -61.81 -51.54 75.12 Favored Pre-proline 0 C--N 1.292 -1.911 0 N-CA-C 116.929 2.196 . . . . 0.12 116.929 -177.161 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' A' ' 124' ' ' LEU . 31.5 Cg_exo -58.97 -45.04 30.62 Favored 'Trans proline' 1 C--N 1.241 -5.116 0 C-N-CA 121.966 1.777 . . . . 0.14999999999999999 109.411 -177.064 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LEU . . . . . 0.508 ' N ' ' OD1' ' A' ' 123' ' ' ASP . 29.0 tp -57.76 -48.26 80.14 Favored 'General case' 0 C--N 1.308 -1.216 0 O-C-N 121.383 -0.823 . . . . 0.16 110.157 177.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 94.8 mt -69.84 -32.35 70.7 Favored 'General case' 0 C--N 1.282 -2.36 0 O-C-N 121.164 -0.96 . . . . 0.13 111.817 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -64.61 -37.73 88.56 Favored 'General case' 0 C--N 1.278 -2.517 0 N-CA-C 106.538 -1.653 . . . . 0.14999999999999999 106.538 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -75.42 -41.7 55.36 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 113.476 0.917 . . . . 0.19 113.476 177.828 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 39.4 mmtt -95.8 -27.81 15.05 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 116.582 2.067 . . . . 0.20000000000000001 116.582 -176.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.54 142.73 35.47 Favored 'General case' 0 C--N 1.258 -3.378 0 N-CA-C 115.437 1.643 . . . . 0.14999999999999999 115.437 -177.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 46.3 tptt -55.47 -38.25 68.85 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 108.066 -1.087 . . . . 0.17999999999999999 108.066 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.3 t -163.71 143.21 8.21 Favored 'General case' 0 C--N 1.287 -2.152 0 C-N-CA 125.004 1.321 . . . . 0.13 111.15 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 10.0 p -94.97 -1.26 52.84 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-N 114.794 -1.093 . . . . 0.11 110.255 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 33.4 mt -54.93 131.85 45.45 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 106.78 -1.563 . . . . 0.10000000000000001 106.78 177.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 77.2 m -119.79 101.84 47.66 Favored Pre-proline 0 C--N 1.292 -1.893 0 N-CA-C 115.272 1.582 . . . . 0.070000000000000007 115.272 -174.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -71.16 141.68 40.15 Favored 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 117.425 -1.25 . . . . 0.089999999999999997 115.078 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . 0.309 0.6 OUTLIER -124.79 104.61 13.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 105.207 -2.146 . . . . 0.059999999999999998 105.207 174.152 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 139' ' ' VAL . . . . . 0.487 ' CG1' ' CD1' ' A' ' 33' ' ' ILE . 19.8 m -124.02 158.17 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 N-CA-C 116.458 2.021 . . . . 0.089999999999999997 116.458 -176.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.584 ' N ' HD12 ' A' ' 140' ' ' ILE . 1.4 mp -96.71 125.55 49.64 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.344 0 N-CA-C 104.618 -2.364 . . . . 0.11 104.618 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 53.6 p -98.44 -4.47 34.49 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-O 123.231 1.491 . . . . 0.14000000000000001 112.956 -175.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ASN . . . . . 0.428 ' O ' ' C ' ' A' ' 143' ' ' MET 0.491 42.1 t30 -98.13 16.05 22.43 Favored 'General case' 0 C--N 1.259 -3.357 0 C-N-CA 130.089 3.356 . . . . 0.14999999999999999 114.344 -179.74 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 143' ' ' MET . . . . . 0.428 ' C ' ' O ' ' A' ' 142' ' ' ASN . 95.3 mmm -34.54 -44.39 0.2 Allowed 'General case' 0 C--N 1.28 -2.452 0 N-CA-C 115.646 1.721 . . . . 0.16 115.646 -174.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -64.51 -11.64 36.09 Favored 'General case' 0 C--N 1.248 -3.811 0 O-C-N 119.762 -1.837 . . . . 0.26000000000000001 113.099 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLU . . . . . 0.402 ' HB2' ' ND2' ' A' ' 142' ' ' ASN . 80.4 mt-10 -106.88 14.56 26.46 Favored 'General case' 0 CA--C 1.475 -1.922 0 CA-C-N 121.225 1.829 . . . . 0.17000000000000001 111.28 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 10.5 pt -121.99 140.29 46.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 C-N-CA 116.082 -2.247 . . . . 0.16 114.056 -178.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . 0.256 49.0 tptt -73.83 -55.12 6.6 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 114.275 -1.329 . . . . 0.20000000000000001 109.584 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 166' ' ' ILE . 2.6 tt0 -147.64 144.61 28.51 Favored 'General case' 0 C--N 1.286 -2.154 0 O-C-N 119.889 -1.757 . . . . 0.17000000000000001 114.6 177.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.8 tt -114.73 111.66 21.62 Favored 'General case' 0 N--CA 1.415 -2.177 0 CA-C-N 111.309 -2.678 . . . . 0.13 110.262 177.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 70.1 mt -108.1 112.41 40.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 114.567 -1.197 . . . . 0.14000000000000001 107.844 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -85.0 130.32 34.64 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 124.301 1.04 . . . . 0.11 113.113 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 152' ' ' LEU 0.302 39.2 mt -94.67 175.94 6.47 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-O 123.007 1.384 . . . . 0.11 112.371 -179.618 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . 0.293 50.9 m -132.02 159.34 39.07 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 113.416 -1.72 . . . . 0.11 115.145 -174.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 101.4 -158.74 18.73 Favored Glycine 0 C--O 1.214 -1.096 0 N-CA-C 118.92 2.328 . . . . 0.10000000000000001 118.92 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 64.6 m -94.83 142.51 27.38 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 112.1 -2.05 . . . . 0.12 109.601 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' VAL . . . . . 0.624 HG11 HG12 ' A' ' 163' ' ' VAL . 6.4 m -131.59 160.31 42.46 Favored 'Isoleucine or valine' 0 CA--C 1.462 -2.429 0 CA-C-O 122.995 1.379 . . . . 0.089999999999999997 109.996 -177.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 29.3 m -123.63 122.73 38.89 Favored 'General case' 0 C--N 1.269 -2.903 0 CA-C-N 112.854 -1.975 . . . . 0.12 108.773 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 9.3 p -37.07 122.48 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.736 0 CA-C-O 123.547 1.641 . . . . 0.089999999999999997 114.697 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 62.17 26.34 67.52 Favored Glycine 0 CA--C 1.489 -1.546 0 CA-C-N 112.871 -1.968 . . . . 0.10000000000000001 113.934 176.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -137.43 -51.4 0.64 Allowed 'General case' 0 C--N 1.283 -2.317 0 C-N-CA 119.624 -0.83 . . . . 0.14000000000000001 112.581 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.599 ' CG2' HG12 ' A' ' 156' ' ' VAL . 11.9 m -86.09 123.59 71.6 Favored Pre-proline 0 C--N 1.28 -2.415 0 N-CA-C 113.971 1.1 . . . . 0.10000000000000001 113.971 -176.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -63.08 141.22 82.48 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.963 2.442 . . . . 0.11 109.957 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' VAL . . . . . 0.624 HG12 HG11 ' A' ' 156' ' ' VAL . 18.4 m -116.25 -28.59 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.306 -0.871 . . . . 0.070000000000000007 111.881 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 34.8 mt -141.36 149.73 20.24 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 CA-C-O 122.064 0.935 . . . . 0.089999999999999997 109.005 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -124.73 130.75 53.02 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 105.78 -1.933 . . . . 0.13 105.78 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ILE . . . . . 0.825 HG13 ' HB ' ' A' ' 20' ' ' ILE . 5.8 pt -128.71 155.0 40.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.298 -0.961 . . . . 0.13 109.927 -177.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' LYS . . . . . 0.446 ' O ' ' C ' ' A' ' 168' ' ' LYS . 80.0 tttt -120.1 154.25 34.96 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 109.064 -0.717 . . . . 0.17999999999999999 109.064 176.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 167' ' ' LYS . 17.1 tttt . . . . . 0 C--N 1.319 -0.732 0 CA-C-N 115.75 -0.659 . . . . 0.19 110.044 -177.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 301' ' ' MET . . . . . 0.513 ' HB2' ' HG2' ' B' ' 366' ' ' GLU . 4.2 ttm . . . . . 0 C--O 1.219 -0.545 0 N-CA-C 108.473 -0.936 . . . . 0.20000000000000001 108.473 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 302' ' ' PHE . . . . . 0.534 ' CD2' ' HA ' ' B' ' 371' ' ' GLN . 74.9 t80 -142.93 140.91 31.33 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.219 -1.4 . . . . 0.19 107.219 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -150.85 157.34 42.8 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 120.998 -1.064 . . . . 0.16 109.461 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -153.18 147.62 25.97 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.024 -1.472 . . . . 0.17999999999999999 107.024 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.97 151.96 19.17 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.296 -1.001 . . . . 0.17000000000000001 108.296 178.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.62 144.31 17.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 107.345 -1.354 . . . . 0.14999999999999999 107.345 174.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 87.1 m -93.9 136.69 33.92 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.596 0.712 . . . . 0.19 110.107 178.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 59.0 mt -85.69 114.12 25.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 104.653 -2.351 . . . . 0.19 104.653 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 61.1 p -106.44 -3.86 20.49 Favored 'General case' 0 N--CA 1.514 2.729 0 N-CA-C 114.57 1.322 . . . . 0.23000000000000001 114.57 -178.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 310' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' B' ' 384' ' ' LEU . . . -71.74 139.2 83.12 Favored Pre-proline 0 N--CA 1.487 1.396 0 CA-C-N 120.314 1.415 . . . . 0.20999999999999999 110.701 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -46.45 -44.87 20.18 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 123.012 2.475 . . . . 0.26000000000000001 117.095 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -103.72 29.29 5.88 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 115.758 -2.377 . . . . 1.04 107.145 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 60.39 -122.47 29.96 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 117.615 -2.231 . . . . 0.19 108.839 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 314' ' ' LEU . . . . . 0.422 ' O ' ' O ' ' B' ' 315' ' ' HIS . 4.6 tp -117.51 81.63 1.69 Allowed 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.322 -0.992 . . . . 0.14999999999999999 108.322 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 315' ' ' HIS . . . . . 1.22 ' ND1' ' P ' ' B' ' 200' ' ' PO3 . 3.5 p80 -66.08 -141.4 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 O-C-N 120.402 -1.436 . . . . 0.32000000000000001 108.211 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 316' ' ' THR . . . . . 0.652 ' H ' ' CG ' ' B' ' 315' ' ' HIS . 8.7 m -84.96 -46.37 11.3 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 115.5 1.667 . . . . 0.28000000000000003 115.5 -176.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 317' ' ' ARG . . . . . 0.674 ' H ' ' CE1' ' B' ' 315' ' ' HIS . 18.9 ttm180 -71.01 -42.96 12.97 Favored Pre-proline 0 N--CA 1.494 1.774 0 C-N-CA 116.091 -2.244 . . . . 1.1000000000000001 113.356 -172.404 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 318' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' B' ' 317' ' ' ARG . 11.5 Cg_endo -68.9 -28.86 29.01 Favored 'Trans proline' 0 C--N 1.296 -2.233 0 CA-C-N 121.165 1.452 . . . . 0.17000000000000001 111.919 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -69.46 -35.43 75.62 Favored 'General case' 0 N--CA 1.509 2.5 0 O-C-N 120.777 -1.202 . . . . 0.13 108.839 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -71.52 -39.32 70.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.798 -1.189 . . . . 0.16 108.867 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -67.84 -35.93 79.44 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 118.084 -1.447 . . . . 1.7 108.7 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -64.25 -44.62 91.23 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 122.408 1.099 . . . . 0.12 108.704 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.71 -40.37 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-N 115.227 -0.897 . . . . 0.13 110.539 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -64.52 -41.06 96.63 Favored 'General case' 0 C--N 1.292 -1.898 0 O-C-N 120.804 -1.185 . . . . 1.1799999999999999 109.735 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -68.27 -40.17 81.96 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.152 -0.685 . . . . 0.16 109.152 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.58 -42.31 92.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.945 -1.097 . . . . 0.14000000000000001 109.283 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -62.82 -15.05 52.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.034 -1.041 . . . . 1.6000000000000001 112.875 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -78.36 -11.26 85.5 Favored Glycine 0 N--CA 1.478 1.498 0 N-CA-C 108.85 -1.7 . . . . 0.19 108.85 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 329' ' ' PHE . . . . . 0.541 ' HE1' ' HE3' ' B' ' 372' ' ' LYS . 82.3 m-85 -103.88 144.99 30.77 Favored 'General case' 0 N--CA 1.507 2.388 0 CA-C-N 118.713 1.257 . . . . 0.17000000000000001 110.129 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 74.4 p -76.9 -28.7 55.44 Favored 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 118.611 -0.709 . . . . 0.22 112.503 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 20.3 m -58.92 157.58 9.63 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 123.384 1.564 . . . . 0.17999999999999999 114.899 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.6 128.49 33.46 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 102.22 -3.252 . . . . 0.17999999999999999 102.22 172.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 41.7 mt -125.76 133.93 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 108.203 -1.036 . . . . 0.14000000000000001 108.203 -175.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 97.6 m -124.58 140.68 52.72 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 122.267 1.032 . . . . 0.14000000000000001 109.184 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 335' ' ' VAL . . . . . 0.436 HG23 ' HB2' ' B' ' 344' ' ' ALA . 93.1 t -107.33 127.38 63.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 105.34 -2.096 . . . . 0.12 105.34 174.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 88.3 m -124.73 121.04 33.52 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.881 0.848 . . . . 0.14999999999999999 110.396 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 337' ' ' SER . . . . . 0.498 ' HB2' HG12 ' B' ' 361' ' ' VAL . 33.5 t -125.65 123.83 39.82 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 118.425 -1.31 . . . . 0.17000000000000001 108.129 177.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 58.5 t30 49.71 40.19 19.43 Favored 'General case' 0 N--CA 1.514 2.765 0 N-CA-C 112.872 0.693 . . . . 0.22 112.872 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 81.05 12.23 82.78 Favored Glycine 0 N--CA 1.485 1.923 0 O-C-N 120.487 -1.383 . . . . 0.20000000000000001 113.334 176.421 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -121.8 136.69 54.94 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 103.539 -2.763 . . . . 2.48 103.539 178.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 68.8 m -121.55 156.1 33.6 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-O 124.321 2.01 . . . . 0.17000000000000001 114.996 -175.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -151.52 148.01 27.52 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 111.848 -2.433 . . . . 0.14999999999999999 110.82 176.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 7.6 t -65.59 132.93 50.08 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.416 -1.698 . . . . 0.14999999999999999 106.416 173.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 344' ' ' ALA . . . . . 0.436 ' HB2' HG23 ' B' ' 335' ' ' VAL . . . -73.47 -6.02 43.71 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 120.285 -1.509 . . . . 0.11 110.842 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -98.23 12.74 33.68 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.966 -1.084 . . . . 0.17000000000000001 109.189 -178.035 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.23 105.64 6.74 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 123.122 1.439 . . . . 0.17999999999999999 110.557 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 28.9 tp -57.34 -37.59 72.78 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 113.949 -1.478 . . . . 0.19 109.303 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 348' ' ' PHE . . . . . 0.435 ' CB ' ' OE1' ' A' ' 86' ' ' GLU . 72.5 t80 -61.18 -50.4 73.32 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 120.355 -1.465 . . . . 0.38 112.975 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -69.54 -31.75 70.15 Favored 'General case' 0 C--N 1.314 -0.963 0 O-C-N 119.609 -1.932 . . . . 1.1699999999999999 110.554 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 3.1 mt -65.25 -32.03 73.49 Favored 'General case' 0 C--N 1.285 -2.233 0 C-N-CA 119.177 -1.009 . . . . 0.14999999999999999 109.309 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 351' ' ' GLN . . . . . 0.541 ' O ' ' CD ' ' A' ' 69' ' ' LYS . 89.6 mt-30 -68.21 -10.64 55.93 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.96 -0.462 . . . . 0.82999999999999996 109.819 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 2.7 p -91.95 -3.91 55.31 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 118.292 -1.363 . . . . 0.23000000000000001 110.804 -177.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 353' ' ' LEU . . . . . 0.482 HD22 ' HB3' ' B' ' 337' ' ' SER . 25.5 mt -94.7 157.05 16.13 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.257 -0.902 . . . . 0.17000000000000001 110.076 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -86.3 106.45 3.09 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 104.713 -3.355 . . . . 0.17999999999999999 104.713 177.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 91.3 mt -122.37 48.39 1.76 Allowed 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 106.153 -1.795 . . . . 0.16 106.153 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 24.1 p -83.12 171.02 14.16 Favored 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 109.335 -0.617 . . . . 0.25 109.335 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 62.6 tt0 -57.7 138.52 55.36 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.177 -0.952 . . . . 0.25 110.675 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 92.19 -3.13 76.05 Favored Glycine 0 N--CA 1.474 1.173 0 C-N-CA 119.39 -1.385 . . . . 0.20999999999999999 112.61 177.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 55.3 m -84.82 132.98 34.34 Favored 'General case' 0 C--N 1.291 -1.975 0 O-C-N 121.507 -0.996 . . . . 0.17999999999999999 111.185 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 94.7 t -94.44 122.86 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 107.031 -1.47 . . . . 0.17999999999999999 107.031 177.091 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 361' ' ' VAL . . . . . 0.498 HG12 ' HB2' ' B' ' 337' ' ' SER . 17.8 m -112.73 161.33 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 C-N-CA 116.891 -1.923 . . . . 0.13 109.891 178.039 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 85.4 m -110.06 130.52 55.52 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 106.324 -1.732 . . . . 0.13 106.324 175.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 54.5 mt -110.33 120.43 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 102.869 -3.011 . . . . 0.11 102.869 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.42 146.43 49.62 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 107.716 -1.216 . . . . 0.13 107.716 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -141.05 153.66 45.6 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 117.566 -1.653 . . . . 0.16 108.63 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 366' ' ' GLU . . . . . 0.513 ' HG2' ' HB2' ' B' ' 301' ' ' MET . 0.0 OUTLIER -141.79 111.91 6.87 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.06 -1.459 . . . . 0.22 107.06 178.701 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 165.25 -173.49 41.04 Favored Glycine 0 C--N 1.294 -1.766 0 C-N-CA 117.651 -2.214 . . . . 0.20999999999999999 108.64 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -54.78 -41.5 70.62 Favored 'General case' 0 C--N 1.285 -2.213 0 C-N-CA 124.134 0.974 . . . . 0.28000000000000003 113.253 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 15.2 p30 -116.04 36.71 3.93 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 117.002 -1.879 . . . . 0.20999999999999999 108.135 -177.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -58.97 -30.35 67.87 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 119.001 2.963 . . . . 0.20000000000000001 119.001 -175.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 371' ' ' GLN . . . . . 0.534 ' HA ' ' CD2' ' B' ' 302' ' ' PHE . 0.0 OUTLIER -78.2 -43.36 28.72 Favored 'General case' 0 N--CA 1.512 2.66 0 O-C-N 119.647 -1.908 . . . . 0.23000000000000001 109.768 -177.953 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 372' ' ' LYS . . . . . 0.541 ' HE3' ' HE1' ' B' ' 329' ' ' PHE . 13.2 ttpp -63.78 -40.71 97.33 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 106.878 -1.527 . . . . 0.22 106.878 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.21 -46.89 86.86 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 118.441 -1.303 . . . . 0.16 110.599 -178.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 68.7 t -68.78 -39.54 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 N-CA-C 108.521 -0.918 . . . . 0.14000000000000001 108.521 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -58.21 -46.49 85.75 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.846 0.831 . . . . 0.20999999999999999 109.508 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 376' ' ' HIS . . . . . 0.462 ' CE1' ' HZ2' ' B' ' 372' ' ' LYS . 3.5 m80 -71.05 -35.81 72.08 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 113.347 0.869 . . . . 0.20000000000000001 113.347 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 95.8 mt -79.87 -25.11 40.79 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.447 -1.301 . . . . 0.13 111.786 -175.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 2.1 t -73.13 -38.88 56.0 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 N-CA-C 106.288 -1.745 . . . . 0.14999999999999999 106.288 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -68.83 -48.6 63.13 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 107.563 -1.273 . . . . 0.22 107.563 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 380' ' ' LEU . . . . . 0.569 ' HG ' ' CD2' ' B' ' 384' ' ' LEU . 28.2 tp -55.53 -47.37 76.4 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 118.773 -1.171 . . . . 0.14999999999999999 110.754 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 2.9 ttm -61.49 -35.02 76.48 Favored 'General case' 0 C--N 1.309 -1.168 0 O-C-N 120.721 -1.237 . . . . 0.14999999999999999 113.44 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -77.48 -29.46 52.66 Favored 'General case' 0 C--N 1.282 -2.36 0 O-C-N 121.229 -0.919 . . . . 0.19 108.856 -178.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . 0.265 32.3 mt-10 -76.37 -36.76 57.97 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 121.787 0.803 . . . . 0.22 111.757 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 384' ' ' LEU . . . . . 0.569 ' CD2' ' HG ' ' B' ' 380' ' ' LEU . 0.0 OUTLIER -55.21 127.42 29.17 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 125.822 2.725 . . . . 0.17999999999999999 113.15 -176.099 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 385' ' ' GLU . . . . . 0.401 ' CD ' ' H ' ' B' ' 385' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.307 -1.247 2 CA-C-N 108.129 -4.123 . . . . 0.22 111.168 -178.21 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 200' ' ' PO3 . . . . . 1.236 ' P ' ' NE2' ' A' ' 90' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.217 -0.633 0 CA-C-O 122.405 1.098 . . . . 0.15 112.795 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.814 ' HB ' ' CG1' ' A' ' 166' ' ' ILE . 2.3 mp -105.93 130.77 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.023 0 CA-C-O 122.637 1.208 . . . . 0.13 110.744 177.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -100.49 124.86 46.59 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.225 -1.352 . . . . 0.12 110.302 176.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.4 mm -94.79 123.4 46.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 105.961 -1.866 . . . . 0.08 105.961 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.1 mm -92.11 146.77 5.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 CA-C-O 122.553 1.168 . . . . 0.09 111.839 -178.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.68 121.14 51.52 Favored Pre-proline 0 N--CA 1.429 -1.504 0 N-CA-C 115.336 1.606 . . . . 0.05 115.336 -178.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -76.16 -19.99 15.04 Favored 'Trans proline' 0 CA--C 1.558 1.709 0 C-N-CA 121.488 1.458 . . . . 0.04 111.386 -177.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.466 ' N ' HD12 ' A' ' 26' ' ' LEU 0.324 0.0 OUTLIER -147.44 161.22 41.48 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 123.82 0.848 . . . . 0.05 110.185 175.253 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.9 m -82.6 148.13 28.18 Favored 'General case' 0 CA--C 1.498 -1.023 0 CA-C-O 121.709 0.766 . . . . 0.08 111.11 177.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 156.84 -155.38 26.31 Favored Glycine 0 N--CA 1.431 -1.682 0 C-N-CA 119.078 -1.534 . . . . 0.08 111.003 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.04 134.82 54.27 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 114.002 -1.099 . . . . 0.12 110.156 -177.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.0 mt -74.41 141.5 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 C-N-CA 117.621 -1.632 . . . . 0.09 110.333 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.4 t -132.64 155.94 41.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 114.496 -1.229 . . . . 0.1 108.714 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.502 ' HB3' ' OE2' ' A' ' 34' ' ' GLU . 13.6 m120 -71.51 138.37 48.86 Favored 'General case' 0 CA--C 1.497 -1.076 0 CA-C-O 121.477 0.656 . . . . 0.11 111.064 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.422 ' CD1' ' CG1' ' A' ' 139' ' ' VAL . 8.2 tt -67.84 -23.67 29.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 C-N-CA 118.678 -1.209 . . . . 0.12 108.659 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.502 ' OE2' ' HB3' ' A' ' 32' ' ' ASN . 0.8 OUTLIER -73.91 -14.08 61.0 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 118.649 -1.22 . . . . 0.14 110.589 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -95.0 12.48 28.29 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 113.694 0.998 . . . . 0.14 113.694 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 t -86.5 130.99 47.16 Favored Pre-proline 0 C--N 1.289 -2.045 0 CA-C-O 120.955 0.407 . . . . 0.15 109.921 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -70.49 48.01 0.72 Allowed 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 122.695 2.264 . . . . 0.16 111.758 -173.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.555 ' CG ' HH21 ' B' ' 317' ' ' ARG . 62.6 t0 -150.68 115.82 5.34 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.662 -1.236 . . . . 0.22 107.662 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.9 m -60.4 -37.81 75.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 C-N-CA 119.016 -1.074 . . . . 0.19 111.601 -178.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . 0.406 16.1 m -62.46 -34.8 66.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 116.907 -1.917 . . . . 0.27 112.174 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -84.25 -44.32 13.99 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 120.21 -1.556 . . . . 0.19 109.822 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.51 -36.2 77.79 Favored 'General case' 0 CA--C 1.487 -1.461 0 N-CA-C 108.946 -0.761 . . . . 0.15 108.946 -177.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -91.06 7.78 38.73 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 118.219 -1.393 . . . . 0.81 110.579 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.54 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 0.3 OUTLIER 52.37 39.82 28.19 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 113.943 1.09 . . . . 0.15 113.943 176.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.0 mm -67.14 -30.44 49.38 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.963 0 CA-C-O 123.717 1.723 . . . . 0.17 110.676 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.293 2.3 t -89.48 -7.71 10.82 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.916 0 CA-C-N 112.366 -2.197 . . . . 0.5 111.81 -175.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.54 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . 133.45 -175.57 20.12 Favored Glycine 0 C--O 1.207 -1.574 0 N-CA-C 108.773 -1.731 . . . . 0.13 108.773 176.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -119.52 155.39 32.24 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 117.835 -1.546 . . . . 0.11 112.797 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 172.22 -137.68 4.39 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 117.703 -2.189 . . . . 0.09 111.178 177.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.444 ' C ' HD12 ' A' ' 50' ' ' ILE . 2.8 pp -135.05 175.21 11.53 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.695 0 O-C-N 121.579 -0.954 . . . . 0.07 108.596 178.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -121.58 158.52 28.38 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 124.7 1.2 . . . . 0.08 108.428 175.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.3 mt -133.36 128.87 55.85 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.84 0 O-C-N 121.595 -0.691 . . . . 0.07 111.005 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -86.23 108.88 19.21 Favored Pre-proline 0 C--N 1.308 -1.224 0 N-CA-C 101.46 -3.533 . . . . 0.13 101.46 174.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.429 ' HB3' HD22 ' A' ' 26' ' ' LEU . 2.0 Cg_endo -71.26 150.1 58.5 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 123.735 2.956 . . . . 0.1 113.064 -170.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.7 p -138.66 1.68 2.14 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 121.746 -0.596 . . . . 0.11 110.16 177.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -108.81 -144.48 10.85 Favored Glycine 0 CA--C 1.534 1.268 0 O-C-N 121.485 -0.759 . . . . 0.09 114.573 -177.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -142.97 14.52 1.89 Allowed 'General case' 0 CA--C 1.492 -1.265 0 O-C-N 122.351 -0.499 . . . . 0.1 112.068 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -157.3 155.12 30.16 Favored 'General case' 0 N--CA 1.415 -2.187 0 C-N-CA 115.405 -2.518 . . . . 0.09 113.142 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -114.89 121.4 43.08 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.872 -1.058 . . . . 0.06 109.077 178.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 m -114.13 174.58 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.8 0 CA-C-O 122.733 1.254 . . . . 0.06 110.998 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.13 126.64 92.89 Favored Pre-proline 0 C--N 1.289 -2.058 0 CA-C-N 113.705 -1.589 . . . . 0.08 109.729 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -85.84 -1.52 8.83 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 CA-C-N 120.027 1.045 . . . . 0.07 110.439 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.449 HG21 ' HB3' ' A' ' 81' ' ' SER . 17.2 m -158.49 164.95 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-O 121.493 0.663 . . . . 0.1 111.185 -178.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.8 ' OD1' HG23 ' A' ' 115' ' ' VAL . 48.5 m-20 -81.45 127.19 32.54 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 103.558 -2.756 . . . . 0.13 103.558 174.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 80' ' ' GLU . . . 174.0 -157.82 26.15 Favored Glycine 0 C--N 1.301 -1.395 0 N-CA-C 110.753 -0.939 . . . . 0.12 110.753 -175.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.0 m -123.71 134.85 53.64 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 119.854 -0.739 . . . . 0.15 111.316 -177.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.7 mm -68.79 140.42 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.028 0 C-N-CA 117.626 -1.629 . . . . 0.13 107.365 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -101.7 -64.25 0.76 Allowed Glycine 0 C--N 1.282 -2.471 0 CA-C-O 122.029 0.794 . . . . 0.13 114.332 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.5 ' H ' ' HB2' ' A' ' 78' ' ' SER . 2.3 tmtp? -141.4 136.43 31.39 Favored 'General case' 0 C--N 1.279 -2.497 0 CA-C-O 123.053 1.406 . . . . 2.16 111.954 -177.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 75.5 mt -116.19 125.45 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 105.532 -2.025 . . . . 0.12 105.532 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -62.65 145.41 54.64 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.172 -1.047 . . . . 0.21 108.172 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -61.87 -14.91 38.15 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 123.67 0.788 . . . . 0.4 110.454 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.508 ' OG1' ' ND1' ' A' ' 75' ' ' HIS . 41.4 p -97.7 5.03 49.83 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 123.618 1.675 . . . . 0.15 109.055 178.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.784 ' ND2' HH21 ' A' ' 105' ' ' ARG . 23.5 m120 50.41 44.39 26.82 Favored 'General case' 0 C--N 1.26 -3.292 0 CA-C-N 113.24 -1.8 . . . . 0.11 112.608 175.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.508 ' ND1' ' OG1' ' A' ' 73' ' ' THR . 23.7 p-80 -126.38 -1.55 6.91 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 113.652 0.982 . . . . 0.18 113.652 -177.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.31 152.69 31.42 Favored 'General case' 0 N--CA 1.411 -2.388 0 O-C-N 120.79 -1.193 . . . . 0.09 111.122 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -152.49 166.36 32.23 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 123.077 1.418 . . . . 0.09 113.276 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.5 ' HB2' ' H ' ' A' ' 69' ' ' LYS 0.26 15.8 m -118.34 139.74 50.9 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 113.302 -1.772 . . . . 0.11 109.789 -178.877 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.6 tt -143.3 150.0 17.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 107.607 -1.257 . . . . 0.11 107.607 175.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.489 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 84.6 tt0 -118.37 129.89 55.68 Favored 'General case' 0 C--O 1.201 -1.483 0 N-CA-C 105.647 -1.983 . . . . 0.84 105.647 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.449 ' HB3' HG21 ' A' ' 63' ' ' VAL . 93.9 p -80.9 167.31 20.02 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 118.441 -1.304 . . . . 0.14 108.264 -176.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -68.13 -31.06 70.39 Favored 'General case' 0 C--N 1.276 -2.6 0 C-N-CA 118.572 -1.251 . . . . 0.16 108.232 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.16 4.46 2.17 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 125.26 1.424 . . . . 0.15 112.053 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.68 14.48 82.03 Favored Glycine 0 C--N 1.28 -2.57 0 N-CA-C 117.386 1.715 . . . . 0.15 117.386 -178.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.762 HG21 HD11 ' A' ' 166' ' ' ILE . 48.8 t -92.35 133.0 35.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 121.202 2.501 . . . . 0.13 110.863 177.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.422 ' OE1' ' CB ' ' B' ' 348' ' ' PHE . 97.3 mt-10 -96.97 121.97 39.44 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 121.643 -0.661 . . . . 1.7 110.207 176.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -116.32 158.79 22.87 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 122.001 0.905 . . . . 0.1 110.851 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -143.65 111.87 6.28 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 122.989 1.376 . . . . 0.18 109.77 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.1 t -101.7 115.56 43.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 114.046 -1.434 . . . . 0.07 111.464 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.449 ' O ' ' HD2' ' A' ' 137' ' ' PRO . 18.4 t-80 -123.2 105.1 9.6 Favored 'General case' 0 C--O 1.2 -1.531 0 CA-C-N 115.549 -0.751 . . . . 0.16 111.086 -178.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -63.63 124.14 20.64 Favored 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 116.665 2.098 . . . . 0.1 116.665 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.35 -175.88 32.07 Favored Glycine 0 C--O 1.215 -1.093 0 CA-C-O 122.572 1.096 . . . . 0.11 114.526 175.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 49.0 mm -118.0 132.59 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-O 123.151 1.453 . . . . 0.15 109.2 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 54.65 25.84 6.83 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 114.089 -1.414 . . . . 0.18 111.246 -177.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.3 p -64.44 -19.9 65.83 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 115.437 1.643 . . . . 0.14 115.437 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.3 p -57.06 -32.82 41.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 O-C-N 120.125 -1.609 . . . . 0.17 109.321 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -58.56 -20.07 43.53 Favored 'General case' 0 CA--C 1.566 1.594 0 C-N-CA 119.91 -0.716 . . . . 0.24 112.098 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mp -78.19 -3.24 41.61 Favored 'General case' 0 CA--C 1.564 1.488 0 O-C-N 119.716 -1.865 . . . . 0.16 113.86 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? 48.91 46.21 22.22 Favored 'General case' 0 C--N 1.278 -2.525 0 N-CA-C 116.077 1.88 . . . . 3.21 116.077 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 90.76 -13.3 66.19 Favored Glycine 0 CA--C 1.542 1.77 0 N-CA-C 115.433 0.933 . . . . 0.13 115.433 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.04 121.21 12.45 Favored 'General case' 0 C--N 1.283 -2.284 0 O-C-N 121.296 -1.12 . . . . 0.16 112.016 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.517 ' O ' ' NZ ' ' A' ' 104' ' ' LYS . . . 97.71 -7.03 63.01 Favored Glycine 0 C--O 1.201 -1.926 0 N-CA-C 114.87 0.708 . . . . 0.12 114.87 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -115.73 152.28 33.52 Favored 'General case' 0 C--N 1.283 -2.298 0 C-N-CA 124.117 0.967 . . . . 0.1 111.012 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.517 ' NZ ' ' O ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -141.92 113.47 7.77 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 124.597 1.159 . . . . 0.1 109.235 176.83 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.784 HH21 ' ND2' ' A' ' 74' ' ' ASN . 4.9 ttm180 -67.32 123.56 20.68 Favored 'General case' 0 CA--C 1.462 -2.439 0 C-N-CA 120.403 -0.519 . . . . 0.12 109.924 178.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.403 HG13 ' HG3' ' A' ' 121' ' ' GLU . 24.0 mm -106.27 -35.02 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.256 0 C-N-CA 114.991 -2.684 . . . . 0.09 108.1 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.16 178.23 5.61 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 118.675 -1.21 . . . . 0.1 112.187 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -118.3 151.52 37.53 Favored 'General case' 0 C--O 1.213 -0.861 0 N-CA-C 112.582 0.586 . . . . 0.14 112.582 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -60.92 137.2 58.23 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 118.559 -1.256 . . . . 1.6 107.967 175.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.36 -5.27 84.16 Favored Glycine 0 N--CA 1.475 1.272 0 N-CA-C 111.622 -0.591 . . . . 0.14 111.622 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -65.76 138.03 57.66 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-O 122.899 1.333 . . . . 0.13 112.888 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.519 ' CG ' HH11 ' A' ' 112' ' ' ARG . 0.0 OUTLIER -86.25 132.7 33.93 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-N 114.111 -1.404 . . . . 0.17 107.297 175.64 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.7 m -139.93 160.35 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.04 0 C-N-CA 117.458 -1.697 . . . . 0.12 113.02 -176.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.494 ' HE3' ' OD2' ' A' ' 117' ' ' ASP . 0.5 OUTLIER -110.78 156.73 20.66 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 111.88 -2.418 . . . . 0.14 108.398 174.671 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.8 HG23 ' OD1' ' A' ' 64' ' ' ASP . 44.2 t -45.73 135.73 2.12 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 CA-C-O 121.593 0.711 . . . . 0.11 111.655 176.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.14 -12.98 64.62 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 120.853 -0.689 . . . . 0.09 114.423 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.494 ' OD2' ' HE3' ' A' ' 114' ' ' LYS . 91.6 m-20 -63.08 136.35 57.74 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 120.926 -1.338 . . . . 0.11 109.812 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.5 m -76.7 132.4 39.31 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-O 122.951 1.358 . . . . 0.08 111.084 -177.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.475 ' O ' HG13 ' A' ' 120' ' ' ILE . 44.8 t -105.86 -48.4 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.695 0 CA-C-N 113.42 -1.718 . . . . 0.07 109.304 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 119' ' ' VAL . 10.9 mt -148.36 143.51 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.722 0 N-CA-C 114.077 1.139 . . . . 0.07 114.077 -177.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.502 ' O ' ' HD2' ' A' ' 104' ' ' LYS . 49.5 mt-10 -112.28 147.41 36.35 Favored 'General case' 0 CA--C 1.484 -1.587 0 C-N-CA 116.685 -2.006 . . . . 0.09 107.314 175.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.516 ' HA ' ' O ' ' A' ' 102' ' ' GLY . 36.0 p90 -132.9 163.6 28.79 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 122.059 0.933 . . . . 0.09 111.609 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.438 ' OD1' ' HD2' ' A' ' 125' ' ' PRO . 10.3 t0 -100.42 97.84 8.53 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 124.758 1.223 . . . . 0.13 109.799 176.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.62 ' HB3' ' HD3' ' A' ' 125' ' ' PRO . 3.2 tp -59.28 -54.75 53.13 Favored Pre-proline 0 C--N 1.292 -1.913 0 N-CA-C 116.068 1.877 . . . . 0.13 116.068 -176.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.62 ' HD3' ' HB3' ' A' ' 124' ' ' LEU . 20.7 Cg_exo -56.9 -44.71 42.17 Favored 'Trans proline' 1 C--N 1.247 -4.812 0 C-N-CA 121.472 1.448 . . . . 0.15 109.698 -175.685 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.811 ' CD1' ' HG3' ' A' ' 130' ' ' LYS . 0.5 OUTLIER -57.17 -50.96 71.21 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.132 -0.692 . . . . 0.15 109.132 177.757 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.4 mt -68.45 -31.37 70.63 Favored 'General case' 0 C--N 1.281 -2.4 0 O-C-N 121.178 -0.951 . . . . 0.14 112.068 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -65.16 -37.61 87.93 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 106.699 -1.593 . . . . 0.16 106.699 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -75.32 -42.27 54.91 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.205 -0.907 . . . . 0.2 113.335 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.811 ' HG3' ' CD1' ' A' ' 126' ' ' LEU . 0.1 OUTLIER -94.77 -29.3 14.84 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 116.361 1.985 . . . . 0.2 116.361 -175.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.54 142.93 36.99 Favored 'General case' 0 C--N 1.262 -3.229 0 N-CA-C 115.382 1.623 . . . . 0.16 115.382 -176.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.493 ' HA ' ' HD2' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -55.68 -37.78 68.78 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.428 -0.953 . . . . 0.19 108.428 179.025 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.8 t -163.84 143.92 8.35 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 124.986 1.314 . . . . 0.15 110.654 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 76.8 p -95.95 -0.6 50.52 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 114.784 -1.098 . . . . 0.12 110.539 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.507 ' HA ' HD23 ' A' ' 135' ' ' LEU . 17.0 mt -56.36 130.43 44.63 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.22 -1.4 . . . . 0.12 107.22 177.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 93.5 m -118.81 96.98 50.57 Favored Pre-proline 0 N--CA 1.431 -1.397 0 N-CA-C 118.121 2.638 . . . . 0.08 118.121 -173.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.449 ' HD2' ' O ' ' A' ' 90' ' ' HIS . 8.3 Cg_exo -66.94 142.86 63.94 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 117.192 -1.406 . . . . 0.09 114.406 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . 0.313 1.6 m -125.79 104.68 13.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 105.186 -2.153 . . . . 0.06 105.186 173.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.422 ' CG1' ' CD1' ' A' ' 33' ' ' ILE . 16.3 m -123.49 158.84 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 N-CA-C 116.258 1.948 . . . . 0.1 116.258 -176.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.8 mp -97.57 125.44 50.71 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.294 0 N-CA-C 104.591 -2.374 . . . . 0.11 104.591 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 53.3 p -98.35 -4.42 34.92 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 123.15 1.452 . . . . 0.14 112.927 -175.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.464 HD22 ' HA ' ' A' ' 142' ' ' ASN 0.483 0.0 OUTLIER -97.86 15.23 24.47 Favored 'General case' 0 C--N 1.258 -3.41 0 C-N-CA 130.114 3.366 . . . . 0.15 114.442 -179.679 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.431 ' C ' ' O ' ' A' ' 142' ' ' ASN . 62.1 mmm -33.76 -45.0 0.17 Allowed 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 115.584 1.698 . . . . 0.15 115.584 -174.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -64.1 -11.71 32.51 Favored 'General case' 0 C--N 1.252 -3.663 0 O-C-N 119.852 -1.78 . . . . 0.24 113.105 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -106.03 12.71 30.11 Favored 'General case' 0 CA--C 1.479 -1.777 0 CA-C-N 121.18 1.809 . . . . 0.17 111.546 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 2.5 pt -120.34 140.86 43.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 C-N-CA 115.979 -2.288 . . . . 0.15 113.96 -177.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.747 ' HB2' ' HB3' ' A' ' 168' ' ' LYS 0.258 12.0 tptt -74.46 -54.77 6.9 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 114.496 -1.229 . . . . 0.18 109.786 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' ' 166' ' ' ILE . 0.0 OUTLIER -147.33 145.57 29.38 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 123.729 1.728 . . . . 0.14 114.017 177.053 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.65 112.35 21.97 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 111.077 -2.783 . . . . 0.11 109.866 177.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 61.9 mt -108.97 112.23 39.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 114.531 -1.213 . . . . 0.11 107.882 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 34.6 mttt -84.94 129.91 34.72 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 124.474 1.11 . . . . 0.09 113.325 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.299 31.4 mt -94.48 175.74 6.56 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-O 122.688 1.233 . . . . 0.08 112.315 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . 0.278 0.5 OUTLIER -131.11 160.43 34.75 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 113.51 -1.677 . . . . 0.09 114.763 -174.341 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 100.26 -158.83 19.42 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 118.88 2.312 . . . . 0.09 118.88 174.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.76 142.15 27.79 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 112.102 -2.049 . . . . 0.11 109.949 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.555 HG11 HG12 ' A' ' 163' ' ' VAL . 16.5 m -131.84 159.73 42.9 Favored 'Isoleucine or valine' 0 CA--C 1.459 -2.54 0 CA-C-O 122.834 1.302 . . . . 0.08 110.032 -177.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 20.7 m -122.79 123.62 41.47 Favored 'General case' 0 C--N 1.274 -2.709 0 CA-C-N 112.702 -2.044 . . . . 0.11 108.24 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 12.1 p -37.23 123.64 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.63 0 CA-C-O 123.7 1.714 . . . . 0.08 113.966 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 61.18 25.83 65.11 Favored Glycine 0 CA--C 1.488 -1.642 0 CA-C-N 112.837 -1.983 . . . . 0.1 114.179 175.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.42 -53.26 0.72 Allowed 'General case' 0 C--N 1.287 -2.118 0 CA-C-O 121.929 0.871 . . . . 0.13 111.957 178.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.463 ' CG2' HG12 ' A' ' 156' ' ' VAL . 9.0 m -85.36 123.0 73.59 Favored Pre-proline 0 C--N 1.282 -2.346 0 N-CA-C 114.179 1.177 . . . . 0.09 114.179 -175.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -62.5 141.5 86.75 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.003 2.469 . . . . 0.09 109.719 177.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.555 HG12 HG11 ' A' ' 156' ' ' VAL . 28.6 m -116.65 -27.96 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 121.647 -0.658 . . . . 0.06 112.217 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 30.3 mt -141.12 150.98 19.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 N-CA-C 108.527 -0.916 . . . . 0.08 108.527 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 5.9 mtt180 -125.78 130.79 52.15 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 105.746 -1.946 . . . . 0.11 105.746 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.814 ' CG1' ' HB ' ' A' ' 20' ' ' ILE . 39.7 pt -128.35 155.6 40.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 C-N-CA 118.987 -1.085 . . . . 0.12 109.771 -178.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 168' ' ' LYS . 1.1 tttt -120.75 154.23 35.93 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.023 -0.732 . . . . 0.16 109.023 176.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.747 ' HB3' ' HB2' ' A' ' 147' ' ' LYS . 9.6 tttt . . . . . 0 C--N 1.322 -0.601 0 N-CA-C 108.887 -0.783 . . . . 0.18 108.887 -177.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 301' ' ' MET . . . . . 0.514 ' HB2' ' HG2' ' B' ' 366' ' ' GLU . 4.2 ttm . . . . . 0 C--O 1.218 -0.566 0 N-CA-C 108.459 -0.941 . . . . 0.21 108.459 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 302' ' ' PHE . . . . . 0.533 ' CD2' ' HA ' ' B' ' 371' ' ' GLN . 74.6 t80 -142.88 140.93 31.42 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.181 -1.414 . . . . 0.17 107.181 178.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -150.83 157.33 42.8 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.037 -1.039 . . . . 0.17 109.46 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -153.2 147.6 25.92 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.001 -1.481 . . . . 0.16 107.001 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.92 152.02 19.15 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.319 -0.993 . . . . 0.16 108.319 178.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 7.3 p -149.68 144.29 17.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 107.35 -1.352 . . . . 0.13 107.35 174.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 86.5 m -93.84 136.73 33.83 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 121.605 0.717 . . . . 0.17 110.119 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 58.9 mt -85.75 114.13 25.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 104.572 -2.381 . . . . 0.16 104.572 177.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 61.1 p -106.45 -3.93 20.41 Favored 'General case' 0 N--CA 1.514 2.746 0 N-CA-C 114.545 1.313 . . . . 0.21 114.545 -178.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 310' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' B' ' 384' ' ' LEU . . . -71.65 139.21 83.38 Favored Pre-proline 0 N--CA 1.487 1.422 0 CA-C-N 120.312 1.414 . . . . 0.2 110.766 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -46.42 -44.96 19.92 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 123.033 2.488 . . . . 0.24 117.068 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -103.66 29.23 5.89 Favored 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 115.813 -2.355 . . . . 1.08 107.127 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 59.52 -148.66 41.1 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 117.624 -2.226 . . . . 0.18 111.007 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.452 ' HG ' ' HB2' ' B' ' 319' ' ' ALA . 17.1 tp -87.11 74.1 9.69 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 118.331 -1.347 . . . . 0.15 108.996 -177.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 315' ' ' HIS . . . . . 0.506 ' H ' ' CD2' ' B' ' 315' ' ' HIS . 7.7 p80 -69.27 -178.06 1.25 Allowed 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 118.667 -1.213 . . . . 0.81 112.688 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 3.0 m -48.93 -60.26 2.9 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 118.842 2.904 . . . . 0.21 118.842 -174.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 317' ' ' ARG . . . . . 0.555 HH21 ' CG ' ' A' ' 38' ' ' ASP . 20.9 ttm180 -64.01 -44.19 77.31 Favored Pre-proline 0 C--N 1.282 -2.326 0 CA-C-N 122.599 2.454 . . . . 1.24 113.038 -176.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 318' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' B' ' 317' ' ' ARG . 10.5 Cg_endo -68.09 -28.92 34.22 Favored 'Trans proline' 0 C--N 1.296 -2.185 0 CA-C-N 121.171 1.454 . . . . 0.18 111.934 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . 0.452 ' HB2' ' HG ' ' B' ' 314' ' ' LEU . . . -69.45 -35.37 75.57 Favored 'General case' 0 N--CA 1.508 2.473 0 O-C-N 120.836 -1.165 . . . . 0.14 108.853 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -71.56 -39.35 70.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.805 -1.185 . . . . 0.17 108.855 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -67.77 -36.0 79.7 Favored 'General case' 0 N--CA 1.501 2.093 0 C-N-CA 118.123 -1.431 . . . . 1.74 108.714 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -64.28 -44.61 91.17 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.93 -1.106 . . . . 0.13 108.657 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.63 -40.42 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 CA-C-N 115.229 -0.896 . . . . 0.14 110.538 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -64.55 -41.05 96.58 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 120.809 -1.182 . . . . 1.22 109.688 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -68.28 -40.16 81.93 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.58 -0.7 . . . . 0.17 109.121 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.57 -42.32 92.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.893 -1.129 . . . . 0.14 109.287 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -62.82 -15.04 52.55 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.136 -0.977 . . . . 1.43 112.905 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -78.34 -11.23 85.53 Favored Glycine 0 N--CA 1.479 1.513 0 N-CA-C 108.847 -1.701 . . . . 0.19 108.847 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . 0.542 ' HE1' ' HE3' ' B' ' 372' ' ' LYS . 82.4 m-85 -103.91 145.08 30.65 Favored 'General case' 0 N--CA 1.506 2.355 0 CA-C-N 118.731 1.266 . . . . 0.18 110.083 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 75.4 p -76.95 -28.78 55.32 Favored 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 118.609 -0.71 . . . . 0.22 112.477 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 20.3 m -58.87 157.55 9.57 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-O 123.384 1.564 . . . . 0.18 114.893 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.53 128.48 33.42 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 102.25 -3.241 . . . . 0.19 102.25 172.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 42.0 mt -125.78 133.98 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 108.18 -1.045 . . . . 0.15 108.18 -175.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 97.5 m -124.61 140.64 52.75 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 122.204 1.002 . . . . 0.16 109.229 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 335' ' ' VAL . . . . . 0.437 HG23 ' HB2' ' B' ' 344' ' ' ALA . 93.1 t -107.37 127.39 63.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 105.349 -2.093 . . . . 0.13 105.349 174.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 88.2 m -124.7 121.04 33.54 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.893 0.854 . . . . 0.16 110.432 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 337' ' ' SER . . . . . 0.498 ' HB2' HG12 ' B' ' 361' ' ' VAL . 33.4 t -125.59 123.84 39.92 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 118.389 -1.324 . . . . 0.17 108.154 177.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 49.78 40.09 19.49 Favored 'General case' 0 N--CA 1.514 2.747 0 N-CA-C 112.879 0.696 . . . . 0.22 112.879 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 81.07 12.26 82.71 Favored Glycine 0 N--CA 1.485 1.961 0 O-C-N 120.442 -1.411 . . . . 0.21 113.314 176.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -121.84 136.65 54.94 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 103.55 -2.759 . . . . 2.59 103.55 178.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 68.2 m -121.49 156.09 33.53 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-O 124.348 2.023 . . . . 0.18 115.04 -175.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -151.52 147.98 27.47 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 111.86 -2.427 . . . . 0.15 110.804 177.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 7.6 t -65.65 132.96 50.08 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 106.362 -1.718 . . . . 0.16 106.362 173.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 344' ' ' ALA . . . . . 0.437 ' HB2' HG23 ' B' ' 335' ' ' VAL . . . -73.46 -6.08 44.11 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.281 -1.512 . . . . 0.12 110.845 178.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -98.13 12.72 33.55 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.998 -1.064 . . . . 0.17 109.224 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.2 105.67 6.77 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 123.146 1.45 . . . . 0.17 110.544 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 26.6 tp -57.32 -37.64 72.82 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 113.948 -1.478 . . . . 0.19 109.31 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 348' ' ' PHE . . . . . 0.422 ' CB ' ' OE1' ' A' ' 86' ' ' GLU . 67.1 t80 -61.06 -50.48 73.14 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 120.395 -1.44 . . . . 0.34 113.018 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -69.51 -31.74 70.16 Favored 'General case' 0 C--N 1.313 -1.01 0 O-C-N 119.589 -1.944 . . . . 1.13 110.526 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 3.1 mt -65.35 -32.02 73.45 Favored 'General case' 0 C--N 1.284 -2.25 0 C-N-CA 119.19 -1.004 . . . . 0.15 109.242 -177.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 351' ' ' GLN . . . . . 0.427 ' OE1' ' OG ' ' A' ' 78' ' ' SER . 89.7 mt-30 -68.14 -10.78 56.7 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.938 -0.476 . . . . 0.78 109.816 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 2.7 p -91.86 -3.94 55.43 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.385 -1.326 . . . . 0.22 110.815 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . 0.48 HD22 ' HB3' ' B' ' 337' ' ' SER . 25.6 mt -94.72 157.04 16.13 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.255 -0.903 . . . . 0.16 110.094 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -86.28 106.43 3.08 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 104.785 -3.326 . . . . 0.16 104.785 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 91.2 mt -122.42 48.4 1.76 Allowed 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 106.133 -1.803 . . . . 0.15 106.133 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 18.4 p -83.08 170.99 14.23 Favored 'General case' 0 C--O 1.215 -0.746 0 N-CA-C 109.363 -0.606 . . . . 0.21 109.363 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -57.72 138.48 55.44 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.178 -0.951 . . . . 0.23 110.659 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 92.25 -3.15 75.88 Favored Glycine 0 N--CA 1.473 1.108 0 C-N-CA 119.431 -1.366 . . . . 0.18 112.627 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 55.0 m -84.77 132.89 34.38 Favored 'General case' 0 C--N 1.291 -1.966 0 O-C-N 121.497 -1.002 . . . . 0.16 111.182 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 95.3 t -94.38 122.91 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 106.972 -1.492 . . . . 0.16 106.972 177.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 361' ' ' VAL . . . . . 0.498 HG12 ' HB2' ' B' ' 337' ' ' SER . 17.8 m -112.71 161.3 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 C-N-CA 116.922 -1.911 . . . . 0.12 109.955 177.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 84.9 m -110.1 130.48 55.53 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 106.32 -1.733 . . . . 0.14 106.32 175.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 54.3 mt -110.29 120.43 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 102.902 -2.999 . . . . 0.11 102.902 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.41 146.43 49.61 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.746 -1.205 . . . . 0.14 107.746 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -141.09 153.7 45.57 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 117.549 -1.66 . . . . 0.17 108.599 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 366' ' ' GLU . . . . . 0.514 ' HG2' ' HB2' ' B' ' 301' ' ' MET . 0.0 OUTLIER -141.81 111.94 6.88 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.002 -1.481 . . . . 0.23 107.002 178.753 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 165.25 -173.45 41.03 Favored Glycine 0 C--N 1.295 -1.734 0 C-N-CA 117.672 -2.204 . . . . 0.21 108.649 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -54.86 -41.49 70.85 Favored 'General case' 0 C--N 1.286 -2.191 0 C-N-CA 124.134 0.974 . . . . 0.27 113.24 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 15.1 p30 -116.05 36.75 3.91 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 116.966 -1.894 . . . . 0.2 108.114 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -58.99 -30.34 67.89 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 118.961 2.949 . . . . 0.2 118.961 -175.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 371' ' ' GLN . . . . . 0.533 ' HA ' ' CD2' ' B' ' 302' ' ' PHE . 0.0 OUTLIER -78.23 -43.43 28.39 Favored 'General case' 0 N--CA 1.513 2.696 0 O-C-N 119.721 -1.862 . . . . 0.21 109.743 -177.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 372' ' ' LYS . . . . . 0.567 ' NZ ' ' CE1' ' B' ' 376' ' ' HIS . 13.2 ttpp -63.65 -40.75 97.63 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 106.948 -1.501 . . . . 0.21 106.948 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.23 -46.78 87.35 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 118.375 -1.33 . . . . 0.15 110.705 -178.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 68.5 t -68.82 -39.57 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 108.525 -0.917 . . . . 0.13 108.525 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -58.12 -46.58 85.35 Favored 'General case' 0 N--CA 1.502 2.169 0 CA-C-O 121.839 0.828 . . . . 0.19 109.523 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 376' ' ' HIS . . . . . 0.567 ' CE1' ' NZ ' ' B' ' 372' ' ' LYS . 13.2 m-70 -71.01 -35.87 72.2 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 113.308 0.855 . . . . 0.19 113.308 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 95.9 mt -79.84 -25.14 40.86 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 118.443 -1.303 . . . . 0.12 111.788 -175.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 2.1 t -73.11 -38.89 56.13 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 N-CA-C 106.267 -1.753 . . . . 0.13 106.267 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -68.84 -48.61 63.07 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.538 -1.282 . . . . 0.21 107.538 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 380' ' ' LEU . . . . . 0.572 ' HG ' ' CD2' ' B' ' 384' ' ' LEU . 28.2 tp -55.55 -47.36 76.48 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.836 -1.165 . . . . 0.16 110.717 176.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 2.9 ttm -61.46 -35.04 76.49 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 120.712 -1.242 . . . . 0.14 113.51 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -77.48 -29.36 52.59 Favored 'General case' 0 C--N 1.282 -2.341 0 O-C-N 121.183 -0.948 . . . . 0.18 108.896 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . 0.266 31.7 mt-10 -76.47 -36.77 57.68 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.81 0.814 . . . . 0.21 111.723 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 384' ' ' LEU . . . . . 0.572 ' CD2' ' HG ' ' B' ' 380' ' ' LEU . 0.0 OUTLIER -55.23 127.38 29.05 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 125.934 2.778 . . . . 0.18 113.135 -176.119 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 385' ' ' GLU . . . . . 0.402 ' CD ' ' H ' ' B' ' 385' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.308 -1.214 2 CA-C-N 108.1 -4.136 . . . . 0.22 111.168 -178.233 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.217 -0.613 0 CA-C-O 122.391 1.091 . . . . 0.16 112.81 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.815 ' HB ' ' CG1' ' A' ' 166' ' ' ILE . 2.3 mp -106.02 130.73 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.019 0 CA-C-O 122.663 1.22 . . . . 0.13 110.698 177.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -100.46 124.86 46.53 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.229 -1.35 . . . . 0.13 110.318 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.4 mm -94.8 123.44 46.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 105.89 -1.893 . . . . 0.08 105.89 176.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.2 mm -92.1 146.79 5.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 122.546 1.165 . . . . 0.09 111.834 -178.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.71 121.09 51.22 Favored Pre-proline 0 N--CA 1.428 -1.541 0 N-CA-C 115.379 1.622 . . . . 0.06 115.379 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -76.11 -20.02 15.11 Favored 'Trans proline' 0 CA--C 1.559 1.752 0 C-N-CA 121.494 1.463 . . . . 0.05 111.396 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.465 ' N ' HD12 ' A' ' 26' ' ' LEU 0.325 0.0 OUTLIER -147.43 161.19 41.54 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 123.815 0.846 . . . . 0.05 110.173 175.29 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.9 m -82.61 148.14 28.17 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 121.729 0.776 . . . . 0.09 111.099 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 156.81 -155.3 26.24 Favored Glycine 0 N--CA 1.431 -1.688 0 C-N-CA 119.086 -1.531 . . . . 0.08 111.041 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.15 134.79 54.34 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.038 -1.081 . . . . 0.1 110.063 -177.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.1 mt -74.38 141.45 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 C-N-CA 117.694 -1.602 . . . . 0.08 110.383 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.3 t -132.62 155.9 41.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 114.519 -1.219 . . . . 0.09 108.786 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.501 ' HB3' ' OE2' ' A' ' 34' ' ' GLU . 13.6 m120 -71.41 138.35 49.04 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-O 121.443 0.639 . . . . 0.11 111.099 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.422 ' CD1' ' CG1' ' A' ' 139' ' ' VAL . 8.2 tt -67.8 -23.67 29.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 C-N-CA 118.65 -1.22 . . . . 0.11 108.724 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.501 ' OE2' ' HB3' ' A' ' 32' ' ' ASN . 0.8 OUTLIER -73.91 -14.09 61.0 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 118.566 -1.254 . . . . 0.13 110.543 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -94.9 12.32 28.64 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 113.689 0.996 . . . . 0.12 113.689 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 t -86.42 130.95 47.5 Favored Pre-proline 0 C--N 1.29 -2.011 0 CA-C-O 120.918 0.39 . . . . 0.13 109.963 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -70.46 48.03 0.72 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 122.711 2.274 . . . . 0.15 111.781 -173.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.555 ' CG ' HH21 ' B' ' 317' ' ' ARG . 56.3 t0 -150.66 115.83 5.36 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.733 -1.21 . . . . 0.22 107.733 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.2 m -60.36 -37.8 75.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 C-N-CA 119.005 -1.078 . . . . 0.2 111.618 -178.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . 0.405 18.9 m -62.45 -34.94 67.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 116.861 -1.936 . . . . 0.25 112.127 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -84.18 -44.15 14.25 Favored 'General case' 0 C--N 1.261 -3.254 0 O-C-N 120.178 -1.576 . . . . 0.2 109.897 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.6 -36.24 78.09 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 108.937 -0.764 . . . . 0.14 108.937 -177.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -91.09 7.89 38.24 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 118.173 -1.411 . . . . 1.08 110.584 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.54 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 0.3 OUTLIER 52.37 39.78 28.1 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 113.973 1.101 . . . . 0.15 113.973 176.62 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.4 mm -67.19 -30.32 48.94 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.958 0 CA-C-O 123.786 1.755 . . . . 0.18 110.703 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.293 2.1 t -89.55 -7.71 10.82 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.882 0 CA-C-N 112.375 -2.193 . . . . 0.49 111.844 -175.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.54 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . 133.46 -175.57 20.13 Favored Glycine 0 C--O 1.206 -1.627 0 N-CA-C 108.743 -1.743 . . . . 0.13 108.743 176.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -119.52 155.45 32.13 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 117.851 -1.539 . . . . 0.12 112.768 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 172.18 -137.77 4.44 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 117.725 -2.179 . . . . 0.09 111.158 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.444 ' C ' HD12 ' A' ' 50' ' ' ILE . 2.8 pp -134.98 175.24 11.51 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.716 0 O-C-N 121.592 -0.946 . . . . 0.07 108.596 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -121.59 158.51 28.41 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 124.716 1.206 . . . . 0.07 108.424 175.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.3 mt -133.33 128.81 55.87 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.826 0 O-C-N 121.641 -0.662 . . . . 0.06 111.051 178.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -86.11 108.81 18.71 Favored Pre-proline 0 C--N 1.308 -1.232 0 N-CA-C 101.478 -3.527 . . . . 0.11 101.478 174.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.428 ' HB3' HD22 ' A' ' 26' ' ' LEU . 2.0 Cg_endo -71.22 150.12 58.8 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 123.725 2.95 . . . . 0.09 113.074 -170.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.3 p -138.61 1.6 2.14 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 121.774 -0.579 . . . . 0.11 110.161 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -108.83 -144.5 10.84 Favored Glycine 0 CA--C 1.534 1.238 0 O-C-N 121.444 -0.785 . . . . 0.1 114.581 -177.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -142.97 14.48 1.89 Allowed 'General case' 0 CA--C 1.491 -1.291 0 O-C-N 122.363 -0.492 . . . . 0.12 112.079 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -157.28 155.17 30.28 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 115.415 -2.514 . . . . 0.1 113.092 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -114.96 121.44 43.18 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.868 -1.06 . . . . 0.07 109.054 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 m -114.15 174.54 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 CA-C-O 122.74 1.257 . . . . 0.07 110.964 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.15 126.66 92.92 Favored Pre-proline 0 C--N 1.289 -2.057 0 CA-C-N 113.663 -1.608 . . . . 0.07 109.742 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -85.85 -1.5 8.82 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 CA-C-N 120.029 1.046 . . . . 0.07 110.429 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.449 ' HA ' HG22 ' A' ' 115' ' ' VAL . 17.2 m -158.53 164.96 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-O 121.579 0.704 . . . . 0.09 111.139 -178.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.799 ' OD1' HG23 ' A' ' 115' ' ' VAL . 48.0 m-20 -81.44 127.19 32.54 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 103.595 -2.743 . . . . 0.13 103.595 174.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 80' ' ' GLU . . . 174.0 -157.85 26.2 Favored Glycine 0 C--N 1.301 -1.375 0 N-CA-C 110.78 -0.928 . . . . 0.11 110.78 -175.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.6 m -123.69 134.93 53.64 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 119.814 -0.754 . . . . 0.13 111.309 -177.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.7 mm -68.76 140.42 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.041 0 C-N-CA 117.619 -1.632 . . . . 0.12 107.394 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -101.76 -64.21 0.75 Allowed Glycine 0 C--N 1.282 -2.457 0 CA-C-O 121.955 0.753 . . . . 0.14 114.291 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.53 ' CD ' ' O ' ' B' ' 351' ' ' GLN . 0.2 OUTLIER -141.35 136.47 31.51 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-O 122.991 1.377 . . . . 2.18 111.934 -177.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 75.8 mt -116.24 125.46 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 N-CA-C 105.514 -2.032 . . . . 0.14 105.514 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -62.72 145.46 54.7 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.164 -1.05 . . . . 0.18 108.164 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -61.91 -14.9 38.59 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 123.674 0.79 . . . . 0.71 110.488 -178.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.482 ' OG1' ' ND1' ' A' ' 75' ' ' HIS . 25.5 p -97.69 5.02 49.87 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 123.655 1.693 . . . . 0.2 109.093 178.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.785 ' ND2' HH21 ' A' ' 105' ' ' ARG . 23.5 m120 50.51 44.31 27.11 Favored 'General case' 0 C--N 1.261 -3.269 0 CA-C-N 113.211 -1.813 . . . . 0.14 112.59 175.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.649 ' HE2' ' CE1' ' A' ' 90' ' ' HIS . 13.7 p-80 -126.38 -1.52 6.92 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 113.64 0.978 . . . . 0.21 113.64 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.32 152.75 31.47 Favored 'General case' 0 N--CA 1.412 -2.345 0 O-C-N 120.781 -1.2 . . . . 0.1 111.022 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -152.53 166.33 32.36 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 123.072 1.415 . . . . 0.09 113.245 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.501 ' HB2' ' H ' ' A' ' 69' ' ' LYS 0.259 15.8 m -118.29 139.72 50.9 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 113.278 -1.783 . . . . 0.12 109.849 -178.894 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.6 tt -143.27 150.03 17.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.585 -1.265 . . . . 0.1 107.585 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.489 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 84.6 tt0 -118.42 129.91 55.67 Favored 'General case' 0 C--O 1.201 -1.466 0 N-CA-C 105.628 -1.99 . . . . 0.52 105.628 177.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.447 ' HB3' HG21 ' A' ' 63' ' ' VAL . 94.0 p -80.91 167.32 20.0 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 118.457 -1.297 . . . . 0.13 108.28 -176.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -68.11 -31.02 70.33 Favored 'General case' 0 C--N 1.277 -2.569 0 C-N-CA 118.538 -1.265 . . . . 0.15 108.264 177.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.22 4.44 2.21 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 125.212 1.405 . . . . 0.14 111.998 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.73 14.51 81.98 Favored Glycine 0 C--N 1.28 -2.557 0 N-CA-C 117.351 1.7 . . . . 0.14 117.351 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.761 HG21 HD11 ' A' ' 166' ' ' ILE . 48.8 t -92.42 133.01 35.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 121.189 2.494 . . . . 0.12 110.886 177.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.435 ' OE1' ' CB ' ' B' ' 348' ' ' PHE . 96.5 mt-10 -96.9 121.92 39.3 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.669 -0.645 . . . . 1.73 110.229 176.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -116.32 158.84 22.79 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.986 0.898 . . . . 0.09 110.922 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -143.66 111.87 6.27 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 122.988 1.375 . . . . 0.31 109.759 177.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.1 t -101.73 115.6 43.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 114.05 -1.432 . . . . 0.07 111.41 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.649 ' CE1' ' HE2' ' A' ' 75' ' ' HIS . 2.1 t-80 -123.24 105.07 9.56 Favored 'General case' 0 C--O 1.199 -1.564 0 CA-C-N 115.501 -0.772 . . . . 0.16 111.098 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -63.56 124.13 20.57 Favored 'General case' 0 CA--C 1.558 1.278 0 N-CA-C 116.688 2.107 . . . . 0.1 116.688 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.28 -175.84 31.91 Favored Glycine 0 C--O 1.214 -1.123 0 CA-C-O 122.578 1.099 . . . . 0.1 114.496 175.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 49.1 mm -118.0 132.62 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-O 123.129 1.442 . . . . 0.14 109.158 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 54.69 25.75 6.79 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 114.104 -1.407 . . . . 0.18 111.227 -177.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.3 p -64.42 -19.82 65.76 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 115.451 1.648 . . . . 0.15 115.451 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.3 p -57.09 -32.83 41.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 O-C-N 120.124 -1.61 . . . . 0.17 109.32 177.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -58.61 -19.99 43.47 Favored 'General case' 0 CA--C 1.566 1.581 0 C-N-CA 119.867 -0.733 . . . . 0.25 112.092 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mp -78.22 -3.24 41.72 Favored 'General case' 0 CA--C 1.564 1.485 0 O-C-N 119.733 -1.855 . . . . 0.17 113.913 177.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 32.4 mtmm 48.95 46.23 22.34 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 116.082 1.882 . . . . 3.19 116.082 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 90.69 -13.24 66.25 Favored Glycine 0 CA--C 1.543 1.799 0 N-CA-C 115.492 0.957 . . . . 0.16 115.492 176.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.14 121.29 12.71 Favored 'General case' 0 C--N 1.284 -2.263 0 O-C-N 121.36 -1.082 . . . . 0.18 112.008 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 122' ' ' PHE . . . 97.68 -7.09 63.1 Favored Glycine 0 C--O 1.201 -1.956 0 N-CA-C 114.902 0.721 . . . . 0.14 114.902 178.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -115.67 152.25 33.52 Favored 'General case' 0 C--N 1.284 -2.282 0 C-N-CA 124.121 0.968 . . . . 0.13 111.008 177.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . 0.513 ' NZ ' ' O ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -141.95 113.41 7.71 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 124.625 1.17 . . . . 0.13 109.199 176.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.785 HH21 ' ND2' ' A' ' 74' ' ' ASN . 5.0 ttm180 -67.19 123.53 20.55 Favored 'General case' 0 CA--C 1.462 -2.416 0 C-N-CA 120.448 -0.501 . . . . 0.14 109.946 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . 0.405 HG13 ' HG3' ' A' ' 121' ' ' GLU . 24.0 mm -106.31 -34.99 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.251 0 C-N-CA 114.928 -2.709 . . . . 0.12 108.119 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.08 178.22 5.62 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 118.682 -1.207 . . . . 0.12 112.235 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -118.31 151.46 37.66 Favored 'General case' 0 C--O 1.213 -0.83 0 N-CA-C 112.594 0.59 . . . . 0.15 112.594 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -60.89 137.26 58.23 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 118.498 -1.281 . . . . 1.68 108.021 175.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.27 -5.23 84.31 Favored Glycine 0 N--CA 1.475 1.253 0 N-CA-C 111.624 -0.591 . . . . 0.14 111.624 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -65.72 138.04 57.69 Favored 'General case' 0 C--N 1.288 -2.07 0 C-N-CA 118.398 -1.321 . . . . 0.13 112.879 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.52 ' CG ' HH11 ' A' ' 112' ' ' ARG . 0.0 OUTLIER -86.23 132.67 33.94 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 114.121 -1.4 . . . . 0.15 107.307 175.611 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 m -139.87 160.33 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.023 0 C-N-CA 117.475 -1.69 . . . . 0.11 113.051 -176.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.493 ' HE3' ' OD2' ' A' ' 117' ' ' ASP . 0.5 OUTLIER -110.81 156.7 20.73 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 111.905 -2.407 . . . . 0.14 108.406 174.63 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.799 HG23 ' OD1' ' A' ' 64' ' ' ASP . 43.9 t -45.7 135.74 2.09 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 CA-C-O 121.596 0.712 . . . . 0.11 111.675 176.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.2 -13.05 64.5 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 120.831 -0.699 . . . . 0.09 114.38 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . 0.493 ' OD2' ' HE3' ' A' ' 114' ' ' LYS . 91.5 m-20 -63.14 136.38 57.72 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 118.866 1.333 . . . . 0.11 109.797 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.4 m -76.68 132.38 39.33 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-O 122.912 1.339 . . . . 0.1 111.123 -177.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.474 ' O ' HG13 ' A' ' 120' ' ' ILE . 44.8 t -105.83 -48.45 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.684 0 CA-C-N 113.495 -1.684 . . . . 0.09 109.315 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 119' ' ' VAL . 10.8 mt -148.37 143.56 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.707 0 N-CA-C 114.085 1.143 . . . . 0.09 114.085 -177.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . 0.503 ' O ' ' HD2' ' A' ' 104' ' ' LYS . 49.4 mt-10 -112.28 147.47 36.22 Favored 'General case' 0 CA--C 1.483 -1.627 0 C-N-CA 116.646 -2.022 . . . . 0.12 107.279 175.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.518 ' HA ' ' O ' ' A' ' 102' ' ' GLY . 36.0 p90 -132.94 163.55 28.94 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 122.08 0.943 . . . . 0.11 111.57 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.437 ' OD1' ' HD2' ' A' ' 125' ' ' PRO . 10.3 t0 -100.41 97.85 8.55 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 124.72 1.208 . . . . 0.15 109.813 176.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.62 ' HB3' ' HD3' ' A' ' 125' ' ' PRO . 3.1 tp -59.22 -54.79 52.77 Favored Pre-proline 0 C--N 1.292 -1.899 0 N-CA-C 116.061 1.874 . . . . 0.12 116.061 -176.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.62 ' HD3' ' HB3' ' A' ' 124' ' ' LEU . 20.6 Cg_exo -56.92 -44.68 42.37 Favored 'Trans proline' 1 C--N 1.247 -4.804 0 C-N-CA 121.483 1.455 . . . . 0.15 109.706 -175.647 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.813 ' CD1' ' HG3' ' A' ' 130' ' ' LYS . 0.5 OUTLIER -57.17 -51.0 71.07 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.134 -0.691 . . . . 0.16 109.134 177.738 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.5 mt -68.36 -31.42 70.79 Favored 'General case' 0 C--N 1.281 -2.394 0 O-C-N 121.092 -1.005 . . . . 0.13 112.098 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -65.13 -37.62 88.03 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 106.727 -1.582 . . . . 0.15 106.727 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -75.26 -42.3 55.37 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.218 -0.901 . . . . 0.19 113.33 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . 0.813 ' HG3' ' CD1' ' A' ' 126' ' ' LEU . 0.1 OUTLIER -94.79 -29.28 14.83 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 116.38 1.992 . . . . 0.2 116.38 -175.817 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.56 142.96 36.93 Favored 'General case' 0 C--N 1.262 -3.207 0 N-CA-C 115.329 1.603 . . . . 0.15 115.329 -176.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.491 ' HA ' ' HD2' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -55.7 -37.82 68.88 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 108.436 -0.95 . . . . 0.18 108.436 178.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.8 t -163.78 143.93 8.44 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 125.037 1.335 . . . . 0.13 110.686 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 76.8 p -95.96 -0.57 50.55 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 114.773 -1.103 . . . . 0.11 110.58 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.508 ' HA ' HD23 ' A' ' 135' ' ' LEU . 17.1 mt -56.33 130.39 44.41 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.263 -1.384 . . . . 0.1 107.263 177.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 93.3 m -118.77 96.92 50.5 Favored Pre-proline 0 N--CA 1.43 -1.432 0 N-CA-C 118.124 2.638 . . . . 0.07 118.124 -173.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . 0.45 ' HD2' ' O ' ' A' ' 90' ' ' HIS . 8.5 Cg_exo -67.02 142.94 63.78 Favored 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 117.163 -1.425 . . . . 0.09 114.357 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . 0.313 1.6 m -125.83 104.66 13.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 105.192 -2.151 . . . . 0.06 105.192 173.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.422 ' CG1' ' CD1' ' A' ' 33' ' ' ILE . 16.3 m -123.51 158.84 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 N-CA-C 116.237 1.939 . . . . 0.09 116.237 -176.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.8 mp -97.61 125.51 50.74 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.319 0 N-CA-C 104.566 -2.383 . . . . 0.11 104.566 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 17.2 p -98.41 -4.41 34.75 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 123.158 1.456 . . . . 0.14 112.936 -175.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.464 HD22 ' HA ' ' A' ' 142' ' ' ASN 0.482 0.0 OUTLIER -97.8 15.17 24.53 Favored 'General case' 0 C--N 1.258 -3.386 0 C-N-CA 130.087 3.355 . . . . 0.15 114.505 -179.757 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.432 ' C ' ' O ' ' A' ' 142' ' ' ASN 0.251 62.1 mmm -33.68 -45.09 0.17 Allowed 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 115.555 1.687 . . . . 0.16 115.555 -174.261 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -64.11 -11.64 31.85 Favored 'General case' 0 C--N 1.251 -3.682 0 O-C-N 119.891 -1.755 . . . . 0.26 113.099 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -106.02 12.68 30.18 Favored 'General case' 0 CA--C 1.479 -1.758 0 CA-C-N 121.225 1.829 . . . . 0.17 111.57 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 2.5 pt -120.36 140.81 43.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 C-N-CA 115.906 -2.317 . . . . 0.16 113.983 -177.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . 0.75 ' HB2' ' HB3' ' A' ' 168' ' ' LYS 0.255 12.1 tptt -74.45 -54.73 7.0 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 114.49 -1.232 . . . . 0.2 109.794 -179.864 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' ' 166' ' ' ILE . 0.0 OUTLIER -147.31 145.59 29.4 Favored 'General case' 0 C--N 1.289 -2.063 0 O-C-N 119.913 -1.742 . . . . 0.17 114.055 177.017 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.68 112.31 21.9 Favored 'General case' 0 N--CA 1.415 -2.177 0 CA-C-N 111.066 -2.788 . . . . 0.13 109.881 177.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 61.8 mt -108.94 112.19 39.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 114.515 -1.221 . . . . 0.14 107.92 177.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 34.5 mttt -84.93 129.84 34.74 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 124.492 1.117 . . . . 0.11 113.399 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.299 31.3 mt -94.4 175.78 6.55 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-O 122.732 1.253 . . . . 0.11 112.325 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . 0.276 0.5 OUTLIER -131.09 160.43 34.72 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 113.484 -1.689 . . . . 0.11 114.773 -174.325 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 100.25 -158.82 19.43 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 118.906 2.322 . . . . 0.1 118.906 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.8 142.13 27.83 Favored 'General case' 0 C--O 1.213 -0.841 0 CA-C-N 112.064 -2.068 . . . . 0.12 109.892 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.555 HG11 HG12 ' A' ' 163' ' ' VAL . 16.5 m -131.83 159.68 42.93 Favored 'Isoleucine or valine' 0 CA--C 1.46 -2.511 0 CA-C-O 122.783 1.277 . . . . 0.09 110.041 -177.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 20.8 m -122.77 123.7 41.66 Favored 'General case' 0 C--N 1.273 -2.734 0 CA-C-N 112.754 -2.021 . . . . 0.12 108.194 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 12.1 p -37.38 123.68 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 CA-C-O 123.725 1.726 . . . . 0.09 113.991 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 61.15 25.82 65.03 Favored Glycine 0 CA--C 1.487 -1.68 0 CA-C-N 112.804 -1.998 . . . . 0.1 114.232 176.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.43 -53.24 0.72 Allowed 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 119.593 -0.843 . . . . 0.14 111.958 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.462 ' CG2' HG12 ' A' ' 156' ' ' VAL . 9.1 m -85.35 122.98 73.61 Favored Pre-proline 0 C--N 1.282 -2.352 0 N-CA-C 114.219 1.192 . . . . 0.1 114.219 -175.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -62.44 141.46 86.92 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.964 2.443 . . . . 0.11 109.766 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.555 HG12 HG11 ' A' ' 156' ' ' VAL . 28.9 m -116.64 -27.92 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.625 -0.672 . . . . 0.07 112.196 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 30.5 mt -141.17 150.94 19.85 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 108.502 -0.925 . . . . 0.09 108.502 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 5.9 mtt180 -125.76 130.83 52.25 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 105.784 -1.932 . . . . 0.13 105.784 176.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.815 ' CG1' ' HB ' ' A' ' 20' ' ' ILE . 39.9 pt -128.36 155.57 40.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 119.075 -1.05 . . . . 0.13 109.813 -177.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 168' ' ' LYS . 1.1 tttt -120.72 154.21 35.92 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.987 -0.746 . . . . 0.18 108.987 176.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.75 ' HB3' ' HB2' ' A' ' 147' ' ' LYS . 9.6 tttt . . . . . 0 C--N 1.322 -0.595 0 N-CA-C 108.87 -0.789 . . . . 0.19 108.87 -177.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 301' ' ' MET . . . . . 0.513 ' HB2' ' HG2' ' B' ' 366' ' ' GLU . 4.2 ttm . . . . . 0 C--O 1.219 -0.545 0 N-CA-C 108.473 -0.936 . . . . 0.2 108.473 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 302' ' ' PHE . . . . . 0.534 ' CD2' ' HA ' ' B' ' 371' ' ' GLN . 74.9 t80 -142.93 140.91 31.33 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.219 -1.4 . . . . 0.19 107.219 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -150.85 157.34 42.8 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 120.998 -1.064 . . . . 0.16 109.461 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -153.18 147.62 25.97 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.024 -1.472 . . . . 0.18 107.024 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.97 151.96 19.17 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.296 -1.001 . . . . 0.17 108.296 178.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.62 144.31 17.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 107.345 -1.354 . . . . 0.15 107.345 174.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 87.1 m -93.9 136.69 33.92 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.596 0.712 . . . . 0.19 110.107 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 59.0 mt -85.69 114.12 25.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 104.653 -2.351 . . . . 0.19 104.653 177.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 61.1 p -106.44 -3.86 20.49 Favored 'General case' 0 N--CA 1.514 2.729 0 N-CA-C 114.57 1.322 . . . . 0.23 114.57 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 310' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' B' ' 384' ' ' LEU . . . -71.74 139.2 83.12 Favored Pre-proline 0 N--CA 1.487 1.396 0 CA-C-N 120.314 1.415 . . . . 0.21 110.701 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -46.45 -44.87 20.18 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 123.012 2.475 . . . . 0.26 117.095 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -103.72 29.29 5.88 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 115.758 -2.377 . . . . 1.04 107.145 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 59.49 -148.71 40.94 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 117.615 -2.231 . . . . 0.19 110.981 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.452 ' HG ' ' HB2' ' B' ' 319' ' ' ALA . 17.1 tp -87.07 74.15 9.71 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 118.267 -1.373 . . . . 0.15 108.985 -177.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 315' ' ' HIS . . . . . 0.436 ' CD2' ' CG ' ' B' ' 318' ' ' PRO . 2.5 p80 -69.24 -178.04 1.24 Allowed 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 118.656 -1.217 . . . . 0.32 112.678 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 26.8 m -49.04 -60.19 2.99 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 118.77 2.878 . . . . 0.28 118.77 -174.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 317' ' ' ARG . . . . . 0.555 HH21 ' CG ' ' A' ' 38' ' ' ASP . 18.8 ttm180 -63.93 -44.53 78.98 Favored Pre-proline 0 C--N 1.281 -2.395 0 CA-C-N 122.671 2.487 . . . . 1.1 112.902 -176.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 318' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' B' ' 317' ' ' ARG . 9.2 Cg_endo -67.95 -28.89 35.14 Favored 'Trans proline' 0 C--N 1.296 -2.194 0 CA-C-N 121.149 1.446 . . . . 0.17 111.937 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . 0.452 ' HB2' ' HG ' ' B' ' 314' ' ' LEU . . . -69.44 -35.43 75.65 Favored 'General case' 0 N--CA 1.509 2.5 0 O-C-N 120.824 -1.172 . . . . 0.13 108.839 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -71.52 -39.32 70.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.798 -1.189 . . . . 0.16 108.867 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -67.84 -35.93 79.44 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 118.084 -1.447 . . . . 1.7 108.7 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -64.25 -44.62 91.23 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 122.408 1.099 . . . . 0.12 108.704 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 55.1 t -64.67 -40.45 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-N 115.227 -0.897 . . . . 0.13 110.526 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -64.47 -41.06 96.72 Favored 'General case' 0 C--N 1.293 -1.879 0 O-C-N 120.752 -1.217 . . . . 1.18 109.735 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -68.27 -40.17 81.96 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.152 -0.685 . . . . 0.16 109.152 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.58 -42.31 92.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.945 -1.097 . . . . 0.14 109.283 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -62.82 -15.05 52.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.034 -1.041 . . . . 1.6 112.875 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -78.36 -11.26 85.5 Favored Glycine 0 N--CA 1.478 1.498 0 N-CA-C 108.85 -1.7 . . . . 0.19 108.85 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . 0.541 ' HE1' ' HE3' ' B' ' 372' ' ' LYS . 82.3 m-85 -103.88 144.99 30.77 Favored 'General case' 0 N--CA 1.507 2.388 0 CA-C-N 118.713 1.257 . . . . 0.17 110.129 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 74.4 p -76.9 -28.7 55.44 Favored 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 118.611 -0.709 . . . . 0.22 112.503 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 20.3 m -58.92 157.58 9.63 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 123.384 1.564 . . . . 0.18 114.899 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.6 128.49 33.46 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 102.22 -3.252 . . . . 0.18 102.22 172.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 41.7 mt -125.76 133.93 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 108.203 -1.036 . . . . 0.14 108.203 -175.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 97.6 m -124.58 140.68 52.72 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 122.267 1.032 . . . . 0.14 109.184 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 335' ' ' VAL . . . . . 0.436 HG23 ' HB2' ' B' ' 344' ' ' ALA . 93.1 t -107.33 127.38 63.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 105.34 -2.096 . . . . 0.12 105.34 174.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 88.3 m -124.73 121.04 33.52 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.881 0.848 . . . . 0.15 110.396 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 337' ' ' SER . . . . . 0.498 ' HB2' HG12 ' B' ' 361' ' ' VAL . 33.5 t -125.65 123.83 39.82 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 118.425 -1.31 . . . . 0.17 108.129 177.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 49.71 40.19 19.43 Favored 'General case' 0 N--CA 1.514 2.765 0 N-CA-C 112.872 0.693 . . . . 0.22 112.872 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 81.05 12.23 82.78 Favored Glycine 0 N--CA 1.485 1.923 0 O-C-N 120.487 -1.383 . . . . 0.2 113.334 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -121.8 136.69 54.94 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 103.539 -2.763 . . . . 2.48 103.539 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 68.8 m -121.55 156.1 33.6 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-O 124.321 2.01 . . . . 0.17 114.996 -175.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -151.52 148.01 27.52 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 111.848 -2.433 . . . . 0.15 110.82 176.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 7.6 t -65.59 132.93 50.08 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.416 -1.698 . . . . 0.15 106.416 173.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 344' ' ' ALA . . . . . 0.436 ' HB2' HG23 ' B' ' 335' ' ' VAL . . . -73.47 -6.02 43.71 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 120.285 -1.509 . . . . 0.11 110.842 178.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -98.23 12.74 33.68 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.966 -1.084 . . . . 0.17 109.189 -178.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.23 105.64 6.74 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 123.122 1.439 . . . . 0.18 110.557 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 32.6 tp -57.34 -37.59 72.78 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 113.949 -1.478 . . . . 0.19 109.303 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 348' ' ' PHE . . . . . 0.435 ' CB ' ' OE1' ' A' ' 86' ' ' GLU . 72.5 t80 -61.18 -50.4 73.32 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 120.355 -1.465 . . . . 0.38 112.975 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -69.57 -31.68 70.0 Favored 'General case' 0 C--N 1.314 -0.963 0 O-C-N 119.609 -1.932 . . . . 1.17 110.56 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 3.1 mt -65.29 -32.03 73.47 Favored 'General case' 0 C--N 1.285 -2.236 0 C-N-CA 119.201 -0.999 . . . . 0.15 109.309 -177.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 351' ' ' GLN . . . . . 0.53 ' O ' ' CD ' ' A' ' 69' ' ' LYS . 89.6 mt-30 -68.17 -10.72 56.36 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.96 -0.462 . . . . 0.83 109.833 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 2.0 p -91.86 -4.02 55.33 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 118.347 -1.341 . . . . 0.23 110.78 -177.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . 0.484 HD22 ' HB3' ' B' ' 337' ' ' SER . 25.1 mt -94.63 157.05 16.14 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.233 -0.917 . . . . 0.17 110.076 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -86.3 106.45 3.09 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 104.713 -3.355 . . . . 0.18 104.713 177.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 91.3 mt -122.37 48.39 1.76 Allowed 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 106.153 -1.795 . . . . 0.16 106.153 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 43.0 p -83.12 171.02 14.16 Favored 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 109.335 -0.617 . . . . 0.25 109.335 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -57.7 138.52 55.36 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.177 -0.952 . . . . 0.25 110.675 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 92.19 -3.13 76.05 Favored Glycine 0 N--CA 1.474 1.173 0 C-N-CA 119.39 -1.385 . . . . 0.21 112.61 177.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 55.3 m -84.82 132.98 34.34 Favored 'General case' 0 C--N 1.291 -1.975 0 O-C-N 121.507 -0.996 . . . . 0.18 111.185 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 94.7 t -94.44 122.86 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 107.031 -1.47 . . . . 0.18 107.031 177.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 361' ' ' VAL . . . . . 0.498 HG12 ' HB2' ' B' ' 337' ' ' SER . 17.8 m -112.73 161.33 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 C-N-CA 116.891 -1.923 . . . . 0.13 109.891 178.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 85.4 m -110.06 130.52 55.52 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 106.324 -1.732 . . . . 0.13 106.324 175.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 54.5 mt -110.33 120.43 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 102.869 -3.011 . . . . 0.11 102.869 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.42 146.43 49.62 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 107.716 -1.216 . . . . 0.13 107.716 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -141.05 153.66 45.6 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 117.566 -1.653 . . . . 0.16 108.63 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 366' ' ' GLU . . . . . 0.513 ' HG2' ' HB2' ' B' ' 301' ' ' MET . 0.0 OUTLIER -141.79 111.91 6.87 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.06 -1.459 . . . . 0.22 107.06 178.701 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 165.25 -173.49 41.04 Favored Glycine 0 C--N 1.294 -1.766 0 C-N-CA 117.651 -2.214 . . . . 0.21 108.64 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -54.78 -41.5 70.62 Favored 'General case' 0 C--N 1.285 -2.213 0 C-N-CA 124.134 0.974 . . . . 0.28 113.253 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 15.2 p30 -116.04 36.71 3.93 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 117.002 -1.879 . . . . 0.21 108.135 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -58.97 -30.35 67.87 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 119.001 2.963 . . . . 0.2 119.001 -175.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 371' ' ' GLN . . . . . 0.534 ' HA ' ' CD2' ' B' ' 302' ' ' PHE . 0.0 OUTLIER -78.2 -43.36 28.72 Favored 'General case' 0 N--CA 1.512 2.66 0 O-C-N 119.647 -1.908 . . . . 0.23 109.768 -177.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 372' ' ' LYS . . . . . 0.569 ' NZ ' ' CE1' ' B' ' 376' ' ' HIS . 13.2 ttpp -63.78 -40.71 97.33 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 106.878 -1.527 . . . . 0.22 106.878 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.21 -46.89 86.86 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 118.441 -1.303 . . . . 0.16 110.599 -178.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 68.7 t -68.78 -39.54 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 N-CA-C 108.521 -0.918 . . . . 0.14 108.521 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -58.21 -46.49 85.75 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.846 0.831 . . . . 0.21 109.508 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 376' ' ' HIS . . . . . 0.569 ' CE1' ' NZ ' ' B' ' 372' ' ' LYS . 13.2 m-70 -71.05 -35.81 72.08 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 113.347 0.869 . . . . 0.2 113.347 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 95.8 mt -79.87 -25.11 40.79 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.447 -1.301 . . . . 0.13 111.786 -175.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 2.1 t -73.13 -38.88 56.0 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 N-CA-C 106.288 -1.745 . . . . 0.15 106.288 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -68.83 -48.6 63.13 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 107.563 -1.273 . . . . 0.22 107.563 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 380' ' ' LEU . . . . . 0.569 ' HG ' ' CD2' ' B' ' 384' ' ' LEU . 28.2 tp -55.53 -47.37 76.4 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 118.773 -1.171 . . . . 0.15 110.754 176.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 2.9 ttm -61.49 -35.02 76.48 Favored 'General case' 0 C--N 1.309 -1.168 0 O-C-N 120.721 -1.237 . . . . 0.15 113.44 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -77.48 -29.46 52.66 Favored 'General case' 0 C--N 1.282 -2.36 0 O-C-N 121.229 -0.919 . . . . 0.19 108.856 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . 0.265 32.3 mt-10 -76.37 -36.76 57.97 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 121.787 0.803 . . . . 0.22 111.757 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 384' ' ' LEU . . . . . 0.569 ' CD2' ' HG ' ' B' ' 380' ' ' LEU . 0.0 OUTLIER -55.21 127.42 29.17 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 125.822 2.725 . . . . 0.18 113.15 -176.099 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 385' ' ' GLU . . . . . 0.401 ' CD ' ' H ' ' B' ' 385' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.307 -1.247 2 CA-C-N 108.129 -4.123 . . . . 0.22 111.168 -178.21 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.217 -0.613 0 CA-C-O 122.391 1.091 . . . . 0.16 112.81 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.825 ' HB ' HG13 ' A' ' 166' ' ' ILE . 2.3 mp -106.02 130.73 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.019 0 CA-C-O 122.663 1.22 . . . . 0.13 110.698 177.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -100.46 124.86 46.53 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.229 -1.35 . . . . 0.13 110.318 176.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.4 mm -94.8 123.44 46.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 105.89 -1.893 . . . . 0.08 105.89 176.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.2 mm -92.1 146.79 5.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 122.546 1.165 . . . . 0.09 111.834 -178.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.71 121.09 51.22 Favored Pre-proline 0 N--CA 1.428 -1.541 0 N-CA-C 115.379 1.622 . . . . 0.06 115.379 -178.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -76.11 -20.02 15.11 Favored 'Trans proline' 0 CA--C 1.559 1.752 0 C-N-CA 121.494 1.463 . . . . 0.05 111.396 -177.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.465 ' N ' HD12 ' A' ' 26' ' ' LEU 0.325 0.0 OUTLIER -147.43 161.19 41.54 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 123.815 0.846 . . . . 0.05 110.173 175.29 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.9 m -82.61 148.14 28.17 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 121.729 0.776 . . . . 0.09 111.099 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 156.81 -155.3 26.24 Favored Glycine 0 N--CA 1.431 -1.688 0 C-N-CA 119.086 -1.531 . . . . 0.08 111.041 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.15 134.79 54.34 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.038 -1.081 . . . . 0.1 110.063 -177.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.1 mt -74.38 141.45 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 C-N-CA 117.694 -1.602 . . . . 0.08 110.383 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.3 t -132.62 155.9 41.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 114.519 -1.219 . . . . 0.09 108.786 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.501 ' HB3' ' OE2' ' A' ' 34' ' ' GLU . 13.6 m120 -71.41 138.35 49.04 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-O 121.443 0.639 . . . . 0.11 111.099 178.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.487 ' CD1' ' CG1' ' A' ' 139' ' ' VAL . 8.2 tt -67.8 -23.67 29.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 C-N-CA 118.65 -1.22 . . . . 0.11 108.724 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.501 ' OE2' ' HB3' ' A' ' 32' ' ' ASN . 0.8 OUTLIER -73.91 -14.09 61.0 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 118.566 -1.254 . . . . 0.13 110.543 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -94.9 12.32 28.64 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 113.689 0.996 . . . . 0.12 113.689 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 t -86.42 130.95 47.5 Favored Pre-proline 0 C--N 1.29 -2.011 0 CA-C-O 120.918 0.39 . . . . 0.13 109.963 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -70.46 48.03 0.72 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 122.711 2.274 . . . . 0.15 111.781 -173.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.543 ' CG ' HH21 ' B' ' 317' ' ' ARG . 65.3 t0 -150.66 115.83 5.36 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.733 -1.21 . . . . 0.22 107.733 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.8 m -60.34 -37.9 75.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 C-N-CA 119.005 -1.078 . . . . 0.2 111.569 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' VAL . . . . . . . . . . . . 0.404 19.3 m -62.41 -34.89 66.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 C-N-CA 116.864 -1.934 . . . . 0.25 112.148 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -84.18 -44.27 14.13 Favored 'General case' 0 C--N 1.262 -3.23 0 O-C-N 120.132 -1.605 . . . . 0.2 109.841 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.52 -36.24 77.9 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 108.937 -0.764 . . . . 0.14 108.937 -177.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -91.05 7.81 38.55 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 118.173 -1.411 . . . . 1.08 110.585 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.54 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 0.3 OUTLIER 52.42 39.78 28.26 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 113.973 1.101 . . . . 0.15 113.973 176.651 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.3 mm -67.18 -30.35 49.04 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.958 0 CA-C-O 123.747 1.737 . . . . 0.18 110.696 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.293 2.1 t -89.52 -7.71 10.82 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.898 0 CA-C-N 112.336 -2.211 . . . . 0.49 111.844 -175.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.54 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . 133.46 -175.57 20.13 Favored Glycine 0 C--O 1.206 -1.627 0 N-CA-C 108.743 -1.743 . . . . 0.13 108.743 176.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -119.52 155.45 32.13 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 117.851 -1.539 . . . . 0.12 112.768 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 172.18 -137.77 4.44 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 117.725 -2.179 . . . . 0.09 111.158 177.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.444 ' C ' HD12 ' A' ' 50' ' ' ILE . 2.8 pp -134.98 175.24 11.51 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.716 0 O-C-N 121.592 -0.946 . . . . 0.07 108.596 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -121.59 158.51 28.41 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 124.716 1.206 . . . . 0.07 108.424 175.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.3 mt -133.33 128.81 55.87 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.826 0 O-C-N 121.641 -0.662 . . . . 0.06 111.051 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -86.11 108.81 18.71 Favored Pre-proline 0 C--N 1.308 -1.232 0 N-CA-C 101.478 -3.527 . . . . 0.11 101.478 174.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.428 ' HB3' HD22 ' A' ' 26' ' ' LEU . 2.0 Cg_endo -71.22 150.12 58.8 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 123.725 2.95 . . . . 0.09 113.074 -170.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.3 p -138.61 1.6 2.14 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 121.774 -0.579 . . . . 0.11 110.161 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -108.83 -144.5 10.84 Favored Glycine 0 CA--C 1.534 1.238 0 O-C-N 121.444 -0.785 . . . . 0.1 114.581 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -142.97 14.48 1.89 Allowed 'General case' 0 CA--C 1.491 -1.291 0 O-C-N 122.363 -0.492 . . . . 0.12 112.079 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -157.28 155.17 30.28 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 115.415 -2.514 . . . . 0.1 113.092 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -114.96 121.44 43.18 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.868 -1.06 . . . . 0.07 109.054 178.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 m -114.15 174.54 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 CA-C-O 122.74 1.257 . . . . 0.07 110.964 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.15 126.66 92.92 Favored Pre-proline 0 C--N 1.289 -2.057 0 CA-C-N 113.663 -1.608 . . . . 0.07 109.742 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -85.85 -1.5 8.82 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 CA-C-N 120.029 1.046 . . . . 0.07 110.429 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.447 HG21 ' HB3' ' A' ' 81' ' ' SER . 17.2 m -158.53 164.96 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-O 121.579 0.704 . . . . 0.09 111.139 -178.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.862 ' OD1' HG23 ' A' ' 115' ' ' VAL . 48.0 m-20 -81.44 127.19 32.54 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 103.595 -2.743 . . . . 0.13 103.595 174.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 80' ' ' GLU . . . 174.0 -157.85 26.2 Favored Glycine 0 C--N 1.301 -1.375 0 N-CA-C 110.78 -0.928 . . . . 0.11 110.78 -175.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.6 m -123.69 134.93 53.64 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 119.814 -0.754 . . . . 0.13 111.309 -177.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.7 mm -68.76 140.42 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.041 0 C-N-CA 117.619 -1.632 . . . . 0.12 107.394 178.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -101.76 -64.21 0.75 Allowed Glycine 0 C--N 1.282 -2.457 0 CA-C-O 121.955 0.753 . . . . 0.14 114.291 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.541 ' CD ' ' O ' ' B' ' 351' ' ' GLN . 0.1 OUTLIER -141.38 136.47 31.46 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-O 123.059 1.409 . . . . 2.18 111.925 -177.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 75.8 mt -116.23 125.46 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 N-CA-C 105.514 -2.032 . . . . 0.14 105.514 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -62.72 145.46 54.7 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.164 -1.05 . . . . 0.18 108.164 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -61.91 -14.9 38.59 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 123.674 0.79 . . . . 0.71 110.488 -178.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.535 ' OG1' ' ND1' ' A' ' 75' ' ' HIS . 16.7 p -97.67 4.98 49.95 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 123.593 1.663 . . . . 0.2 109.068 178.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.682 HD21 ' NH2' ' A' ' 105' ' ' ARG . 23.5 m120 50.53 44.31 27.19 Favored 'General case' 0 C--N 1.26 -3.305 0 CA-C-N 113.23 -1.805 . . . . 0.14 112.59 175.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' HIS . . . . . 0.559 ' NE2' ' CE1' ' A' ' 90' ' ' HIS . 20.1 p-80 -126.41 -1.45 6.9 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 113.661 0.986 . . . . 0.21 113.661 -177.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.37 152.75 31.44 Favored 'General case' 0 N--CA 1.412 -2.345 0 O-C-N 120.836 -1.165 . . . . 0.1 111.022 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -152.53 166.33 32.36 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 123.072 1.415 . . . . 0.09 113.245 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . 0.501 ' HB2' ' H ' ' A' ' 69' ' ' LYS 0.259 15.8 m -118.29 139.72 50.9 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 113.278 -1.783 . . . . 0.12 109.849 -178.894 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.6 tt -143.27 150.03 17.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.585 -1.265 . . . . 0.1 107.585 175.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . 0.489 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 84.6 tt0 -118.42 129.91 55.67 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 105.628 -1.99 . . . . 0.52 105.628 177.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' SER . . . . . 0.447 ' HB3' HG21 ' A' ' 63' ' ' VAL . 94.0 p -80.91 167.32 20.0 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 118.457 -1.297 . . . . 0.13 108.28 -176.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.406 ' OD1' ' NH1' ' A' ' 112' ' ' ARG . 83.0 m-20 -68.11 -31.02 70.33 Favored 'General case' 0 C--N 1.277 -2.569 0 C-N-CA 118.538 -1.265 . . . . 0.15 108.264 177.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.22 4.44 2.21 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 125.212 1.405 . . . . 0.14 111.998 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.73 14.51 81.98 Favored Glycine 0 C--N 1.28 -2.557 0 N-CA-C 117.351 1.7 . . . . 0.14 117.351 -178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.671 HG21 ' CD1' ' A' ' 166' ' ' ILE . 48.8 t -92.42 133.01 35.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 121.189 2.494 . . . . 0.12 110.886 177.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.435 ' OE1' ' CB ' ' B' ' 348' ' ' PHE . 96.5 mt-10 -96.9 121.92 39.3 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.669 -0.645 . . . . 1.73 110.229 176.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -116.32 158.84 22.79 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.986 0.898 . . . . 0.09 110.922 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -147.34 140.69 25.35 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.674 -0.694 . . . . 0.31 109.919 177.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 45.7 t -131.85 131.98 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.69 -0.631 . . . . 0.07 110.003 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.559 ' CE1' ' NE2' ' A' ' 75' ' ' HIS . 2.9 t-80 -120.29 80.72 1.64 Allowed 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 108.462 -0.94 . . . . 0.16 108.462 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PHE . . . . . 0.413 ' C ' ' O ' ' A' ' 90' ' ' HIS . 30.3 t80 -42.84 119.9 1.61 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.239 -0.913 . . . . 0.1 110.295 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.34 -175.54 32.64 Favored Glycine 0 C--N 1.303 -1.27 0 CA-C-O 122.885 1.269 . . . . 0.1 114.623 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 18.6 mm -118.4 132.61 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-O 122.93 1.348 . . . . 0.14 109.132 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 54.65 25.89 6.87 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 114.12 -1.4 . . . . 0.18 111.213 -177.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.1 p -64.47 -20.08 65.96 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 115.162 1.541 . . . . 0.15 115.162 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.5 p -56.94 -32.82 40.45 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 O-C-N 119.578 -1.951 . . . . 0.17 109.296 178.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -58.61 -19.99 43.5 Favored 'General case' 0 CA--C 1.566 1.581 0 O-C-N 121.524 -0.735 . . . . 0.25 112.092 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.635 ' N ' HD12 ' A' ' 98' ' ' LEU . 7.3 mp -78.02 -3.67 43.27 Favored 'General case' 0 CA--C 1.566 1.565 0 O-C-N 119.733 -1.855 . . . . 0.17 113.877 177.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm 49.23 46.23 22.99 Favored 'General case' 0 C--N 1.276 -2.624 0 N-CA-C 116.082 1.882 . . . . 3.19 116.082 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 90.63 -13.17 66.34 Favored Glycine 0 CA--C 1.544 1.871 0 O-C-N 121.26 -0.9 . . . . 0.16 115.338 176.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -62.21 120.92 11.87 Favored 'General case' 0 C--N 1.28 -2.456 0 O-C-N 121.024 -1.28 . . . . 0.18 112.235 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 122' ' ' PHE . . . 98.69 -8.68 61.87 Favored Glycine 0 C--O 1.196 -2.274 0 O-C-N 121.637 -0.664 . . . . 0.14 114.597 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -115.02 151.6 33.92 Favored 'General case' 0 C--N 1.278 -2.534 0 C-N-CA 124.136 0.974 . . . . 0.13 111.326 178.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -141.23 112.95 7.67 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 124.43 1.092 . . . . 0.13 109.504 177.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ARG . . . . . 0.682 ' NH2' HD21 ' A' ' 74' ' ' ASN . 29.0 ttm180 -67.3 123.26 19.86 Favored 'General case' 0 CA--C 1.453 -2.758 0 C-N-CA 120.337 -0.545 . . . . 0.14 109.966 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 29.8 mm -106.22 -34.5 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.251 0 C-N-CA 115.112 -2.635 . . . . 0.12 108.289 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.82 177.66 5.7 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 118.721 -1.191 . . . . 0.12 112.391 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -118.26 150.58 39.2 Favored 'General case' 0 C--O 1.215 -0.754 0 N-CA-C 112.963 0.727 . . . . 0.15 112.963 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -60.14 137.26 58.14 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 118.385 -1.326 . . . . 1.68 108.021 176.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.54 -5.8 83.58 Favored Glycine 0 N--CA 1.475 1.253 0 N-CA-C 111.455 -0.658 . . . . 0.14 111.455 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -65.88 137.17 57.01 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-O 122.843 1.306 . . . . 0.13 113.289 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ARG . . . . . 0.406 ' NH1' ' OD1' ' A' ' 82' ' ' ASP . 0.9 OUTLIER -85.23 133.07 34.19 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 107.095 -1.446 . . . . 0.15 107.095 176.153 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.3 m -140.66 159.72 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.042 0 C-N-CA 117.678 -1.609 . . . . 0.11 113.286 -177.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -110.42 156.11 21.27 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 112.032 -2.349 . . . . 0.14 108.773 175.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.862 HG23 ' OD1' ' A' ' 64' ' ' ASP . 28.7 t -45.3 135.43 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.457 0 CA-C-O 121.677 0.751 . . . . 0.11 111.837 176.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.52 -13.2 64.59 Favored Glycine 0 CA--C 1.537 1.42 0 C-N-CA 120.786 -0.721 . . . . 0.09 114.285 178.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -63.05 136.24 57.7 Favored 'General case' 0 C--N 1.288 -2.085 0 O-C-N 120.547 -1.561 . . . . 0.11 109.912 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 55.6 m -76.61 132.22 39.32 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 122.915 1.341 . . . . 0.1 111.231 -177.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 120' ' ' ILE . 38.5 t -106.03 -47.83 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.684 0 CA-C-N 113.544 -1.662 . . . . 0.09 109.414 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 119' ' ' VAL . 11.5 mt -148.78 143.49 18.67 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.836 0 N-CA-C 114.135 1.161 . . . . 0.09 114.135 -177.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -112.71 146.64 38.37 Favored 'General case' 0 CA--C 1.487 -1.457 0 C-N-CA 116.788 -1.965 . . . . 0.12 107.591 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' PHE . . . . . 0.517 ' HA ' ' O ' ' A' ' 102' ' ' GLY . 42.6 p90 -133.0 162.37 31.87 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 122.669 1.223 . . . . 0.11 112.003 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 126' ' ' LEU . 7.9 t70 -99.05 99.59 10.63 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.605 -1.179 . . . . 0.15 108.888 177.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LEU . . . . . 0.553 ' HB3' ' HD3' ' A' ' 125' ' ' PRO . 26.9 tp -61.81 -51.54 75.12 Favored Pre-proline 0 C--N 1.292 -1.911 0 N-CA-C 116.929 2.196 . . . . 0.12 116.929 -177.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' A' ' 124' ' ' LEU . 31.5 Cg_exo -58.97 -45.04 30.62 Favored 'Trans proline' 1 C--N 1.241 -5.116 0 C-N-CA 121.966 1.777 . . . . 0.15 109.411 -177.064 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' LEU . . . . . 0.508 ' N ' ' OD1' ' A' ' 123' ' ' ASP . 29.0 tp -57.76 -48.26 80.14 Favored 'General case' 0 C--N 1.308 -1.216 0 O-C-N 121.383 -0.823 . . . . 0.16 110.157 177.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 94.8 mt -69.84 -32.35 70.7 Favored 'General case' 0 C--N 1.282 -2.36 0 O-C-N 121.164 -0.96 . . . . 0.13 111.817 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -64.61 -37.73 88.56 Favored 'General case' 0 C--N 1.278 -2.517 0 N-CA-C 106.538 -1.653 . . . . 0.15 106.538 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -75.42 -41.7 55.36 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 113.476 0.917 . . . . 0.19 113.476 177.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 39.4 mmtt -95.8 -27.81 15.05 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 116.582 2.067 . . . . 0.2 116.582 -176.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.54 142.73 35.47 Favored 'General case' 0 C--N 1.258 -3.378 0 N-CA-C 115.437 1.643 . . . . 0.15 115.437 -177.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 46.3 tptt -55.47 -38.25 68.85 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 108.066 -1.087 . . . . 0.18 108.066 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.3 t -163.71 143.21 8.21 Favored 'General case' 0 C--N 1.287 -2.152 0 C-N-CA 125.004 1.321 . . . . 0.13 111.15 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 10.0 p -94.97 -1.26 52.84 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-N 114.794 -1.093 . . . . 0.11 110.255 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 33.4 mt -54.93 131.85 45.45 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 106.78 -1.563 . . . . 0.1 106.78 177.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 77.2 m -119.79 101.84 47.66 Favored Pre-proline 0 C--N 1.292 -1.893 0 N-CA-C 115.272 1.582 . . . . 0.07 115.272 -174.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -71.16 141.68 40.15 Favored 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 117.425 -1.25 . . . . 0.09 115.078 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' VAL . . . . . . . . . . . . 0.309 0.6 OUTLIER -124.79 104.61 13.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 105.207 -2.146 . . . . 0.06 105.207 174.152 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' VAL . . . . . 0.487 ' CG1' ' CD1' ' A' ' 33' ' ' ILE . 19.8 m -124.02 158.17 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 N-CA-C 116.458 2.021 . . . . 0.09 116.458 -176.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.584 HD12 ' N ' ' A' ' 140' ' ' ILE . 1.4 mp -96.71 125.55 49.64 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.344 0 N-CA-C 104.618 -2.364 . . . . 0.11 104.618 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 53.6 p -98.44 -4.47 34.49 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-O 123.231 1.491 . . . . 0.14 112.956 -175.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ASN . . . . . 0.693 HD21 ' CD ' ' A' ' 145' ' ' GLU 0.491 0.8 OUTLIER -98.13 16.05 22.43 Favored 'General case' 0 C--N 1.259 -3.357 0 C-N-CA 130.089 3.356 . . . . 0.15 114.344 -179.74 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' MET . . . . . 0.428 ' C ' ' O ' ' A' ' 142' ' ' ASN . 95.3 mmm -34.54 -44.39 0.2 Allowed 'General case' 0 C--N 1.28 -2.452 0 N-CA-C 115.646 1.721 . . . . 0.16 115.646 -174.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -64.51 -11.64 36.09 Favored 'General case' 0 C--N 1.248 -3.811 0 O-C-N 119.762 -1.837 . . . . 0.26 113.099 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLU . . . . . 0.693 ' CD ' HD21 ' A' ' 142' ' ' ASN . 80.4 mt-10 -106.88 14.56 26.46 Favored 'General case' 0 CA--C 1.475 -1.922 0 CA-C-N 121.225 1.829 . . . . 0.17 111.28 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 10.5 pt -121.99 140.29 46.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 C-N-CA 116.082 -2.247 . . . . 0.16 114.056 -178.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LYS . . . . . . . . . . . . 0.256 49.0 tptt -73.83 -55.12 6.6 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 114.275 -1.329 . . . . 0.2 109.584 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 166' ' ' ILE . 2.6 tt0 -147.64 144.61 28.51 Favored 'General case' 0 C--N 1.286 -2.154 0 O-C-N 119.889 -1.757 . . . . 0.17 114.6 177.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.8 tt -114.73 111.66 21.62 Favored 'General case' 0 N--CA 1.415 -2.177 0 CA-C-N 111.309 -2.678 . . . . 0.13 110.262 177.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 70.1 mt -108.1 112.41 40.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 114.567 -1.197 . . . . 0.14 107.844 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -85.0 130.32 34.64 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 124.301 1.04 . . . . 0.11 113.113 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 152' ' ' LEU 0.302 39.2 mt -94.67 175.94 6.47 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-O 123.007 1.384 . . . . 0.11 112.371 -179.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' SER . . . . . . . . . . . . 0.293 50.9 m -132.02 159.34 39.07 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 113.416 -1.72 . . . . 0.11 115.145 -174.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 101.4 -158.74 18.73 Favored Glycine 0 C--O 1.214 -1.096 0 N-CA-C 118.92 2.328 . . . . 0.1 118.92 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 64.6 m -94.83 142.51 27.38 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 112.1 -2.05 . . . . 0.12 109.601 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' VAL . . . . . 0.624 HG11 HG12 ' A' ' 163' ' ' VAL . 6.4 m -131.59 160.31 42.46 Favored 'Isoleucine or valine' 0 CA--C 1.462 -2.429 0 CA-C-O 122.995 1.379 . . . . 0.09 109.996 -177.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 29.3 m -123.63 122.73 38.89 Favored 'General case' 0 C--N 1.269 -2.903 0 CA-C-N 112.854 -1.975 . . . . 0.12 108.773 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 9.3 p -37.07 122.48 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.736 0 CA-C-O 123.547 1.641 . . . . 0.09 114.697 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 62.17 26.34 67.52 Favored Glycine 0 CA--C 1.489 -1.546 0 CA-C-N 112.871 -1.968 . . . . 0.1 113.934 176.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -137.43 -51.4 0.64 Allowed 'General case' 0 C--N 1.283 -2.317 0 C-N-CA 119.624 -0.83 . . . . 0.14 112.581 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.599 ' CG2' HG12 ' A' ' 156' ' ' VAL . 11.9 m -86.09 123.59 71.6 Favored Pre-proline 0 C--N 1.28 -2.415 0 N-CA-C 113.971 1.1 . . . . 0.1 113.971 -176.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -63.08 141.22 82.48 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.963 2.442 . . . . 0.11 109.957 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' VAL . . . . . 0.624 HG12 HG11 ' A' ' 156' ' ' VAL . 18.4 m -116.25 -28.59 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.306 -0.871 . . . . 0.07 111.881 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 34.8 mt -141.36 149.73 20.24 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 CA-C-O 122.064 0.935 . . . . 0.09 109.005 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -124.73 130.75 53.02 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 105.78 -1.933 . . . . 0.13 105.78 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ILE . . . . . 0.825 HG13 ' HB ' ' A' ' 20' ' ' ILE . 5.8 pt -128.71 155.0 40.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.298 -0.961 . . . . 0.13 109.927 -177.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' LYS . . . . . 0.446 ' O ' ' C ' ' A' ' 168' ' ' LYS . 80.0 tttt -120.1 154.25 34.96 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 109.064 -0.717 . . . . 0.18 109.064 176.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 167' ' ' LYS . 17.1 tttt . . . . . 0 C--N 1.319 -0.732 0 CA-C-N 115.75 -0.659 . . . . 0.19 110.044 -177.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 301' ' ' MET . . . . . 0.513 ' HB2' ' HG2' ' B' ' 366' ' ' GLU . 4.2 ttm . . . . . 0 C--O 1.219 -0.545 0 N-CA-C 108.473 -0.936 . . . . 0.2 108.473 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 302' ' ' PHE . . . . . 0.534 ' CD2' ' HA ' ' B' ' 371' ' ' GLN . 74.9 t80 -142.93 140.91 31.33 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.219 -1.4 . . . . 0.19 107.219 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -150.85 157.34 42.8 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 120.998 -1.064 . . . . 0.16 109.461 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -153.18 147.62 25.97 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.024 -1.472 . . . . 0.18 107.024 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.97 151.96 19.17 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.296 -1.001 . . . . 0.17 108.296 178.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.62 144.31 17.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 107.345 -1.354 . . . . 0.15 107.345 174.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 87.1 m -93.9 136.69 33.92 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.596 0.712 . . . . 0.19 110.107 178.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 59.0 mt -85.69 114.12 25.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 104.653 -2.351 . . . . 0.19 104.653 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 61.1 p -106.44 -3.86 20.49 Favored 'General case' 0 N--CA 1.514 2.729 0 N-CA-C 114.57 1.322 . . . . 0.23 114.57 -178.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 310' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' B' ' 384' ' ' LEU . . . -71.74 139.2 83.12 Favored Pre-proline 0 N--CA 1.487 1.396 0 CA-C-N 120.314 1.415 . . . . 0.21 110.701 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -46.45 -44.87 20.18 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 123.012 2.475 . . . . 0.26 117.095 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -103.72 29.29 5.88 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 115.758 -2.377 . . . . 1.04 107.145 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 60.39 -122.47 29.96 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 117.615 -2.231 . . . . 0.19 108.839 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 314' ' ' LEU . . . . . 0.422 ' O ' ' O ' ' B' ' 315' ' ' HIS . 4.6 tp -117.51 81.63 1.69 Allowed 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.322 -0.992 . . . . 0.15 108.322 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 315' ' ' HIS . . . . . 0.674 ' CE1' ' H ' ' B' ' 317' ' ' ARG . 3.5 p80 -66.08 -141.4 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 O-C-N 120.402 -1.436 . . . . 0.32 108.211 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 316' ' ' THR . . . . . 0.652 ' H ' ' CG ' ' B' ' 315' ' ' HIS . 8.7 m -84.96 -46.37 11.3 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 115.5 1.667 . . . . 0.28 115.5 -176.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 317' ' ' ARG . . . . . 0.674 ' H ' ' CE1' ' B' ' 315' ' ' HIS . 18.9 ttm180 -71.01 -42.96 12.97 Favored Pre-proline 0 N--CA 1.494 1.774 0 C-N-CA 116.091 -2.244 . . . . 1.1 113.356 -172.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 318' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' B' ' 317' ' ' ARG . 11.5 Cg_endo -68.9 -28.86 29.01 Favored 'Trans proline' 0 C--N 1.296 -2.233 0 CA-C-N 121.165 1.452 . . . . 0.17 111.919 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -69.46 -35.43 75.62 Favored 'General case' 0 N--CA 1.509 2.5 0 O-C-N 120.777 -1.202 . . . . 0.13 108.839 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -71.52 -39.32 70.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.798 -1.189 . . . . 0.16 108.867 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -67.84 -35.93 79.44 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 118.084 -1.447 . . . . 1.7 108.7 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -64.25 -44.62 91.23 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 122.408 1.099 . . . . 0.12 108.704 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.71 -40.37 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-N 115.227 -0.897 . . . . 0.13 110.539 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -64.52 -41.06 96.63 Favored 'General case' 0 C--N 1.292 -1.898 0 O-C-N 120.804 -1.185 . . . . 1.18 109.735 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -68.27 -40.17 81.96 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.152 -0.685 . . . . 0.16 109.152 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.58 -42.31 92.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.945 -1.097 . . . . 0.14 109.283 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -62.82 -15.05 52.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.034 -1.041 . . . . 1.6 112.875 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -78.36 -11.26 85.5 Favored Glycine 0 N--CA 1.478 1.498 0 N-CA-C 108.85 -1.7 . . . . 0.19 108.85 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 329' ' ' PHE . . . . . 0.541 ' HE1' ' HE3' ' B' ' 372' ' ' LYS . 82.3 m-85 -103.88 144.99 30.77 Favored 'General case' 0 N--CA 1.507 2.388 0 CA-C-N 118.713 1.257 . . . . 0.17 110.129 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 74.4 p -76.9 -28.7 55.44 Favored 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 118.611 -0.709 . . . . 0.22 112.503 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 20.3 m -58.92 157.58 9.63 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 123.384 1.564 . . . . 0.18 114.899 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.6 128.49 33.46 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 102.22 -3.252 . . . . 0.18 102.22 172.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 41.7 mt -125.76 133.93 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 108.203 -1.036 . . . . 0.14 108.203 -175.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 97.6 m -124.58 140.68 52.72 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 122.267 1.032 . . . . 0.14 109.184 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 335' ' ' VAL . . . . . 0.436 HG23 ' HB2' ' B' ' 344' ' ' ALA . 93.1 t -107.33 127.38 63.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 105.34 -2.096 . . . . 0.12 105.34 174.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 88.3 m -124.73 121.04 33.52 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.881 0.848 . . . . 0.15 110.396 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 337' ' ' SER . . . . . 0.498 ' HB2' HG12 ' B' ' 361' ' ' VAL . 33.5 t -125.65 123.83 39.82 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 118.425 -1.31 . . . . 0.17 108.129 177.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 49.71 40.19 19.43 Favored 'General case' 0 N--CA 1.514 2.765 0 N-CA-C 112.872 0.693 . . . . 0.22 112.872 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 81.05 12.23 82.78 Favored Glycine 0 N--CA 1.485 1.923 0 O-C-N 120.487 -1.383 . . . . 0.2 113.334 176.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -121.8 136.69 54.94 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 103.539 -2.763 . . . . 2.48 103.539 178.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 68.8 m -121.55 156.1 33.6 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-O 124.321 2.01 . . . . 0.17 114.996 -175.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -151.52 148.01 27.52 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 111.848 -2.433 . . . . 0.15 110.82 176.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 7.6 t -65.59 132.93 50.08 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.416 -1.698 . . . . 0.15 106.416 173.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 344' ' ' ALA . . . . . 0.436 ' HB2' HG23 ' B' ' 335' ' ' VAL . . . -73.47 -6.02 43.71 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 120.285 -1.509 . . . . 0.11 110.842 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -98.23 12.74 33.68 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.966 -1.084 . . . . 0.17 109.189 -178.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.23 105.64 6.74 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 123.122 1.439 . . . . 0.18 110.557 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 28.9 tp -57.34 -37.59 72.78 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 113.949 -1.478 . . . . 0.19 109.303 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 348' ' ' PHE . . . . . 0.435 ' CB ' ' OE1' ' A' ' 86' ' ' GLU . 72.5 t80 -61.18 -50.4 73.32 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 120.355 -1.465 . . . . 0.38 112.975 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -69.54 -31.75 70.15 Favored 'General case' 0 C--N 1.314 -0.963 0 O-C-N 119.609 -1.932 . . . . 1.17 110.554 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 3.1 mt -65.25 -32.03 73.49 Favored 'General case' 0 C--N 1.285 -2.233 0 C-N-CA 119.177 -1.009 . . . . 0.15 109.309 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 351' ' ' GLN . . . . . 0.541 ' O ' ' CD ' ' A' ' 69' ' ' LYS . 89.6 mt-30 -68.21 -10.64 55.93 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.96 -0.462 . . . . 0.83 109.819 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 2.7 p -91.95 -3.91 55.31 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 118.292 -1.363 . . . . 0.23 110.804 -177.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 353' ' ' LEU . . . . . 0.482 HD22 ' HB3' ' B' ' 337' ' ' SER . 25.5 mt -94.7 157.05 16.13 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.257 -0.902 . . . . 0.17 110.076 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -86.3 106.45 3.09 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 104.713 -3.355 . . . . 0.18 104.713 177.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 91.3 mt -122.37 48.39 1.76 Allowed 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 106.153 -1.795 . . . . 0.16 106.153 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 24.1 p -83.12 171.02 14.16 Favored 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 109.335 -0.617 . . . . 0.25 109.335 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -57.7 138.52 55.36 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.177 -0.952 . . . . 0.25 110.675 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 92.19 -3.13 76.05 Favored Glycine 0 N--CA 1.474 1.173 0 C-N-CA 119.39 -1.385 . . . . 0.21 112.61 177.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 55.3 m -84.82 132.98 34.34 Favored 'General case' 0 C--N 1.291 -1.975 0 O-C-N 121.507 -0.996 . . . . 0.18 111.185 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 94.7 t -94.44 122.86 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 107.031 -1.47 . . . . 0.18 107.031 177.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 361' ' ' VAL . . . . . 0.498 HG12 ' HB2' ' B' ' 337' ' ' SER . 17.8 m -112.73 161.33 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 C-N-CA 116.891 -1.923 . . . . 0.13 109.891 178.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 85.4 m -110.06 130.52 55.52 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 106.324 -1.732 . . . . 0.13 106.324 175.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 54.5 mt -110.33 120.43 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 102.869 -3.011 . . . . 0.11 102.869 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.42 146.43 49.62 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 107.716 -1.216 . . . . 0.13 107.716 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -141.05 153.66 45.6 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 117.566 -1.653 . . . . 0.16 108.63 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 366' ' ' GLU . . . . . 0.513 ' HG2' ' HB2' ' B' ' 301' ' ' MET . 0.0 OUTLIER -141.79 111.91 6.87 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.06 -1.459 . . . . 0.22 107.06 178.701 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 165.25 -173.49 41.04 Favored Glycine 0 C--N 1.294 -1.766 0 C-N-CA 117.651 -2.214 . . . . 0.21 108.64 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -54.78 -41.5 70.62 Favored 'General case' 0 C--N 1.285 -2.213 0 C-N-CA 124.134 0.974 . . . . 0.28 113.253 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 15.2 p30 -116.04 36.71 3.93 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 117.002 -1.879 . . . . 0.21 108.135 -177.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -58.97 -30.35 67.87 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 119.001 2.963 . . . . 0.2 119.001 -175.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 371' ' ' GLN . . . . . 0.534 ' HA ' ' CD2' ' B' ' 302' ' ' PHE . 0.0 OUTLIER -78.2 -43.36 28.72 Favored 'General case' 0 N--CA 1.512 2.66 0 O-C-N 119.647 -1.908 . . . . 0.23 109.768 -177.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 372' ' ' LYS . . . . . 0.569 ' NZ ' ' CE1' ' B' ' 376' ' ' HIS . 13.2 ttpp -63.78 -40.71 97.33 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 106.878 -1.527 . . . . 0.22 106.878 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.21 -46.89 86.86 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 118.441 -1.303 . . . . 0.16 110.599 -178.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 68.7 t -68.78 -39.54 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 N-CA-C 108.521 -0.918 . . . . 0.14 108.521 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -58.21 -46.49 85.75 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.846 0.831 . . . . 0.21 109.508 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 376' ' ' HIS . . . . . 0.569 ' CE1' ' NZ ' ' B' ' 372' ' ' LYS . 13.2 m-70 -71.05 -35.81 72.08 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 113.347 0.869 . . . . 0.2 113.347 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 95.8 mt -79.87 -25.11 40.79 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.447 -1.301 . . . . 0.13 111.786 -175.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 2.1 t -73.13 -38.88 56.0 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 N-CA-C 106.288 -1.745 . . . . 0.15 106.288 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -68.83 -48.6 63.13 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 107.563 -1.273 . . . . 0.22 107.563 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 380' ' ' LEU . . . . . 0.569 ' HG ' ' CD2' ' B' ' 384' ' ' LEU . 28.2 tp -55.53 -47.37 76.4 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 118.773 -1.171 . . . . 0.15 110.754 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 2.9 ttm -61.49 -35.02 76.48 Favored 'General case' 0 C--N 1.309 -1.168 0 O-C-N 120.721 -1.237 . . . . 0.15 113.44 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -77.48 -29.46 52.66 Favored 'General case' 0 C--N 1.282 -2.36 0 O-C-N 121.229 -0.919 . . . . 0.19 108.856 -178.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 383' ' ' GLU . . . . . . . . . . . . 0.265 32.3 mt-10 -76.37 -36.76 57.97 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 121.787 0.803 . . . . 0.22 111.757 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 384' ' ' LEU . . . . . 0.569 ' CD2' ' HG ' ' B' ' 380' ' ' LEU . 0.0 OUTLIER -55.21 127.42 29.17 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 125.822 2.725 . . . . 0.18 113.15 -176.099 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 385' ' ' GLU . . . . . 0.401 ' CD ' ' H ' ' B' ' 385' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.307 -1.247 2 CA-C-N 108.129 -4.123 . . . . 0.22 111.168 -178.21 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.217 -0.633 0 CA-C-O 122.405 1.098 . . . . 0.15 112.795 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.814 ' HB ' ' CG1' ' A' ' 166' ' ' ILE . 2.3 mp -105.93 130.77 56.93 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.023 0 CA-C-O 122.637 1.208 . . . . 0.13 110.744 177.46 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -100.49 124.86 46.59 Favored 'General case' 0 C--N 1.305 -1.347 0 CA-C-N 114.225 -1.352 . . . . 0.12 110.302 176.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.4 mm -94.79 123.4 46.89 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 N-CA-C 105.961 -1.866 . . . . 0.08 105.961 176.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.1 mm -92.11 146.77 5.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 CA-C-O 122.553 1.168 . . . . 0.09 111.839 -178.369 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.68 121.14 51.52 Favored Pre-proline 0 N--CA 1.429 -1.504 0 N-CA-C 115.336 1.606 . . . . 0.05 115.336 -178.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 16.5 Cg_endo -76.16 -19.99 15.04 Favored 'Trans proline' 0 CA--C 1.558 1.709 0 C-N-CA 121.488 1.458 . . . . 0.04 111.386 -177.536 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.466 ' N ' HD12 ' A' ' 26' ' ' LEU 0.324 0.0 OUTLIER -147.44 161.22 41.48 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 123.82 0.848 . . . . 0.05 110.185 175.253 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.9 m -82.6 148.13 28.18 Favored 'General case' 0 CA--C 1.498 -1.023 0 CA-C-O 121.709 0.766 . . . . 0.08 111.11 177.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 156.84 -155.38 26.31 Favored Glycine 0 N--CA 1.431 -1.682 0 C-N-CA 119.078 -1.534 . . . . 0.08 111.003 178.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.04 134.82 54.27 Favored 'General case' 0 C--N 1.294 -1.816 0 CA-C-N 114.002 -1.099 . . . . 0.12 110.156 -177.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.0 mt -74.41 141.5 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.553 0 C-N-CA 117.621 -1.632 . . . . 0.09 110.333 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.4 t -132.64 155.94 41.83 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 114.496 -1.229 . . . . 0.1 108.714 -178.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.502 ' HB3' ' OE2' ' A' ' 34' ' ' GLU . 13.6 m120 -71.51 138.37 48.86 Favored 'General case' 0 CA--C 1.497 -1.076 0 CA-C-O 121.477 0.656 . . . . 0.11 111.064 178.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.422 ' CD1' ' CG1' ' A' ' 139' ' ' VAL . 8.2 tt -67.84 -23.67 29.62 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 C-N-CA 118.678 -1.209 . . . . 0.12 108.659 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.502 ' OE2' ' HB3' ' A' ' 32' ' ' ASN . 0.8 OUTLIER -73.91 -14.08 61.0 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 118.649 -1.22 . . . . 0.14 110.589 -179.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -95.0 12.48 28.29 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 113.694 0.998 . . . . 0.14 113.694 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 t -86.5 130.99 47.16 Favored Pre-proline 0 C--N 1.289 -2.045 0 CA-C-O 120.955 0.407 . . . . 0.15 109.921 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -70.49 48.01 0.72 Allowed 'Trans proline' 0 C--N 1.314 -1.276 0 C-N-CA 122.695 2.264 . . . . 0.16 111.758 -173.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.555 ' CG ' HH21 ' B' ' 317' ' ' ARG . 62.6 t0 -150.68 115.82 5.34 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 107.662 -1.236 . . . . 0.22 107.662 179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 25.9 m -60.4 -37.81 75.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.201 0 C-N-CA 119.016 -1.074 . . . . 0.19 111.601 -178.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . 0.406 16.1 m -62.46 -34.8 66.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 116.907 -1.917 . . . . 0.27 112.174 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -84.25 -44.32 13.99 Favored 'General case' 0 C--N 1.261 -3.255 0 O-C-N 120.21 -1.556 . . . . 0.19 109.822 179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.51 -36.2 77.79 Favored 'General case' 0 CA--C 1.487 -1.461 0 N-CA-C 108.946 -0.761 . . . . 0.15 108.946 -177.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -91.06 7.78 38.73 Favored 'General case' 0 C--N 1.297 -1.699 0 C-N-CA 118.219 -1.393 . . . . 0.81 110.579 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.54 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 0.3 OUTLIER 52.37 39.82 28.19 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 113.943 1.09 . . . . 0.15 113.943 176.665 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.0 mm -67.14 -30.44 49.38 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.963 0 CA-C-O 123.717 1.723 . . . . 0.17 110.676 178.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.293 2.3 t -89.48 -7.71 10.82 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.916 0 CA-C-N 112.366 -2.197 . . . . 0.5 111.81 -175.524 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.54 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . 133.45 -175.57 20.12 Favored Glycine 0 C--O 1.207 -1.574 0 N-CA-C 108.773 -1.731 . . . . 0.13 108.773 176.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -119.52 155.39 32.24 Favored 'General case' 0 C--N 1.311 -1.104 0 C-N-CA 117.835 -1.546 . . . . 0.11 112.797 179.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 172.22 -137.68 4.39 Favored Glycine 0 CA--C 1.537 1.421 0 C-N-CA 117.703 -2.189 . . . . 0.09 111.178 177.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.444 ' C ' HD12 ' A' ' 50' ' ' ILE . 2.8 pp -135.05 175.21 11.53 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.695 0 O-C-N 121.579 -0.954 . . . . 0.07 108.596 178.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -121.58 158.52 28.38 Favored 'General case' 0 C--N 1.305 -1.363 0 C-N-CA 124.7 1.2 . . . . 0.08 108.428 175.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.3 mt -133.36 128.87 55.85 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.84 0 O-C-N 121.595 -0.691 . . . . 0.07 111.005 178.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -86.23 108.88 19.21 Favored Pre-proline 0 C--N 1.308 -1.224 0 N-CA-C 101.46 -3.533 . . . . 0.13 101.46 174.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.429 ' HB3' HD22 ' A' ' 26' ' ' LEU . 2.0 Cg_endo -71.26 150.1 58.5 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 123.735 2.956 . . . . 0.1 113.064 -170.849 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 73.7 p -138.66 1.68 2.14 Favored 'General case' 0 C--N 1.315 -0.921 0 O-C-N 121.746 -0.596 . . . . 0.11 110.16 177.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -108.81 -144.48 10.85 Favored Glycine 0 CA--C 1.534 1.268 0 O-C-N 121.485 -0.759 . . . . 0.09 114.573 -177.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -142.97 14.52 1.89 Allowed 'General case' 0 CA--C 1.492 -1.265 0 O-C-N 122.351 -0.499 . . . . 0.1 112.068 -179.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -157.3 155.12 30.16 Favored 'General case' 0 N--CA 1.415 -2.187 0 C-N-CA 115.405 -2.518 . . . . 0.09 113.142 178.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -114.89 121.4 43.08 Favored 'General case' 0 N--CA 1.438 -1.049 0 CA-C-N 114.872 -1.058 . . . . 0.06 109.077 178.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 m -114.13 174.58 2.68 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.8 0 CA-C-O 122.733 1.254 . . . . 0.06 110.998 -179.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.13 126.64 92.89 Favored Pre-proline 0 C--N 1.289 -2.058 0 CA-C-N 113.705 -1.589 . . . . 0.08 109.729 179.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -85.84 -1.52 8.83 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 CA-C-N 120.027 1.045 . . . . 0.07 110.439 -179.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.449 HG21 ' HB3' ' A' ' 81' ' ' SER . 17.2 m -158.49 164.95 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.941 0 CA-C-O 121.493 0.663 . . . . 0.1 111.185 -178.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.8 ' OD1' HG23 ' A' ' 115' ' ' VAL . 48.5 m-20 -81.45 127.19 32.54 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 103.558 -2.756 . . . . 0.13 103.558 174.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 80' ' ' GLU . . . 174.0 -157.82 26.15 Favored Glycine 0 C--N 1.301 -1.395 0 N-CA-C 110.753 -0.939 . . . . 0.12 110.753 -175.571 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 90.0 m -123.71 134.85 53.64 Favored 'General case' 0 C--N 1.314 -0.94 0 C-N-CA 119.854 -0.739 . . . . 0.15 111.316 -177.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.7 mm -68.79 140.42 18.94 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.028 0 C-N-CA 117.626 -1.629 . . . . 0.13 107.365 178.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -101.7 -64.25 0.76 Allowed Glycine 0 C--N 1.282 -2.471 0 CA-C-O 122.029 0.794 . . . . 0.13 114.332 179.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.5 ' H ' ' HB2' ' A' ' 78' ' ' SER . 2.3 tmtp? -141.4 136.43 31.39 Favored 'General case' 0 C--N 1.279 -2.497 0 CA-C-O 123.053 1.406 . . . . 2.16 111.954 -177.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 75.5 mt -116.19 125.45 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 N-CA-C 105.532 -2.025 . . . . 0.12 105.532 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -62.65 145.41 54.64 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.172 -1.047 . . . . 0.21 108.172 -179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -61.87 -14.91 38.15 Favored 'General case' 0 C--N 1.297 -1.712 0 C-N-CA 123.67 0.788 . . . . 0.4 110.454 -178.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.508 ' OG1' ' ND1' ' A' ' 75' ' ' HIS . 41.4 p -97.7 5.03 49.83 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 123.618 1.675 . . . . 0.15 109.055 178.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.784 ' ND2' HH21 ' A' ' 105' ' ' ARG . 23.5 m120 50.41 44.39 26.82 Favored 'General case' 0 C--N 1.26 -3.292 0 CA-C-N 113.24 -1.8 . . . . 0.11 112.608 175.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.508 ' ND1' ' OG1' ' A' ' 73' ' ' THR . 23.7 p-80 -126.38 -1.55 6.91 Favored 'General case' 0 N--CA 1.428 -1.569 0 N-CA-C 113.652 0.982 . . . . 0.18 113.652 -177.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.31 152.69 31.42 Favored 'General case' 0 N--CA 1.411 -2.388 0 O-C-N 120.79 -1.193 . . . . 0.09 111.122 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -152.49 166.36 32.23 Favored 'General case' 0 C--N 1.308 -1.203 0 CA-C-O 123.077 1.418 . . . . 0.09 113.276 178.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.5 ' HB2' ' H ' ' A' ' 69' ' ' LYS 0.26 15.8 m -118.34 139.74 50.9 Favored 'General case' 0 N--CA 1.439 -0.994 0 CA-C-N 113.302 -1.772 . . . . 0.11 109.789 -178.877 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.6 tt -143.3 150.0 17.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 107.607 -1.257 . . . . 0.11 107.607 175.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.489 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 84.6 tt0 -118.37 129.89 55.68 Favored 'General case' 0 C--O 1.201 -1.483 0 N-CA-C 105.647 -1.983 . . . . 0.84 105.647 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.449 ' HB3' HG21 ' A' ' 63' ' ' VAL . 93.9 p -80.9 167.31 20.02 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 118.441 -1.304 . . . . 0.14 108.264 -176.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -68.13 -31.06 70.39 Favored 'General case' 0 C--N 1.276 -2.6 0 C-N-CA 118.572 -1.251 . . . . 0.16 108.232 177.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.16 4.46 2.17 Favored 'General case' 0 C--N 1.314 -0.96 0 C-N-CA 125.26 1.424 . . . . 0.15 112.053 -179.716 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.68 14.48 82.03 Favored Glycine 0 C--N 1.28 -2.57 0 N-CA-C 117.386 1.715 . . . . 0.15 117.386 -178.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.762 HG21 HD11 ' A' ' 166' ' ' ILE . 48.8 t -92.35 133.0 35.13 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 CA-C-N 121.202 2.501 . . . . 0.13 110.863 177.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.422 ' OE1' ' CB ' ' B' ' 348' ' ' PHE . 97.3 mt-10 -96.97 121.97 39.44 Favored 'General case' 0 N--CA 1.476 0.833 0 O-C-N 121.643 -0.661 . . . . 1.7 110.207 176.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -116.32 158.79 22.87 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-O 122.001 0.905 . . . . 0.1 110.851 -178.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 60.5 t80 -143.65 111.87 6.28 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 122.989 1.376 . . . . 0.18 109.77 177.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.1 t -101.7 115.56 43.71 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 CA-C-N 114.046 -1.434 . . . . 0.07 111.464 179.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.449 ' O ' ' HD2' ' A' ' 137' ' ' PRO . 18.4 t-80 -123.2 105.1 9.6 Favored 'General case' 0 C--O 1.2 -1.531 0 CA-C-N 115.549 -0.751 . . . . 0.16 111.086 -178.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -63.63 124.14 20.64 Favored 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 116.665 2.098 . . . . 0.1 116.665 178.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.35 -175.88 32.07 Favored Glycine 0 C--O 1.215 -1.093 0 CA-C-O 122.572 1.096 . . . . 0.11 114.526 175.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 49.0 mm -118.0 132.59 67.39 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-O 123.151 1.453 . . . . 0.15 109.2 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 54.65 25.84 6.83 Favored 'General case' 0 N--CA 1.429 -1.503 0 CA-C-N 114.089 -1.414 . . . . 0.18 111.246 -177.123 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.3 p -64.44 -19.9 65.83 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 115.437 1.643 . . . . 0.14 115.437 -179.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.3 p -57.06 -32.82 41.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 O-C-N 120.125 -1.609 . . . . 0.17 109.321 177.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -58.56 -20.07 43.53 Favored 'General case' 0 CA--C 1.566 1.594 0 C-N-CA 119.91 -0.716 . . . . 0.24 112.098 -179.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mp -78.19 -3.24 41.61 Favored 'General case' 0 CA--C 1.564 1.488 0 O-C-N 119.716 -1.865 . . . . 0.16 113.86 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 9.7 mtmp? 48.91 46.21 22.22 Favored 'General case' 0 C--N 1.278 -2.525 0 N-CA-C 116.077 1.88 . . . . 3.21 116.077 -179.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 90.76 -13.3 66.19 Favored Glycine 0 CA--C 1.542 1.77 0 N-CA-C 115.433 0.933 . . . . 0.13 115.433 176.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.04 121.21 12.45 Favored 'General case' 0 C--N 1.283 -2.284 0 O-C-N 121.296 -1.12 . . . . 0.16 112.016 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.517 ' O ' ' NZ ' ' A' ' 104' ' ' LYS . . . 97.71 -7.03 63.01 Favored Glycine 0 C--O 1.201 -1.926 0 N-CA-C 114.87 0.708 . . . . 0.12 114.87 178.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -115.73 152.28 33.52 Favored 'General case' 0 C--N 1.283 -2.298 0 C-N-CA 124.117 0.967 . . . . 0.1 111.012 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.517 ' NZ ' ' O ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -141.92 113.47 7.77 Favored 'General case' 0 N--CA 1.442 -0.841 0 C-N-CA 124.597 1.159 . . . . 0.1 109.235 176.83 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.784 HH21 ' ND2' ' A' ' 74' ' ' ASN . 4.9 ttm180 -67.32 123.56 20.68 Favored 'General case' 0 CA--C 1.462 -2.439 0 C-N-CA 120.403 -0.519 . . . . 0.12 109.924 178.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.403 HG13 ' HG3' ' A' ' 121' ' ' GLU . 24.0 mm -106.27 -35.02 3.06 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.256 0 C-N-CA 114.991 -2.684 . . . . 0.09 108.1 -179.354 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.16 178.23 5.61 Favored 'General case' 0 N--CA 1.435 -1.178 0 C-N-CA 118.675 -1.21 . . . . 0.1 112.187 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -118.3 151.52 37.53 Favored 'General case' 0 C--O 1.213 -0.861 0 N-CA-C 112.582 0.586 . . . . 0.14 112.582 178.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -60.92 137.2 58.23 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 118.559 -1.256 . . . . 1.6 107.967 175.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.36 -5.27 84.16 Favored Glycine 0 N--CA 1.475 1.272 0 N-CA-C 111.622 -0.591 . . . . 0.14 111.622 -179.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 30.1 tt0 -65.76 138.03 57.66 Favored 'General case' 0 C--N 1.288 -2.07 0 CA-C-O 122.899 1.333 . . . . 0.13 112.888 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.519 ' CG ' HH11 ' A' ' 112' ' ' ARG . 0.0 OUTLIER -86.25 132.7 33.93 Favored 'General case' 0 N--CA 1.421 -1.906 0 CA-C-N 114.111 -1.404 . . . . 0.17 107.297 175.64 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.7 m -139.93 160.35 26.63 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.04 0 C-N-CA 117.458 -1.697 . . . . 0.12 113.02 -176.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.494 ' HE3' ' OD2' ' A' ' 117' ' ' ASP . 0.5 OUTLIER -110.78 156.73 20.66 Favored 'General case' 0 C--N 1.286 -2.179 0 CA-C-N 111.88 -2.418 . . . . 0.14 108.398 174.671 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.8 HG23 ' OD1' ' A' ' 64' ' ' ASP . 44.2 t -45.73 135.73 2.12 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.138 0 CA-C-O 121.593 0.711 . . . . 0.11 111.655 176.429 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.14 -12.98 64.62 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 120.853 -0.689 . . . . 0.09 114.423 177.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.494 ' OD2' ' HE3' ' A' ' 114' ' ' LYS . 91.6 m-20 -63.08 136.35 57.74 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 120.926 -1.338 . . . . 0.11 109.812 179.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.5 m -76.7 132.4 39.31 Favored 'General case' 0 CA--C 1.498 -1.038 0 CA-C-O 122.951 1.358 . . . . 0.08 111.084 -177.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.475 ' O ' HG13 ' A' ' 120' ' ' ILE . 44.8 t -105.86 -48.4 8.93 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.695 0 CA-C-N 113.42 -1.718 . . . . 0.07 109.304 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.475 HG13 ' O ' ' A' ' 119' ' ' VAL . 10.9 mt -148.36 143.51 19.04 Favored 'Isoleucine or valine' 0 CA--C 1.48 -1.722 0 N-CA-C 114.077 1.139 . . . . 0.07 114.077 -177.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.502 ' O ' ' HD2' ' A' ' 104' ' ' LYS . 49.5 mt-10 -112.28 147.41 36.35 Favored 'General case' 0 CA--C 1.484 -1.587 0 C-N-CA 116.685 -2.006 . . . . 0.09 107.314 175.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.516 ' HA ' ' O ' ' A' ' 102' ' ' GLY . 36.0 p90 -132.9 163.6 28.79 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 122.059 0.933 . . . . 0.09 111.609 -179.234 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.438 ' OD1' ' HD2' ' A' ' 125' ' ' PRO . 10.3 t0 -100.42 97.84 8.53 Favored 'General case' 0 C--N 1.318 -0.777 0 C-N-CA 124.758 1.223 . . . . 0.13 109.799 176.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.62 ' HB3' ' HD3' ' A' ' 125' ' ' PRO . 3.2 tp -59.28 -54.75 53.13 Favored Pre-proline 0 C--N 1.292 -1.913 0 N-CA-C 116.068 1.877 . . . . 0.13 116.068 -176.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.62 ' HD3' ' HB3' ' A' ' 124' ' ' LEU . 20.7 Cg_exo -56.9 -44.71 42.17 Favored 'Trans proline' 1 C--N 1.247 -4.812 0 C-N-CA 121.472 1.448 . . . . 0.15 109.698 -175.685 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.811 ' CD1' ' HG3' ' A' ' 130' ' ' LYS . 0.5 OUTLIER -57.17 -50.96 71.21 Favored 'General case' 0 C--N 1.315 -0.931 0 N-CA-C 109.132 -0.692 . . . . 0.15 109.132 177.757 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.4 mt -68.45 -31.37 70.63 Favored 'General case' 0 C--N 1.281 -2.4 0 O-C-N 121.178 -0.951 . . . . 0.14 112.068 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -65.16 -37.61 87.93 Favored 'General case' 0 C--N 1.278 -2.527 0 N-CA-C 106.699 -1.593 . . . . 0.16 106.699 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -75.32 -42.27 54.91 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 115.205 -0.907 . . . . 0.2 113.335 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.811 ' HG3' ' CD1' ' A' ' 126' ' ' LEU . 0.1 OUTLIER -94.77 -29.3 14.84 Favored 'General case' 0 C--N 1.308 -1.227 0 N-CA-C 116.361 1.985 . . . . 0.2 116.361 -175.817 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.54 142.93 36.99 Favored 'General case' 0 C--N 1.262 -3.229 0 N-CA-C 115.382 1.623 . . . . 0.16 115.382 -176.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.493 ' HA ' ' HD2' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -55.68 -37.78 68.78 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 108.428 -0.953 . . . . 0.19 108.428 179.025 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.8 t -163.84 143.92 8.35 Favored 'General case' 0 C--N 1.296 -1.746 0 C-N-CA 124.986 1.314 . . . . 0.15 110.654 178.282 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 76.8 p -95.95 -0.6 50.52 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 114.784 -1.098 . . . . 0.12 110.539 179.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.507 ' HA ' HD23 ' A' ' 135' ' ' LEU . 17.0 mt -56.36 130.43 44.63 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 107.22 -1.4 . . . . 0.12 107.22 177.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 93.5 m -118.81 96.98 50.57 Favored Pre-proline 0 N--CA 1.431 -1.397 0 N-CA-C 118.121 2.638 . . . . 0.08 118.121 -173.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.449 ' HD2' ' O ' ' A' ' 90' ' ' HIS . 8.3 Cg_exo -66.94 142.86 63.94 Favored 'Trans proline' 0 N--CA 1.447 -1.244 0 C-N-CA 117.192 -1.406 . . . . 0.09 114.406 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . 0.313 1.6 m -125.79 104.68 13.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.705 0 N-CA-C 105.186 -2.153 . . . . 0.06 105.186 173.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.422 ' CG1' ' CD1' ' A' ' 33' ' ' ILE . 16.3 m -123.49 158.84 28.68 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.658 0 N-CA-C 116.258 1.948 . . . . 0.1 116.258 -176.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.8 mp -97.57 125.44 50.71 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.294 0 N-CA-C 104.591 -2.374 . . . . 0.11 104.591 178.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 53.3 p -98.35 -4.42 34.92 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-O 123.15 1.452 . . . . 0.14 112.927 -175.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.464 HD22 ' HA ' ' A' ' 142' ' ' ASN 0.483 0.0 OUTLIER -97.86 15.23 24.47 Favored 'General case' 0 C--N 1.258 -3.41 0 C-N-CA 130.114 3.366 . . . . 0.15 114.442 -179.679 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.431 ' C ' ' O ' ' A' ' 142' ' ' ASN . 62.1 mmm -33.76 -45.0 0.17 Allowed 'General case' 0 C--N 1.281 -2.374 0 N-CA-C 115.584 1.698 . . . . 0.15 115.584 -174.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -64.1 -11.71 32.51 Favored 'General case' 0 C--N 1.252 -3.663 0 O-C-N 119.852 -1.78 . . . . 0.24 113.105 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -106.03 12.71 30.11 Favored 'General case' 0 CA--C 1.479 -1.777 0 CA-C-N 121.18 1.809 . . . . 0.17 111.546 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 2.5 pt -120.34 140.86 43.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 C-N-CA 115.979 -2.288 . . . . 0.15 113.96 -177.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.747 ' HB2' ' HB3' ' A' ' 168' ' ' LYS 0.258 12.0 tptt -74.46 -54.77 6.9 Favored 'General case' 0 C--O 1.222 -0.36 0 CA-C-N 114.496 -1.229 . . . . 0.18 109.786 -179.852 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' ' 166' ' ' ILE . 0.0 OUTLIER -147.33 145.57 29.38 Favored 'General case' 0 C--N 1.29 -2.017 0 CA-C-O 123.729 1.728 . . . . 0.14 114.017 177.053 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.65 112.35 21.97 Favored 'General case' 0 N--CA 1.416 -2.166 0 CA-C-N 111.077 -2.783 . . . . 0.11 109.866 177.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 61.9 mt -108.97 112.23 39.56 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.227 0 CA-C-N 114.531 -1.213 . . . . 0.11 107.882 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 34.6 mttt -84.94 129.91 34.72 Favored 'General case' 0 C--N 1.305 -1.33 0 C-N-CA 124.474 1.11 . . . . 0.09 113.325 -179.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.299 31.4 mt -94.48 175.74 6.56 Favored 'General case' 0 N--CA 1.417 -2.122 0 CA-C-O 122.688 1.233 . . . . 0.08 112.315 -179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . 0.278 0.5 OUTLIER -131.11 160.43 34.75 Favored 'General case' 0 C--N 1.296 -1.748 0 CA-C-N 113.51 -1.677 . . . . 0.09 114.763 -174.341 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 100.26 -158.83 19.42 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 118.88 2.312 . . . . 0.09 118.88 174.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.76 142.15 27.79 Favored 'General case' 0 C--O 1.214 -0.813 0 CA-C-N 112.102 -2.049 . . . . 0.11 109.949 -178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.555 HG11 HG12 ' A' ' 163' ' ' VAL . 16.5 m -131.84 159.73 42.9 Favored 'Isoleucine or valine' 0 CA--C 1.459 -2.54 0 CA-C-O 122.834 1.302 . . . . 0.08 110.032 -177.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 20.7 m -122.79 123.62 41.47 Favored 'General case' 0 C--N 1.274 -2.709 0 CA-C-N 112.702 -2.044 . . . . 0.11 108.24 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 12.1 p -37.23 123.64 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.217 -0.63 0 CA-C-O 123.7 1.714 . . . . 0.08 113.966 179.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 61.18 25.83 65.11 Favored Glycine 0 CA--C 1.488 -1.642 0 CA-C-N 112.837 -1.983 . . . . 0.1 114.179 175.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.42 -53.26 0.72 Allowed 'General case' 0 C--N 1.287 -2.118 0 CA-C-O 121.929 0.871 . . . . 0.13 111.957 178.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.463 ' CG2' HG12 ' A' ' 156' ' ' VAL . 9.0 m -85.36 123.0 73.59 Favored Pre-proline 0 C--N 1.282 -2.346 0 N-CA-C 114.179 1.177 . . . . 0.09 114.179 -175.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -62.5 141.5 86.75 Favored 'Trans proline' 0 CA--C 1.54 0.78 0 C-N-CA 123.003 2.469 . . . . 0.09 109.719 177.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.555 HG12 HG11 ' A' ' 156' ' ' VAL . 28.6 m -116.65 -27.96 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 O-C-N 121.647 -0.658 . . . . 0.06 112.217 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 30.3 mt -141.12 150.98 19.89 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.022 0 N-CA-C 108.527 -0.916 . . . . 0.08 108.527 179.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 5.9 mtt180 -125.78 130.79 52.15 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 105.746 -1.946 . . . . 0.11 105.746 176.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.814 ' CG1' ' HB ' ' A' ' 20' ' ' ILE . 39.7 pt -128.35 155.6 40.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 C-N-CA 118.987 -1.085 . . . . 0.12 109.771 -178.024 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 168' ' ' LYS . 1.1 tttt -120.75 154.23 35.93 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 109.023 -0.732 . . . . 0.16 109.023 176.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.747 ' HB3' ' HB2' ' A' ' 147' ' ' LYS . 9.6 tttt . . . . . 0 C--N 1.322 -0.601 0 N-CA-C 108.887 -0.783 . . . . 0.18 108.887 -177.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 301' ' ' MET . . . . . 0.514 ' HB2' ' HG2' ' B' ' 366' ' ' GLU . 4.2 ttm . . . . . 0 C--O 1.218 -0.566 0 N-CA-C 108.459 -0.941 . . . . 0.21 108.459 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 302' ' ' PHE . . . . . 0.533 ' CD2' ' HA ' ' B' ' 371' ' ' GLN . 74.6 t80 -142.88 140.93 31.42 Favored 'General case' 0 C--N 1.295 -1.793 0 N-CA-C 107.181 -1.414 . . . . 0.17 107.181 178.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -150.83 157.33 42.8 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.037 -1.039 . . . . 0.17 109.46 -179.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 21.5 mm-40 -153.2 147.6 25.92 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 107.001 -1.481 . . . . 0.16 107.001 -179.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.92 152.02 19.15 Favored 'General case' 0 C--N 1.31 -1.132 0 N-CA-C 108.319 -0.993 . . . . 0.16 108.319 178.288 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 7.3 p -149.68 144.29 17.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 107.35 -1.352 . . . . 0.13 107.35 174.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 86.5 m -93.84 136.73 33.83 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 121.605 0.717 . . . . 0.17 110.119 178.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 58.9 mt -85.75 114.13 25.05 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 N-CA-C 104.572 -2.381 . . . . 0.16 104.572 177.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 61.1 p -106.45 -3.93 20.41 Favored 'General case' 0 N--CA 1.514 2.746 0 N-CA-C 114.545 1.313 . . . . 0.21 114.545 -178.508 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 310' ' ' ALA . . . . . 0.427 ' HB2' ' O ' ' B' ' 384' ' ' LEU . . . -71.65 139.21 83.38 Favored Pre-proline 0 N--CA 1.487 1.422 0 CA-C-N 120.312 1.414 . . . . 0.2 110.766 179.74 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_exo -46.42 -44.96 19.92 Favored 'Trans proline' 0 N--CA 1.497 1.701 0 C-N-CA 123.033 2.488 . . . . 0.24 117.068 179.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -103.66 29.23 5.89 Favored 'General case' 0 N--CA 1.502 2.139 0 C-N-CA 115.813 -2.355 . . . . 1.08 107.127 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 59.52 -148.66 41.1 Favored Glycine 0 N--CA 1.489 2.202 0 C-N-CA 117.624 -2.226 . . . . 0.18 111.007 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.452 ' HG ' ' HB2' ' B' ' 319' ' ' ALA . 17.1 tp -87.11 74.1 9.69 Favored 'General case' 0 C--N 1.314 -0.975 0 C-N-CA 118.331 -1.347 . . . . 0.15 108.996 -177.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 315' ' ' HIS . . . . . 0.506 ' H ' ' CD2' ' B' ' 315' ' ' HIS . 7.7 p80 -69.27 -178.06 1.25 Allowed 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 118.667 -1.213 . . . . 0.81 112.688 -178.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 3.0 m -48.93 -60.26 2.9 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 118.842 2.904 . . . . 0.21 118.842 -174.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 317' ' ' ARG . . . . . 0.555 HH21 ' CG ' ' A' ' 38' ' ' ASP . 20.9 ttm180 -64.01 -44.19 77.31 Favored Pre-proline 0 C--N 1.282 -2.326 0 CA-C-N 122.599 2.454 . . . . 1.24 113.038 -176.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 318' ' ' PRO . . . . . 0.437 ' CD ' ' N ' ' B' ' 317' ' ' ARG . 10.5 Cg_endo -68.09 -28.92 34.22 Favored 'Trans proline' 0 C--N 1.296 -2.185 0 CA-C-N 121.171 1.454 . . . . 0.18 111.934 179.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . 0.452 ' HB2' ' HG ' ' B' ' 314' ' ' LEU . . . -69.45 -35.37 75.57 Favored 'General case' 0 N--CA 1.508 2.473 0 O-C-N 120.836 -1.165 . . . . 0.14 108.853 179.622 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -71.56 -39.35 70.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.805 -1.185 . . . . 0.17 108.855 177.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -67.77 -36.0 79.7 Favored 'General case' 0 N--CA 1.501 2.093 0 C-N-CA 118.123 -1.431 . . . . 1.74 108.714 179.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 79.1 t80 -64.28 -44.61 91.17 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.93 -1.106 . . . . 0.13 108.657 -179.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 60.9 t -64.63 -40.42 88.99 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 CA-C-N 115.229 -0.896 . . . . 0.14 110.538 179.545 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 78.4 tttt -64.55 -41.05 96.58 Favored 'General case' 0 C--N 1.293 -1.869 0 O-C-N 120.809 -1.182 . . . . 1.22 109.688 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -68.28 -40.16 81.93 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.58 -0.7 . . . . 0.17 109.121 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.57 -42.32 92.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.893 -1.129 . . . . 0.14 109.287 178.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -62.82 -15.04 52.55 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.136 -0.977 . . . . 1.43 112.905 178.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -78.34 -11.23 85.53 Favored Glycine 0 N--CA 1.479 1.513 0 N-CA-C 108.847 -1.701 . . . . 0.19 108.847 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . 0.542 ' HE1' ' HE3' ' B' ' 372' ' ' LYS . 82.4 m-85 -103.91 145.08 30.65 Favored 'General case' 0 N--CA 1.506 2.355 0 CA-C-N 118.731 1.266 . . . . 0.18 110.083 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 75.4 p -76.95 -28.78 55.32 Favored 'General case' 0 N--CA 1.504 2.231 0 CA-C-O 118.609 -0.71 . . . . 0.22 112.477 -179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 20.3 m -58.87 157.55 9.57 Favored 'General case' 0 N--CA 1.483 1.195 0 CA-C-O 123.384 1.564 . . . . 0.18 114.893 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.53 128.48 33.42 Favored 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 102.25 -3.241 . . . . 0.19 102.25 172.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 42.0 mt -125.78 133.98 67.74 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 N-CA-C 108.18 -1.045 . . . . 0.15 108.18 -175.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 97.5 m -124.61 140.64 52.75 Favored 'General case' 0 C--N 1.306 -1.285 0 CA-C-O 122.204 1.002 . . . . 0.16 109.229 -179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 335' ' ' VAL . . . . . 0.437 HG23 ' HB2' ' B' ' 344' ' ' ALA . 93.1 t -107.37 127.39 63.26 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.785 0 N-CA-C 105.349 -2.093 . . . . 0.13 105.349 174.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 88.2 m -124.7 121.04 33.54 Favored 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.893 0.854 . . . . 0.16 110.432 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 337' ' ' SER . . . . . 0.498 ' HB2' HG12 ' B' ' 361' ' ' VAL . 33.4 t -125.59 123.84 39.92 Favored 'General case' 0 N--CA 1.496 1.845 0 C-N-CA 118.389 -1.324 . . . . 0.17 108.154 177.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 49.78 40.09 19.49 Favored 'General case' 0 N--CA 1.514 2.747 0 N-CA-C 112.879 0.696 . . . . 0.22 112.879 -178.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 81.07 12.26 82.71 Favored Glycine 0 N--CA 1.485 1.961 0 O-C-N 120.442 -1.411 . . . . 0.21 113.314 176.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -121.84 136.65 54.94 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 103.55 -2.759 . . . . 2.59 103.55 178.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 68.2 m -121.49 156.09 33.53 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-O 124.348 2.023 . . . . 0.18 115.04 -175.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -151.52 147.98 27.47 Favored 'General case' 0 C--N 1.288 -2.073 0 CA-C-N 111.86 -2.427 . . . . 0.15 110.804 177.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 7.6 t -65.65 132.96 50.08 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 106.362 -1.718 . . . . 0.16 106.362 173.02 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . 0.437 ' HB2' HG23 ' B' ' 335' ' ' VAL . . . -73.46 -6.08 44.11 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 120.281 -1.512 . . . . 0.12 110.845 178.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -98.13 12.72 33.55 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.998 -1.064 . . . . 0.17 109.224 -178.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.2 105.67 6.77 Favored 'General case' 0 N--CA 1.48 1.046 0 CA-C-O 123.146 1.45 . . . . 0.17 110.544 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 26.6 tp -57.32 -37.64 72.82 Favored 'General case' 0 N--CA 1.49 1.558 0 CA-C-N 113.948 -1.478 . . . . 0.19 109.31 178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 348' ' ' PHE . . . . . 0.422 ' CB ' ' OE1' ' A' ' 86' ' ' GLU . 67.1 t80 -61.06 -50.48 73.14 Favored 'General case' 0 N--CA 1.506 2.332 0 O-C-N 120.395 -1.44 . . . . 0.34 113.018 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 67.6 mmtt -69.51 -31.74 70.16 Favored 'General case' 0 C--N 1.313 -1.01 0 O-C-N 119.589 -1.944 . . . . 1.13 110.526 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 3.1 mt -65.35 -32.02 73.45 Favored 'General case' 0 C--N 1.284 -2.25 0 C-N-CA 119.19 -1.004 . . . . 0.15 109.242 -177.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.427 ' OE1' ' OG ' ' A' ' 78' ' ' SER . 89.7 mt-30 -68.14 -10.78 56.7 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.938 -0.476 . . . . 0.78 109.816 -178.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 2.7 p -91.86 -3.94 55.43 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.385 -1.326 . . . . 0.22 110.815 -177.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . 0.48 HD22 ' HB3' ' B' ' 337' ' ' SER . 25.6 mt -94.72 157.04 16.13 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.255 -0.903 . . . . 0.16 110.094 179.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -86.28 106.43 3.08 Favored Glycine 0 N--CA 1.498 2.786 0 N-CA-C 104.785 -3.326 . . . . 0.16 104.785 177.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 91.2 mt -122.42 48.4 1.76 Allowed 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 106.133 -1.803 . . . . 0.15 106.133 -178.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 18.4 p -83.08 170.99 14.23 Favored 'General case' 0 C--O 1.215 -0.746 0 N-CA-C 109.363 -0.606 . . . . 0.21 109.363 179.488 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -57.72 138.48 55.44 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.178 -0.951 . . . . 0.23 110.659 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 92.25 -3.15 75.88 Favored Glycine 0 N--CA 1.473 1.108 0 C-N-CA 119.431 -1.366 . . . . 0.18 112.627 177.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 55.0 m -84.77 132.89 34.38 Favored 'General case' 0 C--N 1.291 -1.966 0 O-C-N 121.497 -1.002 . . . . 0.16 111.182 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 95.3 t -94.38 122.91 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 N-CA-C 106.972 -1.492 . . . . 0.16 106.972 177.072 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 361' ' ' VAL . . . . . 0.498 HG12 ' HB2' ' B' ' 337' ' ' SER . 17.8 m -112.71 161.3 11.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 C-N-CA 116.922 -1.911 . . . . 0.12 109.955 177.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 84.9 m -110.1 130.48 55.53 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 106.32 -1.733 . . . . 0.14 106.32 175.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 54.3 mt -110.29 120.43 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 N-CA-C 102.902 -2.999 . . . . 0.11 102.902 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.41 146.43 49.61 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 107.746 -1.205 . . . . 0.14 107.746 -179.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -141.09 153.7 45.57 Favored 'General case' 0 C--N 1.298 -1.664 0 C-N-CA 117.549 -1.66 . . . . 0.17 108.599 178.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 366' ' ' GLU . . . . . 0.514 ' HG2' ' HB2' ' B' ' 301' ' ' MET . 0.0 OUTLIER -141.81 111.94 6.88 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.002 -1.481 . . . . 0.23 107.002 178.753 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 165.25 -173.45 41.03 Favored Glycine 0 C--N 1.295 -1.734 0 C-N-CA 117.672 -2.204 . . . . 0.21 108.649 179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -54.86 -41.49 70.85 Favored 'General case' 0 C--N 1.286 -2.191 0 C-N-CA 124.134 0.974 . . . . 0.27 113.24 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 15.1 p30 -116.05 36.75 3.91 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 116.966 -1.894 . . . . 0.2 108.114 -177.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -58.99 -30.34 67.89 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 118.961 2.949 . . . . 0.2 118.961 -175.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 371' ' ' GLN . . . . . 0.533 ' HA ' ' CD2' ' B' ' 302' ' ' PHE . 0.0 OUTLIER -78.23 -43.43 28.39 Favored 'General case' 0 N--CA 1.513 2.696 0 O-C-N 119.721 -1.862 . . . . 0.21 109.743 -177.953 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 372' ' ' LYS . . . . . 0.567 ' NZ ' ' CE1' ' B' ' 376' ' ' HIS . 13.2 ttpp -63.65 -40.75 97.63 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 106.948 -1.501 . . . . 0.21 106.948 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.23 -46.78 87.35 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 118.375 -1.33 . . . . 0.15 110.705 -178.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 68.5 t -68.82 -39.57 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.323 0 N-CA-C 108.525 -0.917 . . . . 0.13 108.525 -179.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -58.12 -46.58 85.35 Favored 'General case' 0 N--CA 1.502 2.169 0 CA-C-O 121.839 0.828 . . . . 0.19 109.523 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 376' ' ' HIS . . . . . 0.567 ' CE1' ' NZ ' ' B' ' 372' ' ' LYS . 13.2 m-70 -71.01 -35.87 72.2 Favored 'General case' 0 C--N 1.283 -2.316 0 N-CA-C 113.308 0.855 . . . . 0.19 113.308 -179.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 95.9 mt -79.84 -25.14 40.86 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 118.443 -1.303 . . . . 0.12 111.788 -175.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 2.1 t -73.11 -38.89 56.13 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.08 0 N-CA-C 106.267 -1.753 . . . . 0.13 106.267 179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -68.84 -48.61 63.07 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 107.538 -1.282 . . . . 0.21 107.538 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . 0.572 ' HG ' ' CD2' ' B' ' 384' ' ' LEU . 28.2 tp -55.55 -47.36 76.48 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 120.836 -1.165 . . . . 0.16 110.717 176.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 2.9 ttm -61.46 -35.04 76.49 Favored 'General case' 0 C--N 1.309 -1.156 0 O-C-N 120.712 -1.242 . . . . 0.14 113.51 -177.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -77.48 -29.36 52.59 Favored 'General case' 0 C--N 1.282 -2.341 0 O-C-N 121.183 -0.948 . . . . 0.18 108.896 -178.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . 0.266 31.7 mt-10 -76.47 -36.77 57.68 Favored 'General case' 0 N--CA 1.486 1.339 0 CA-C-O 121.81 0.814 . . . . 0.21 111.723 179.198 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 384' ' ' LEU . . . . . 0.572 ' CD2' ' HG ' ' B' ' 380' ' ' LEU . 0.0 OUTLIER -55.23 127.38 29.05 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 125.934 2.778 . . . . 0.18 113.135 -176.119 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 385' ' ' GLU . . . . . 0.402 ' CD ' ' H ' ' B' ' 385' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.308 -1.214 2 CA-C-N 108.1 -4.136 . . . . 0.22 111.168 -178.233 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 200' ' ' PO3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.217 -0.613 0 CA-C-O 122.391 1.091 . . . . 0.16 112.81 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.815 ' HB ' ' CG1' ' A' ' 166' ' ' ILE . 2.3 mp -106.02 130.73 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.019 0 CA-C-O 122.663 1.22 . . . . 0.13 110.698 177.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -100.46 124.86 46.53 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.229 -1.35 . . . . 0.13 110.318 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.4 mm -94.8 123.44 46.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 105.89 -1.893 . . . . 0.08 105.89 176.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.2 mm -92.1 146.79 5.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 122.546 1.165 . . . . 0.09 111.834 -178.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.71 121.09 51.22 Favored Pre-proline 0 N--CA 1.428 -1.541 0 N-CA-C 115.379 1.622 . . . . 0.06 115.379 -178.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -76.11 -20.02 15.11 Favored 'Trans proline' 0 CA--C 1.559 1.752 0 C-N-CA 121.494 1.463 . . . . 0.05 111.396 -177.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.465 ' N ' HD12 ' A' ' 26' ' ' LEU 0.325 0.0 OUTLIER -147.43 161.19 41.54 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 123.815 0.846 . . . . 0.05 110.173 175.29 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.9 m -82.61 148.14 28.17 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 121.729 0.776 . . . . 0.09 111.099 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 156.81 -155.3 26.24 Favored Glycine 0 N--CA 1.431 -1.688 0 C-N-CA 119.086 -1.531 . . . . 0.08 111.041 178.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.15 134.79 54.34 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.038 -1.081 . . . . 0.1 110.063 -177.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.1 mt -74.38 141.45 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 C-N-CA 117.694 -1.602 . . . . 0.08 110.383 -179.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.3 t -132.62 155.9 41.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 114.519 -1.219 . . . . 0.09 108.786 -178.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.501 ' HB3' ' OE2' ' A' ' 34' ' ' GLU . 13.6 m120 -71.41 138.35 49.04 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-O 121.443 0.639 . . . . 0.11 111.099 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.422 ' CD1' ' CG1' ' A' ' 139' ' ' VAL . 8.2 tt -67.8 -23.67 29.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 C-N-CA 118.65 -1.22 . . . . 0.11 108.724 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.501 ' OE2' ' HB3' ' A' ' 32' ' ' ASN . 0.8 OUTLIER -73.91 -14.09 61.0 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 118.566 -1.254 . . . . 0.13 110.543 -179.983 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -94.9 12.32 28.64 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 113.689 0.996 . . . . 0.12 113.689 -179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 t -86.42 130.95 47.5 Favored Pre-proline 0 C--N 1.29 -2.011 0 CA-C-O 120.918 0.39 . . . . 0.13 109.963 179.288 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -70.46 48.03 0.72 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 122.711 2.274 . . . . 0.15 111.781 -173.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.555 ' CG ' HH21 ' B' ' 317' ' ' ARG . 56.3 t0 -150.66 115.83 5.36 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.733 -1.21 . . . . 0.22 107.733 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 28.2 m -60.36 -37.8 75.49 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 C-N-CA 119.005 -1.078 . . . . 0.2 111.618 -178.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . 0.405 18.9 m -62.45 -34.94 67.31 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 116.861 -1.936 . . . . 0.25 112.127 -179.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 59.5 m-85 -84.18 -44.15 14.25 Favored 'General case' 0 C--N 1.261 -3.254 0 O-C-N 120.178 -1.576 . . . . 0.2 109.897 179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.6 -36.24 78.09 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 108.937 -0.764 . . . . 0.14 108.937 -177.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -91.09 7.89 38.24 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 118.173 -1.411 . . . . 1.08 110.584 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.54 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 0.3 OUTLIER 52.37 39.78 28.1 Favored 'General case' 0 C--N 1.291 -1.945 0 N-CA-C 113.973 1.101 . . . . 0.15 113.973 176.62 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.4 mm -67.19 -30.32 48.94 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.958 0 CA-C-O 123.786 1.755 . . . . 0.18 110.703 178.681 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.293 2.1 t -89.55 -7.71 10.82 Favored 'Isoleucine or valine' 0 C--N 1.27 -2.882 0 CA-C-N 112.375 -2.193 . . . . 0.49 111.844 -175.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.54 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . 133.46 -175.57 20.13 Favored Glycine 0 C--O 1.206 -1.627 0 N-CA-C 108.743 -1.743 . . . . 0.13 108.743 176.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -119.52 155.45 32.13 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 117.851 -1.539 . . . . 0.12 112.768 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 172.18 -137.77 4.44 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 117.725 -2.179 . . . . 0.09 111.158 177.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.444 ' C ' HD12 ' A' ' 50' ' ' ILE . 2.8 pp -134.98 175.24 11.51 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.716 0 O-C-N 121.592 -0.946 . . . . 0.07 108.596 178.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -121.59 158.51 28.41 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 124.716 1.206 . . . . 0.07 108.424 175.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.3 mt -133.33 128.81 55.87 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.826 0 O-C-N 121.641 -0.662 . . . . 0.06 111.051 178.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -86.11 108.81 18.71 Favored Pre-proline 0 C--N 1.308 -1.232 0 N-CA-C 101.478 -3.527 . . . . 0.11 101.478 174.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.428 ' HB3' HD22 ' A' ' 26' ' ' LEU . 2.0 Cg_endo -71.22 150.12 58.8 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 123.725 2.95 . . . . 0.09 113.074 -170.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.3 p -138.61 1.6 2.14 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 121.774 -0.579 . . . . 0.11 110.161 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -108.83 -144.5 10.84 Favored Glycine 0 CA--C 1.534 1.238 0 O-C-N 121.444 -0.785 . . . . 0.1 114.581 -177.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -142.97 14.48 1.89 Allowed 'General case' 0 CA--C 1.491 -1.291 0 O-C-N 122.363 -0.492 . . . . 0.12 112.079 -179.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -157.28 155.17 30.28 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 115.415 -2.514 . . . . 0.1 113.092 178.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -114.96 121.44 43.18 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.868 -1.06 . . . . 0.07 109.054 178.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 m -114.15 174.54 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 CA-C-O 122.74 1.257 . . . . 0.07 110.964 -179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.15 126.66 92.92 Favored Pre-proline 0 C--N 1.289 -2.057 0 CA-C-N 113.663 -1.608 . . . . 0.07 109.742 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -85.85 -1.5 8.82 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 CA-C-N 120.029 1.046 . . . . 0.07 110.429 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.449 ' HA ' HG22 ' A' ' 115' ' ' VAL . 17.2 m -158.53 164.96 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-O 121.579 0.704 . . . . 0.09 111.139 -178.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.799 ' OD1' HG23 ' A' ' 115' ' ' VAL . 48.0 m-20 -81.44 127.19 32.54 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 103.595 -2.743 . . . . 0.13 103.595 174.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 80' ' ' GLU . . . 174.0 -157.85 26.2 Favored Glycine 0 C--N 1.301 -1.375 0 N-CA-C 110.78 -0.928 . . . . 0.11 110.78 -175.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.6 m -123.69 134.93 53.64 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 119.814 -0.754 . . . . 0.13 111.309 -177.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.7 mm -68.76 140.42 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.041 0 C-N-CA 117.619 -1.632 . . . . 0.12 107.394 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -101.76 -64.21 0.75 Allowed Glycine 0 C--N 1.282 -2.457 0 CA-C-O 121.955 0.753 . . . . 0.14 114.291 179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.53 ' CD ' ' O ' ' B' ' 351' ' ' GLN . 0.2 OUTLIER -141.35 136.47 31.51 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-O 122.991 1.377 . . . . 2.18 111.934 -177.842 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 75.8 mt -116.24 125.46 73.3 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 N-CA-C 105.514 -2.032 . . . . 0.14 105.514 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -62.72 145.46 54.7 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.164 -1.05 . . . . 0.18 108.164 -179.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -61.91 -14.9 38.59 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 123.674 0.79 . . . . 0.71 110.488 -178.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.482 ' OG1' ' ND1' ' A' ' 75' ' ' HIS . 25.5 p -97.69 5.02 49.87 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 123.655 1.693 . . . . 0.2 109.093 178.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.785 ' ND2' HH21 ' A' ' 105' ' ' ARG . 23.5 m120 50.51 44.31 27.11 Favored 'General case' 0 C--N 1.261 -3.269 0 CA-C-N 113.211 -1.813 . . . . 0.14 112.59 175.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.649 ' HE2' ' CE1' ' A' ' 90' ' ' HIS . 13.7 p-80 -126.38 -1.52 6.92 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 113.64 0.978 . . . . 0.21 113.64 -177.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.32 152.75 31.47 Favored 'General case' 0 N--CA 1.412 -2.345 0 O-C-N 120.781 -1.2 . . . . 0.1 111.022 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -152.53 166.33 32.36 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 123.072 1.415 . . . . 0.09 113.245 178.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.501 ' HB2' ' H ' ' A' ' 69' ' ' LYS 0.259 15.8 m -118.29 139.72 50.9 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 113.278 -1.783 . . . . 0.12 109.849 -178.894 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.6 tt -143.27 150.03 17.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.585 -1.265 . . . . 0.1 107.585 175.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.489 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 84.6 tt0 -118.42 129.91 55.67 Favored 'General case' 0 C--O 1.201 -1.466 0 N-CA-C 105.628 -1.99 . . . . 0.52 105.628 177.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.447 ' HB3' HG21 ' A' ' 63' ' ' VAL . 94.0 p -80.91 167.32 20.0 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 118.457 -1.297 . . . . 0.13 108.28 -176.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 83.0 m-20 -68.11 -31.02 70.33 Favored 'General case' 0 C--N 1.277 -2.569 0 C-N-CA 118.538 -1.265 . . . . 0.15 108.264 177.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.22 4.44 2.21 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 125.212 1.405 . . . . 0.14 111.998 -179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.73 14.51 81.98 Favored Glycine 0 C--N 1.28 -2.557 0 N-CA-C 117.351 1.7 . . . . 0.14 117.351 -178.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.761 HG21 HD11 ' A' ' 166' ' ' ILE . 48.8 t -92.42 133.01 35.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 121.189 2.494 . . . . 0.12 110.886 177.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.435 ' OE1' ' CB ' ' B' ' 348' ' ' PHE . 96.5 mt-10 -96.9 121.92 39.3 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.669 -0.645 . . . . 1.73 110.229 176.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -116.32 158.84 22.79 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.986 0.898 . . . . 0.09 110.922 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 62.8 t80 -143.66 111.87 6.27 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-O 122.988 1.375 . . . . 0.31 109.759 177.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 22.1 t -101.73 115.6 43.83 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.983 0 CA-C-N 114.05 -1.432 . . . . 0.07 111.41 179.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.649 ' CE1' ' HE2' ' A' ' 75' ' ' HIS . 2.1 t-80 -123.24 105.07 9.56 Favored 'General case' 0 C--O 1.199 -1.564 0 CA-C-N 115.501 -0.772 . . . . 0.16 111.098 -178.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . . . . . . . . . 28.6 t80 -63.56 124.13 20.57 Favored 'General case' 0 CA--C 1.558 1.278 0 N-CA-C 116.688 2.107 . . . . 0.1 116.688 178.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.28 -175.84 31.91 Favored Glycine 0 C--O 1.214 -1.123 0 CA-C-O 122.578 1.099 . . . . 0.1 114.496 175.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 49.1 mm -118.0 132.62 67.3 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-O 123.129 1.442 . . . . 0.14 109.158 179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 54.69 25.75 6.79 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 114.104 -1.407 . . . . 0.18 111.227 -177.17 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 2.3 p -64.42 -19.82 65.76 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 115.451 1.648 . . . . 0.15 115.451 -179.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 12.3 p -57.09 -32.83 41.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.878 0 O-C-N 120.124 -1.61 . . . . 0.17 109.32 177.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -58.61 -19.99 43.47 Favored 'General case' 0 CA--C 1.566 1.581 0 C-N-CA 119.867 -0.733 . . . . 0.25 112.092 -179.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 4.2 mp -78.22 -3.24 41.72 Favored 'General case' 0 CA--C 1.564 1.485 0 O-C-N 119.733 -1.855 . . . . 0.17 113.913 177.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 32.4 mtmm 48.95 46.23 22.34 Favored 'General case' 0 C--N 1.277 -2.556 0 N-CA-C 116.082 1.882 . . . . 3.19 116.082 -179.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 90.69 -13.24 66.25 Favored Glycine 0 CA--C 1.543 1.799 0 N-CA-C 115.492 0.957 . . . . 0.16 115.492 176.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.14 121.29 12.71 Favored 'General case' 0 C--N 1.284 -2.263 0 O-C-N 121.36 -1.082 . . . . 0.18 112.008 -179.462 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.518 ' O ' ' HA ' ' A' ' 122' ' ' PHE . . . 97.68 -7.09 63.1 Favored Glycine 0 C--O 1.201 -1.956 0 N-CA-C 114.902 0.721 . . . . 0.14 114.902 178.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 -115.67 152.25 33.52 Favored 'General case' 0 C--N 1.284 -2.282 0 C-N-CA 124.121 0.968 . . . . 0.13 111.008 177.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . 0.513 ' NZ ' ' O ' ' A' ' 102' ' ' GLY . 0.0 OUTLIER -141.95 113.41 7.71 Favored 'General case' 0 N--CA 1.442 -0.867 0 C-N-CA 124.625 1.17 . . . . 0.13 109.199 176.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.785 HH21 ' ND2' ' A' ' 74' ' ' ASN . 5.0 ttm180 -67.19 123.53 20.55 Favored 'General case' 0 CA--C 1.462 -2.416 0 C-N-CA 120.448 -0.501 . . . . 0.14 109.946 178.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . 0.405 HG13 ' HG3' ' A' ' 121' ' ' GLU . 24.0 mm -106.31 -34.99 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.251 0 C-N-CA 114.928 -2.709 . . . . 0.12 108.119 -179.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.08 178.22 5.62 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 118.682 -1.207 . . . . 0.12 112.235 -179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -118.31 151.46 37.66 Favored 'General case' 0 C--O 1.213 -0.83 0 N-CA-C 112.594 0.59 . . . . 0.15 112.594 178.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -60.89 137.26 58.23 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 118.498 -1.281 . . . . 1.68 108.021 175.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.27 -5.23 84.31 Favored Glycine 0 N--CA 1.475 1.253 0 N-CA-C 111.624 -0.591 . . . . 0.14 111.624 -179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 30.2 tt0 -65.72 138.04 57.69 Favored 'General case' 0 C--N 1.288 -2.07 0 C-N-CA 118.398 -1.321 . . . . 0.13 112.879 179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.52 ' CG ' HH11 ' A' ' 112' ' ' ARG . 0.0 OUTLIER -86.23 132.67 33.94 Favored 'General case' 0 N--CA 1.421 -1.912 0 CA-C-N 114.121 -1.4 . . . . 0.15 107.307 175.611 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 34.6 m -139.87 160.33 26.81 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.023 0 C-N-CA 117.475 -1.69 . . . . 0.11 113.051 -176.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.493 ' HE3' ' OD2' ' A' ' 117' ' ' ASP . 0.5 OUTLIER -110.81 156.7 20.73 Favored 'General case' 0 C--N 1.285 -2.217 0 CA-C-N 111.905 -2.407 . . . . 0.14 108.406 174.63 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.799 HG23 ' OD1' ' A' ' 64' ' ' ASP . 43.9 t -45.7 135.74 2.09 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.161 0 CA-C-O 121.596 0.712 . . . . 0.11 111.675 176.438 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.2 -13.05 64.5 Favored Glycine 0 CA--C 1.533 1.162 0 C-N-CA 120.831 -0.699 . . . . 0.09 114.38 177.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.493 ' OD2' ' HE3' ' A' ' 114' ' ' LYS . 91.5 m-20 -63.14 136.38 57.72 Favored 'General case' 0 C--N 1.292 -1.914 0 CA-C-N 118.866 1.333 . . . . 0.11 109.797 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 23.4 m -76.68 132.38 39.33 Favored 'General case' 0 CA--C 1.497 -1.068 0 CA-C-O 122.912 1.339 . . . . 0.1 111.123 -177.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.474 ' O ' HG13 ' A' ' 120' ' ' ILE . 44.8 t -105.83 -48.45 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.684 0 CA-C-N 113.495 -1.684 . . . . 0.09 109.315 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.474 HG13 ' O ' ' A' ' 119' ' ' VAL . 10.8 mt -148.37 143.56 19.02 Favored 'Isoleucine or valine' 0 CA--C 1.481 -1.707 0 N-CA-C 114.085 1.143 . . . . 0.09 114.085 -177.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . 0.503 ' O ' ' HD2' ' A' ' 104' ' ' LYS . 49.4 mt-10 -112.28 147.47 36.22 Favored 'General case' 0 CA--C 1.483 -1.627 0 C-N-CA 116.646 -2.022 . . . . 0.12 107.279 175.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.518 ' HA ' ' O ' ' A' ' 102' ' ' GLY . 36.0 p90 -132.94 163.55 28.94 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-O 122.08 0.943 . . . . 0.11 111.57 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.437 ' OD1' ' HD2' ' A' ' 125' ' ' PRO . 10.3 t0 -100.41 97.85 8.55 Favored 'General case' 0 C--N 1.319 -0.752 0 C-N-CA 124.72 1.208 . . . . 0.15 109.813 176.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.62 ' HB3' ' HD3' ' A' ' 125' ' ' PRO . 3.1 tp -59.22 -54.79 52.77 Favored Pre-proline 0 C--N 1.292 -1.899 0 N-CA-C 116.061 1.874 . . . . 0.12 116.061 -176.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.62 ' HD3' ' HB3' ' A' ' 124' ' ' LEU . 20.6 Cg_exo -56.92 -44.68 42.37 Favored 'Trans proline' 1 C--N 1.247 -4.804 0 C-N-CA 121.483 1.455 . . . . 0.15 109.706 -175.647 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.813 ' CD1' ' HG3' ' A' ' 130' ' ' LYS . 0.5 OUTLIER -57.17 -51.0 71.07 Favored 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 109.134 -0.691 . . . . 0.16 109.134 177.738 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 49.5 mt -68.36 -31.42 70.79 Favored 'General case' 0 C--N 1.281 -2.394 0 O-C-N 121.092 -1.005 . . . . 0.13 112.098 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 20.5 mt-10 -65.13 -37.62 88.03 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 106.727 -1.582 . . . . 0.15 106.727 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.2 tt0 -75.26 -42.3 55.37 Favored 'General case' 0 C--N 1.301 -1.518 0 CA-C-N 115.218 -0.901 . . . . 0.19 113.33 177.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.813 ' HG3' ' CD1' ' A' ' 126' ' ' LEU . 0.1 OUTLIER -94.79 -29.28 14.83 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 116.38 1.992 . . . . 0.2 116.38 -175.817 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -78.56 142.96 36.93 Favored 'General case' 0 C--N 1.262 -3.207 0 N-CA-C 115.329 1.603 . . . . 0.15 115.329 -176.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.491 ' HA ' ' HD2' ' A' ' 132' ' ' LYS . 0.0 OUTLIER -55.7 -37.82 68.88 Favored 'General case' 0 CA--C 1.544 0.739 0 N-CA-C 108.436 -0.95 . . . . 0.18 108.436 178.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 3.8 t -163.78 143.93 8.44 Favored 'General case' 0 C--N 1.295 -1.77 0 C-N-CA 125.037 1.335 . . . . 0.13 110.686 178.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 76.8 p -95.96 -0.57 50.55 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 114.773 -1.103 . . . . 0.11 110.58 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.508 ' HA ' HD23 ' A' ' 135' ' ' LEU . 17.1 mt -56.33 130.39 44.41 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 107.263 -1.384 . . . . 0.1 107.263 177.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 93.3 m -118.77 96.92 50.5 Favored Pre-proline 0 N--CA 1.43 -1.432 0 N-CA-C 118.124 2.638 . . . . 0.07 118.124 -173.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . 0.45 ' HD2' ' O ' ' A' ' 90' ' ' HIS . 8.5 Cg_exo -67.02 142.94 63.78 Favored 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 117.163 -1.425 . . . . 0.09 114.357 -179.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . 0.313 1.6 m -125.83 104.66 13.49 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.663 0 N-CA-C 105.192 -2.151 . . . . 0.06 105.192 173.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.422 ' CG1' ' CD1' ' A' ' 33' ' ' ILE . 16.3 m -123.51 158.84 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 N-CA-C 116.237 1.939 . . . . 0.09 116.237 -176.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 1.8 mp -97.61 125.51 50.74 Favored 'Isoleucine or valine' 0 CA--C 1.491 -1.319 0 N-CA-C 104.566 -2.383 . . . . 0.11 104.566 178.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 17.2 p -98.41 -4.41 34.75 Favored 'General case' 0 C--N 1.296 -1.747 0 CA-C-O 123.158 1.456 . . . . 0.14 112.936 -175.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.464 HD22 ' HA ' ' A' ' 142' ' ' ASN 0.482 0.0 OUTLIER -97.8 15.17 24.53 Favored 'General case' 0 C--N 1.258 -3.386 0 C-N-CA 130.087 3.355 . . . . 0.15 114.505 -179.757 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.432 ' C ' ' O ' ' A' ' 142' ' ' ASN 0.251 62.1 mmm -33.68 -45.09 0.17 Allowed 'General case' 0 C--N 1.282 -2.369 0 N-CA-C 115.555 1.687 . . . . 0.16 115.555 -174.261 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 91.6 m-20 -64.11 -11.64 31.85 Favored 'General case' 0 C--N 1.251 -3.682 0 O-C-N 119.891 -1.755 . . . . 0.26 113.099 179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . . . . . . . . . 22.6 mt-10 -106.02 12.68 30.18 Favored 'General case' 0 CA--C 1.479 -1.758 0 CA-C-N 121.225 1.829 . . . . 0.17 111.57 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 2.5 pt -120.36 140.81 43.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 C-N-CA 115.906 -2.317 . . . . 0.16 113.983 -177.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . 0.75 ' HB2' ' HB3' ' A' ' 168' ' ' LYS 0.255 12.1 tptt -74.45 -54.73 7.0 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 114.49 -1.232 . . . . 0.2 109.794 -179.864 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' ' 166' ' ' ILE . 0.0 OUTLIER -147.31 145.59 29.4 Favored 'General case' 0 C--N 1.289 -2.063 0 O-C-N 119.913 -1.742 . . . . 0.17 114.055 177.017 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -115.68 112.31 21.9 Favored 'General case' 0 N--CA 1.415 -2.177 0 CA-C-N 111.066 -2.788 . . . . 0.13 109.881 177.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 61.8 mt -108.94 112.19 39.39 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.236 0 CA-C-N 114.515 -1.221 . . . . 0.14 107.92 177.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 34.5 mttt -84.93 129.84 34.74 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 124.492 1.117 . . . . 0.11 113.399 -179.187 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . . . . . . . . 0.299 31.3 mt -94.4 175.78 6.55 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-O 122.732 1.253 . . . . 0.11 112.325 -179.298 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . 0.276 0.5 OUTLIER -131.09 160.43 34.72 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-N 113.484 -1.689 . . . . 0.11 114.773 -174.325 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 100.25 -158.82 19.43 Favored Glycine 0 CA--C 1.53 1.022 0 N-CA-C 118.906 2.322 . . . . 0.1 118.906 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -94.8 142.13 27.83 Favored 'General case' 0 C--O 1.213 -0.841 0 CA-C-N 112.064 -2.068 . . . . 0.12 109.892 -178.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.555 HG11 HG12 ' A' ' 163' ' ' VAL . 16.5 m -131.83 159.68 42.93 Favored 'Isoleucine or valine' 0 CA--C 1.46 -2.511 0 CA-C-O 122.783 1.277 . . . . 0.09 110.041 -177.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 20.8 m -122.77 123.7 41.66 Favored 'General case' 0 C--N 1.273 -2.734 0 CA-C-N 112.754 -2.021 . . . . 0.12 108.194 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 12.1 p -37.38 123.68 0.16 Allowed 'Isoleucine or valine' 0 C--O 1.216 -0.662 0 CA-C-O 123.725 1.726 . . . . 0.09 113.991 179.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 61.15 25.82 65.03 Favored Glycine 0 CA--C 1.487 -1.68 0 CA-C-N 112.804 -1.998 . . . . 0.1 114.232 176.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -136.43 -53.24 0.72 Allowed 'General case' 0 C--N 1.288 -2.066 0 C-N-CA 119.593 -0.843 . . . . 0.14 111.958 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.462 ' CG2' HG12 ' A' ' 156' ' ' VAL . 9.1 m -85.35 122.98 73.61 Favored Pre-proline 0 C--N 1.282 -2.352 0 N-CA-C 114.219 1.192 . . . . 0.1 114.219 -175.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -62.44 141.46 86.92 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 122.964 2.443 . . . . 0.11 109.766 177.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.555 HG12 HG11 ' A' ' 156' ' ' VAL . 28.9 m -116.64 -27.92 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.625 -0.672 . . . . 0.07 112.196 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 30.5 mt -141.17 150.94 19.85 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.991 0 N-CA-C 108.502 -0.925 . . . . 0.09 108.502 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 5.9 mtt180 -125.76 130.83 52.25 Favored 'General case' 0 C--N 1.306 -1.288 0 N-CA-C 105.784 -1.932 . . . . 0.13 105.784 176.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.815 ' CG1' ' HB ' ' A' ' 20' ' ' ILE . 39.9 pt -128.36 155.57 40.13 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.605 0 C-N-CA 119.075 -1.05 . . . . 0.13 109.813 -177.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.43 ' O ' ' C ' ' A' ' 168' ' ' LYS . 1.1 tttt -120.72 154.21 35.92 Favored 'General case' 0 C--N 1.296 -1.751 0 N-CA-C 108.987 -0.746 . . . . 0.18 108.987 176.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.75 ' HB3' ' HB2' ' A' ' 147' ' ' LYS . 9.6 tttt . . . . . 0 C--N 1.322 -0.595 0 N-CA-C 108.87 -0.789 . . . . 0.19 108.87 -177.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 301' ' ' MET . . . . . 0.513 ' HB2' ' HG2' ' B' ' 366' ' ' GLU . 4.2 ttm . . . . . 0 C--O 1.219 -0.545 0 N-CA-C 108.473 -0.936 . . . . 0.2 108.473 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 302' ' ' PHE . . . . . 0.534 ' CD2' ' HA ' ' B' ' 371' ' ' GLN . 74.9 t80 -142.93 140.91 31.33 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.219 -1.4 . . . . 0.19 107.219 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -150.85 157.34 42.8 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 120.998 -1.064 . . . . 0.16 109.461 -179.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -153.18 147.62 25.97 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.024 -1.472 . . . . 0.18 107.024 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.97 151.96 19.17 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.296 -1.001 . . . . 0.17 108.296 178.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.62 144.31 17.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 107.345 -1.354 . . . . 0.15 107.345 174.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 87.1 m -93.9 136.69 33.92 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.596 0.712 . . . . 0.19 110.107 178.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 59.0 mt -85.69 114.12 25.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 104.653 -2.351 . . . . 0.19 104.653 177.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 61.1 p -106.44 -3.86 20.49 Favored 'General case' 0 N--CA 1.514 2.729 0 N-CA-C 114.57 1.322 . . . . 0.23 114.57 -178.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 310' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' B' ' 384' ' ' LEU . . . -71.74 139.2 83.12 Favored Pre-proline 0 N--CA 1.487 1.396 0 CA-C-N 120.314 1.415 . . . . 0.21 110.701 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -46.45 -44.87 20.18 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 123.012 2.475 . . . . 0.26 117.095 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 91.0 m-20 -103.72 29.29 5.88 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 115.758 -2.377 . . . . 1.04 107.145 179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 59.49 -148.71 40.94 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 117.615 -2.231 . . . . 0.19 110.981 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.452 ' HG ' ' HB2' ' B' ' 319' ' ' ALA . 17.1 tp -87.07 74.15 9.71 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 118.267 -1.373 . . . . 0.15 108.985 -177.687 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 315' ' ' HIS . . . . . 0.436 ' CD2' ' CG ' ' B' ' 318' ' ' PRO . 2.5 p80 -69.24 -178.04 1.24 Allowed 'General case' 0 N--CA 1.497 1.892 0 C-N-CA 118.656 -1.217 . . . . 0.32 112.678 -178.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 316' ' ' THR . . . . . . . . . . . . . 26.8 m -49.04 -60.19 2.99 Favored 'General case' 0 N--CA 1.499 2.002 0 N-CA-C 118.77 2.878 . . . . 0.28 118.77 -174.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 317' ' ' ARG . . . . . 0.555 HH21 ' CG ' ' A' ' 38' ' ' ASP . 18.8 ttm180 -63.93 -44.53 78.98 Favored Pre-proline 0 C--N 1.281 -2.395 0 CA-C-N 122.671 2.487 . . . . 1.1 112.902 -176.628 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 318' ' ' PRO . . . . . 0.44 ' CD ' ' N ' ' B' ' 317' ' ' ARG . 9.2 Cg_endo -67.95 -28.89 35.14 Favored 'Trans proline' 0 C--N 1.296 -2.194 0 CA-C-N 121.149 1.446 . . . . 0.17 111.937 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . 0.452 ' HB2' ' HG ' ' B' ' 314' ' ' LEU . . . -69.44 -35.43 75.65 Favored 'General case' 0 N--CA 1.509 2.5 0 O-C-N 120.824 -1.172 . . . . 0.13 108.839 179.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -71.52 -39.32 70.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.798 -1.189 . . . . 0.16 108.867 177.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -67.84 -35.93 79.44 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 118.084 -1.447 . . . . 1.7 108.7 179.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -64.25 -44.62 91.23 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 122.408 1.099 . . . . 0.12 108.704 -179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 55.1 t -64.67 -40.45 89.09 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-N 115.227 -0.897 . . . . 0.13 110.526 179.529 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 76.5 tttt -64.47 -41.06 96.72 Favored 'General case' 0 C--N 1.293 -1.879 0 O-C-N 120.752 -1.217 . . . . 1.18 109.735 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -68.27 -40.17 81.96 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.152 -0.685 . . . . 0.16 109.152 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.58 -42.31 92.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.945 -1.097 . . . . 0.14 109.283 178.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 86.0 mttt -62.82 -15.05 52.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.034 -1.041 . . . . 1.6 112.875 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -78.36 -11.26 85.5 Favored Glycine 0 N--CA 1.478 1.498 0 N-CA-C 108.85 -1.7 . . . . 0.19 108.85 -179.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . 0.541 ' HE1' ' HE3' ' B' ' 372' ' ' LYS . 82.3 m-85 -103.88 144.99 30.77 Favored 'General case' 0 N--CA 1.507 2.388 0 CA-C-N 118.713 1.257 . . . . 0.17 110.129 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 74.4 p -76.9 -28.7 55.44 Favored 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 118.611 -0.709 . . . . 0.22 112.503 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 20.3 m -58.92 157.58 9.63 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 123.384 1.564 . . . . 0.18 114.899 179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.6 128.49 33.46 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 102.22 -3.252 . . . . 0.18 102.22 172.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 41.7 mt -125.76 133.93 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 108.203 -1.036 . . . . 0.14 108.203 -175.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 97.6 m -124.58 140.68 52.72 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 122.267 1.032 . . . . 0.14 109.184 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 335' ' ' VAL . . . . . 0.436 HG23 ' HB2' ' B' ' 344' ' ' ALA . 93.1 t -107.33 127.38 63.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 105.34 -2.096 . . . . 0.12 105.34 174.282 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 88.3 m -124.73 121.04 33.52 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.881 0.848 . . . . 0.15 110.396 -179.65 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 337' ' ' SER . . . . . 0.498 ' HB2' HG12 ' B' ' 361' ' ' VAL . 33.5 t -125.65 123.83 39.82 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 118.425 -1.31 . . . . 0.17 108.129 177.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 49.71 40.19 19.43 Favored 'General case' 0 N--CA 1.514 2.765 0 N-CA-C 112.872 0.693 . . . . 0.22 112.872 -178.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 81.05 12.23 82.78 Favored Glycine 0 N--CA 1.485 1.923 0 O-C-N 120.487 -1.383 . . . . 0.2 113.334 176.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -121.8 136.69 54.94 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 103.539 -2.763 . . . . 2.48 103.539 178.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 68.8 m -121.55 156.1 33.6 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-O 124.321 2.01 . . . . 0.17 114.996 -175.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -151.52 148.01 27.52 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 111.848 -2.433 . . . . 0.15 110.82 176.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 7.6 t -65.59 132.93 50.08 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.416 -1.698 . . . . 0.15 106.416 173.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . 0.436 ' HB2' HG23 ' B' ' 335' ' ' VAL . . . -73.47 -6.02 43.71 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 120.285 -1.509 . . . . 0.11 110.842 178.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -98.23 12.74 33.68 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.966 -1.084 . . . . 0.17 109.189 -178.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.23 105.64 6.74 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 123.122 1.439 . . . . 0.18 110.557 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 32.6 tp -57.34 -37.59 72.78 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 113.949 -1.478 . . . . 0.19 109.303 178.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 348' ' ' PHE . . . . . 0.435 ' CB ' ' OE1' ' A' ' 86' ' ' GLU . 72.5 t80 -61.18 -50.4 73.32 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 120.355 -1.465 . . . . 0.38 112.975 -179.575 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 25.1 mmtm -69.57 -31.68 70.0 Favored 'General case' 0 C--N 1.314 -0.963 0 O-C-N 119.609 -1.932 . . . . 1.17 110.56 -179.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 3.1 mt -65.29 -32.03 73.47 Favored 'General case' 0 C--N 1.285 -2.236 0 C-N-CA 119.201 -0.999 . . . . 0.15 109.309 -177.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.53 ' O ' ' CD ' ' A' ' 69' ' ' LYS . 89.6 mt-30 -68.17 -10.72 56.36 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.96 -0.462 . . . . 0.83 109.833 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 2.0 p -91.86 -4.02 55.33 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 118.347 -1.341 . . . . 0.23 110.78 -177.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . 0.484 HD22 ' HB3' ' B' ' 337' ' ' SER . 25.1 mt -94.63 157.05 16.14 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.233 -0.917 . . . . 0.17 110.076 179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -86.3 106.45 3.09 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 104.713 -3.355 . . . . 0.18 104.713 177.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 91.3 mt -122.37 48.39 1.76 Allowed 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 106.153 -1.795 . . . . 0.16 106.153 -178.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 43.0 p -83.12 171.02 14.16 Favored 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 109.335 -0.617 . . . . 0.25 109.335 179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -57.7 138.52 55.36 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.177 -0.952 . . . . 0.25 110.675 179.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 92.19 -3.13 76.05 Favored Glycine 0 N--CA 1.474 1.173 0 C-N-CA 119.39 -1.385 . . . . 0.21 112.61 177.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 55.3 m -84.82 132.98 34.34 Favored 'General case' 0 C--N 1.291 -1.975 0 O-C-N 121.507 -0.996 . . . . 0.18 111.185 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 94.7 t -94.44 122.86 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 107.031 -1.47 . . . . 0.18 107.031 177.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 361' ' ' VAL . . . . . 0.498 HG12 ' HB2' ' B' ' 337' ' ' SER . 17.8 m -112.73 161.33 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 C-N-CA 116.891 -1.923 . . . . 0.13 109.891 178.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 85.4 m -110.06 130.52 55.52 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 106.324 -1.732 . . . . 0.13 106.324 175.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 54.5 mt -110.33 120.43 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 102.869 -3.011 . . . . 0.11 102.869 178.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.42 146.43 49.62 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 107.716 -1.216 . . . . 0.13 107.716 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -141.05 153.66 45.6 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 117.566 -1.653 . . . . 0.16 108.63 178.262 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 366' ' ' GLU . . . . . 0.513 ' HG2' ' HB2' ' B' ' 301' ' ' MET . 0.0 OUTLIER -141.79 111.91 6.87 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.06 -1.459 . . . . 0.22 107.06 178.701 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 165.25 -173.49 41.04 Favored Glycine 0 C--N 1.294 -1.766 0 C-N-CA 117.651 -2.214 . . . . 0.21 108.64 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -54.78 -41.5 70.62 Favored 'General case' 0 C--N 1.285 -2.213 0 C-N-CA 124.134 0.974 . . . . 0.28 113.253 179.621 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 15.2 p30 -116.04 36.71 3.93 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 117.002 -1.879 . . . . 0.21 108.135 -177.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -58.97 -30.35 67.87 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 119.001 2.963 . . . . 0.2 119.001 -175.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 371' ' ' GLN . . . . . 0.534 ' HA ' ' CD2' ' B' ' 302' ' ' PHE . 0.0 OUTLIER -78.2 -43.36 28.72 Favored 'General case' 0 N--CA 1.512 2.66 0 O-C-N 119.647 -1.908 . . . . 0.23 109.768 -177.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 372' ' ' LYS . . . . . 0.569 ' NZ ' ' CE1' ' B' ' 376' ' ' HIS . 13.2 ttpp -63.78 -40.71 97.33 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 106.878 -1.527 . . . . 0.22 106.878 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.21 -46.89 86.86 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 118.441 -1.303 . . . . 0.16 110.599 -178.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 68.7 t -68.78 -39.54 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 N-CA-C 108.521 -0.918 . . . . 0.14 108.521 -178.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -58.21 -46.49 85.75 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.846 0.831 . . . . 0.21 109.508 -179.508 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 376' ' ' HIS . . . . . 0.569 ' CE1' ' NZ ' ' B' ' 372' ' ' LYS . 13.2 m-70 -71.05 -35.81 72.08 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 113.347 0.869 . . . . 0.2 113.347 -179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 95.8 mt -79.87 -25.11 40.79 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.447 -1.301 . . . . 0.13 111.786 -175.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 2.1 t -73.13 -38.88 56.0 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 N-CA-C 106.288 -1.745 . . . . 0.15 106.288 179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -68.83 -48.6 63.13 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 107.563 -1.273 . . . . 0.22 107.563 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . 0.569 ' HG ' ' CD2' ' B' ' 384' ' ' LEU . 28.2 tp -55.53 -47.37 76.4 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 118.773 -1.171 . . . . 0.15 110.754 176.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 2.9 ttm -61.49 -35.02 76.48 Favored 'General case' 0 C--N 1.309 -1.168 0 O-C-N 120.721 -1.237 . . . . 0.15 113.44 -177.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -77.48 -29.46 52.66 Favored 'General case' 0 C--N 1.282 -2.36 0 O-C-N 121.229 -0.919 . . . . 0.19 108.856 -178.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . 0.265 32.3 mt-10 -76.37 -36.76 57.97 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 121.787 0.803 . . . . 0.22 111.757 179.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 384' ' ' LEU . . . . . 0.569 ' CD2' ' HG ' ' B' ' 380' ' ' LEU . 0.0 OUTLIER -55.21 127.42 29.17 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 125.822 2.725 . . . . 0.18 113.15 -176.099 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 385' ' ' GLU . . . . . 0.401 ' CD ' ' H ' ' B' ' 385' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.307 -1.247 2 CA-C-N 108.129 -4.123 . . . . 0.22 111.168 -178.21 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 200' ' ' PO3 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.217 -0.613 0 CA-C-O 122.391 1.091 . . . . 0.16 112.81 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.825 ' HB ' HG13 ' A' ' 166' ' ' ILE . 2.3 mp -106.02 130.73 57.13 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.019 0 CA-C-O 122.663 1.22 . . . . 0.13 110.698 177.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -100.46 124.86 46.53 Favored 'General case' 0 C--N 1.305 -1.331 0 CA-C-N 114.229 -1.35 . . . . 0.13 110.318 176.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 10.4 mm -94.8 123.44 46.92 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.402 0 N-CA-C 105.89 -1.893 . . . . 0.08 105.89 176.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 22.2 mm -92.1 146.79 5.87 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 122.546 1.165 . . . . 0.09 111.834 -178.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.71 121.09 51.22 Favored Pre-proline 0 N--CA 1.428 -1.541 0 N-CA-C 115.379 1.622 . . . . 0.06 115.379 -178.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -76.11 -20.02 15.11 Favored 'Trans proline' 0 CA--C 1.559 1.752 0 C-N-CA 121.494 1.463 . . . . 0.05 111.396 -177.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.465 ' N ' HD12 ' A' ' 26' ' ' LEU 0.325 0.0 OUTLIER -147.43 161.19 41.54 Favored 'General case' 0 C--N 1.315 -0.921 0 C-N-CA 123.815 0.846 . . . . 0.05 110.173 175.29 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' SER . . . . . . . . . . . . . 49.9 m -82.61 148.14 28.17 Favored 'General case' 0 CA--C 1.497 -1.064 0 CA-C-O 121.729 0.776 . . . . 0.09 111.099 177.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 156.81 -155.3 26.24 Favored Glycine 0 N--CA 1.431 -1.688 0 C-N-CA 119.086 -1.531 . . . . 0.08 111.041 178.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -117.15 134.79 54.34 Favored 'General case' 0 C--N 1.294 -1.833 0 CA-C-N 114.038 -1.081 . . . . 0.1 110.063 -177.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 71.1 mt -74.38 141.45 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.609 0 C-N-CA 117.694 -1.602 . . . . 0.08 110.383 -179.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 14.3 t -132.62 155.9 41.8 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.121 0 CA-C-N 114.519 -1.219 . . . . 0.09 108.786 -178.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.501 ' HB3' ' OE2' ' A' ' 34' ' ' GLU . 13.6 m120 -71.41 138.35 49.04 Favored 'General case' 0 CA--C 1.497 -1.087 0 CA-C-O 121.443 0.639 . . . . 0.11 111.099 178.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.487 ' CD1' ' CG1' ' A' ' 139' ' ' VAL . 8.2 tt -67.8 -23.67 29.69 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 C-N-CA 118.65 -1.22 . . . . 0.11 108.724 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.501 ' OE2' ' HB3' ' A' ' 32' ' ' ASN . 0.8 OUTLIER -73.91 -14.09 61.0 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 118.566 -1.254 . . . . 0.13 110.543 -179.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -94.9 12.32 28.64 Favored 'General case' 0 C--N 1.307 -1.26 0 N-CA-C 113.689 0.996 . . . . 0.12 113.689 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.0 t -86.42 130.95 47.5 Favored Pre-proline 0 C--N 1.29 -2.011 0 CA-C-O 120.918 0.39 . . . . 0.13 109.963 179.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -70.46 48.03 0.72 Allowed 'Trans proline' 0 C--N 1.313 -1.302 0 C-N-CA 122.711 2.274 . . . . 0.15 111.781 -173.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.543 ' CG ' HH21 ' B' ' 317' ' ' ARG . 65.3 t0 -150.66 115.83 5.36 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 107.733 -1.21 . . . . 0.22 107.733 179.77 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 21.8 m -60.34 -37.9 75.73 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.248 0 C-N-CA 119.005 -1.078 . . . . 0.2 111.569 -178.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' VAL . . . . . . . . . . . . 0.404 19.3 m -62.41 -34.89 66.87 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.564 0 C-N-CA 116.864 -1.934 . . . . 0.25 112.148 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PHE . . . . . . . . . . . . . 30.0 m-85 -84.18 -44.27 14.13 Favored 'General case' 0 C--N 1.262 -3.23 0 O-C-N 120.132 -1.605 . . . . 0.2 109.841 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.52 -36.24 77.9 Favored 'General case' 0 CA--C 1.487 -1.476 0 N-CA-C 108.937 -0.764 . . . . 0.14 108.937 -177.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -91.05 7.81 38.55 Favored 'General case' 0 C--N 1.297 -1.7 0 C-N-CA 118.173 -1.411 . . . . 1.08 110.585 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.54 ' HB3' ' O ' ' A' ' 47' ' ' GLY . 0.3 OUTLIER 52.42 39.78 28.26 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 113.973 1.101 . . . . 0.15 113.973 176.651 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ILE . . . . . . . . . . . . . 13.3 mm -67.18 -30.35 49.04 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.958 0 CA-C-O 123.747 1.737 . . . . 0.18 110.696 178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . 0.293 2.1 t -89.52 -7.71 10.82 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.898 0 CA-C-N 112.336 -2.211 . . . . 0.49 111.844 -175.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.54 ' O ' ' HB3' ' A' ' 44' ' ' LYS . . . 133.46 -175.57 20.13 Favored Glycine 0 C--O 1.206 -1.627 0 N-CA-C 108.743 -1.743 . . . . 0.13 108.743 176.57 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -119.52 155.45 32.13 Favored 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 117.851 -1.539 . . . . 0.12 112.768 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 172.18 -137.77 4.44 Favored Glycine 0 CA--C 1.537 1.435 0 C-N-CA 117.725 -2.179 . . . . 0.09 111.158 177.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.444 ' C ' HD12 ' A' ' 50' ' ' ILE . 2.8 pp -134.98 175.24 11.51 Favored 'Isoleucine or valine' 0 C--O 1.215 -0.716 0 O-C-N 121.592 -0.946 . . . . 0.07 108.596 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -121.59 158.51 28.41 Favored 'General case' 0 C--N 1.305 -1.359 0 C-N-CA 124.716 1.206 . . . . 0.07 108.424 175.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ILE . . . . . . . . . . . . . 59.3 mt -133.33 128.81 55.87 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.826 0 O-C-N 121.641 -0.662 . . . . 0.06 111.051 178.004 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -86.11 108.81 18.71 Favored Pre-proline 0 C--N 1.308 -1.232 0 N-CA-C 101.478 -3.527 . . . . 0.11 101.478 174.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.428 ' HB3' HD22 ' A' ' 26' ' ' LEU . 2.0 Cg_endo -71.22 150.12 58.8 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 123.725 2.95 . . . . 0.09 113.074 -170.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 74.3 p -138.61 1.6 2.14 Favored 'General case' 0 C--N 1.314 -0.964 0 O-C-N 121.774 -0.579 . . . . 0.11 110.161 177.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -108.83 -144.5 10.84 Favored Glycine 0 CA--C 1.534 1.238 0 O-C-N 121.444 -0.785 . . . . 0.1 114.581 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.0 p30 -142.97 14.48 1.89 Allowed 'General case' 0 CA--C 1.491 -1.291 0 O-C-N 122.363 -0.492 . . . . 0.12 112.079 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -157.28 155.17 30.28 Favored 'General case' 0 N--CA 1.415 -2.214 0 C-N-CA 115.415 -2.514 . . . . 0.1 113.092 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -114.96 121.44 43.18 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-N 114.868 -1.06 . . . . 0.07 109.054 178.744 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 3.0 m -114.15 174.54 2.7 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.78 0 CA-C-O 122.74 1.257 . . . . 0.07 110.964 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ALA . . . . . . . . . . . . . . . -68.15 126.66 92.92 Favored Pre-proline 0 C--N 1.289 -2.057 0 CA-C-N 113.663 -1.608 . . . . 0.07 109.742 179.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -85.85 -1.5 8.82 Favored 'Trans proline' 0 CA--C 1.54 0.776 0 CA-C-N 120.029 1.046 . . . . 0.07 110.429 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.447 HG21 ' HB3' ' A' ' 81' ' ' SER . 17.2 m -158.53 164.96 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.479 1.012 0 CA-C-O 121.579 0.704 . . . . 0.09 111.139 -178.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.862 ' OD1' HG23 ' A' ' 115' ' ' VAL . 48.0 m-20 -81.44 127.19 32.54 Favored 'General case' 0 C--N 1.318 -0.795 0 N-CA-C 103.595 -2.743 . . . . 0.13 103.595 174.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 80' ' ' GLU . . . 174.0 -157.85 26.2 Favored Glycine 0 C--N 1.301 -1.375 0 N-CA-C 110.78 -0.928 . . . . 0.11 110.78 -175.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 89.6 m -123.69 134.93 53.64 Favored 'General case' 0 C--N 1.315 -0.932 0 C-N-CA 119.814 -0.754 . . . . 0.13 111.309 -177.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.7 mm -68.76 140.42 18.95 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.041 0 C-N-CA 117.619 -1.632 . . . . 0.12 107.394 178.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -101.76 -64.21 0.75 Allowed Glycine 0 C--N 1.282 -2.457 0 CA-C-O 121.955 0.753 . . . . 0.14 114.291 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.541 ' CD ' ' O ' ' B' ' 351' ' ' GLN . 0.1 OUTLIER -141.38 136.47 31.46 Favored 'General case' 0 C--N 1.278 -2.506 0 CA-C-O 123.059 1.409 . . . . 2.18 111.925 -177.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 75.8 mt -116.23 125.46 73.29 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.02 0 N-CA-C 105.514 -2.032 . . . . 0.14 105.514 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -62.72 145.46 54.7 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.164 -1.05 . . . . 0.18 108.164 -179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -61.91 -14.9 38.59 Favored 'General case' 0 C--N 1.296 -1.718 0 C-N-CA 123.674 0.79 . . . . 0.71 110.488 -178.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.535 ' OG1' ' ND1' ' A' ' 75' ' ' HIS . 16.7 p -97.67 4.98 49.95 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-O 123.593 1.663 . . . . 0.2 109.068 178.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.682 HD21 ' NH2' ' A' ' 105' ' ' ARG . 23.5 m120 50.53 44.31 27.19 Favored 'General case' 0 C--N 1.26 -3.305 0 CA-C-N 113.23 -1.805 . . . . 0.14 112.59 175.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' HIS . . . . . 0.559 ' NE2' ' CE1' ' A' ' 90' ' ' HIS . 20.1 p-80 -126.41 -1.45 6.9 Favored 'General case' 0 N--CA 1.427 -1.588 0 N-CA-C 113.661 0.986 . . . . 0.21 113.661 -177.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -153.37 152.75 31.44 Favored 'General case' 0 N--CA 1.412 -2.345 0 O-C-N 120.836 -1.165 . . . . 0.1 111.022 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -152.53 166.33 32.36 Favored 'General case' 0 C--N 1.309 -1.17 0 CA-C-O 123.072 1.415 . . . . 0.09 113.245 178.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.501 ' HB2' ' H ' ' A' ' 69' ' ' LYS 0.259 15.8 m -118.29 139.72 50.9 Favored 'General case' 0 N--CA 1.44 -0.973 0 CA-C-N 113.278 -1.783 . . . . 0.12 109.849 -178.894 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.6 tt -143.27 150.03 17.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.585 -1.265 . . . . 0.1 107.585 175.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . 0.489 ' O ' ' HA3' ' A' ' 65' ' ' GLY . 84.6 tt0 -118.42 129.91 55.67 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 105.628 -1.99 . . . . 0.52 105.628 177.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.447 ' HB3' HG21 ' A' ' 63' ' ' VAL . 94.0 p -80.91 167.32 20.0 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 118.457 -1.297 . . . . 0.13 108.28 -176.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.406 ' OD1' ' NH1' ' A' ' 112' ' ' ARG . 83.0 m-20 -68.11 -31.02 70.33 Favored 'General case' 0 C--N 1.277 -2.569 0 C-N-CA 118.538 -1.265 . . . . 0.15 108.264 177.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.22 4.44 2.21 Favored 'General case' 0 C--N 1.314 -0.968 0 C-N-CA 125.212 1.405 . . . . 0.14 111.998 -179.633 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 78.73 14.51 81.98 Favored Glycine 0 C--N 1.28 -2.557 0 N-CA-C 117.351 1.7 . . . . 0.14 117.351 -178.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.671 HG21 ' CD1' ' A' ' 166' ' ' ILE . 48.8 t -92.42 133.01 35.18 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 CA-C-N 121.189 2.494 . . . . 0.12 110.886 177.8 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.435 ' OE1' ' CB ' ' B' ' 348' ' ' PHE . 96.5 mt-10 -96.9 121.92 39.3 Favored 'General case' 0 N--CA 1.475 0.816 0 O-C-N 121.669 -0.645 . . . . 1.73 110.229 176.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -116.32 158.84 22.79 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.986 0.898 . . . . 0.09 110.922 -178.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -147.34 140.69 25.35 Favored 'General case' 0 C--N 1.298 -1.673 0 CA-C-N 115.674 -0.694 . . . . 0.31 109.919 177.549 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' VAL . . . . . . . . . . . . . 45.7 t -131.85 131.98 61.78 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 121.69 -0.631 . . . . 0.07 110.003 179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 1.236 ' NE2' ' P ' ' B' ' 200' ' ' PO3 . 2.9 t-80 -120.29 80.72 1.64 Allowed 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 108.462 -0.94 . . . . 0.16 108.462 179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PHE . . . . . 0.413 ' C ' ' O ' ' A' ' 90' ' ' HIS . 30.3 t80 -42.84 119.9 1.61 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.239 -0.913 . . . . 0.1 110.295 -178.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLY . . . . . . . . . . . . . . . 69.34 -175.54 32.64 Favored Glycine 0 C--N 1.303 -1.27 0 CA-C-O 122.885 1.269 . . . . 0.1 114.623 179.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 18.6 mm -118.4 132.61 67.76 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.242 0 CA-C-O 122.93 1.348 . . . . 0.14 109.132 179.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 54.65 25.89 6.87 Favored 'General case' 0 N--CA 1.428 -1.541 0 CA-C-N 114.12 -1.4 . . . . 0.18 111.213 -177.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 8.1 p -64.47 -20.08 65.96 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 115.162 1.541 . . . . 0.15 115.162 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' VAL . . . . . . . . . . . . . 13.5 p -56.94 -32.82 40.45 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.241 0 O-C-N 119.578 -1.951 . . . . 0.17 109.296 178.05 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -58.61 -19.99 43.5 Favored 'General case' 0 CA--C 1.566 1.581 0 O-C-N 121.524 -0.735 . . . . 0.25 112.092 -179.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.635 ' N ' HD12 ' A' ' 98' ' ' LEU . 7.3 mp -78.02 -3.67 43.27 Favored 'General case' 0 CA--C 1.566 1.565 0 O-C-N 119.733 -1.855 . . . . 0.17 113.877 177.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 30.1 mtmm 49.23 46.23 22.99 Favored 'General case' 0 C--N 1.276 -2.624 0 N-CA-C 116.082 1.882 . . . . 3.19 116.082 -179.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 90.63 -13.17 66.34 Favored Glycine 0 CA--C 1.544 1.871 0 O-C-N 121.26 -0.9 . . . . 0.16 115.338 176.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -62.21 120.92 11.87 Favored 'General case' 0 C--N 1.28 -2.456 0 O-C-N 121.024 -1.28 . . . . 0.18 112.235 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 122' ' ' PHE . . . 98.69 -8.68 61.87 Favored Glycine 0 C--O 1.196 -2.274 0 O-C-N 121.637 -0.664 . . . . 0.14 114.597 178.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -115.02 151.6 33.92 Favored 'General case' 0 C--N 1.278 -2.534 0 C-N-CA 124.136 0.974 . . . . 0.13 111.326 178.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' LYS . . . . . . . . . . . . . 5.2 mptt -141.23 112.95 7.67 Favored 'General case' 0 C--N 1.311 -1.068 0 C-N-CA 124.43 1.092 . . . . 0.13 109.504 177.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ARG . . . . . 0.682 ' NH2' HD21 ' A' ' 74' ' ' ASN . 29.0 ttm180 -67.3 123.26 19.86 Favored 'General case' 0 CA--C 1.453 -2.758 0 C-N-CA 120.337 -0.545 . . . . 0.14 109.966 179.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ILE . . . . . . . . . . . . . 29.8 mm -106.22 -34.5 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.251 0 C-N-CA 115.112 -2.635 . . . . 0.12 108.289 -179.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ALA . . . . . . . . . . . . . . . -95.82 177.66 5.7 Favored 'General case' 0 N--CA 1.436 -1.152 0 C-N-CA 118.721 -1.191 . . . . 0.12 112.391 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -118.26 150.58 39.2 Favored 'General case' 0 C--O 1.215 -0.754 0 N-CA-C 112.963 0.727 . . . . 0.15 112.963 179.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 92.1 mt-10 -60.14 137.26 58.14 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 118.385 -1.326 . . . . 1.68 108.021 176.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 89.54 -5.8 83.58 Favored Glycine 0 N--CA 1.475 1.253 0 N-CA-C 111.455 -0.658 . . . . 0.14 111.455 -179.442 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLN . . . . . . . . . . . . . 59.1 tt0 -65.88 137.17 57.01 Favored 'General case' 0 C--N 1.285 -2.201 0 CA-C-O 122.843 1.306 . . . . 0.13 113.289 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ARG . . . . . 0.406 ' NH1' ' OD1' ' A' ' 82' ' ' ASP . 0.9 OUTLIER -85.23 133.07 34.19 Favored 'General case' 0 N--CA 1.421 -1.912 0 N-CA-C 107.095 -1.446 . . . . 0.15 107.095 176.153 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.3 m -140.66 159.72 24.35 Favored 'Isoleucine or valine' 0 CA--C 1.472 -2.042 0 C-N-CA 117.678 -1.609 . . . . 0.11 113.286 -177.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 20.3 mtmt -110.42 156.11 21.27 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 112.032 -2.349 . . . . 0.14 108.773 175.03 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.862 HG23 ' OD1' ' A' ' 64' ' ' ASP . 28.7 t -45.3 135.43 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.279 -2.457 0 CA-C-O 121.677 0.751 . . . . 0.11 111.837 176.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . 89.52 -13.2 64.59 Favored Glycine 0 CA--C 1.537 1.42 0 C-N-CA 120.786 -0.721 . . . . 0.09 114.285 178.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -63.05 136.24 57.7 Favored 'General case' 0 C--N 1.288 -2.085 0 O-C-N 120.547 -1.561 . . . . 0.11 109.912 179.318 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 55.6 m -76.61 132.22 39.32 Favored 'General case' 0 CA--C 1.498 -1.045 0 CA-C-O 122.915 1.341 . . . . 0.1 111.231 -177.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.435 ' O ' HG13 ' A' ' 120' ' ' ILE . 38.5 t -106.03 -47.83 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.405 -2.684 0 CA-C-N 113.544 -1.662 . . . . 0.09 109.414 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 119' ' ' VAL . 11.5 mt -148.78 143.49 18.67 Favored 'Isoleucine or valine' 0 CA--C 1.477 -1.836 0 N-CA-C 114.135 1.161 . . . . 0.09 114.135 -177.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -112.71 146.64 38.37 Favored 'General case' 0 CA--C 1.487 -1.457 0 C-N-CA 116.788 -1.965 . . . . 0.12 107.591 176.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' PHE . . . . . 0.517 ' HA ' ' O ' ' A' ' 102' ' ' GLY . 42.6 p90 -133.0 162.37 31.87 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-O 122.669 1.223 . . . . 0.11 112.003 -178.671 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 126' ' ' LEU . 7.9 t70 -99.05 99.59 10.63 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 114.605 -1.179 . . . . 0.15 108.888 177.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.553 ' HB3' ' HD3' ' A' ' 125' ' ' PRO . 26.9 tp -61.81 -51.54 75.12 Favored Pre-proline 0 C--N 1.292 -1.911 0 N-CA-C 116.929 2.196 . . . . 0.12 116.929 -177.161 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.553 ' HD3' ' HB3' ' A' ' 124' ' ' LEU . 31.5 Cg_exo -58.97 -45.04 30.62 Favored 'Trans proline' 1 C--N 1.241 -5.116 0 C-N-CA 121.966 1.777 . . . . 0.15 109.411 -177.064 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LEU . . . . . 0.508 ' N ' ' OD1' ' A' ' 123' ' ' ASP . 29.0 tp -57.76 -48.26 80.14 Favored 'General case' 0 C--N 1.308 -1.216 0 O-C-N 121.383 -0.823 . . . . 0.16 110.157 177.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 94.8 mt -69.84 -32.35 70.7 Favored 'General case' 0 C--N 1.282 -2.36 0 O-C-N 121.164 -0.96 . . . . 0.13 111.817 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 83.2 mt-10 -64.61 -37.73 88.56 Favored 'General case' 0 C--N 1.278 -2.517 0 N-CA-C 106.538 -1.653 . . . . 0.15 106.538 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -75.42 -41.7 55.36 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 113.476 0.917 . . . . 0.19 113.476 177.828 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 39.4 mmtt -95.8 -27.81 15.05 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 116.582 2.067 . . . . 0.2 116.582 -176.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ALA . . . . . . . . . . . . . . . -79.54 142.73 35.47 Favored 'General case' 0 C--N 1.258 -3.378 0 N-CA-C 115.437 1.643 . . . . 0.15 115.437 -177.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 46.3 tptt -55.47 -38.25 68.85 Favored 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 108.066 -1.087 . . . . 0.18 108.066 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 23.3 t -163.71 143.21 8.21 Favored 'General case' 0 C--N 1.287 -2.152 0 C-N-CA 125.004 1.321 . . . . 0.13 111.15 178.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' THR . . . . . . . . . . . . . 10.0 p -94.97 -1.26 52.84 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-N 114.794 -1.093 . . . . 0.11 110.255 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 33.4 mt -54.93 131.85 45.45 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 106.78 -1.563 . . . . 0.1 106.78 177.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' THR . . . . . . . . . . . . . 77.2 m -119.79 101.84 47.66 Favored Pre-proline 0 C--N 1.292 -1.893 0 N-CA-C 115.272 1.582 . . . . 0.07 115.272 -174.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -71.16 141.68 40.15 Favored 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 117.425 -1.25 . . . . 0.09 115.078 177.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' VAL . . . . . . . . . . . . 0.309 0.6 OUTLIER -124.79 104.61 13.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 105.207 -2.146 . . . . 0.06 105.207 174.152 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' VAL . . . . . 0.487 ' CG1' ' CD1' ' A' ' 33' ' ' ILE . 19.8 m -124.02 158.17 30.47 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.65 0 N-CA-C 116.458 2.021 . . . . 0.09 116.458 -176.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.584 HD12 ' N ' ' A' ' 140' ' ' ILE . 1.4 mp -96.71 125.55 49.64 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.344 0 N-CA-C 104.618 -2.364 . . . . 0.11 104.618 179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 53.6 p -98.44 -4.47 34.49 Favored 'General case' 0 C--N 1.293 -1.887 0 CA-C-O 123.231 1.491 . . . . 0.14 112.956 -175.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ASN . . . . . 0.693 HD21 ' CD ' ' A' ' 145' ' ' GLU 0.491 0.8 OUTLIER -98.13 16.05 22.43 Favored 'General case' 0 C--N 1.259 -3.357 0 C-N-CA 130.089 3.356 . . . . 0.15 114.344 -179.74 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' MET . . . . . 0.428 ' C ' ' O ' ' A' ' 142' ' ' ASN . 95.3 mmm -34.54 -44.39 0.2 Allowed 'General case' 0 C--N 1.28 -2.452 0 N-CA-C 115.646 1.721 . . . . 0.16 115.646 -174.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -64.51 -11.64 36.09 Favored 'General case' 0 C--N 1.248 -3.811 0 O-C-N 119.762 -1.837 . . . . 0.26 113.099 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLU . . . . . 0.693 ' CD ' HD21 ' A' ' 142' ' ' ASN . 80.4 mt-10 -106.88 14.56 26.46 Favored 'General case' 0 CA--C 1.475 -1.922 0 CA-C-N 121.225 1.829 . . . . 0.17 111.28 179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 10.5 pt -121.99 140.29 46.39 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.981 0 C-N-CA 116.082 -2.247 . . . . 0.16 114.056 -178.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LYS . . . . . . . . . . . . 0.256 49.0 tptt -73.83 -55.12 6.6 Favored 'General case' 0 C--O 1.22 -0.476 0 CA-C-N 114.275 -1.329 . . . . 0.2 109.584 -179.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' GLU . . . . . 0.472 ' O ' ' HA ' ' A' ' 166' ' ' ILE . 2.6 tt0 -147.64 144.61 28.51 Favored 'General case' 0 C--N 1.286 -2.154 0 O-C-N 119.889 -1.757 . . . . 0.17 114.6 177.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 5.8 tt -114.73 111.66 21.62 Favored 'General case' 0 N--CA 1.415 -2.177 0 CA-C-N 111.309 -2.678 . . . . 0.13 110.262 177.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ILE . . . . . . . . . . . . . 70.1 mt -108.1 112.41 40.13 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.271 0 CA-C-N 114.567 -1.197 . . . . 0.14 107.844 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -85.0 130.32 34.64 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 124.301 1.04 . . . . 0.11 113.113 -179.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 152' ' ' LEU 0.302 39.2 mt -94.67 175.94 6.47 Favored 'General case' 0 N--CA 1.415 -2.186 0 CA-C-O 123.007 1.384 . . . . 0.11 112.371 -179.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . 0.293 50.9 m -132.02 159.34 39.07 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 113.416 -1.72 . . . . 0.11 115.145 -174.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . 101.4 -158.74 18.73 Favored Glycine 0 C--O 1.214 -1.096 0 N-CA-C 118.92 2.328 . . . . 0.1 118.92 175.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 64.6 m -94.83 142.51 27.38 Favored 'General case' 0 C--O 1.216 -0.667 0 CA-C-N 112.1 -2.05 . . . . 0.12 109.601 -179.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' VAL . . . . . 0.624 HG11 HG12 ' A' ' 163' ' ' VAL . 6.4 m -131.59 160.31 42.46 Favored 'Isoleucine or valine' 0 CA--C 1.462 -2.429 0 CA-C-O 122.995 1.379 . . . . 0.09 109.996 -177.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 29.3 m -123.63 122.73 38.89 Favored 'General case' 0 C--N 1.269 -2.903 0 CA-C-N 112.854 -1.975 . . . . 0.12 108.773 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' VAL . . . . . . . . . . . . . 9.3 p -37.07 122.48 0.13 Allowed 'Isoleucine or valine' 0 C--O 1.215 -0.736 0 CA-C-O 123.547 1.641 . . . . 0.09 114.697 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 62.17 26.34 67.52 Favored Glycine 0 CA--C 1.489 -1.546 0 CA-C-N 112.871 -1.968 . . . . 0.1 113.934 176.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . . . . . . . . . 41.7 tp10 -137.43 -51.4 0.64 Allowed 'General case' 0 C--N 1.283 -2.317 0 C-N-CA 119.624 -0.83 . . . . 0.14 112.581 178.581 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.599 ' CG2' HG12 ' A' ' 156' ' ' VAL . 11.9 m -86.09 123.59 71.6 Favored Pre-proline 0 C--N 1.28 -2.415 0 N-CA-C 113.971 1.1 . . . . 0.1 113.971 -176.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -63.08 141.22 82.48 Favored 'Trans proline' 0 CA--C 1.543 0.935 0 C-N-CA 122.963 2.442 . . . . 0.11 109.957 177.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' VAL . . . . . 0.624 HG12 HG11 ' A' ' 156' ' ' VAL . 18.4 m -116.25 -28.59 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.854 0 O-C-N 121.306 -0.871 . . . . 0.07 111.881 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ILE . . . . . . . . . . . . . 34.8 mt -141.36 149.73 20.24 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.211 0 CA-C-O 122.064 0.935 . . . . 0.09 109.005 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 91.3 mtt180 -124.73 130.75 53.02 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 105.78 -1.933 . . . . 0.13 105.78 177.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ILE . . . . . 0.825 HG13 ' HB ' ' A' ' 20' ' ' ILE . 5.8 pt -128.71 155.0 40.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 C-N-CA 119.298 -0.961 . . . . 0.13 109.927 -177.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' LYS . . . . . 0.446 ' O ' ' C ' ' A' ' 168' ' ' LYS . 80.0 tttt -120.1 154.25 34.96 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 109.064 -0.717 . . . . 0.18 109.064 176.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' LYS . . . . . 0.446 ' C ' ' O ' ' A' ' 167' ' ' LYS . 17.1 tttt . . . . . 0 C--N 1.319 -0.732 0 CA-C-N 115.75 -0.659 . . . . 0.19 110.044 -177.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 301' ' ' MET . . . . . 0.513 ' HB2' ' HG2' ' B' ' 366' ' ' GLU . 4.2 ttm . . . . . 0 C--O 1.219 -0.545 0 N-CA-C 108.473 -0.936 . . . . 0.2 108.473 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 302' ' ' PHE . . . . . 0.534 ' CD2' ' HA ' ' B' ' 371' ' ' GLN . 74.9 t80 -142.93 140.91 31.33 Favored 'General case' 0 C--N 1.294 -1.836 0 N-CA-C 107.219 -1.4 . . . . 0.19 107.219 178.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 303' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -150.85 157.34 42.8 Favored 'General case' 0 N--CA 1.485 1.284 0 O-C-N 120.998 -1.064 . . . . 0.16 109.461 -179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 304' ' ' GLN . . . . . . . . . . . . . 21.6 mm-40 -153.18 147.62 25.97 Favored 'General case' 0 C--N 1.293 -1.856 0 N-CA-C 107.024 -1.472 . . . . 0.18 107.024 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 305' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -93.97 151.96 19.17 Favored 'General case' 0 C--N 1.309 -1.154 0 N-CA-C 108.296 -1.001 . . . . 0.17 108.296 178.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 306' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.62 144.31 17.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 107.345 -1.354 . . . . 0.15 107.345 174.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 307' ' ' THR . . . . . . . . . . . . . 87.1 m -93.9 136.69 33.92 Favored 'General case' 0 N--CA 1.483 1.196 0 CA-C-O 121.596 0.712 . . . . 0.19 110.107 178.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 308' ' ' ILE . . . . . . . . . . . . . 59.0 mt -85.69 114.12 25.0 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.32 0 N-CA-C 104.653 -2.351 . . . . 0.19 104.653 177.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 309' ' ' THR . . . . . . . . . . . . . 61.1 p -106.44 -3.86 20.49 Favored 'General case' 0 N--CA 1.514 2.729 0 N-CA-C 114.57 1.322 . . . . 0.23 114.57 -178.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 310' ' ' ALA . . . . . 0.426 ' HB2' ' O ' ' B' ' 384' ' ' LEU . . . -71.74 139.2 83.12 Favored Pre-proline 0 N--CA 1.487 1.396 0 CA-C-N 120.314 1.415 . . . . 0.21 110.701 179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 311' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -46.45 -44.87 20.18 Favored 'Trans proline' 0 N--CA 1.496 1.624 0 C-N-CA 123.012 2.475 . . . . 0.26 117.095 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 312' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -103.72 29.29 5.88 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 115.758 -2.377 . . . . 1.04 107.145 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 313' ' ' GLY . . . . . . . . . . . . . . . 60.39 -122.47 29.96 Favored Glycine 0 N--CA 1.489 2.172 0 C-N-CA 117.615 -2.231 . . . . 0.19 108.839 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 314' ' ' LEU . . . . . 0.422 ' O ' ' O ' ' B' ' 315' ' ' HIS . 4.6 tp -117.51 81.63 1.69 Allowed 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 108.322 -0.992 . . . . 0.15 108.322 -179.637 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 315' ' ' HIS . . . . . 1.22 ' ND1' ' P ' ' B' ' 200' ' ' PO3 . 3.5 p80 -66.08 -141.4 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.329 0 O-C-N 120.402 -1.436 . . . . 0.32 108.211 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 316' ' ' THR . . . . . 0.652 ' H ' ' CG ' ' B' ' 315' ' ' HIS . 8.7 m -84.96 -46.37 11.3 Favored 'General case' 0 C--N 1.293 -1.883 0 N-CA-C 115.5 1.667 . . . . 0.28 115.5 -176.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 317' ' ' ARG . . . . . 0.674 ' H ' ' CE1' ' B' ' 315' ' ' HIS . 18.9 ttm180 -71.01 -42.96 12.97 Favored Pre-proline 0 N--CA 1.494 1.774 0 C-N-CA 116.091 -2.244 . . . . 1.1 113.356 -172.404 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 318' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' B' ' 317' ' ' ARG . 11.5 Cg_endo -68.9 -28.86 29.01 Favored 'Trans proline' 0 C--N 1.296 -2.233 0 CA-C-N 121.165 1.452 . . . . 0.17 111.919 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 319' ' ' ALA . . . . . . . . . . . . . . . -69.46 -35.43 75.62 Favored 'General case' 0 N--CA 1.509 2.5 0 O-C-N 120.777 -1.202 . . . . 0.13 108.839 179.531 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 320' ' ' ALA . . . . . . . . . . . . . . . -71.52 -39.32 70.85 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.798 -1.189 . . . . 0.16 108.867 177.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 321' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -67.84 -35.93 79.44 Favored 'General case' 0 N--CA 1.501 2.123 0 C-N-CA 118.084 -1.447 . . . . 1.7 108.7 179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 322' ' ' PHE . . . . . . . . . . . . . 78.9 t80 -64.25 -44.62 91.23 Favored 'General case' 0 N--CA 1.486 1.352 0 CA-C-O 122.408 1.099 . . . . 0.12 108.704 -179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 323' ' ' VAL . . . . . . . . . . . . . 60.6 t -64.71 -40.37 88.85 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 CA-C-N 115.227 -0.897 . . . . 0.13 110.539 179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 324' ' ' LYS . . . . . . . . . . . . . 78.0 tttt -64.52 -41.06 96.63 Favored 'General case' 0 C--N 1.292 -1.898 0 O-C-N 120.804 -1.185 . . . . 1.18 109.735 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 325' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -68.27 -40.17 81.96 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.152 -0.685 . . . . 0.16 109.152 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 326' ' ' ALA . . . . . . . . . . . . . . . -59.58 -42.31 92.24 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.945 -1.097 . . . . 0.14 109.283 178.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 327' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -62.82 -15.05 52.53 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.034 -1.041 . . . . 1.6 112.875 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 328' ' ' GLY . . . . . . . . . . . . . . . -78.36 -11.26 85.5 Favored Glycine 0 N--CA 1.478 1.498 0 N-CA-C 108.85 -1.7 . . . . 0.19 108.85 -179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 329' ' ' PHE . . . . . 0.541 ' HE1' ' HE3' ' B' ' 372' ' ' LYS . 82.3 m-85 -103.88 144.99 30.77 Favored 'General case' 0 N--CA 1.507 2.388 0 CA-C-N 118.713 1.257 . . . . 0.17 110.129 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 330' ' ' THR . . . . . . . . . . . . . 74.4 p -76.9 -28.7 55.44 Favored 'General case' 0 N--CA 1.504 2.254 0 CA-C-O 118.611 -0.709 . . . . 0.22 112.503 -179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 331' ' ' SER . . . . . . . . . . . . . 20.3 m -58.92 157.58 9.63 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 123.384 1.564 . . . . 0.18 114.899 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 332' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.6 128.49 33.46 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 102.22 -3.252 . . . . 0.18 102.22 172.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 333' ' ' ILE . . . . . . . . . . . . . 41.7 mt -125.76 133.93 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.115 0 N-CA-C 108.203 -1.036 . . . . 0.14 108.203 -175.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 334' ' ' THR . . . . . . . . . . . . . 97.6 m -124.58 140.68 52.72 Favored 'General case' 0 C--N 1.306 -1.283 0 CA-C-O 122.267 1.032 . . . . 0.14 109.184 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 335' ' ' VAL . . . . . 0.436 HG23 ' HB2' ' B' ' 344' ' ' ALA . 93.1 t -107.33 127.38 63.19 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 N-CA-C 105.34 -2.096 . . . . 0.12 105.34 174.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 336' ' ' THR . . . . . . . . . . . . . 88.3 m -124.73 121.04 33.52 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.881 0.848 . . . . 0.15 110.396 -179.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 337' ' ' SER . . . . . 0.498 ' HB2' HG12 ' B' ' 361' ' ' VAL . 33.5 t -125.65 123.83 39.82 Favored 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 118.425 -1.31 . . . . 0.17 108.129 177.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 338' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 49.71 40.19 19.43 Favored 'General case' 0 N--CA 1.514 2.765 0 N-CA-C 112.872 0.693 . . . . 0.22 112.872 -178.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 339' ' ' GLY . . . . . . . . . . . . . . . 81.05 12.23 82.78 Favored Glycine 0 N--CA 1.485 1.923 0 O-C-N 120.487 -1.383 . . . . 0.2 113.334 176.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 340' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -121.8 136.69 54.94 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 103.539 -2.763 . . . . 2.48 103.539 178.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 341' ' ' SER . . . . . . . . . . . . . 68.8 m -121.55 156.1 33.6 Favored 'General case' 0 C--N 1.287 -2.145 0 CA-C-O 124.321 2.01 . . . . 0.17 114.996 -175.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 342' ' ' ALA . . . . . . . . . . . . . . . -151.52 148.01 27.52 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-N 111.848 -2.433 . . . . 0.15 110.82 176.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 343' ' ' SER . . . . . . . . . . . . . 7.6 t -65.59 132.93 50.08 Favored 'General case' 0 C--N 1.296 -1.741 0 N-CA-C 106.416 -1.698 . . . . 0.15 106.416 173.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 344' ' ' ALA . . . . . 0.436 ' HB2' HG23 ' B' ' 335' ' ' VAL . . . -73.47 -6.02 43.71 Favored 'General case' 0 C--N 1.295 -1.766 0 O-C-N 120.285 -1.509 . . . . 0.11 110.842 178.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 345' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -98.23 12.74 33.68 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.966 -1.084 . . . . 0.17 109.189 -178.035 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 346' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.23 105.64 6.74 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 123.122 1.439 . . . . 0.18 110.557 -179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 347' ' ' LEU . . . . . . . . . . . . . 28.9 tp -57.34 -37.59 72.78 Favored 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 113.949 -1.478 . . . . 0.19 109.303 178.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 348' ' ' PHE . . . . . 0.435 ' CB ' ' OE1' ' A' ' 86' ' ' GLU . 72.5 t80 -61.18 -50.4 73.32 Favored 'General case' 0 N--CA 1.505 2.291 0 O-C-N 120.355 -1.465 . . . . 0.38 112.975 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 349' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -69.54 -31.75 70.15 Favored 'General case' 0 C--N 1.314 -0.963 0 O-C-N 119.609 -1.932 . . . . 1.17 110.554 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 350' ' ' LEU . . . . . . . . . . . . . 3.1 mt -65.25 -32.03 73.49 Favored 'General case' 0 C--N 1.285 -2.233 0 C-N-CA 119.177 -1.009 . . . . 0.15 109.309 -177.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 351' ' ' GLN . . . . . 0.541 ' O ' ' CD ' ' A' ' 69' ' ' LYS . 89.6 mt-30 -68.21 -10.64 55.93 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.96 -0.462 . . . . 0.83 109.819 -178.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 352' ' ' THR . . . . . . . . . . . . . 2.7 p -91.95 -3.91 55.31 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 118.292 -1.363 . . . . 0.23 110.804 -177.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 353' ' ' LEU . . . . . 0.482 HD22 ' HB3' ' B' ' 337' ' ' SER . 25.5 mt -94.7 157.05 16.13 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.257 -0.902 . . . . 0.17 110.076 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 354' ' ' GLY . . . . . . . . . . . . . . . -86.3 106.45 3.09 Favored Glycine 0 N--CA 1.499 2.846 0 N-CA-C 104.713 -3.355 . . . . 0.18 104.713 177.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 355' ' ' LEU . . . . . . . . . . . . . 91.3 mt -122.37 48.39 1.76 Allowed 'General case' 0 C--N 1.316 -0.86 0 N-CA-C 106.153 -1.795 . . . . 0.16 106.153 -178.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 356' ' ' THR . . . . . . . . . . . . . 24.1 p -83.12 171.02 14.16 Favored 'General case' 0 C--O 1.215 -0.712 0 N-CA-C 109.335 -0.617 . . . . 0.25 109.335 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 357' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -57.7 138.52 55.36 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.177 -0.952 . . . . 0.25 110.675 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 358' ' ' GLY . . . . . . . . . . . . . . . 92.19 -3.13 76.05 Favored Glycine 0 N--CA 1.474 1.173 0 C-N-CA 119.39 -1.385 . . . . 0.21 112.61 177.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 359' ' ' THR . . . . . . . . . . . . . 55.3 m -84.82 132.98 34.34 Favored 'General case' 0 C--N 1.291 -1.975 0 O-C-N 121.507 -0.996 . . . . 0.18 111.185 -179.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 360' ' ' VAL . . . . . . . . . . . . . 94.7 t -94.44 122.86 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 N-CA-C 107.031 -1.47 . . . . 0.18 107.031 177.091 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 361' ' ' VAL . . . . . 0.498 HG12 ' HB2' ' B' ' 337' ' ' SER . 17.8 m -112.73 161.33 11.7 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 C-N-CA 116.891 -1.923 . . . . 0.13 109.891 178.039 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 362' ' ' THR . . . . . . . . . . . . . 85.4 m -110.06 130.52 55.52 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 106.324 -1.732 . . . . 0.13 106.324 175.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 363' ' ' ILE . . . . . . . . . . . . . 54.5 mt -110.33 120.43 61.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 N-CA-C 102.869 -3.011 . . . . 0.11 102.869 178.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 364' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -125.42 146.43 49.62 Favored 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 107.716 -1.216 . . . . 0.13 107.716 -179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 365' ' ' ALA . . . . . . . . . . . . . . . -141.05 153.66 45.6 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 117.566 -1.653 . . . . 0.16 108.63 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 366' ' ' GLU . . . . . 0.513 ' HG2' ' HB2' ' B' ' 301' ' ' MET . 0.0 OUTLIER -141.79 111.91 6.87 Favored 'General case' 0 C--N 1.297 -1.701 0 N-CA-C 107.06 -1.459 . . . . 0.22 107.06 178.701 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 367' ' ' GLY . . . . . . . . . . . . . . . 165.25 -173.49 41.04 Favored Glycine 0 C--N 1.294 -1.766 0 C-N-CA 117.651 -2.214 . . . . 0.21 108.64 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 368' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -54.78 -41.5 70.62 Favored 'General case' 0 C--N 1.285 -2.213 0 C-N-CA 124.134 0.974 . . . . 0.28 113.253 179.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 369' ' ' ASP . . . . . . . . . . . . . 15.2 p30 -116.04 36.71 3.93 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 117.002 -1.879 . . . . 0.21 108.135 -177.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 370' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -58.97 -30.35 67.87 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 119.001 2.963 . . . . 0.2 119.001 -175.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 371' ' ' GLN . . . . . 0.534 ' HA ' ' CD2' ' B' ' 302' ' ' PHE . 0.0 OUTLIER -78.2 -43.36 28.72 Favored 'General case' 0 N--CA 1.512 2.66 0 O-C-N 119.647 -1.908 . . . . 0.23 109.768 -177.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 372' ' ' LYS . . . . . 0.569 ' NZ ' ' CE1' ' B' ' 376' ' ' HIS . 13.2 ttpp -63.78 -40.71 97.33 Favored 'General case' 0 C--N 1.287 -2.133 0 N-CA-C 106.878 -1.527 . . . . 0.22 106.878 179.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 373' ' ' ALA . . . . . . . . . . . . . . . -62.21 -46.89 86.86 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 118.441 -1.303 . . . . 0.16 110.599 -178.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 374' ' ' VAL . . . . . . . . . . . . . 68.7 t -68.78 -39.54 80.25 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.31 0 N-CA-C 108.521 -0.918 . . . . 0.14 108.521 -178.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 375' ' ' GLU . . . . . . . . . . . . . 83.5 mt-10 -58.21 -46.49 85.75 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.846 0.831 . . . . 0.21 109.508 -179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 376' ' ' HIS . . . . . 0.569 ' CE1' ' NZ ' ' B' ' 372' ' ' LYS . 13.2 m-70 -71.05 -35.81 72.08 Favored 'General case' 0 C--N 1.283 -2.309 0 N-CA-C 113.347 0.869 . . . . 0.2 113.347 -179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 377' ' ' LEU . . . . . . . . . . . . . 95.8 mt -79.87 -25.11 40.79 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.447 -1.301 . . . . 0.13 111.786 -175.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 378' ' ' VAL . . . . . . . . . . . . . 2.1 t -73.13 -38.88 56.0 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.11 0 N-CA-C 106.288 -1.745 . . . . 0.15 106.288 179.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 379' ' ' LYS . . . . . . . . . . . . . 3.3 ttpt -68.83 -48.6 63.13 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 107.563 -1.273 . . . . 0.22 107.563 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 380' ' ' LEU . . . . . 0.569 ' HG ' ' CD2' ' B' ' 384' ' ' LEU . 28.2 tp -55.53 -47.37 76.4 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 118.773 -1.171 . . . . 0.15 110.754 176.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 381' ' ' MET . . . . . . . . . . . . . 2.9 ttm -61.49 -35.02 76.48 Favored 'General case' 0 C--N 1.309 -1.168 0 O-C-N 120.721 -1.237 . . . . 0.15 113.44 -177.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 382' ' ' ALA . . . . . . . . . . . . . . . -77.48 -29.46 52.66 Favored 'General case' 0 C--N 1.282 -2.36 0 O-C-N 121.229 -0.919 . . . . 0.19 108.856 -178.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 383' ' ' GLU . . . . . . . . . . . . 0.265 32.3 mt-10 -76.37 -36.76 57.97 Favored 'General case' 0 N--CA 1.487 1.381 0 CA-C-O 121.787 0.803 . . . . 0.22 111.757 179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 384' ' ' LEU . . . . . 0.569 ' CD2' ' HG ' ' B' ' 380' ' ' LEU . 0.0 OUTLIER -55.21 127.42 29.17 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-O 125.822 2.725 . . . . 0.18 113.15 -176.099 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 385' ' ' GLU . . . . . 0.401 ' CD ' ' H ' ' B' ' 385' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.307 -1.247 2 CA-C-N 108.129 -4.123 . . . . 0.22 111.168 -178.21 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 200' ' ' PO3 . . . . . 1.236 ' P ' ' NE2' ' A' ' 90' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_